SEC Info  
    Home      Search      My Interests      Help      Sign In      Please Sign In

John Hancock Life Insurance Co of New York Separate Account B, et al. – ‘N-6/A’ on 7/15/14

On:  Tuesday, 7/15/14, at 6:31pm ET   ·   As of:  7/16/14   ·   Private-to-Public:  Document/Exhibit  –  Release Delayed   ·   Accession #:  1193125-14-269400   ·   File #s:  811-08329, 333-194819

Previous ‘N-6’:  ‘N-6/A’ on 5/19/14   ·   Next:  ‘N-6’ on 10/31/17   ·   Latest:  ‘N-6/A’ on 6/5/20   ·   3 References:   

Find Words in Filings emoji
 
  in    Show  and   Hints

  As Of                Filer                Filing    For·On·As Docs:Size              Issuer               Agent

 7/16/14  John Hancock Life Ins Co of NY… B N-6/A7/15/14   10:10M                                    Donnelley … Solutions/FAJohn Hancock Life Insurance Co. of New York Separate Account B Simplified Life

Pre-Effective Amendment to Registration Statement for a Separate Account (Unit Investment Trust)   —   Form N-6
Filing Table of Contents

Document/Exhibit                   Description                      Pages   Size 

 1: N-6/A       Jhny B - Simplified Life                            HTML   5.07M 
10: CORRESP   ¶ Comment-Response or Other Letter to the SEC         HTML      9K 
 2: EX-99.(26)(D)(1)  Specimen Flexible Premium Variable Universal  HTML    177K 
                Life Insurance Policy                                            
 3: EX-99.(26)(D)(2)  Specimen Return of Premium Rider              HTML     22K 
 4: EX-99.(26)(D)(3)  Specimen Accelerated Benefit Rider            HTML     16K 
 5: EX-99.(26)(E)  Specimen Policy Application                      HTML     41K 
 6: EX-99.(26)(G)  Specimen Reinsurance Agreement                   HTML     81K 
 7: EX-99.(26)(I)  Powers of Attorney                               HTML     37K 
 8: EX-99.(26)(K)  Opinion of Counsel                               HTML     10K 
 9: EX-99.(26)(N)  Consents of Independent Registered Public        HTML      8K 
                Accounting Firm                                                  


‘N-6/A’   —   Jhny B – Simplified Life
Document Table of Contents

Page (sequential)   (alphabetic) Top
 
11st Page  –  Filing Submission
"Table Of Contents
"Summary of Benefits and Risks
"The nature of the policy
"Summary of policy benefits
"Death benefit
"Surrender of the policy
"Withdrawals
"Policy loans
"Optional supplementary benefit riders
"Investment options
"Summary of policy risks
"Lapse risk
"Investment risk
"Transfer risk
"Early surrender
"Market timing and disruptive trading risks
"Tax risks
"Fee Tables
"Detailed Information
"Table of Investment Options and Investment Subadvisers
"Description of John Hancock NY
"Description of Separate Account B
"The death benefit
"Limitations on payment of death benefit
"The minimum death benefit
"Coverage at and after age 121
"Requesting a decrease in coverage
"Change of death benefit option
"Tax consequences of coverage changes
"Your beneficiary
"Ways in which we pay out policy proceeds
"Changing a payment option
"Tax impact of payment option chosen
"Premiums
"Planned premiums
"Minimum initial premium
"Maximum premium payments
"Processing premium payments
"Ways to pay premiums
"Lapse and reinstatement
"Lapse
"No-lapse guarantee
"Cumulative premium test
"Death during grace period
"Reinstatement
"The policy value
"Asset credit
"Allocation of future premium payments
"Transfers of existing policy value
"Surrender and withdrawals
"Surrender
"Repayment of policy loans
"Effects of policy loans
"Description of charges at the policy level
"Deduction from premium payments
"Deductions from policy value
"Additional information about how certain policy charges work
"Sales expenses and related charges
"Method of deduction
"Special purchase programs for eligible classes
"Other charges we could impose in the future
"Description of charges at the portfolio level
"Other policy benefits, rights and limitations
"Optional supplementary benefit riders you can add
"Variations in policy terms
"Procedures for issuance of a policy
"Commencement of insurance coverage
"Backdating
"Temporary coverage prior to policy delivery
"Monthly deduction dates
"Changes that we can make as to your policy
"The owner of the policy
"Policy cancellation right
"Reports that you will receive
"Assigning your policy
"When we pay policy proceeds
"General
"Delay to challenge coverage
"Delay for check clearance
"Delay of separate account proceeds
"How you communicate with us
"General rules
"Telephone, facsimile and internet transactions
"Distribution of policies
"Compensation
"Tax considerations
"Death benefit proceeds and other policy distributions
"Diversification rules and ownership of the Separate Account
"7-Pay Premium Limit and Modified Endowment Contract Status
"Corporate and H.R. 10 retirement plans
"Withholding
"Life insurance purchases by residents of Puerto Rico
"Life insurance purchases by non-resident aliens
"Life insurance owned by citizens or residents living abroad
"Financial statements reference
"Registration statement filed with the SEC
"Independent registered public accounting firm
"Description of the Depositor
"Description of the Registrant
"Services
"Legal and Regulatory Matters
"Principal Underwriter/Distributor
"Additional Information About Charges
"Reduction in Charges
"Report of Independent Auditors
"Balance Sheets
"Statements of Operations
"Statements of Comprehensive Income (Loss)
"Statements of Changes in Shareholder's Equity
"Statements of Cash Flows
"Notes to Financial Statements
"Report of Independent Registered Public Accounting Firm
"Statements of Assets and Contract Owners' Equity
"Statements of Operations and Changes in Contract Owners' Equity
"Organization
"Significant Accounting Policies
"Contract Charges
"Federal Income Taxes
"Purchases and Sales of Investments
"Transaction with Affiliates
"Diversification Requirements
"Subsequent Events
"Financial Highlights

This is an HTML Document rendered as filed.  [ Alternative Formats ]



  JHNY B - Simplified Life  
Table of Contents
As filed with the U.S. Securities and Exchange Commission on July 15, 2014
Registration No. 333-194819

U.S. SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549


FORM N-6

SEC File No 811-8329

REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933

Pre-Effective Amendment No. 1 [X]

REGISTRATION STATEMENT UNDER THE INVESTMENT COMPANY ACT OF 1940
AMENDMENT NO. 58 [X]

John Hancock Life Insurance Company of New York Separate Account B

(Exact Name of Registrant)

John Hancock Life Insurance Company of New York

(Name of Depositor)

197 Clarendon Street
Boston, MA 02116

(Complete address of depositor’s principal executive offices)

Depositor’s Telephone Number: 617-572-6000


JAMES C. HOODLET
John Hancock Life Insurance Company of New York
U.S. INSURANCE LAW
JOHN HANCOCK PLACE
BOSTON, MA 02117

(Name and complete address of agent for service)


It is proposed that this filing will become effective as soon as practicable after the effective date of the Registration Statement.

Pursuant to the provisions of Rule 24f-2, Registrant has registered an indefinite amount of the securities under the Securities Act of 1933.



Table of Contents

Prospectus dated July 25, 2014

for interests in

John Hancock Life Insurance Company of New York Separate Account B

Interests are made available under

SIMPLIFIED LIFE

a flexible premium variable universal life insurance policy

JOHN HANCOCK LIFE INSURANCE COMPANY OF NEW YORK
(“John Hancock NY”)

The policy provides the following investment accounts:

500 Index B
Active Bond
All Cap Core
Alpha Opportunities
American Asset Allocation
American Global Growth
American Growth
American Growth-Income
American International
American New World
Blue Chip Growth
Bond
Capital Appreciation
Capital Appreciation Value
Core Bond
Core Strategy
Emerging Markets Value
Equity-Income
Financial Services
Franklin Templeton Founding Allocation
Fundamental All Cap Core
Fundamental Large Cap Value
Fundamental Value
Global
Global Bond
Health Sciences
High Yield
International Core
International Equity Index B
International Growth Stock
International Small Company
International Value
Investment Quality Bond
Lifestyle Aggressive MVP
Lifestyle Balanced MVP
Lifestyle Conservative MVP
Lifestyle Growth MVP
Lifestyle Moderate MVP
Mid Cap Index
Mid Cap Stock
Mid Value
Money Market B
Natural Resources
PIMCO VIT All Asset
Real Estate Securities
Real Return Bond
Science & Technology
Short Term Government Income
Small Cap Growth
Small Cap Index
Small Cap Opportunities
Small Cap Value
Small Company Value
Strategic Income Opportunities
Total Bond Market B
Total Return
Total Stock Market Index
Ultra Short Term Bond
U.S. Equity
Utilities
Value

* * * * * * * * * * * *

Please note that the Securities and Exchange Commission (“SEC”) has not approved or disapproved these securities, or determined if this prospectus is truthful or complete. Any representation to the contrary is a criminal offense.


GUIDE TO THIS PROSPECTUS

This prospectus is arranged in the following way:

Prior to making any investment decisions, you should carefully review this product prospectus and all applicable supplements. In addition, you will receive the prospectuses for the underlying funds that we make available as investment options under the policies. The funds’ prospectuses describe the investment objectives, policies and restrictions of, and the risks relating to, investment in the funds. In the case of any of the portfolios that are operated as feeder funds, the prospectus for the corresponding master fund is also provided. If you need to obtain additional copies of any of these documents, please contact your John Hancock NY representative or contact our Service Office at the address and telephone number on the back page of this product prospectus.

2

TABLE OF CONTENTS
Page No.
   
SUMMARY OF BENEFITS AND RISKS
4
The nature of the policy
4
Summary of policy benefits
4
Death benefit
4
Surrender of the policy
4
Withdrawals
4
Policy loans
5
Optional supplementary benefit riders
5
Investment options
5
Summary of policy risks
5
Lapse risk
5
Investment risk
5
Transfer risk
5
Early surrender
6
Market timing and disruptive trading risks
6
Tax risks
6
FEE TABLES
8
DETAILED INFORMATION
14
Table of Investment Options and Investment Subadvisers
14
Description of John Hancock NY
19
Description of Separate Account B
19
The death benefit
19
Limitations on payment of death benefit
19
The minimum death benefit
20
Coverage at and after age 121
20
Requesting a decrease in coverage
20
Change of death benefit option
21
Tax consequences of coverage changes
21
Your beneficiary
21
Ways in which we pay out policy proceeds
21
Changing a payment option
21
Tax impact of payment option chosen
22
Premiums
22
Planned premiums
22
Minimum initial premium
22
Maximum premium payments
22
Processing premium payments
22
Ways to pay premiums
23
Lapse and reinstatement
23
Lapse
23
No-lapse guarantee
23
Cumulative premium test
24
Death during grace period
24
Reinstatement
24
The policy value
24
Asset credit
25
Allocation of future premium payments
25
Transfers of existing policy value
25
Surrender and withdrawals
26
Surrender
26
Withdrawals
26
Policy loans
27
Repayment of policy loans
27
Effects of policy loans
27
Description of charges at the policy level
28
Deduction from premium payments
28
Deductions from policy value
28
Additional information about how certain policy charges work
29
Sales expenses and related charges
29
Method of deduction
30
Special purchase programs for eligible classes
30
Other charges we could impose in the future
30
Description of charges at the portfolio level
30
Other policy benefits, rights and limitations
30
Optional supplementary benefit riders you can add
30
Variations in policy terms
31
Procedures for issuance of a policy
32
Commencement of insurance coverage
32
Backdating
32
Temporary coverage prior to policy delivery
32
Monthly deduction dates
32
Changes that we can make as to your policy
32
The owner of the policy
33
Policy cancellation right
33
Reports that you will receive
33
Assigning your policy
33
When we pay policy proceeds
34
General
34
Delay to challenge coverage
34
Delay for check clearance
34
Delay of separate account proceeds
34
How you communicate with us
34
General rules
34
Telephone, facsimile and internet transactions
35
Distribution of policies
35
Compensation
36
Tax considerations
36
General
37
Death benefit proceeds and other policy distributions
37
Policy loans
38
Diversification rules and ownership of the Separate Account
38
7-pay premium limit and modified endowment contract status
39
Corporate and H.R. 10 retirement plans
40
Withholding
40
Life insurance purchases by residents of Puerto Rico
40
Life insurance purchases by non-resident aliens
40
Life insurance owned by citizens or residents living abroad
40
Financial statements reference
40
Registration statement filed with the SEC
40
Independent registered public accounting firm
41

Table Of Contents

SUMMARY OF BENEFITS AND RISKS

The nature of the policy

The policy’s primary purpose is to provide lifetime protection against economic loss due to the death of the insured person. The policy is unsuitable as a short-term savings vehicle because of the substantial policy-level charges. We are obligated to pay all amounts promised under the policy. The value of the amount you have invested under the policy may increase or decrease daily based upon the investment results of the investment accounts that you choose. This policy does not offer a fixed account option upon which you can invest. The amount we pay to the policy’s beneficiary on the death of the insured person (we call this the “death benefit”) may be similarly affected. That’s why the policy is referred to as a “variable” life insurance policy. We call the investments you make in the policy “premiums” or “premium payments.” The amount we require as your first premium depends upon the specifics of your policy and the insured person. Except as noted in the “Detailed Information” section of this prospectus, you can make any other premium payments you wish at any time. That’s why the policy is called a “flexible premium” policy.

You should discuss your insurance needs and financial objectives with your registered representative before purchasing any life insurance product.

Summary of policy benefits

Death benefit

When the insured person dies, we will pay the death benefit minus any policy debt and unpaid fees and charges. There are two ways of calculating the death benefit (Option 1 and Option 2), as described below.

Your policy will be issued with death benefit Option 2. After the first policy year, you may request to change the death benefit from Option 2 to Option 1.

Surrender of the policy

You may surrender the policy in full at any time. If you do, we will pay you the policy value less any outstanding policy debt and less any surrender charge that then applies. This is called your “net cash surrender value.” You must return your policy when you request a surrender.

If you have not taken a loan on your policy, the “policy value” of your policy will, on any given date, be equal to:

If you take a loan on your policy, your policy value will be computed somewhat differently (see “Effects of policy loans”).

Withdrawals

After the first policy year, you may make a withdrawal of part of your net cash surrender value. Generally, each withdrawal must be at least $500. Your policy value is automatically reduced by the amount of the withdrawal and any surrender charge that then applies. A withdrawal may also reduce the Face Amount (see “Surrender and withdrawals — Withdrawals”). We also reserve the right to refuse any withdrawal that would cause the policy’s Face Amount to fall below $50,000.

4

Table Of Contents

Policy loans

If your policy is in force and has sufficient policy value, you may borrow from it at any time by completing the appropriate form. Generally, the minimum amount of each loan is $500. The maximum amount you can borrow is determined by a formula as described in your policy. Interest is charged on each loan. You can pay the interest or allow it to become part of the outstanding loan balance. You can repay all or part of a loan at any time. If there is an outstanding loan when the insured person dies, it will be deducted from the death benefit. Policy loans permanently affect the calculation of your policy value, and may also result in adverse tax consequences.

Optional supplementary benefit riders

When you apply for the policy, you can request any of the optional supplementary benefit riders that we make available. Charges for most riders will be deducted monthly from the policy value. Some riders may not be available in combination with other riders or benefits (see “Other policy benefits, rights and limitations — Optional supplementary benefit riders you can add”).

Investment options

The policy offers a number of variable investment options, as listed on page 1 of this prospectus. These variable investment options are subaccounts of John Hancock Life Insurance Company of New York Separate Account B (“Separate Account”), a separate account operated by us under New York law. The variable investment options have returns that vary depending upon the investment results of underlying portfolios. These options are referred to in this prospectus as “investment accounts.” The investment accounts cover a broad spectrum of investment styles and strategies. Although the portfolios of the series funds that underlie those investment accounts operate like publicly traded mutual funds, there are important differences between the investment accounts and publicly traded mutual funds. You can transfer money from one investment account to another without tax liability. Moreover, any dividends and capital gains distributed by each underlying portfolio are automatically reinvested and reflected in the portfolio’s value and create no taxable event for you. If and when policy earnings are distributed (generally as a result of a surrender or withdrawal), they will be treated as ordinary income instead of as capital gains. Also, you must keep in mind that you are purchasing an insurance policy and you will be assessed charges at the policy level as well as at the fund level. Such policy level charges, in aggregate, are significant and will reduce the investment performance of your policy.

Summary of policy risks

Lapse risk

If the net cash surrender value is insufficient to pay the charges when due and the No-Lapse Guarantee is not in effect, your policy can terminate (i.e. “lapse”). This can happen because you haven’t paid enough premium or because the investment performance of the investment accounts you’ve chosen has been poor or because of a combination of both factors. You will be given a “grace period” within which to make additional premium payments to keep the policy in effect. If lapse occurs, you may be given the opportunity to reinstate the policy by making the required premium payments and satisfying certain other conditions (see “Lapse and reinstatement”).

Since withdrawals reduce your policy value, withdrawals increase the risk of lapse. Policy loans also increase the risk of lapse.

Investment risk

As mentioned above, the investment performance of any investment account may be good or bad. Your policy value will rise or fall based on the investment performance of the investment accounts you’ve chosen. Some investment accounts are riskier than others. These risks (and potential rewards) are discussed in detail in the prospectuses of the underlying portfolios.

Transfer risk

There is a risk that you will not be able to transfer your policy value from one investment account to another because of limitations on the dollar amount or frequency of transfers you can make.

5

Table Of Contents

Early surrender risk

There are surrender charges assessed if you surrender your policy in the first ten policy years. Surrender charges may also apply to a Face Amount decrease (see “The death benefit — Requesting a decrease in coverage”). Depending on the policy value at the time you are considering surrender, there may be little or no surrender value payable to you.

Market timing and disruptive trading risks

The policy is not designed for professional market timers or highly active traders, including persons or entities that engage in programmed, large or frequent transfers among the investment accounts or between the investment accounts and any available fixed account. The policy is also not designed to accommodate trading that results in transfers that are large in relation to the total assets of the underlying portfolio.

Variable investment accounts in variable life insurance products can be a prime target for abusive transfer activity because these products value their investment accounts on a daily basis and allow transfers among investment accounts without immediate tax consequences. As a result, some investors may seek to frequently transfer into and out of investment accounts or to make large transfers in reaction to market news or to exploit a perceived pricing inefficiency. Whatever the reason, long-term investors in an investment account can be harmed by large or frequent transfer activity. For example, such activity may expose the investment account’s underlying portfolio to increased portfolio transaction costs and/or disrupt the portfolio manager’s ability to effectively manage the portfolio’s investments in accordance with the portfolio’s investment objectives and policies. This could include causing the portfolio to maintain higher levels of cash than would otherwise be the case, or liquidating investments prematurely. Accordingly, frequent or large transfers may result in dilution with respect to interests held for long-term investment and adversely affect policy owners, beneficiaries and the underlying portfolios.

To discourage market timing and disruptive trading activity, we impose restrictions on transfers (see “Transfers of existing policy value”) and reserve the right to change, suspend or terminate telephone, facsimile and internet transaction privileges (see “How you communicate with us”). In addition, we reserve the right to take other actions at any time to restrict trading, including, but not limited to:

(i) restricting the number of transfers made during a defined period,

(ii) restricting the dollar amount of transfers,

(iii) restricting transfers into and out of certain investment accounts,

(iv) restricting the method used to submit transfers, and

(v) deferring a transfer at any time we are unable to purchase or redeem shares of the underlying portfolio.

We may also impose additional administrative conditions upon, or prohibit a transfer request made by a third party giving instructions on behalf of multiple policies, whether owned by the same owner or different owners. If you engage a third party for asset allocation services, then you may be subject to these transfer restrictions because of the actions of that party in providing those services. We will notify the third party you have engaged if we exercise this right.

While we seek to identify and prevent disruptive trading activity, it may not always be possible to do so. Therefore, no assurance can be given that the restrictions we impose will be successful in preventing all disruptive trading and avoiding harm to long-term investors.

Tax risks

Life insurance death benefits are ordinarily not subject to income tax. Other Federal and state taxes may apply as further discussed below. In general, you will be taxed on the amount of lifetime distributions that exceed the premiums paid under the policy. Any taxable distribution will be treated as ordinary income (rather than as capital gains) for tax purposes.

In order for you to receive the tax benefits extended to life insurance under the Internal Revenue Code, your policy must comply with certain requirements of the Code. We will monitor your policy for compliance with these requirements, but a policy might fail to qualify as life insurance in spite of our monitoring. If this were to occur, you would be subject to income tax on the income credited to your policy for the period of disqualification and all subsequent periods. The tax laws also contain a so-called “7 pay limit” that limits the amount of premium that can be paid in relation to the policy’s death benefit. If the limit is violated, the policy will be treated as a “modified endowment contract,” which can have adverse tax consequences. There are also certain Treasury Department rules referred to as the “investor control rules” that determine whether you would be treated as the “owner” of the assets underlying your policy. If that were determined to be the case, you would be taxed on

6

Table Of Contents
any income or gains those assets generate. In other words, you would lose the value of the so-called “inside build-up” that is a major benefit of life insurance.

There is a tax risk associated with policy loans. Although no part of a loan is treated as income to you when the loan is made unless your policy is a “modified endowment contract,” surrender or lapse of the policy would result in the loan being treated as a distribution at the time of lapse or surrender. This could result in a considerable tax bill. Under certain circumstances involving large amounts of outstanding loans and an insured person of advanced age, you might find yourself having to choose between high premium requirements to keep your policy from lapsing and a significant tax burden if you allow the lapse to occur.

Tax consequences of ownership or receipt of policy proceeds under Federal, state and local estate, inheritance, gift and other tax laws can vary greatly depending upon the circumstances of each owner or beneficiary. There can also be unfavorable tax consequences on such things as the change of policy ownership or assignment of ownership interests. For these and all the other reasons mentioned above, we recommend you consult with a qualified tax adviser before buying the policy and before exercising certain rights under the policy.

7

Table Of Contents

FEE TABLES

This section contains tables that describe all of the fees and expenses that you will pay when buying, owning and surrendering the policy. In the first three tables, certain entries show the minimum charge, the maximum charge and the charge for a representative insured person. Other entries show only the maximum charge we can assess and are labeled as such. Except where necessary to show a rate greater than zero, all rates shown in the tables have been rounded to two decimal places as required by prospectus disclosure rules. Consequently, the actual rates charged may be slightly higher or lower than those shown in the tables.

The first table below describes the fees and expenses that you will pay at the time that you pay a premium, surrender the policy, lapse the policy or transfer policy value between investment accounts. A portion of the premium charge is used to cover premium taxes. Currently, the premium tax in New York is 0.7% of each premium payment.

Transaction Fees
Charge When Charge is Deducted Amount Deducted
Maximum premium charge(1) Upon payment of premium 8% of each premium paid
Surrender charge(2) Upon surrender, policy lapse or reduction in Face Amount
Minimum charge $12.30 per $1,000 of Face Amount
Maximum charge $45.59 per $1,000 of Face Amount
Charge for representative insured person $26.91 per $1,000 of Face Amount
Maximum transfer fee(3) Upon each transfer into or out of an investment account beyond an annual limit of not less than twelve $25 (currently $0)

(1) The maximum premium charge on premiums paid is 6% in year 2-10 and 2% in years 11 and thereafter.
(2) A surrender charge is applicable for ten policy years from the Policy Date, and varies based upon the sex, issue age and duration, risk classification of the insured person, the death benefit option elected, any riders elected under the policy, and premiums paid under the policy. The minimum charge shown in the table is for a 30 year old female smoker underwriting risk with death benefit Option 2 for which the guideline single premium has been paid in the first policy year. The maximum charge shown in the table is the amount shown in month one in the first policy year for a 59 year old male non-smoker underwriting risk with death benefit Option 2 for which the Minimum Initial Premium under the policy has been paid. The charge for the representative insured shown in the table is the amount for a 45 year old male nonsmoker underwriting risk with death benefit Option 2 for which the Target Premium in policy year 1 has been paid. (For more information about the surrender charge, see “Deductions from policy value - - Surrender charge.”) The charges shown in this table may not be particularly relevant to your current situation. For more information, contact your John Hancock NY representative.
(3) This charge is not currently imposed, but we reserve the right to do so in the policy.

8

Table Of Contents

The next two tables describe the charges and expenses that you will pay periodically during the time you own the policy . These tables do not include fees and expenses paid at the portfolio level. The second table is devoted only to optional supplementary rider benefits. For more information about the cost of insurance rates and other charges talk to your John Hancock NY representative.

Periodic Charges Other Than Fund Operating Expenses
Charge When Charge is Deducted Amount Deducted
Cost of insurance charge(1) Monthly
Minimum charge $0.05 per $1,000 of NAR
Maximum charge $83.33 per $1,000 of NAR
Charge for representative insured person $0.22 per $1,000 of NAR
Face Amount charge(2) Monthly for ten policy years from the Policy Date
Minimum charge $0.14 per $1,000 of Face Amount
Maximum charge $2.00 per $1,000 of Face Amount
Charge for representative insured person $0.30 per $1,000 of Face Amount
Administrative charge Monthly $20
Asset-based risk charge(3) Monthly 0.025% of policy value
Maximum policy loan interest rate(4) Accrues daily
Payable annually
3.50%

(1) The cost of insurance charge is determined by multiplying the net amount of insurance for which we are at risk (the net amount at risk or “NAR”) by the applicable cost of insurance rate. The rates vary widely depending upon the length of time the policy has been in effect, the insurance risk characteristics of the insured person and (generally) the gender of the insured person. The minimum guaranteed rate shown in the table is the rate in the first policy year for a policy issued to cover a 30 year old female non-smoker underwriting risk. The maximum guaranteed rate shown in the table is the rate in the fifty-third policy year for a policy issued to cover a 60 year old male non-smoker underwriting risk. The representative insured person referred to in the table is a 45 year old male non-smoker underwriting risk with a policy in the first policy year. The charges shown in this table may not be particularly relevant to your current situation. For more information, contact your John Hancock NY representative.
(2) This charge is determined by multiplying the Face Amount at issue by the applicable rate. The rates vary by the sex, age, death benefit option, and risk classification at issue of the insured person. The charge also varies by policy year. The minimum guaranteed rate shown in the table is for a 35 year old female non-smoker underwriting risk electing death benefit Option 2. The maximum guaranteed rate shown in the table is for a 60 year old male smoker electing death benefit Option 2, and the representative insured person referred to in the table is a 45 year old male non-smoker electing death benefit Option 2. The charges shown in this table may not be particularly relevant to your current situation. For more information, contact your John Hancock NY representative.
(3) This charge only applies to that portion of the policy value held in the investment accounts. This charge is not currently imposed, but we reserve the right to do so in the policy.
(4) 3.50% is the maximum effective annual interest rate we can charge and applies only during policy years 1-10. The effective annual interest rate is 2.00% thereafter (although we reserve the right to increase the rate after the tenth policy year to as much as 2.25%). The amount of any loan is transferred from the investment accounts to a special loan account which earns interest at an effective annual rate of 2.00%. Therefore, the cost of a loan is the difference between the loan interest we charge and the interest we credit to the special loan account.

9

Table Of Contents

Rider Charges
Charge When Charge is Deducted Amount Deducted
Overloan Protection Rider(1) At exercise of benefit
Minimum charge 0.04%
Maximum charge 2.50%
Accelerated Benefit Rider(2) At exercise of benefit $150.00

(1)The charge for this rider is determined as a percentage of unloaned investment account value. The rates vary by the attained age of the insured person at the time of exercise. The rates also differ according to the tax qualification test elected at issue. The guaranteed minimum rate for the guideline premium test is 0.04% and the guaranteed maximum rate is 2.50%. The minimum rate shown in the table is for an insured person who has reached attained age 100 and the guideline premium test has been elected. The maximum rate shown is for an insured person who has reached attained age 75 and the guideline premium test has been elected.

(2)This charge is not currently imposed, but we reserve the right to do so in the policy.

The next table describes the minimum and maximum portfolio level fees and expenses charged by any of the portfolios underlying a variable investment option offered through this prospectus, expressed as a percentage of average net assets (rounded to two decimal places). These expenses are deducted from portfolio assets. For more information, please refer to the prospectus for the portfolio.

Total Annual Portfolio Operating Expenses Minimum Maximum
Range of expenses, including management fees, distribution and/or service (12b-1) fees, and other expenses1 0.48% 1.64%

1 Certain of the portfolios’ advisers or subadvisers have contractually agreed to reimburse or waive certain portfolio level expenses. The minimum and maximum expenses shown do not reflect these contractual expense reimbursements or waivers. If such reimbursements or waivers were reflected, the minimum and maximum expenses would be 0.25% and 1.52%, respectively.

The next table describes the fees and expenses for each portfolio underlying a variable investment option offered through this prospectus. None of the portfolios charge a sales load or surrender fee. The fees and expenses do not reflect the fees and expenses of any variable insurance contract or qualified plan that may use the portfolio as its underlying investment medium. Except for the American Asset Allocation, American Global Growth, American Growth, American Growth-Income, American International, American New World and PIMCO VIT All Asset portfolios, all of the portfolios shown in the table are NAV class shares that are not subject to Rule 12b-1 fees. Except as indicated in the footnotes appearing at the end of the table, the expense ratios are based upon the portfolio’s actual expenses for the year ended December 31, 2013.

Portfolio Annual Expenses
(as a percentage of portfolio average net assets, rounded to two decimal places)

Portfolio Management
Fees
12b-1
Fees
Other
Expenses
Acquired
Fund Fees
and Expenses
Total Fund
Operating
Expenses
500 Index B1 0.46% 0.00% 0.02% 0.00% 0.48%
Active Bond2 0.60% 0.00% 0.04% 0.01% 0.65%
All Cap Core2 0.78% 0.00% 0.04% 0.01% 0.83%
Alpha Opportunities 0.97% 0.00% 0.05% 0.00% 1.02%
American Asset Allocation3 0.28% 0.60% 0.05% 0.00% 0.93%
American Global Growth3 0.52% 0.60% 0.07% 0.00% 1.19%
American Growth3 0.33% 0.60% 0.04% 0.00% 0.97%
American Growth-Income3 0.27% 0.60% 0.04% 0.00% 0.91%
American International3 0.49% 0.60% 0.08% 0.00% 1.17%
American New World3 0.73% 0.60% 0.12% 0.00% 1.45%
Blue Chip Growth 0.78% 0.00% 0.04% 0.00% 0.82%
Bond 0.57% 0.00% 0.03% 0.00% 0.60%
Capital Appreciation 0.70% 0.00% 0.04% 0.00% 0.74%
Capital Appreciation Value2 0.81% 0.00% 0.05% 0.02% 0.88%
Core Bond2 0.59% 0.00% 0.03% 0.01% 0.63%
10

Table Of Contents
Portfolio Management
Fees
12b-1
Fees
Other
Expenses
Acquired
Fund Fees
and Expenses
Total Fund
Operating
Expenses
Core Strategy2 0.04% 0.00% 0.03% 0.54% 0.61%
Emerging Markets Value 0.95% 0.00% 0.13% 0.00% 1.08%
Equity-Income2 0.78% 0.00% 0.04% 0.01% 0.83%
Financial Services 0.78% 0.00% 0.08% 0.00% 0.86%
Franklin Templeton Founding Allocation2 0.04% 0.00% 0.03% 0.90% 0.97%
Fundamental All Cap Core 0.67% 0.00% 0.04% 0.00% 0.71%
Fundamental Large Cap Value 0.65% 0.00% 0.04% 0.00% 0.69%
Fundamental Value 0.76% 0.00% 0.04% 0.00% 0.80%
Global4 0.81% 0.00% 0.10% 0.00% 0.91%
Global Bond 0.70% 0.00% 0.10% 0.00% 0.80%
Health Sciences 0.97% 0.00% 0.07% 0.00% 1.04%
High Yield 0.67% 0.00% 0.07% 0.00% 0.74%
International Core 0.89% 0.00% 0.13% 0.00% 1.02%
International Equity Index B1 0.53% 0.00% 0.03% 0.00% 0.56%
International Growth Stock2 0.79% 0.00% 0.13% 0.01% 0.93%
International Small Company 0.95% 0.00% 0.17% 0.00% 1.12%
International Value 0.80% 0.00% 0.12% 0.00% 0.92%
Investment Quality Bond 0.58% 0.00% 0.06% 0.00% 0.64%

Lifestyle Aggressive MVP2,5 0.04% 0.00% 0.04% 0.88% 0.96%
Lifestyle Balanced MVP2,5 0.04% 0.00% 0.02% 0.68% 0.74%
Lifestyle Conservative MVP2,5 0.04% 0.00% 0.02% 0.65% 0.71%
Lifestyle Growth MVP2,5 0.04% 0.00% 0.02% 0.70% 0.76%
Lifestyle Moderate MVP2,5 0.04% 0.00% 0.02% 0.67% 0.73%
Mid Cap Index2,6 0.48% 0.00% 0.02% 0.01% 0.51%
Mid Cap Stock 0.83% 0.00% 0.04% 0.00% 0.87%
Mid Value2 0.95% 0.00% 0.04% 0.01% 1.00%
Money Market B1 0.50% 0.00% 0.04% 0.00% 0.54%
Natural Resources 1.00% 0.00% 0.11% 0.00% 1.11%
PIMCO VIT All Asset7 0.43% 0.45% 0.76% 0.00% 1.64%
Real Estate Securities 0.70% 0.00% 0.05% 0.00% 0.75%
Real Return Bond8 0.70% 0.00% 0.24% 0.00% 0.94%
Science & Technology2 1.03% 0.00% 0.05% 0.01% 1.09%
Short Term Government Income 0.56% 0.00% 0.04% 0.00% 0.60%
Small Cap Growth 1.06% 0.00% 0.04% 0.00% 1.10%
Small Cap Index2,9 0.49% 0.00% 0.03% 0.09% 0.61%
Small Cap Opportunities2,4 1.00% 0.00% 0.06% 0.03% 1.09%
Small Cap Value2 1.04% 0.00% 0.04% 0.04% 1.12%
Small Company Value2 1.03% 0.00% 0.05% 0.21% 1.29%
Strategic Income Opportunities 0.64% 0.00% 0.09% 0.00% 0.73%
Total Bond Market B2 0.47% 0.00% 0.02% 0.01% 0.50%
Total Return4 0.68% 0.00% 0.04% 0.00% 0.72%
Total Stock Market Index 0.48% 0.00% 0.03% 0.00% 0.51%
Ultra Short Term Bond 0.55% 0.00% 0.07% 0.00% 0.62%
U.S. Equity2 0.75% 0.00% 0.03% 0.01% 0.79%
Utilities 0.83% 0.00% 0.07% 0.00% 0.90%
Value2 0.70% 0.00% 0.04% 0.01% 0.75%

1 John Hancock Investment Management Services, LLC (“JHIMS”) has contractually agreed to waive its advisory fee (or, if necessary, reimburse expenses of the portfolio) in an amount so that the portfolio’s net Total Fund Operating Expenses do not exceed its “Total Fund

11

Table Of Contents
Operating Expenses” as shown in the table above. A portfolio’s “Total Fund Operating Expenses” includes all of its operating expenses including advisory and Rule 12b-1 fees, but excludes taxes, brokerage commissions, interest, short dividends, acquired fund fees, litigation and indemnification expenses and extraordinary expenses of the portfolio not incurred in the ordinary course of the portfolio’s business. JHIMS’ obligation to provide this waiver or reimbursement will remain in effect until April 30, 2015 unless renewed by mutual agreement of the fund and JHIMS based upon a determination that this is appropriate under the circumstances at that time. The fees shown in the table do not reflect this waiver or reimbursement. If this waiver or reimbursement had been reflected, the “Total Fund Operating Expenses” for the portfolios would be as indicated below. For more information, please refer to the prospectus for the portfolio.

Portfolio Total Fund
Operating Expenses
500 Index B 0.25%
International Equity Index B 0.34%
Money Market B 0.28%
Total Bond Market B 0.26%

2 “Acquired Fund Fees and Expenses” are based on indirect net expenses associated with the portfolio’s investments in underlying funds (each an “Acquired Fund”) and are included in the portfolio’s “Total Fund Operating Expenses.” The “Total Fund Operating Expenses” shown may not correlate to the portfolio’s ratio of expenses to average net assets shown in the Financial Highlights section of the prospectus for the portfolio, which does not include “Acquired Fund Fees and Expenses.” For more information, please refer to the prospectus for the portfolio.

3 The table reflects the combined fees of the feeder fund and the master fund.

4 John Hancock Investment Mangement Services, LLC (“JHIMS”) has contractually agreed to waive its advisory fee so that the amount retained by JHIMS after payment of the subadvisory fees for the portfolio does not exceed 0.45% of the portfolio’s average net assets. The current expense limitation agreement expires on April 30, 2015 unless renewed by mutual agreement of the portfolio and JHIMS based upon a determination that this is appropriate under the circumstances at that time. The fees shown in the table do not reflect this expense waiver. If this expense waiver had been reflected, the “Total Fund Operating Expenses” for the Global and Small Cap Opportunities portfolios would be 0.90% and 1.00%, respectively. For more information, please refer to the prospectus for the portfolio.

5 John Hancock Investment Management Services, LLC (“JHIMS”) has contractually agreed to reduce its management fee and/or make payment to the portfolio in an amount equal to the amount by which “Other Expenses” of the fund exceed 0.00% of the average annual net assets (on an annualized basis) of the portfolio. “Other Expenses” means all of the expenses of the portfolio, excluding certain expenses such as advisory fees, taxes, brokerage commissions, interest expense, litigation and indemnification expenses and other extraordinary expenses not incurred in the ordinary course of the portfolio’s business, distribution and service (Rule 12b-1) fees, printing and postage, underlying fund expenses (acquired fund fees), and short dividend expense. The current expense limitation agreement expires on April 30, 2017 unless renewed by mutual agreement of the portfolio and JHIMS based upon a determination that this is appropriate under the circumstances at that time. JHIMS may recapture operating expenses reimbursed or fees waived under previous expense limitation or waiver arrangements for a period of three years following the month in which the reimbursements or waivers occurred to the extent that the portfolio is below its expense limitation during this period. The fees shown in the table do not reflect this expense waiver or reimbursement. If this waiver or reimbursement had been reflected, the “Total Fund Operating Expenses” for the portfolios would be as indicated below. For more information, please refer to the prospectus for the portfolio.

Portfolio Total Fund
Operating Expenses
Lifestyle Aggressive MVP 0.92%
Lifestyle Balanced MVP 0.72%
Lifestyle Conservative MVP 0.69%
Lifestyle Growth MVP 0.74%
Lifestyle Moderate MVP 0.71%

6 John Hancock Investment Management Services, LLC (“JHIMS”) has contractually agreed to waive its management fee by 0.10% as a percentage of the portfolio’s average annual net assets. The current expense limitation agreement expires on April 30, 2015 unless renewed by mutual agreement of the portfolio and JHIMS based upon a determination that this is appropriate under the circumstances at that time. The fees shown in the table do not reflect this waiver. If this waiver had been reflected, the “Total Fund Operating Expenses” for the portfolio would be 0.41%. For more information, please refer to the prospectus for the portfolio.

7 Pacific Investment Management Company LLC (“PIMCO”) has contractually agreed through May 1, 2015, to reduce its management fee to the extent that the underlying fund expenses attributable to management, supervisory and administrative fees exceeds 0.64% of the total assets invested in the underlying funds. PIMCO may recoup these waivers in future periods, not exceeding three years, provided total expenses, including such recoupment, do not exceed the annual expense limit. The fee reduction is implemented based on a calculation of underlying fund expenses attributable to management, supervisory and administrative fees that is different from the calculation of “Acquired Fund Fees and Expenses” shown in the table. “Acquired Fund Fees and Expenses” include interest expense of 0.01%. Interest expense is based on the amount incurred during an underlying fund’s most recent fiscal year as a result of entering into certain investments, such as reverse repurchase agreements. Interest expense is required to be treated as an expense of the underlying fund for accounting purposes and is not payable to PIMCO. The amount of interest expense (if any) will vary based on the underlying fund’s use of such investments as an

12

Table Of Contents
investment strategy. “Total Fund Operating Expenses” excluding interest expense of the underlying fund is 1.64%. The fees shown in the table do not reflect the expense waiver. If this expense waiver had been reflected, the “Total Fund Operating Expenses” (excluding the interest expense of the underlying funds) would be 1.52%. The “Total Fund Operating Expenses” shown may not correlate to the portfolio’s ratio of expense to average net assets shown in the Financial Highlights section of the prospectus for the portfolio, which does not include “Acquired Fund Fees and Expenses.” For more information, please refer to the prospectus for the portfolio.

8 “Other Expenses” reflect interest expense resulting from the portfolio’s use of certain investments such as reverse repurchase agreements or sale-buybacks. Such expense is required to be treated as a portfolio expense for accounting purposes. Any interest expense amount will vary based on the portfolio’s use of those investments as an investment strategy. Had these expenses been excluded, “Other Expenses” would be 0.11%. For more information, please refer to the prospectus for the portfolio.

9 John Hancock Investment Management Services, LLC (“JHIMS”) has contractually agreed to waive its management fee by 0.05% as a percentage of the portfolio’s average annual net assets. The current expense limitation agreement expires on April 30, 2015 unless renewed by mutual agreement of the fund and the advisor based upon a determination that this is appropriate under the circumstances at that time. The fees shown in the table do not reflect this waiver. If this waiver had been reflected, the “Total Fund Operating Expenses” for the portfolio would be 0.56%. For more information, please refer to the prospectus for the portfolio.

13

Table Of Contents

DETAILED INFORMATION

This section of the prospectus provides additional detailed information that is not contained in the Summary of Benefits and Risks section.

Table of Investment Options and Investment Subadvisers

When you select a Separate Account investment option, we invest your money in shares of a corresponding portfolio of the John Hancock Variable Insurance Trust (the “Trust” or “JHVIT”) (or the PIMCO Variable Insurance Trust (the “PIMCO Trust”) with respect to the PIMCO VIT All Asset portfolio) and hold the shares in a subaccount of the Separate Account. The Fee Tables show the investment management fees, Rule 12b-1 fees and other operating expenses for these portfolio shares as a percentage (rounded to two decimal places) of each portfolio’s average net assets for 2013, except as indicated in the footnotes appearing at the end of the table. Fees and expenses of the portfolios are not fixed or specified under the terms of the policies and may vary from year to year. These fees and expenses differ for each portfolio and reduce the investment return of each portfolio. Therefore, they also indirectly reduce the return you will earn on any Separate Account investment options you select.

The JHVIT and the PIMCO Trust are so-called “series” type mutual funds and each is registered under the Investment Company Act of 1940 (“1940 Act”) as an open-end management investment company. John Hancock Investment Management Services, LLC (“JHIMS”) provides investment advisory services to the Trust and receives investment management fees for doing so. JHIMS pays a portion of its investment management fees to other firms that manage the Trust’s portfolios. We are affiliated with JHIMS and may indirectly benefit from any investment management fees JHIMS retains. The PIMCO VIT All Asset portfolio of the PIMCO Trust receives investment advisory services from Pacific Investment Management Company LLC (“PIMCO”) and pays investment management fees to PIMCO.

Each of the American Asset Allocation, American Global Growth, American Growth, American Growth-Income, American International and American New World portfolios invests in Series 1 shares of the corresponding investment portfolio of the Trust. The American Asset Allocation, American Global Growth, American Growth, American Growth-Income, American International and American New World portfolios (“American Portfolios”) operate as “feeder funds,” which means that the portfolios do not buy investment securities directly. Instead, they invest in a “master fund” which in turn purchases investment securities. Each of the American feeder fund portfolios has the same investment objective and limitations as its master fund. The prospectus for the American Fund master fund is included with the prospectuses for the underlying funds. We pay American Funds Distributors, Inc., the principal underwriter for the American Funds Insurance Series, a percentage of some or all of the amounts allocated to the American Portfolios of the Trust for the marketing support services it provides.

The portfolios pay us or certain of our affiliates compensation for some of the distribution, administrative, shareholder support, marketing and other services we or our affiliates provide to the portfolios. The amount of this compensation is based on a percentage of the assets of the portfolios attributable to the variable insurance products that we and our affiliates issue. These percentages may differ from portfolio to portfolio and among classes of shares within a portfolio. In some cases, the compensation is derived from the Rule 12b-1 fees that are deducted from a portfolio’s assets for the services we or our affiliates provide to that portfolio. These compensation payments do not, however, result in any charge to you in addition to what is shown in the Fee Tables.

The following table provides a general description of the portfolios that underlie the variable investment options we make available under the policy. You bear the investment risk of any portfolio you choose as an investment option for your policy. You can find a full description of each portfolio, including the investment objectives, policies, restrictions, and risks, in the prospectus for that portfolio. You should read the portfolio’s prospectus carefully before investing in the corresponding variable investment option.

The investment options in the Separate Account are not publicly traded mutual funds. The investment options are only available to you as investment options in the policies, or in some cases through other variable annuity contracts or variable life insurance policies issued by us or by other life insurance companies. In some cases, the investment options also may be available through participation in certain qualified pension or retirement plans. The portfolios’ investment advisers and managers (i.e. subadvisers) may manage publicly traded mutual funds with similar names and investment objectives. However, the portfolios are not directly related to any publicly traded mutual fund. You should not compare the performance

14

Table Of Contents
of any investment option described in this prospectus with the performance of a publicly traded mutual fund. The performance of any publicly traded mutual fund could differ substantially from that of any of the investment options of our Separate Account.

The portfolios available under the policies, the portfolio managers (engaged by JHIMS or PIMCO) and the investment objective for the portfolio are as described in the following table:

Portfolio Portfolio Manager Investment Objective
500 Index B John Hancock Asset Management, a division of Manulife Asset Management (North America) Limited To approximate the aggregate total return of a broad-based U.S. domestic equity market index.
Active Bond Declaration Management & Research LLC; and John Hancock Asset Management, a division of Manulife Asset Management (US) LLC To seek to provide income and capital appreciation.
All Cap Core QS Investors, LLC To seek to provide long-term growth of capital.
Alpha Opportunities Wellington Management Company, LLP To seek to provide long-term total return.
American Asset Allocation Capital Research and Management Company (Adviser to the American Funds Insurance Series) To seek to provide high total return (including income and capital gains) consistent with preservation of capital over the long-term.
American Global Growth Capital Research and Management Company (Adviser to the American Funds Insurance Series) To seek to provide long-term growth of capital.
American Growth Capital Research and Management Company (Adviser to the American Funds Insurance Series) To seek to provide growth of capital.
American Growth–Income Capital Research and Management Company (Adviser to the American Funds Insurance Series) To seek to provide growth of capital and income.
American International Capital Research and Management Company (Adviser to the American Funds Insurance Series) To seek to provide long-term growth of capital.
American New World Capital Research and Management Company (Adviser to the American Funds Insurance Series) To seek to provide long-term capital appreciation.
Blue Chip Growth T. Rowe Price Associates, Inc. To seek to provide long-term growth of capital. Current income is a secondary objective.
Bond John Hancock Asset Management, a division of Manulife Asset Management (US) LLC To seek to provide income and capital appreciation.
Capital Appreciation Jennison Associates LLC To seek to provide long-term growth of capital.
Capital Appreciation Value T. Rowe Price Associates, Inc. To seek to provide long-term capital appreciation.
Core Bond Wells Capital Management, Incorporated To seek to provide total return consisting of income and capital appreciation.
Core Strategy John Hancock Asset Management, a division of Manulife Asset Management (US) LLC; and John Hancock Asset Management, a division of Manulife Asset Management (North America) Limited To seek to provide long-term growth of capital. Current income is also a consideration.
Emerging Markets Value Dimensional Fund Advisors LP To seek to provide long-term capital appreciation.
Equity-Income T. Rowe Price Associates, Inc. To seek to provide substantial dividend income and also long-term growth of capital.
Financial Services Davis Selected Advisers, L.P. To seek to provide growth of capital.
15

Table Of Contents
Portfolio Portfolio Manager Investment Objective
Franklin Templeton Founding Allocation John Hancock Asset Management, a division of Manulife Asset Management (US) LLC To seek to provide long-term growth of capital.
Fundamental All Cap Core John Hancock Asset Management, a division of Manulife Asset Management (US) LLC To seek to provide long-term growth of capital.
Fundamental Large Cap Value John Hancock Asset Management, a division of Manulife Asset Management (US) LLC To seek to provide long-term capital appreciation.
Fundamental Value Davis Selected Advisers, L.P. To seek to provide capital growth.
Global Templeton Global Advisors Limited To seek to provide long-term capital appreciation.
Global Bond Pacific Investment Management Company LLC To seek to provide maximum total return, consistent with preservation of capital and prudent investment management.
Health Sciences T. Rowe Price Associates, Inc. To seek to provide long-term capital appreciation.
High Yield Western Asset Management Company To seek to provide an above-average total return over a market cycle of 3 to 5 years, consistent with reasonable risk.
International Core Grantham, Mayo, Van Otterloo & Co. LLC To seek to provide high total return.
International Equity Index B SSgA Funds Management, Inc. To seek to track the performance of a broad-based equity index of foreign companies primarily in developed countries and, to a lesser extent, in emerging markets.
International Growth Stock Invesco Advisers, Inc. To seek to provide long-term growth of capital.
International Small Company Dimensional Fund Advisors LP To seek to provide long-term capital appreciation.
International Value Templeton Investment Counsel, LLC To seek to provide long-term growth of capital.
Investment Quality Bond Wellington Management Company, LLP To seek to provide a high level of current income consistent with the maintenance of principal and liquidity.
Lifestyle Aggressive MVP John Hancock Asset Management, a division of Manulife Asset Management (US) LLC; and John Hancock Asset Management, a division of Manulife Asset Management (North America) Limited To seek to provide long-term growth of capital while seeking to both manage the volatility of return and limit the magnitude of portfolio losses.
Lifestyle Balanced MVP John Hancock Asset Management, a division of Manulife Asset Management (US) LLC; and John Hancock Asset Management, a division of Manulife Asset Management (North America) Limited To seek to provide growth of capital and current income while seeking to both manage the volatility of return and limit the magnitude of portfolio losses.
Lifestyle Conservative MVP John Hancock Asset Management, a division of Manulife Asset Management (US) LLC; and John Hancock Asset Management, a division of Manulife Asset Management (North America) Limited To seek to provide current income and growth of capital while seeking to both manage the volatility of return and limit the magnitude of portfolio losses.
Lifestyle Growth MVP John Hancock Asset Management, a division of Manulife Asset Management (US) LLC; and John Hancock Asset Management, a division of Manulife Asset Management (North America) Limited To seek to provide long-term growth of capital while seeking to both manage the volatility of return and limit the magnitude of portfolio losses.
Lifestyle Moderate MVP John Hancock Asset Management, a division of Manulife Asset Management (US) LLC; and John Hancock Asset Management, a division of Manulife Asset Management (North America) Limited To seek to provide current income and growth of capital while seeking to both manage the volatility of return and limit the magnitude of portfolio losses.
16

Table Of Contents
Portfolio Portfolio Manager Investment Objective
Mid Cap Index John Hancock Asset Management, a division of Manulife Asset Management (North America) Limited To seek to approximate the aggregate total return of a medium-capitalization U.S. domestic equity market index.
Mid Cap Stock Wellington Management Company, LLP To seek to provide long-term growth of capital.
Mid Value T. Rowe Price Associates, Inc. To seek to provide long-term capital appreciation.
Money Market B
John Hancock Asset Management, a division of Manulife Asset Management (North America) Limited To seek to obtain maximum current income consistent with preservation of principal and liquidity. Certain market conditions may cause the return of the portfolio to become low or possibly negative.
Natural Resources Wellington Management Company, LLP To seek to provide long-term total return.
PIMCO VIT All Asset (a series of PIMCO Variable Insurance Trust) (only Class M is available) Pacific Investment Management Company LLC To seek to provide maximum real return, consistent with preservation of real capital and prudent investment management.
Real Estate Securities Deutsche Investment Management Americas Inc. To seek to provide a combination of long-term capital appreciation and current income.
Real Return Bond Pacific Investment Management Company LLC To seek to provide maximum real return, consistent with preservation of real capital and prudent investment management.
Science & Technology T. Rowe Price Associates, Inc.; and Allianz Global Investors U.S. LLC To seek to provide long-term growth of capital. Current income is incidental to the portfolio’s objective.
Short Term Government Income John Hancock Asset Management, a division of Manulife Asset Management (US) LLC To seek to provide a high level of current income consistent with preservation of capital. Maintaining a stable share price is a secondary goal.
Small Cap Growth Wellington Management Company, LLP To seek to provide long-term capital appreciation.
Small Cap Index John Hancock Asset Management, a division of Manulife Asset Management (North America) Limited To seek to approximate the aggregate total return of a small-capitalization U.S. domestic equity market index.
Small Cap Opportunities Dimensional Fund Advisors LP; and Invesco Advisers, Inc. To seek to provide long-term capital appreciation.
Small Cap Value Wellington Management Company, LLP To seek to provide long-term capital appreciation.
Small Company Value T. Rowe Price Associates, Inc. To seek to provide long-term growth of capital.
Strategic Income Opportunities John Hancock Asset Management, a division of Manulife Asset Management (US) LLC To seek to provide a high level of current income.
Total Bond Market B
Declaration Management & Research LLC To seek to track the performance of the Barclays U.S. Aggregate Bond Index.*
Total Return Pacific Investment Management Company LLC To seek to provide maximum total return, consistent with preservation of capital and prudent investment management.
Total Stock Market Index John Hancock Asset Management, a division of Manulife Asset Management (North America) Limited To seek to approximate the aggregate total return of a broad U.S. domestic equity market index.
Ultra Short Term Bond John Hancock Asset Management, a division of Manulife Asset Management (US) LLC To seek to provide a high level of current income consistent with the maintenance of liquidity and the preservation of capital.
U.S. Equity Grantham, Mayo, Van Otterloo & Co. LLC To seek to provide long-term capital appreciation.
Utilities Massachusetts Financial Services Company To seek to provide capital growth and current income (income above that available from the portfolio invested entirely in equity securities).
Value Invesco Advisers, Inc. To seek to provide an above-average total return over a market cycle of 3 to 5 years, consistent with reasonable risk.
17

Table Of Contents

*The U.S. Aggregate Bond Index is a broad-based benchmark that measures the investment grade, U.S. dollar-denominated, fixed-rate taxable bond market, including Treasuries, government-related and corporate securities, MBS (agency fixed-rate and hybrid ARM pass throughs), ABS, and CMBS.

If the shares of a portfolio are no longer available for investment or in our judgment investment in a portfolio becomes inappropriate, we may eliminate the shares of a portfolio and substitute shares of another portfolio of the Trust or another open-end registered investment company. Substitution may be made with respect to both existing investments and the investment of future purchase payments. However, we will make no such substitution without first notifying you and obtaining approval of the appropriate insurance regulatory authorities and the SEC (to the extent required by the 1940 Act).

Valuation

We will purchase and redeem series fund shares for the Separate Account at their net asset value without any sales or redemption charges. Shares of a series fund represent an interest in one of the funds of the series fund which corresponds to a subaccount of the Separate Account. Any dividend or capital gains distributions received by the Separate Account will be reinvested in shares of that same fund at their net asset value as of the dates paid.

On each business day, shares of each series fund are purchased or redeemed by us for each subaccount based on, among other things, the amount of net premiums allocated to the subaccount, distributions reinvested, and transfers to, from and among subaccounts, all to be effected as of that date. Such purchases and redemptions are effected at each series fund’s net asset value per share determined for that same date. A “business day” is any date on which the New York Stock Exchange is open for trading. We compute policy values for each business day as of the close of that day (usually 4:00 p.m. Eastern time).

Voting interest

We will vote shares of the portfolios held in the Separate Account at the shareholder meetings according to voting instructions timely received from persons having the voting interest under the policies. We will determine the number of portfolio shares for which voting instructions may be given not more than 90 days prior to the meeting. Proxy material will be distributed to each person having the voting interest under the policy together with appropriate forms for giving voting instructions. We will vote all portfolio shares that we hold in the Separate Account for policy owners in proportion to the instructions timely received by us from policy owners from all our Separate Accounts that are registered with the SEC under the 1940 Act. We will vote all portfolio shares that we otherwise are entitled to vote (including our own shares) on any matter in proportion to the instructions timely received by us and any affiliated insurance companies with respect to the matter from policy owners in Separate Accounts of these insurance companies that are registered with the SEC under the 1940 Act. The effect of this proportional voting is that a small number of policy owners can determine the outcome of a vote.

We determine the number of a series fund’s shares held in a subaccount attributable to each owner by dividing the amount of a policy’s investment account value held in the subaccount by the net asset value of one share in the series fund. Fractional votes will be counted. We determine the number of shares as to which the owner may give instructions as of the record date for a series fund’s meeting. Owners of policies may give instructions regarding the election of the Board of Trustees or Board of Directors of a series fund, ratification of the selection of independent auditors, approval of series fund investment advisory agreements and other matters requiring a shareholder vote. We will furnish owners with information and forms to enable owners to give voting instructions. However, we may, in certain limited circumstances permitted by the SEC’s rules, disregard voting instructions. If we do disregard voting instructions, you will receive a summary of that action and the reasons for it in the next semi-annual report to owners.

The voting privileges described above reflect our understanding of applicable Federal securities law requirements. To the extent that applicable law, regulations or interpretations change to eliminate or restrict the need for such voting privileges, we reserve the right to proceed in accordance with any such revised requirements. We also reserve the right, subject to compliance with applicable law, including approval of owners if so required, (1) to transfer assets determined by John Hancock NY to be associated with the class of policies to which your policy belongs from the Separate Account to another separate account or subaccount, (2) to deregister the Separate Account under the 1940 Act, (3) to substitute for the fund shares held by a subaccount any other investment permitted by law, and (4) to take any action necessary to comply with or obtain any exemptions from the 1940 Act. Any such change will be made only if, in our judgment, the change would best serve the interests of owners of policies in your policy class or would be appropriate in carrying out the purposes of such policies. We would notify owners of any of the foregoing changes and to the extent legally required, obtain approval of affected owners and any regulatory body prior thereto. Such notice and approval, however, may not be legally required in all cases.

18

Table Of Contents

Description of John Hancock NY

John Hancock NY is a stock life insurance company organized under the laws of New York on February 10, 1992. Our principal office is located at 100 Summit Lake Drive, Second Floor, Valhalla, New York 10595. We are a wholly-owned subsidiary of John Hancock Life Insurance Company (U.S.A.). Our ultimate parent is Manulife Financial Corporation (“MFC”), a publicly traded company based in Toronto, Canada. MFC is the holding company of The Manufacturers Life Insurance Company and its subsidiaries, collectively known as Manulife Financial. However, neither John Hancock NY nor any of its affiliated companies guarantees the investment performance of the Separate Account.

We are ranked and rated by independent financial rating services, which may include Moody’s, Standard & Poor’s, Fitch and A.M. Best. The purpose of these ratings is to reflect the financial strength or claims-paying ability of the company, but they do not specifically relate to its products, the performance (return) of these products, the value of any investment in these products upon withdrawal or to individual securities held in any portfolio. These ratings do not apply to the safety and performance of the Separate Account.

Description of Separate Account B

The investment accounts shown on page 1 are in fact subaccounts of John Hancock Life Insurance Company of New York Separate Account B, a separate account operated by us under New York law. The Separate Account meets the definition of “separate account” under the Federal securities laws and is registered as a unit investment trust under the 1940 Act. Such registration does not involve supervision by the SEC of the management of the Separate Account or of us.

The Separate Account’s assets are our property. Each policy provides that amounts we hold in the Separate Account pursuant to the policies cannot be reached by any other persons who may have claims against us and can’t be used to pay any indebtedness of John Hancock NY other than those arising out of policies that use the Separate Account. Income, gains and losses credited to, or charged against, the Separate Account reflect the Separate Account’s own investment experience and not the investment experience of John Hancock NY’s other assets. John Hancock NY is obligated to pay all amounts promised to policy owners under the policies.

New subaccounts may be added and made available to policy owners from time to time. Existing subaccounts may be modified or deleted at any time.

The death benefit

In your application for the policy, you will tell us how much life insurance coverage you want on the life of the insured person. This is called the “Face Amount.”

When the insured person dies, we will pay the death benefit minus any outstanding policy debt and unpaid fees and charges. There are two ways of calculating the death benefit, as described below.

For the same premium payments, the death benefit under Option 2 will tend to be higher than the death benefit under Option 1. On the other hand, the Face Amount charge and resulting cost of insurance charges (based on the higher net amount at risk) will be higher under Option 2. Because of that, the policy value will tend to be higher under Option 1 than under Option 2 for the same premium payments.

Your policy will be issued with death benefit Option 2. After the first policy year, you may request to change the death benefit from Option 2 to Option 1.

Limitations on payment of death benefit

If the insured person commits suicide within certain time periods (generally within two years from the Issue Date of the policy), the amount payable will be equal to the premiums paid, less the amount of any policy debt on the date of death, and less any withdrawals.

19

Table Of Contents

Also if an application misstated the age or sex of the insured person, we will adjust, if necessary, the Face Amount and every other benefit to that which would have been purchased at the correct age or sex by the most recent cost of insurance charge.

The minimum death benefit

In order for a policy to qualify as life insurance under Federal tax law, there has to be a minimum amount of insurance in relation to policy value. The Federal tax law test that will be applied to determine whether your policy qualifies for life insurance is the “guideline premium test.” (see “Tax considerations”)

Under the guideline premium test, we compute the minimum death benefit each business day by multiplying the policy value on that date by the death benefit factor applicable on that date. Factors for some ages are shown in the table below:

Attained Age Applicable Factor
40 and under 250%
45 215%
50 185%
55 150%
60 130%
65 120%
70 115%
75 105%
90 105%
95 and above 100%

A table showing the factor for each age will appear in the policy.

To the extent that the calculation of the minimum death benefit under the guideline premium test causes the death benefit to exceed our limits, we reserve the right to return premiums or distribute a portion of the policy value so that the resulting amount of insurance is maintained within our limits. Alternatively, if we should decide to accept the additional amount of insurance, we may require additional evidence of insurability.

Coverage at and after age 121

Provided the policy is in force at and after the life insured’s age 121:

Requesting a decrease in coverage

After the first policy year, we may approve a reduction in the Face Amount, but only if:

A pro-rata portion of the surrender charge will be payable upon any approved reduction in the Face Amount that reduces the Face Amount to an amount that is below the Face Amount at issue (see “Surrender charge”). For Face Amount reductions, an additional 10% of the Face Amount at issue is also exempt from the partial surrender charge. This 10% surrender charge

20

Table Of Contents
exemption does not apply to full surrenders or net cash surrender withdrawals (see “Surrenders and withdrawals – Withdrawals”). An approved decrease will take effect on the monthly deduction date on or next following the date we approve the request.

Change of death benefit option

Your policy will be issued with death benefit Option 2. Under our current administrative rules, we permit the death benefit option to be changed from 2 to Option 1 after the first policy year. If you request in writing, and we approve a change from Option 2 to Option 1, your Face Amount after the change will equal your Face Amount before the change plus the policy value as of the effective date of the change. If you change from Option 2 to Option 1, your death benefit at death may be lower than what it was if your policy had remained as death benefit option 2. This means, your death benefit will change from one that may increase over time due to the investment experience of the underlying investment accounts to one that is a level death benefit. Changing from Option 2 to Option 1 can also lower the monthly Cost of Insurance charge since this charge is lowered when the Net Amount At Risk is reduced; all other charges under the policy would remain the same. We reserve the right to limit a request for a change if the change would cause the policy to fail to qualify as life insurance for tax purposes.

A change in the death benefit option will result in a change in the policy’s Face Amount, in order to avoid any change in the amount of the death benefit. The new Face Amount will be equal to the Face Amount prior to the change plus the policy value as of the date of the change. The change will take effect on the monthly deduction date on or next following the date the written request for the change is received at our Service Office.

Tax consequences of coverage changes

If you change the death benefit option after the first policy year from Option 2 to Option 1, the “guideline premium test” will continue to apply. Please read “The minimum death benefit” for more information about these Federal tax law tests.

A change in the death benefit option or Face Amount will often change the policy’s limits under the “guideline premium test.” To avoid having the policy cease to qualify as life insurance for tax purposes, we reserve the right to (i) refuse or limit a change in the death benefit option or Face Amount and (ii) change the Guideline Single Premium or Guideline Level Premium, as applicable. Please read “Tax considerations” to learn about possible tax consequences of changing your insurance coverage under the policy.

Your beneficiary

You name your beneficiary when you apply for the policy. The beneficiary is entitled to the proceeds we pay following the insured person’s death. You may change the beneficiary during the insured person’s lifetime. Such a change requires the consent of any named irrevocable beneficiary. A new beneficiary designation will not affect any payments we make before we receive it. If no beneficiary is living when the insured person dies, we will pay the insurance proceeds to the owner or the owner’s estate.

Ways in which we pay out policy proceeds

You may choose to receive proceeds from the policy as a single sum. This includes proceeds that become payable because of death or surrender. As permitted by state law and our current administrative procedures, death claim proceeds may be placed into an interest-bearing John Hancock retained asset account in the beneficiary’s name. The interest earned in a John Hancock retained asset account is normally subject to income tax. You should consult with your tax advisor if you have any questions regarding taxation of the interest earned. We will provide the beneficiary with a checkbook, so checks may be written for all or a part of the proceeds. The retained asset account is part of our general account and is subject to the claims of our creditors. It is not a bank account and it is not insured by the FDIC. We may receive a benefit from managing proceeds held in a retained asset account. Alternatively, you can elect to have proceeds of $1,000 or more applied to any of the other payment options we may offer at the time. You cannot choose an option if the monthly payments under the option would be less than $50. We will issue a supplementary agreement when the proceeds are applied to any alternative payment option. That agreement will spell out the terms of the option in full. Please contact our Service Office for more information.

Changing a payment option

You can change the payment option at any time before the proceeds are payable. If you haven’t made a choice, the payee of the proceeds has a prescribed period in which he or she can make that choice.

21

Table Of Contents

Tax impact of payment option chosen

There may be tax consequences to you or your beneficiary depending upon which payment option is chosen. You should consult with a qualified tax adviser before making that choice.

Premiums

Planned premiums

The Policy Specifications page of your policy will show the “Planned Premium” for the policy. You choose this amount in the policy application. You will also choose how often to pay premiums — annually, semi-annually or quarterly. You may also choose to pay premiums by monthly electronic funds transfers. The premium reminder notice we send you is based on the amount and period you choose. However, payment of Planned Premiums is not necessarily required. You need only pay enough premium to keep the policy in force (see “Lapse and reinstatement”).

Minimum initial premium

The Minimum Initial Premium is set forth in the Policy Specifications page of your policy. After the payment of the initial premium, premiums may be paid at any time and in any amount until the insured person’s attained age 121, subject to the need to pay enough premium to keep the policy in force, and to the limitations on maximum premium amount described below.

Maximum premium payments

Federal tax law limits the amount of premium payments you can make relative to the amount of your policy’s insurance coverage. We will not knowingly accept any amount by which a premium payment exceeds this limit. If you exceed certain other limits, the law may impose a penalty on amounts you take out of your policy. More discussion of these tax law requirements is provided under “Tax considerations.”

Large premium payments may expose us to unanticipated investment risk. In addition, in order to limit our investment risk exposure under certain market conditions, we may refuse to accept additional premium payments. Excessive allocations may also interfere with the effective management of our variable investment account portfolios, if we are unable to make an orderly investment of the additional premium into the portfolios. Also, we may refuse to accept or limit an amount of premium if the amount of the premium would increase our insurance risk exposure, and the insured person doesn’t provide us with adequate evidence that he or she continues to meet our requirements for issuing insurance.

We will notify you in writing of our refusal to accept premium under these provisions within three days following the date that it is received by us, and will promptly thereafter take the necessary steps to return the premium to you. Notwithstanding the foregoing limits on the premium that we will accept, we will not refuse to accept any premium necessary to prevent the policy from terminating.

Processing premium payments

No premiums will be accepted prior to our receipt of a completed application at our Service Office. All premiums received prior to the Issue Date of the policy will be held in the general account and credited with interest from the date of receipt at the rate of return then being earned on amounts allocated to the Money Market B investment account. After the Issue Date but prior to the Allocation Date, premiums received are allocated to the Money Market B investment account. The “Allocation Date” of the policy is the tenth day after the Issue Date. The Issue Date is shown on the Policy Specifications page of the policy. On the Allocation Date, the Net Premiums paid plus interest credited, if any, will be allocated among the investment accounts in accordance with the policy owner’s instructions. The “Net Premium” is the premium paid less the applicable premium charges we deduct from it.

Any Net Premium received on or after the Allocation Date will be allocated among investment accounts as of the business day on or next following the date the premium is received at the Service Office. Monthly deductions are normally due on the Policy Date and at the beginning of each policy month thereafter. However, if the monthly deductions are due prior to the Contract Completion Date, they will be deducted from policy value on the Contract Completion Date instead of the dates they were due (see “Procedures for issuance of a policy” for the definition of “Contract Completion Date”).

22

Table Of Contents

Payment of premiums will not guarantee that the policy will stay in force. Conversely, failure to pay premiums will not necessarily cause the policy to lapse. However, in states where permitted, the policy will have a No-Lapse Guarantee which would prevent the policy from lapsing during the guarantee period, provided certain criteria are satisfied.

Ways to pay premiums

If you pay premiums by check or money order, they must be drawn on a U.S. bank in U.S. dollars and made payable to “John Hancock.” We will not accept credit card checks. We will not accept starter or third party checks if they fail to satisfy our administrative requirements. Premiums after the first must be sent to the John Hancock NY Service Office at the appropriate address shown on the back cover of this prospectus.

We will also accept premiums:

Lapse and reinstatement

Lapse

Unless the No-Lapse Guarantee is in effect, a policy will go into default if at the beginning of any policy month the policy’s net cash surrender value would be zero or below after deducting the monthly deductions then due. Therefore, a policy could lapse eventually if increases in policy value (prior to deduction of policy charges) are not sufficient to cover policy charges. A lapse could have adverse tax consequences as described under “Tax considerations.” We will notify you of the default and will allow a 61 day grace period in which you may make a premium payment sufficient to bring the policy out of default. The required payment will be equal to the amount necessary to bring the net cash surrender value to zero, if it was less than zero on the date of default, plus an amount equal to three times the monthly deductions due on the date of default, plus any applicable premium charge. If the required payment is not received by the end of the grace period, the policy will terminate (i.e., “lapse”) with no value.

No-lapse guarantee

In those states where it is permitted, as long as the cumulative premium test is satisfied during the No-Lapse Guarantee Period, as described below, we will guarantee that the policy will not go into default, even if adverse investment experience or other factors should cause the policy’s surrender value to fall to zero or below during such period.

The monthly No-Lapse Guarantee Premium is one-twelfth of the No-Lapse Guarantee Premium. The No-Lapse Guarantee Premium is not a charge assessed against the policy value. It is an amount used in determining whether the cumulative premium test has been satisfied.

The No-Lapse Guarantee Premium is set at issue on the basis of the Face Amount of the policy, and reflects the age, sex and risk class of the proposed insured, the death benefit option, as well as any additional rating and supplementary benefits, if applicable. It is subject to change if (i) the Face Amount of the policy is changed, (ii) there is a death benefit option change, (iii) there is a decrease in the Face Amount of insurance, or (iv) there is any change in the supplementary benefits added to the policy or in the risk classification of the insured person.

The No-Lapse Guarantee Period is set at issue and is stated in the policy. Certain state limitations may apply, but generally the No-Lapse Guarantee Period for the Face Amount is five years.

While the No-Lapse Guarantee is in effect, we will determine at the beginning of the policy month that your policy would otherwise be in default whether the cumulative premium test, described below, has been met. If the test has not been satisfied, we will notify you of that fact and allow a 61-day grace period in which you may make a premium payment sufficient to keep the policy from going into default. This required payment, as described in the notification, will be equal to the lesser of:

(a) the outstanding premium requirement to satisfy the cumulative premium test at the date of default, plus the monthly No-Lapse Guarantee Premium due for the next three policy months, or
23

Table Of Contents
(b) the amount necessary to bring the Net Cash Surrender Value to zero plus an amount equal to three times the monthly deductions due on the date of default, plus the applicable premium charge.

If the required payment is not received by the end of the grace period, the No-Lapse Guarantee and the policy will terminate. If you make the required payment under (a) described above, only the Face Amount will remain in effect, and any supplementary benefit riders (unless otherwise stated therein) will terminate as of the end of the grace period.

Cumulative premium test

The cumulative premium test is satisfied if, as of the beginning of the policy month that your policy would otherwise be in default, the sum of all premiums paid to date less any withdrawals taken on or before the date of the test and less any policy debt is equal to or exceeds the sum of the monthly No-Lapse Guarantee Premium due from the Policy Date to the date of the test.

Death during grace period

If the insured person should die during the grace period, the policy value used in the calculation of the death benefit will be the policy value as of the date of default, and the death benefit will be reduced by any outstanding monthly deductions due at the time of death.

Reinstatement

By making a written request, you can reinstate a policy that has gone into default and terminated at any time within the three-year period following the date of termination subject to the following conditions:

(a) You must provide to us evidence satisfactory to us that the insured person is insurable, which may include our full underwriting standards, including a medical examination; and
(b) You must pay a premium equal to the amount that was required to bring the policy out of default immediately prior to termination, plus the amount needed to keep the policy in force for at least the next three policy months.

If the reinstatement is approved, the date of reinstatement will be the later of the date we approve your request or the date the required payment is received at our Service Office. In addition, any surrender charges will be reinstated to the amount they were at the date of default. The policy value on the date of reinstatement, prior to the crediting of any Net Premium paid in connection with the reinstatement, will be equal to the policy value on the date the policy terminated. Any policy debt not paid upon termination of a policy will be reinstated if the policy is reinstated.

The incontestability provisions will apply from the effective date of reinstatement. A surrendered policy cannot be reinstated.

The policy value

From each premium payment you make, we deduct the applicable premium charges described under “Deduction from premium payments.” We invest the rest (known as the “Net Premium”) in the investment accounts you’ve elected. Special investment rules apply to premiums processed prior to the Allocation Date (see “Processing premium payments”).

Over time, the amount you’ve invested in any investment account will increase or decrease the same as if you had invested the same amount directly in the corresponding underlying portfolio and had reinvested all portfolios’ dividends and distributions in additional portfolio shares, except that we will deduct certain additional charges which will reduce your policy value. We describe these charges under “Description of charges at the policy level.” Starting in policy year eleven, we may also credit your policy value with an asset credit (see “Asset credit”).

We calculate the unit values for each investment account once every business day as of the close of trading on the New York Stock Exchange, usually 4:00 p.m. Eastern time. Sales and redemptions within any investment account will be transacted using the unit value next calculated after we receive your request either in writing or other form that we specify. If we receive your request before the close of our business day, we’ll use the unit value calculated as of the end of that business day. If we receive your request at or after the close of our business day, we’ll use the unit value calculated as of the end of the next business day. If a scheduled transaction falls on a day that is not a business day, we’ll process it as of the end of the next business day.

24

Table Of Contents

Asset credit

Starting in the eleventh policy year, we will credit your policy value monthly, on the date we calculate your monthly deductions, with an amount equal to the percentage credit listed below multiplied by the policy value in your investment accounts on this date. The asset credit does not apply to the loan account. The asset credit percentage is 0.0125% per month in policy year eleven and thereafter and ceasing at attainment of age 121. We add the credit to the same investment accounts from which we take your monthly deductions.

Allocation of future premium payments

At any time, you may change the investment accounts in which future premium payments will be invested. You make the original allocation in the application for the policy. The percentages you select must be in whole numbers and must total 100%.

Transfers of existing policy value

You may also transfer your existing policy value from one investment account to another, subject to the limitations discussed below. To do so, you must tell us how much to transfer, either as a whole number percentage or as a specific dollar amount. A confirmation of each transfer will be sent to you. Without our approval, the maximum amount you may transfer to or from any investment account in any policy year is $1,000,000.

The policies are not designed for professional market timing organizations or highly active traders, including persons or entities that engage in programmed, large or frequent transfers among investment accounts. As a consequence, we have reserved the right to impose certain restrictions on transfers as described in the “Market timing and disruptive trading risks” section of this prospectus. We also reserve the right to impose a fee of up to $25 for any transfer beyond an annual limit (which will not be less than twelve).

Limitations on transfers to or from an investment account . Our current practice is to restrict transfers into or out of investment accounts to two per calendar month (except with respect to those policies described in the following paragraphs). For purposes of this restriction, and in applying the limitation on the number of free transfers, any transfers made during the period from the opening of a business day (usually 9:00 a.m. Eastern time) to the close of that business day (usually 4:00 p.m. Eastern time) are considered one transfer. You may, however, transfer to the Money Market B investment account even if the two transfer per month limit has been reached, but only if 100% of the investment account value in all investment accounts is transferred to the Money Market B investment account. If such a transfer to the Money Market B investment account is made, then for the 30 calendar day period after such transfer no transfers from the Money Market B investment account to any other investment account may be made. If your policy offers a dollar cost averaging or automatic asset allocation rebalancing program, any transfers pursuant to such program are not considered transfers subject to these restrictions on frequent trading. The restrictions described in this paragraph will be applied uniformly to all policy owners subject to the restrictions.

Policies such as yours may be purchased by a corporation or other entity as a means to informally finance the liabilities created by an employee benefit plan, and to this end the entity may aggregately manage the policies purchased to match its liabilities under the plan. Policies sold under these circumstances are subject to special transfer restrictions. In lieu of the two transfers per month restriction, we will allow the policy owner under these circumstances to rebalance the investment options in its policies within the following limits: (i) during the 10 calendar day period after any policy values are transferred from one investment account into a second investment account, the values can only be transferred out of the second investment account if they are transferred into the Money Market B investment account; and (ii) any policy values that would otherwise not be transferable by application of the 10 day limit described above and that are transferred into the Money Market B investment account may not be transferred out of the Money Market B investment account into any other investment account for 30 calendar days. The restrictions described in this paragraph will be applied uniformly to all policy owners subject to the restrictions.

Subject to our approval, we may offer policies purchased by a corporation or other entity that has purchased policies to match its liabilities under an employee benefit plan, as described above, the ability to electronically rebalance the investment options in its policies. Under these circumstances, in lieu of imposing any specific limit upon the number and timing of transfers, we will monitor aggregate trades among the subaccounts for frequency, pattern and size for potentially harmful investment practices. If we detect trading activity that we believe may be harmful to the overall operation of any investment account or underlying portfolio, we may impose conditions on policies employing electronic rebalancing to submit trades, including setting limits upon the number and timing of transfers, and revoking privileges to make trades by any means other than written communication submitted via U.S. mail.

25

Table Of Contents

While we seek to identify and prevent disruptive frequent trading activity, it may not always be possible to do so. Therefore no assurance can be given that the restrictions we impose will be successful in preventing all disruptive frequent trading and avoiding harm to long-term investors. The restrictions described in these paragraphs will be applied uniformly to all policy holders subject to the restrictions.

Rule 22c-2 under the 1940 Act requires us to provide tax identification numbers and other policy owner transaction information to the Trust or to other investment companies in which the Separate Account invests, at their request. An investment company will use this information to identify any pattern or frequency of investment account transfers that may violate their frequent trading policy. An investment company may require us to impose trading restrictions in addition to those described above if violations of their frequent trading policy are discovered.

Dollar cost averaging . We may offer policy owners a dollar cost averaging (“DCA”) program. Under the DCA program, you will designate an amount that will be transferred monthly from one investment account into any other investment account(s). If insufficient funds exist to effect a DCA transfer, the transfer will not be effected and you will be so notified. No fee is charged for this program.

We reserve the right to cease to offer this program as of 90 days after written notice is sent to you.

Asset allocation balancer transfers . Under the asset allocation balancer program you will designate an allocation of policy value among investment accounts. We will move amounts among the investment accounts at specified intervals you select - annually, semi-annually, quarterly or monthly. A change to your premium allocation instructions will automatically result in a change in asset allocation balancer instructions so that the two are identical unless you either instruct us otherwise or have elected the dollar cost averaging program. No fee is charged for this program.

We reserve the right to cease to offer this program as of 90 days after written notice is sent to you.

Surrender and withdrawals

Surrender

You may surrender your policy in full at any time. If you do, we will pay you the policy value less any policy debt and surrender charge that then applies. This is called your “net cash surrender value.” You must return your policy when you request a surrender. We will process surrenders on the day we receive the surrender request (unless such day is not a business day, in which case we will process surrenders as of the business day next following the date of the receipt).

Withdrawals

After the first policy year, you may make a withdrawal of part of your net cash surrender value once in each policy month. Generally, each withdrawal must be at least $500. If the withdrawal reduces the Face Amount to an amount that is less than the Face Amount at issue (“Face Amount issued”), a charge equal to a pro-rata portion of any surrender charge will be applied during the surrender charge period to the amount surrendered that falls below the Face Amount issued. We will automatically reduce the policy value of your policy by the amount of the withdrawal. Unless otherwise specified by you, each investment account will be reduced in the same proportion as the policy value is then allocated among them. We will not permit a withdrawal if it would cause your surrender value to fall below three months’ worth of monthly deductions (see “Deductions from policy value”). We also reserve the right to refuse any withdrawal that would cause the policy’s Face Amount to fall below $50,000.

Because it reduces the policy value, any withdrawal will reduce your death benefit under either Option 1 or Option 2 (see “The death benefit”). If death benefit Option 1 is in effect at the time of the withdrawal, such withdrawal may reduce the Face Amount. If such a reduction in Face Amount would cause the policy to fail the Internal Revenue Code’s definition of life insurance, we will not permit the withdrawal. As noted above, if the withdrawal reduces the Face Amount to an amount that is less than the Face Amount issued, a charge equal to a pro-rata portion of any surrender charge will be applied during the surrender charge period to the amount surrendered that falls below the Face Amount issued (see “Surrender charge”).

For example, assume the owner of a policy issued with death benefit Option 2 requests a withdrawal of $25,000 on a policy with a Face Amount of $200,000 and a current surrender charge of $10,000. The policy value would be reduced by $25,000 but the Face Amount would remain unchanged, therefore no surrender charge would be applied. If the policy owner had changed the death benefit option from Option 2 to Option 1 after the first policy year, but prior to the withdrawal, and the Face Amount after the death benefit option change were $210,000, then the Face Amount would be reduced by the withdrawal

26

Table Of Contents
amount of $25,000, which is attributed first to the $10,000 of the increased portion of Face Amount resulting from the death benefit option change, and then to $15,000 of the Face Amount issued. Furthermore, the $15,000 reduction of Face Amount issued from $200,000 to $185,000 is subject to a partial surrender charge equal to the surrender charge times the proportionate reduction in Face Amount, in this case equal to $10,000 x ($15,000/$200,000) or $750. The surrender charge after the withdrawal would be equal to $10,000 minus $750 or $9,250.

Policy loans

You may borrow from your policy at any time by completing a form satisfactory to us. The maximum amount you can borrow is the greater of (i) 90% of net cash surrender value and (ii) the amount determined as set out below.

The minimum amount of each loan is $500. The interest charged on any loan is an effective annual rate of 3.25% in the first ten policy years, but we reserve the right to increase the annual rate to 3.50% during that time. After the tenth policy year, the effective annual rate is 2.00%, however, we reserve the right to increase the percentage to as much as 2.25%. Accrued interest will be added to the loan daily and will bear interest at the same rate as the original loan amount. Unless otherwise specified by you, the amount of the loan is deducted from the investment accounts in the same proportion as the policy value is then allocated among them. The amount of the loan is then placed in a special loan account. This special loan account will earn interest at an effective annual rate of 2.00%. The tax consequences of a loan interest credited differential of 0% are unclear. You should consult a tax adviser before effecting a loan to evaluate possible tax consequences. If we determine that a loan will be treated as a taxable distribution because of the differential between the loan interest rate and the rate being credited on the special loan account, we reserve the right to increase the rate charged on the loan to a rate that would, in our reasonable judgment, result in the transaction being treated as a loan under Federal tax law. The right to increase the rate charged on a loan is restricted in New York. We will not decrease the annual rate charged to less than 2.00%. Please see your John Hancock NY representative for details. We process policy loans as of the business day on or next following the day we receive the loan request.

Repayment of policy loans

You can repay all or part of a loan at any time. Each repayment will be allocated among the investment accounts in the same way a new premium payment would be allocated (unless specified by you). While you have a loan outstanding, we will treat any amounts you pay as premium, unless you submit a written request to us that they be treated as loan repayments.

Loan repayments received prior to the close of the New York Stock Exchange will be applied on the same day it was received. Loan repayments received after the close of the New York Stock Exchange will be applied as of the next business day.

Effects of policy loans

The policy value, the net cash surrender value, and any death benefit are permanently affected by any loan, whether or not it is repaid in whole or in part. This is because the amount of the loan is deducted from the accounts and placed in a special loan account. The investment accounts and the special loan account will generally have different rates of investment return.

The amount of the outstanding loan (which includes accrued and unpaid interest) is subtracted from the amount otherwise payable when the policy proceeds become payable.

Taking out a loan on the policy increases the risk that the policy may lapse because of the difference between the interest rate charged on the loan and the interest rate credited to the special loan account. Also, when a loan is outstanding, the amount in the loan account is not available to help pay for any policy charges. If, after deducting your policy loan, there is not enough policy value to cover the policy charges, your policy could lapse. Whenever the outstanding loan equals or exceeds your policy value after the insured person reaches age 121, the policy will terminate 31 days after we have mailed notice of

27

Table Of Contents
termination to you (and to any assignee of record at such assignee’s last known address) specifying the amount that must be paid to avoid termination, unless a repayment of at least the amount specified is made within that period. Policy loans may also result in adverse tax consequences under certain circumstances (see “Tax considerations”).

Description of charges at the policy level

Deduction from premium payments

Deductions from policy value

  (a) is the death benefit as of the first day of the Policy Month, divided by 1.0016516; and

  (b) is the policy value as of the first day of the Policy Month after the deduction of all other monthly deductions.

Since the net amount at risk for death benefit Option 1 is based on a formula that includes as factors the death benefit and the policy value, the net amount at risk is affected by the investment performance of the investment accounts chosen, payment of premiums and charges assessed.

If the minimum death benefit is greater than the Face Amount, the cost of insurance charge will reflect the amount of that additional benefit.

For death benefit Option 2, the net amount at risk is equal to the Face Amount of insurance divided by 1.0016516.

The surrender charge is equal to the lesser of (a) and (b), multiplied by the Surrender Charge Grading Factor in your policy, where

  (a) is a surrender charge for the Face Amount at issue, indicated in the Policy Specifications page of the policy, less the result of 4.11% multiplied by the sum of premiums paid in the first policy year, and

  (b) is an alternate surrender charge for the Face Amount at issue, also indicated in the Policy Specifications page of the policy

Both calculations (a) and (b) are intended to enable us to recoup acquisition expenses incurred in relation to the sale of your policy. The calculation in (a) limits the surrender charge amount in some cases to make sure that your policy conforms to applicable state non-forfeiture laws.

For an example showing how the surrender charge is determined, assume a policy on a male age 45 nonsmoker, providing a $1,000,000 death benefit Option 2 with no riders, paying a Target Premium of $19,790 as of policy year 1, and subject to an applicable Surrender Charge Grading Factor of 100% in policy year 1.

To determine the surrender charge in (a), we subtract from $27,720 the product of 4.11% multiplied by the sum of premiums paid in policy year 1 ($19,790). The result is $26,906.63 – i.e., $27,720 – 4.11% x $19,790 = $26,906.63. We then compare this to the surrender charge amount in (b) indicated in the Policy Specifications page. In our example above, the surrender charge amount in (b) is $34,820.

The lesser of the amounts in (a) and (b) is the $26,906.63, which is the amount derived from the calculation in (a), and thus, that is the amount of the surrender charge that would be applied. In this example, where the surrender occurs in the first policy year, the Surrender Charge Grading Factor that would be applied to the surrender charge is 100%, and therefore the surrender charge for this example is $26,906.63– i.e., $26,906.63 x 100% = $26,906.63. The surrender charge is dependent upon the policy year during which a reduction in Face Amount, lapse or surrender occurs, and the Surrender Charge Grading Factor percentage is graded down over the policy duration until the tenth policy year.

Policy Year Percentage Applied
1 100%
2 96%
3 92%
4 89%
5 85%
6 81%
7 77%
8 67%
9 55%
10 38%
11+ 0%

The above table applies only if the insured person is age 45 at issue. A pro-rata portion of the surrender charge will be payable upon any approved reduction in the Face Amount that reduces the Face Amount to an amount that is below the Face Amount at issue (see “Surrender charge”). For Face Amount reductions, an additional 10% of the Face Amount at issue is also exempt from the partial surrender charge. This 10% surrender charge exemption does not apply to full surrenders or net cash surrender withdrawals (see “Surrenders and withdrawals – Withdrawals” and “Requesting a decrease in coverage”). The pro-rata charge is calculated by dividing the reduction in Face Amount by the Face Amount immediately prior to the reduction and then multiplying the applicable surrender charge by that ratio.

Additional information about how certain policy charges work

Sales expenses and related charges

The premium and Face Amount charges help to compensate us for the cost of selling our policies (see “Description of charges at the policy level”). The amount of the charges in any policy year does not specifically correspond to sales expenses

29

Table Of Contents
for that year. We expect to recover our total sales expenses over the life of the policies. To the extent that the premium and Face Amount charges do not cover total sales expenses, the sales expenses may be recovered from other sources, including the asset-based risk charge and other charges with respect to the policies, or from our general assets. Similarly, administrative expenses not fully recovered by the administrative charge may also be recovered from such other sources.

Method of deduction

We deduct the monthly deductions described in the Fee Tables section from your policy’s investment accounts in proportion to the amount of policy value you have in each, unless otherwise specified by you.

Special purchase programs for eligible classes

With respect to policies issued to a class of associated individuals or to a trustee, employer or similar entity where we anticipate that the sales to the members of the class will result in lower than normal sales or administrative expenses, lower taxes or lower risks to us, we may offer the policies with reduced charges or with additional or enhanced features or benefits. We will make these programs available in accordance with our established administrative procedures in effect at the time of the application for a policy. The factors we consider in determining the eligibility of a particular group for such a program are: (i) the nature of the association and its organizational framework; (ii) the method by which sales will be made to the members of the class; (iii) the facility with which premiums will be collected from the associated individuals and the association’s capabilities with respect to administrative tasks; (iv) the anticipated lapse and surrender rates of the policies; (v) the size of the class of associated individuals and the number of years it has been in existence; (vi) the aggregate amount of premiums paid; and (vii) any other such circumstances which result in a reduction in sales or administrative expenses, lower taxes or lower risks. Any reduction in charges or feature or benefit enhancement will be reasonable and will apply uniformly to all prospective policy purchasers in the class and will not unfairly discriminate against any owner.

The Statement of Additional Information (the “SAI”) contains additional information about any special purchase program we currently make available. For information as to how you may obtain a copy of the SAI, please see the last page of this prospectus.

Other charges we could impose in the future

Except for a portion of the premium charge, we currently make no charge for our Federal income taxes. However, if we incur, or expect to incur, income taxes attributable to any subaccount of the Separate Account or this class of policies in future years, we reserve the right to make a charge for such taxes. Any such charge would reduce what you earn on any affected fixed or investment accounts. However, we expect that no such charge will be necessary.

A portion of the premium charge is used to cover premium taxes. Currently, the premium tax in New York is 0.7% of each premium payment.

Under current laws, we may incur state and local taxes (in addition to premium taxes) in several states. At present, these taxes are not significant. If there is a material change in New York state or local tax laws, we may make charges for such taxes.

Description of charges at the portfolio level

The portfolios must pay investment management fees and other operating expenses. These fees and expenses (shown in the tables of portfolio annual expenses under “Fee Tables”) are different for each portfolio and reduce the investment return of each portfolio. Therefore, they also indirectly reduce the return you will earn on any investment accounts you select. Expenses of the portfolios are not fixed or specified under the terms of the policy, and those expenses may vary from year to year.

Other policy benefits, rights and limitations

Optional supplementary benefit riders you can add

When you apply for a policy, you can request any of the optional supplementary benefit riders that we then make available. Our rules and procedures will govern eligibility for any rider and, in some cases, the configuration of the actual rider benefits. Each rider contains specific details that you should review before you decide to choose the rider. Charges for the riders will be deducted from the policy value. We may change these charges (or the rates that determine them), but not

30

Table Of Contents
above any applicable maximum amount stated in the Policy Specifications page of your policy. We may add to, delete from or modify the list of optional supplementary benefit riders.

When the Overloan Protection Benefit in this rider is invoked, all values in the investment accounts are immediately transferred to the fixed account, described below, and will continue to grow at the current fixed account interest rate. Transfer fees do not apply to these transfers. Thereafter, policy changes and transactions are limited as set forth in the rider; for example, death benefit increases or decreases, additional premium payments, policy loans, withdrawals, surrender and transfers are no longer allowed. Any outstanding policy debt will remain. Interest will continue to be charged at the policy’s specified loan interest rate, and the policy’s loan account will continue to be credited with the policy’s loan interest credited rate. Any applicable No-Lapse Guarantee under the policy no longer applies, and any supplementary benefit rider requiring a monthly deduction will automatically be terminated.

When the Overloan Protection Rider causes the policy to be converted into a fixed policy, there is risk that the Internal Revenue Service could assert that the policy has been effectively terminated and that the outstanding loan balance should be treated as a distribution. Depending on the circumstances, all or part of such deemed distribution may be taxable as income. You should consult a tax adviser as to the risks associated with the Overloan Protection Rider.

Our obligations under the fixed account are backed by our general account assets. Our general account consists of assets owned by us other than those in the Separate Account and in other separate accounts that we may establish. Subject to applicable law, we have sole discretion over the investment of assets of the general account and policy owners do not share in the investment experience of, or have any preferential claim on, those assets. Instead we guarantee that the policy value allocated to any fixed account will accrue interest daily at an effective annual rate that we determine without regard to the actual investment experience of the general account. The effective annual rate we declare for the fixed account will never be less than 2%. Because of exemptive and exclusionary provisions, interests in our fixed account have not been and will not be registered under the Securities Act of 1933 (“1933 Act”) and our general account has not been registered as an investment company under the 1940 Act.

If you satisfy the above conditions, we will pay you 50% of the eligible death benefit, up to a maximum of $1,000,000. We will not make a payment if it would be less than $10,000. Payment of the benefit will reduce your death benefit and any cash value or loan value under your policy. You should consult your tax adviser and social service agencies before you decide to receive the benefit under this rider. This rider is only available with policies that are individually owned.

Variations in policy terms

We may vary the charges and other terms of our policies where special circumstances result in sales or administrative expenses, mortality risks or other risks that are different from those normally associated with the policies. These include the type of variations discussed under “Special purchase programs for eligible classes.” No variation in any charge will exceed any maximum stated in this prospectus with respect to that charge.

Any variation discussed above will be made only in accordance with uniform rules that we adopt and that we apply fairly to our customers.

31

Table Of Contents

Procedures for issuance of a policy

Generally, the policy is available with a minimum Face Amount at issue of $50,000. At the time of issue, the insured person must have an attained age of no more than 90. The insured person must meet certain health and other insurance risk criteria called “underwriting standards.” Our underwriting standards for the issuance of the policy do not require the proposed insured to undergo a medical examination. Although these standards are more convenient, the policy charges are set to reflect a higher risk assumed by us under a policy underwritten in this way, and you may find that a policy subject to a more rigorous (“full”) underwriting is more appropriate for you. Please discuss these considerations with your registered representative.

Commencement of insurance coverage

After you apply for a policy, it can take up to several weeks for us to gather and evaluate all the information we need to decide whether to issue a policy to you and, if so, what the insured person’s risk classification should be. After we approve an application for a policy and assign an appropriate insurance risk classification, we will prepare the policy for delivery. We will not pay a death benefit under a policy unless the policy is in effect when the insured person dies (except for the circumstances described under “Temporary coverage prior to policy delivery” below).

The policy will take effect only if all of the following conditions are satisfied:

The date all of the above conditions are satisfied is referred to in this prospectus as the “Contract Completion Date.” If all of the above conditions are satisfied, the policy will take effect on the date shown in the policy as the “Policy Date.” That is the date on which we begin to deduct monthly charges. Policy months, policy years and policy anniversaries are all measured from the Policy Date.

Backdating

Under limited circumstances, we may backdate a policy, upon request, by assigning a Policy Date earlier than the date the application is signed. However, in no event will a policy be backdated earlier than six months from the date of application for the policy, the earliest date allowed by New York state law. The most common reasons for backdating are to preserve a younger age at issue for the insured person or to retain a common monthly deduction date in certain corporate-owned life insurance cases involving multiple policies issued over time. If used to preserve age, backdating will result in lower insurance charges. However, monthly deductions will begin earlier than would otherwise be the case. Monthly deductions for the period the Policy Date is backdated will actually be deducted from policy value on the Contract Completion Date.

Temporary coverage prior to policy delivery

If a specified amount of premium is paid with the application for a policy and other conditions are met, we will provide temporary term life insurance coverage on the insured person for a period prior to the time coverage under the policy takes effect. Such temporary term coverage will be subject to the terms and conditions described in the Temporary Life Insurance Agreement and Receipt attached to the application for the policy, including conditions to coverage and limits on amount and duration of coverage.

Monthly deduction dates

Each charge that we deduct monthly is assessed against your policy value at the close of business on the Policy Date and at the close of the first day in each subsequent policy month.

Changes that we can make as to your policy

We reserve the right to make any changes in the policy necessary to ensure the policy is within the definition of life insurance under the Federal tax laws and is in compliance with any changes in Federal or state tax laws.

In our policies, we reserve the right to make certain changes if they would serve the best interests of policy owners or would be appropriate in carrying out the purposes of the policies. These changes include the following:

32

Table Of Contents

Any such changes will be made only to the extent permitted by applicable laws and only in the manner permitted by such laws. When required by law, we will obtain your approval of the changes and the approval of any appropriate regulatory authority.

The owner of the policy

Who owns the policy? That’s up to the person who applies for the policy. The owner of the policy is the person who can exercise most of the rights under the policy, such as the right to choose the investment accounts in which to invest or the right to surrender the policy. In many cases, the person buying the policy is also the person who will be the owner. However, the application for a policy can name another person or entity (such as a trust) as owner. Whenever we’ve used the term “you” in this prospectus, we’ve assumed that the reader is the person who has whatever right or privilege is being discussed. There may be tax consequences if the owner and the insured person are different, so you should discuss this issue with your tax adviser.

While the insured person is alive, you will have a number of options under the policy. These options include those listed below:

It is possible to name so-called “joint owners” of the policy. If more than one person owns a policy, all owners must join in most requests to exercise rights under the policy.

Policy cancellation right

You have the right to cancel your policy within ten days after you receive it (the period may be longer in some states). This is often referred to as the “free look” period. During this period, your premiums will be allocated as described under “Processing premium payments” in this prospectus. To cancel your policy, simply deliver or mail the policy to:

The date of cancellation will be the date of such mailing or delivery. You will receive a refund of any premiums you’ve paid.

Reports that you will receive

At least annually, we will send you a statement setting forth at least the following information as of the end of the most recent reporting period: the amount of the death benefit, the portion of the policy value in each investment account, premiums received and charges deducted from premiums since the last report, any outstanding policy loan (and interest charged for the preceding policy year), and any further information required by law. Moreover, you also will receive confirmations of premium payments, transfers among investment accounts, policy loans, partial withdrawals and certain other policy transactions.

Semi-annually we will send you a report containing the financial statements of the portfolios, including a list of securities held in each portfolio.

Assigning your policy

You may assign your rights in the policy to someone else as collateral for a loan or for some other reason. Assignments do not require the consent of any revocable beneficiary. A copy of the assignment must be forwarded to us. We are not responsible for any payment we make or any action we take before we receive a copy of the assignment at our Service Office.

33

Table Of Contents
Nor are we responsible for the validity of the assignment or its efficacy in meeting your objectives. An absolute assignment is a change of ownership. All collateral assignees of record must usually consent to any surrender, withdrawal or loan from the policy.

When we pay policy proceeds

General

We will ordinarily pay any death benefit, withdrawal, surrender value or loan within seven days after we receive the last required form or request (and, with respect to the death benefit, any other documentation that may be required). If we don’t have information about the desired manner of payment within seven days after the date we receive documentation of the insured person’s death, we will pay the proceeds as a single sum.

Delay to challenge coverage

We may challenge the validity of your insurance policy based on any material misstatements made to us in the application for the policy. We cannot make such a challenge, however, beyond the time limit that is specified in your policy, which is generally two years from the Issue Date.

Delay for check clearance

We reserve the right to defer payment of that portion of your policy value that is attributable to a premium payment made by check for a reasonable period of time (not to exceed fifteen days) to allow the check to clear the banking system. We will not delay payment longer than necessary for us to verify a check has cleared the banking system.

Delay of separate account proceeds

We reserve the right to defer payment of any death benefit, loan or other distribution that is derived from an investment account if (1) the New York Stock Exchange is closed (other than customary weekend and holiday closings) or trading on the New York Stock Exchange is restricted; (2) an emergency exists, as determined by the SEC, as a result of which disposal of securities is not reasonably practicable or it is not reasonably practicable to fairly determine the policy value; or (3) the SEC by order permits the delay for the protection of owners. Transfers and allocations of policy value among the investment accounts may also be postponed under these circumstances. If we need to defer calculation of separate account values for any of the foregoing reasons, all delayed transactions will be processed at the next values that we do compute.

How you communicate with us

General rules

You should mail or express all checks and money orders for premium payments and loan repayments to the John Hancock NY Service Office at the appropriate address shown on the back cover.

Under our current rules, certain requests must be made in writing and be signed and dated by you. Those requests include the following.

The following requests may be made either in writing (signed and dated by you) or by telephone or fax or through the Company’s secured website, if a special form is completed (see “Telephone, facsimile and internet transactions” below).

34

Table Of Contents

You should mail or express all written requests to our Service Office at the appropriate address shown on the back cover. You should also send notice of the insured person’s death and related documentation to our Service Office. We do not consider that we’ve “received” any communication until such time as it has arrived at the proper place and in the proper and complete form.

We have special forms that should be used for a number of the requests mentioned above. You can obtain these forms from our Service Office or your John Hancock NY representative. Each communication to us must include your name, your policy number and the name of the insured person. We cannot process any request that doesn’t include this required information. Any communication that arrives after the close of our business day, or on a day that is not a business day, will be considered “received” by us on the next following business day. Our business day currently closes at 4:00 p.m. Eastern time, but special circumstances (such as suspension of trading on a major exchange) may dictate an earlier closing time.

Telephone, facsimile and internet transactions

If you complete a special authorization form, you can request transfers among accounts and changes of allocation among investment accounts simply by telephoning us at 1-877-391-3748, Option 4, or by faxing us at 1-416-926-5809 or through the Company’s secured website. Any fax or internet request should include your name, daytime telephone number, policy number and, in the case of transfers and changes of allocation, the names of the investment accounts involved. We will honor telephone and internet instructions from anyone who provides the correct identifying information, so there is a risk of loss to you if this service is used by an unauthorized person. However, you will receive written confirmation of all telephone/internet transactions. There is also a risk that you will be unable to place your request due to equipment malfunction or heavy phone line or internet usage. If this occurs, you should submit your request in writing.

If you authorize telephone or internet transactions, you will be liable for any loss, expense or cost arising out of any unauthorized or fraudulent telephone or internet instructions which we reasonably believe to be genuine, unless such loss, expense or cost is the result of our mistake or negligence. We employ procedures which provide safeguards against the execution of unauthorized transactions which are reasonably designed to confirm that instructions received by telephone or internet are genuine. These procedures include requiring personal identification, the use of a unique password for internet authorization, recording of telephone calls, and providing written confirmation to the owner. If we do not employ reasonable procedures to confirm that instructions communicated by telephone or internet are genuine, we may be liable for any loss due to unauthorized or fraudulent instructions.

As stated earlier in this prospectus, the policies are not designed for professional market timing organizations or other persons or entities that use programmed, large or frequent transfers among investment options. To discourage disruptive trading, we have imposed certain transfer restrictions (see “Transfers of existing policy value”). In addition, we also reserve the right to change our telephone, facsimile and internet transaction privileges outlined in this section at any time, and to suspend or terminate any or all of those privileges with respect to any owners who we feel are abusing the privileges to the detriment of other owners.

Distribution of policies

John Hancock Distributors LLC (“JH Distributors”), a Delaware limited liability company affiliated with us, is the principal distributor and underwriter of the securities offered through this prospectus and of other annuity and life insurance products we and our affiliates offer. JH Distributors also acts as the principal underwriter of the Trust, whose securities are used to fund certain investment accounts under the policies and under other annuity and life insurance products we offer.

JH Distributors’ principal address is 601 Congress Street, Boston, MA 02210 and it also maintains offices with us at 197 Clarendon Street, Boston, Massachusetts 02116. JH Distributors is a broker-dealer registered under the Securities Exchange Act of 1934 (the “1934 Act”) and a member of the Financial Industry Regulatory Authority (“FINRA”).

We offer the policies for sale through individuals who are licensed as insurance agents and who are registered representatives of broker-dealers that have entered into selling agreements with JH Distributors. Our affiliate, Signator Investors, Inc., is one such broker-dealer. In addition, we, either directly or through JH Distributors, have entered into agreements with other financial intermediaries that provide marketing, sales support and certain administrative services to help promote the policies (“financial intermediaries”). In a limited number of cases, we have entered into loans, leases or other financial agreements with these broker-dealers or financial intermediaries or their affiliates.

35

Table Of Contents

Compensation

The broker-dealers and other financial intermediaries that distribute or support the marketing of our policies may be compensated by means of various compensation and revenue sharing arrangements. A general description of these arrangements is set out below under “Standard compensation” and “Additional compensation and revenue sharing.” These arrangements may differ between firms, and not all broker-dealers or financial intermediaries will receive the same compensation and revenue sharing benefits for distributing our policies. Also, a broker-dealer may receive more or less compensation or other benefits for the promotion and sale of our policy than it would expect to receive from another issuer.

Under their own arrangements, broker-dealers determine how much of any amounts received from us is to be paid to their registered representatives. Our affiliated broker-dealer, Signator Investors, Inc., may pay its registered representatives additional compensation and benefits, such as bonus payments, expense payments, health and retirement benefits or the waiver of overhead costs or expenses in connection with the sale of the policies that they would not receive in connection with the sale of policies issued by unaffiliated companies.

Policy owners do not pay any compensation or revenue sharing benefits directly. These payments are made from JH Distributors’ and our own revenues, profits or retained earnings, which may be derived from a number of sources, such as fees received from an underlying fund’s distribution plan (“12b-1 fees”), the fees and charges imposed under the policy and other sources.

You should contact your registered representative for more information on compensation arrangements in connection with your purchase of a policy. We provide additional information on special compensation or reimbursement arrangements involving broker-dealers and other financial intermediaries in the Statement of Additional Information, which is available upon request.

Standard compensation. JH Distributors pays compensation to broker-dealers for the promotion and sale of the policies, and for providing ongoing service in relation to policies that have already been purchased. We may also pay a limited number of broker-dealers commissions or overrides to “wholesale” the policies; that is, to provide marketing support and training services to the broker-dealer firms that do the actual selling.

The compensation JH Distributors pays to broker-dealers may vary depending on the selling agreement. The compensation paid is not expected to exceed 137% of target premium paid in the first policy year, 30% of target premium paid in year 2 and 8% of target premium paid in years 3-10. Compensation paid on any premium in excess of target will not exceed 10% in any year. This compensation schedule is exclusive of additional compensation and revenue sharing and inclusive of overrides and expense allowances paid to broker-dealers for sale of the policies (not including riders).

Additional compensation and revenue sharing. To the extent permitted by SEC and FINRA rules and other applicable laws and regulations, we may enter into special compensation or reimbursement arrangements (“revenue sharing”), either directly or through JH Distributors, with selected broker-dealers and other financial intermediaries. In consideration of these arrangements, a firm may feature our policy in its sales system, give us preferential access to sales staff, or allow JH Distributors or its affiliates to participate in conferences, seminars or other programs attended by the firm’s sales force. We hope to benefit from these revenue sharing and other arrangements through increased sales of our policies.

Selling broker-dealers and other financial intermediaries may receive, directly or indirectly, additional payments in the form of cash, other compensation or reimbursement. These additional compensation or reimbursement arrangements may include, for example, payments in connection with the firm’s “due diligence” examination of the policies, payments for providing conferences or seminars, sales or training programs for invited registered representatives and other employees, payment for travel expenses, including lodging, incurred by registered representatives and other employees for such seminars or training programs, seminars for the public or client seminars, advertising and sales campaigns regarding the policies, payments to assist a firm in connection with its systems, operations and marketing expenses and/or other events or activities sponsored by the firms. We may contribute to, as well as sponsor, various educational programs, sales promotions, and/or other contests in which participating firms and their sales persons may receive gifts and prizes such as merchandise, cash or other rewards as may be permitted under FINRA rules and other applicable laws and regulations.

Tax considerations

This description of Federal income tax consequences is only a brief summary and is neither exhaustive nor authoritative. It was written to support the promotion of our products. It does not constitute legal or tax advice, and it is not intended to be used and cannot be used to avoid any penalties that may be imposed on you. Tax consequences will vary based on your own

36

Table Of Contents
particular circumstances, and for further information you should consult a qualified tax adviser. Federal, state and local tax laws, regulations and interpretations can change from time to time. As a result, the tax consequences to you and the beneficiary may be altered, in some cases retroactively. The policy may be used in various arrangements, including non-qualified deferred compensation or salary continuation plans, split dollar insurance plans, executive bonus plans, retiree medical benefit plans and others. The tax consequences of such plans may vary depending on the particular facts and circumstances of each individual arrangement. Therefore, if the value of using the policy in any such arrangement depends in part on the tax consequences, a qualified tax adviser should be consulted for advice.

General

We are taxed as a life insurance company. Under current tax law rules, we include the investment income (exclusive of capital gains) of the Separate Account in our taxable income and take deductions for investment income credited to our policy holder reserves. We are also required to capitalize and amortize certain costs instead of deducting those costs when they are incurred. We do not currently charge the Separate Account for any resulting income tax costs, other than a charge we may impose against the Separate Account to compensate us for the cost of a delay in the deductibility of deferred acquisition costs (the “DAC tax” adjustment) pursuant to section 848 of the Internal Revenue Code. We also claim certain tax credits or deductions relating to foreign taxes paid and dividends received by the series funds. These benefits can be material. We do not pass these benefits through to the Separate Account, principally because: (i) the deductions and credits are allowed to us and not the policy owners under applicable tax law; and (ii) the deductions and credits do not represent investment return on the Separate Account assets that is passed through to policy owners.

The policies permit us to deduct a charge for any taxes we incur that are attributable to the operation or existence of the policies or the Separate Account. Currently, we do not anticipate making any specific charge for such taxes other than any DAC tax charge and premium taxes where applicable. If the level of the current taxes increases, however, or is expected to increase in the future, we reserve the right to make a charge in the future.

Death benefit proceeds and other policy distributions

Generally, death benefits paid under policies such as yours are not subject to income tax unless policy ownership has been transferred in exchange for payment. Earnings on your policy value are ordinarily not subject to income tax as long as we don’t pay them out to you. If we do pay out any amount of your policy value upon surrender or partial withdrawal, all or part of that distribution would generally be treated as a return of the premiums you’ve paid and not subjected to income tax. Any portion not treated as a return of your premiums would be includible in your income.

Please note that certain distributions associated with a reduction in death benefit or other policy benefits within the first fifteen years after issuance of the policy are ordinarily taxable in whole or in part. Amounts you borrow are generally not taxable to you. However, some of the tax rules change if your policy becomes a modified endowment contract. This can happen if you’ve paid premiums in excess of limits prescribed by the tax laws. In that case additional taxes and penalties may be payable for policy distributions of any kind, including loans. (See “7-pay premium limit and modified endowment contract status” below.)

We expect the policy to receive the same Federal income and estate tax treatment as fixed benefit life insurance policies. Section 7702 of the Internal Revenue Code defines a life insurance contract for Federal tax purposes. For a policy to be treated as a life insurance contract, it must satisfy the guideline premium test. This test limits the amount of premium that you may pay into the policy. We will monitor compliance with this standard. If we determine that a policy does not satisfy section 7702, we may take whatever steps are appropriate and reasonable to bring it into compliance with section 7702.

If the policy complies with section 7702, the death benefit proceeds under the policy ordinarily should be excludable from the beneficiary’s gross income under section 101 of the Internal Revenue Code. (As noted above, a transfer of the policy for valuable consideration may limit the exclusion of death benefits from the beneficiary’s income.)

Increases in policy value as a result of interest or investment experience will not be subject to Federal income tax unless and until values are received through actual or deemed distributions. In general, unless the policy is a modified endowment contract, the owner will be taxed only on the amount of distributions that exceed the premiums paid under the policy. An exception to this general rule occurs in the case of a decrease in the policy’s death benefit or any other change that reduces benefits under the policy in the first fifteen years after the policy is issued and that results in a cash distribution to the policy owner. Changes that reduce benefits include partial withdrawals, death benefit option changes, and distributions required to

37

Table Of Contents
keep the policy in compliance with section 7702. For purposes of this rule any distribution within the two years immediately before a reduction in benefits will also be treated as if it were a result of the reduction. A cash distribution that reduces policy benefits will be taxed in whole or in part (to the extent of any gain in the policy) under rules prescribed in section 7702. The taxable amount is subject to limits prescribed in section 7702(f)(7). Any taxable distribution will be ordinary income to the owner (rather than capital gain).

Distributions for tax purposes include amounts received upon surrender or partial withdrawals. You may also be deemed to have received a distribution for tax purposes if you assign all or part of your policy rights or change your policy’s ownership.

It is possible that, despite our monitoring, a policy might fail to qualify as a life insurance contract under section 7702 of the Internal Revenue Code. This could happen, for example, if we inadvertently failed to return to you any premium payments that were in excess of permitted amounts, or if any of the funds failed to meet certain investment diversification or other requirements of the Internal Revenue Code. If this were to occur, you would be subject to income tax on the income credited to the policy from the date of issue to the date of the disqualification and for subsequent periods.

Tax consequences of ownership or receipt of policy proceeds under Federal, state and local estate, inheritance, gift and other tax laws will depend on the circumstances of each owner or beneficiary. If the person insured by the policy is also its owner, either directly or indirectly through an entity such as a revocable trust, the death benefit will be includible in his or her estate for purposes of the Federal estate tax. If the owner is not the person insured, the value of the policy will be includible in the owner’s estate upon his or her death. Even if ownership has been transferred, the death proceeds or the policy value may be includible in the former owner’s estate if the transfer occurred less than three years before the former owner’s death or if the former owner retained certain kinds of control over the policy. You should consult your tax adviser regarding these possible tax consequences.

Because there may be unfavorable tax consequences (including recognition of taxable income and the loss of income tax-free treatment for any death benefit payable to the beneficiary), you should consult a qualified tax adviser prior to changing the policy’s ownership or making any assignment of ownership interests.

Policy loans

We expect that, except as noted below (see “7-pay premium limit and modified endowment contract status”), loans received under the policy will be treated as indebtedness of an owner and that no part of any loan will constitute income to the owner. However, if the policy terminates for any reason other than the payment of the death benefit, an amount equal to any outstanding loan that was not previously considered income will be treated as if it had been distributed to the owner upon such termination. This could result in a considerable tax bill. Under certain circumstances involving large amounts of outstanding loans, you might find yourself having to choose between high premiums required to keep your policy from lapsing and a significant tax burden if you allow the lapse to occur.

Diversification rules and ownership of the Separate Account

Your policy will not qualify for the tax benefits of a life insurance contract unless the Separate Account follows certain rules requiring diversification of investments underlying the policy. In addition, the rules require that the policy owner not have “investor control” over the underlying assets.

In certain circumstances, the owner of a variable life insurance policy may be considered the owner, for Federal income tax purposes, of the assets of the Separate Account used to support the policy. In those circumstances, income and gains from the Separate Account assets would be includible in the policy owner’s gross income. The Internal Revenue Service (“IRS”) has stated in published rulings that a variable policy owner will be considered the owner of Separate Account assets if the policy owner possesses incidents of ownership in those assets, such as the ability to exercise investment control over the assets. A Treasury Decision issued in 1986 stated that guidance would be issued in the form of regulations or rulings on the “extent to which Policyholders may direct their investments to particular sub-accounts of a Separate Account without being treated as owners of the underlying assets.” As of the date of this prospectus, no comprehensive guidance on this point has been issued. In Rev. Rul. 2003-91, however, the IRS ruled that a contract holder would not be treated as the owner of assets underlying a variable life insurance or annuity contract despite the owner’s ability to allocate funds among as many as twenty subaccounts.

The ownership rights under your policy are similar to, but different in certain respects from, those described in IRS rulings in which it was determined that policyholders were not owners of Separate Account assets. Since you have greater

38

Table Of Contents
flexibility in allocating premiums and policy values than was the case in those rulings, it is possible that you would be treated as the owner of your policy’s proportionate share of the assets of the Separate Account.

We do not know what future Treasury Department regulations or other guidance may require. We cannot guarantee that the funds will be able to operate as currently described in the series funds’ prospectuses, or that a series fund will not have to change any fund’s investment objectives or policies. We have reserved the right to modify your policy if we believe doing so will prevent you from being considered the owner of your policy’s proportionate share of the assets of the Separate Account, but we are under no obligation to do so.

7-pay premium limit and modified endowment contract status

At the time of policy issuance, we will determine whether the Planned Premium schedule will exceed the 7-pay limit discussed below. If so, our standard procedures prohibit issuance of the policy unless you sign a form acknowledging that fact.

The 7-pay limit at any time during the first seven contract years is the total of net level premiums that would have been payable at or before that time under a comparable fixed policy that would be fully “paid-up” after the payment of seven equal annual premiums. “Paid-up” means that no further premiums would be required to continue the coverage in force until maturity, based on certain prescribed assumptions. If the total premiums paid at any time during the first seven policy years exceed the 7-pay limit, the policy will be treated as a modified endowment contract, which can have adverse tax consequences.

Policies classified as modified endowment contracts are subject to the following tax rules:

These exceptions to the 10% additional tax do not apply in situations where the policy is not owned by an individual.

Furthermore, any time there is a “material change” in a policy, the policy will begin a new 7-pay testing period as if it were a newly-issued policy. The material change rules for determining whether a policy is a modified endowment contract are complex. In general, however, the determination of whether a policy will be a modified endowment contract after a material change depends upon the relationship among the death benefit of the policy at the time of such change, the policy value at the time of the change, and the additional premiums paid into the policy during the seven years starting with the date on which the material change occurs.

Moreover, under a policy insuring a single life, if there is a reduction in benefits (such as a reduction in the death benefit or the reduction or cancellation of certain rider benefits) during a 7-pay testing period, the 7-pay limit will generally be recalculated based on the reduced benefits and the policy will be re-tested, from the beginning of the 7-pay testing period using the lower limit. If the premiums paid to date at any point during the 7-pay testing period are greater than the recalculated 7-pay limit, the policy will become a modified endowment contract. If your policy is a survivorship policy, a reduction in benefits under the policy at any time will require re-testing. For such a policy the 7-pay limit will generally be recalculated based on the reduced benefits and the policy will be re-tested, using the lower limit, from the date it was issued.

If your policy is issued as a result of an exchange subject to section 1035 of the Internal Revenue Code, it may be considered to be a modified endowment contract if the death benefit under the new policy is smaller than the death benefit

39

Table Of Contents
under the exchanged policy, or if you reduce coverage in your new policy after it is issued. Therefore, if you desire to reduce the face amount as part of a 1035 exchange, a qualified tax adviser should be consulted for advice. A new policy issued in exchange for a modified endowment contract will also be a modified endowment contract regardless of any change in the death benefit.

All modified endowment contracts issued by the same insurer (or its affiliates) to the same owner during any calendar year generally are required to be treated as one contract for the purpose of applying the rules on taxation of withdrawals from modified endowment contracts. You should consult your tax adviser if you have questions regarding the possible impact of the 7-pay limit on your policy.

Corporate and H.R. 10 retirement plans

The policy may be acquired in connection with the funding of retirement plans satisfying the qualification requirements of section 401 of the Internal Revenue Code. If so, the Internal Revenue Code provisions relating to such plans and life insurance benefits thereunder should be carefully scrutinized. We are not responsible for compliance with the terms of any such plan or with the requirements of applicable provisions of the Internal Revenue Code.

Withholding

To the extent that policy distributions to you are taxable, they are generally subject to withholding for your Federal income tax liability. However if you reside in the United States, you can generally choose not to have tax withheld from distributions. Electing to have no withholding will not reduce your tax liability and may expose you to penalties under the rules governing payment of estimated taxes.

Life insurance purchases by residents of Puerto Rico

In Rev. Rul. 2004-75, 2004-31 I.R.B. 109, the Internal Revenue Service ruled that income received by residents of Puerto Rico under a life insurance policy issued by a United States company is U.S.-source income that is subject to United States Federal income tax.

Life insurance purchases by non-resident aliens

If you are not a U.S. citizen or resident, you will generally be subject to U.S. Federal withholding tax on taxable distributions from life insurance policies at a 30% rate, unless a lower treaty rate applies. In addition, you may be subject to state and/or municipal taxes and taxes imposed by your country of citizenship or residence. You should consult with a qualified tax adviser before purchasing a policy.

Life insurance owned by citizens or residents living abroad

If you are a U.S. citizen or permanent resident living outside the United States, you are still subject to income taxation by the United States. Since many countries tax on the basis of domicile, you may also be subject to tax in the country or territory in which you are living. The tax-deferred accumulation of gain that a life insurance policy provides under United States tax law may not be available under the tax laws of the country in which you are living. If you are living outside the United States or planning to do so, you should consult with a qualified tax adviser before purchasing or retaining ownership of a policy.


Financial statements reference

The financial statements of John Hancock NY and the Separate Account can be found in the Statement of Additional Information. The financial statements of John Hancock NY should be distinguished from the financial statements of the Separate Account and should be considered only as bearing upon the ability of John Hancock USA to meet its obligations under the policies. Our general account is comprised of securities and other investments, the value of which may decline during periods of adverse market conditions.

Registration statement filed with the SEC

This prospectus omits certain information contained in the Registration Statement which has been filed with the SEC. More details may be obtained from the SEC upon payment of the prescribed fee.

40

Table Of Contents

Independent registered public accounting firm

The financial statements of John Hancock Life Insurance Company of New York at December 31, 2013 and 2012, and for each of the three years in the period ended December 31, 2013, and the financial statements of John Hancock Life Insurance Company of New York Separate Account B at December 31, 2013, and for each of the two years in the period ended December 31, 2013, appearing in the Statement of Additional Information of the Registration Statement have been audited by Ernst &Young LLP, independent registered public accounting firm, as set forth in their reports thereon appearing elsewhere herein, and are included in reliance upon such reports given on the authority of such firm as experts in accounting and auditing.

41

Table Of Contents

In addition to this prospectus, John Hancock NY has filed with the SEC a Statement of Additional Information (the “SAI”) which contains additional information about John Hancock NY and the Separate Account, including information on our history, services provided to the Separate Account, legal and regulatory matters and the audited financial statements for John Hancock NY and the Separate Account. The SAI and personalized illustrations of death benefits, policy values and surrender values are available, without charge, upon request. You may obtain the personalized illustrations from your John Hancock NY representative. The SAI may be obtained by contacting the John Hancock NY Service Office. You should also contact the John Hancock NY Service Office to request any other information about your policy or to make any inquiries about its operation.

JOHN HANCOCK NY SERVICE OFFICE
Principal Office & Express Delivery Mail Delivery
197 Clarendon Street
Boston, MA 02116-5010
1 John Hancock Way, Suite 1350
Boston, MA 02217-1099
Phone: Fax:
1-877-391-3748, Option 4 1-617-572-1571










Information about the Separate Account (including the SAI) can be reviewed and copied at the SEC’s Public Reference Branch, 100 F Street, NE, Room 1580, Washington, DC, 20549. Information on the operation of the Public Reference Room may be obtained by calling the SEC at 202-551-8090. Reports and other information about the Account are available on the SEC’s Internet website at http://www.sec.gov. Copies of such information may be obtained, upon payment of a duplicating fee, by writing the Public Reference Section of the SEC at 100 F Street, NE, Washington, DC 20549-0102.










1940 Act File No. 811-8329  —  1933 Act File No. 333-194819



Table of Contents

Statement of Additional Information
dated July 25, 2014

for interests in

John Hancock Life Insurance Company of New York Separate Account B
(Name of Registrant)

JOHN HANCOCK LIFE INSURANCE COMPANY OF NEW YORK
(“John Hancock NY”)
(Name of Depositor)

This is a Statement of Additional Information (“SAI”). It is not the prospectus. The prospectus, dated the same date as this SAI, may be obtained from a John Hancock NY representative or by contacting the John Hancock NY Service Office at 1-877-391-3748 Option 4.


TABLE OF CONTENTS

Contents of this SAI Page No.
Description of the Depositor
2
Description of the Registrant
2
Services
2
Independent registered public accounting firm
2
Legal and Regulatory Matters
2
Principal Underwriter/Distributor
2
Additional Information About Charges
3
Reduction in Charges
4
Financial Statements of Registrant and Depositor
F-1

Table Of Contents

Description of the Depositor

Under the Federal securities laws, the entity responsible for organization of the registered separate account underlying the variable life insurance policy is known as the “Depositor.” The Depositor is John Hancock NY, a stock life insurance company organized under the laws of New York in 1992. We are a licensed life insurance company in the state of New York. Until 2004, John Hancock NY had been known as The Manufacturers Life Insurance Company of New York.

John Hancock NY is a wholly-owned subsidiary of John Hancock Life Insurance Company (U.S.A.), a life insurance company domiciled in Michigan. Our ultimate parent is Manulife Financial Corporation (“MFC”), a publicly traded company based in Toronto, Canada. MFC is the holding company of The Manufacturers Life Insurance Company and its subsidiaries, collectively known as Manulife Financial.

Description of the Registrant

Under the Federal securities laws, the registered separate account underlying the variable life insurance policy is known as the “Registrant.” John Hancock Life Insurance Company of New York Separate Account B (the “Registrant” or “Separate Account”), is a separate account established by the Depositor under NY law. The variable investment options shown on page 1 of the prospectus are subaccounts of the Separate Account. The Separate Account meets the definition of “separate account” under the Federal securities laws and is registered as a unit investment trust under the Investment Company Act of 1940 (“1940 Act”). Such registration does not involve supervision by the Securities and Exchange Commission (“SEC”) of the management of the Separate Account or of the Depositor.

New subaccounts may be added and made available to policy owners from time to time. Existing subaccounts may be modified or deleted at any time.

Services

Administration of policies issued by the Depositor and of registered separate accounts organized by the Depositor may be provided by other affiliates. Neither the Depositor nor the separate accounts are assessed any charges for such services.

The Depositor, located at 197 Clarendon St., Boston, MA 02116, is the custodian of the assets of the Separate Account. The Depositor has custody of all cash of the Separate Account and handles the collection of proceeds of shares of the underlying funds bought and sold by the Separate Account.

Independent registered public accounting firm

The financial statements of John Hancock Life Insurance Company of New York at December 31, 2013 and 2012, and for each of the three years in the period ended December 31, 2013, and the financial statements of John Hancock Life Insurance Company of New York Separate Account B at December 31, 2013, and for each of the two years in the period ended December 31, 2013, appearing in the Statement of Additional Information of the Registration Statement have been audited by Ernst &Young LLP, independent registered public accounting firm, as set forth in their reports thereon appearing elsewhere herein, and are included in reliance upon such reports given on the authority of such firm as experts in accounting and auditing.

Legal and Regulatory Matters

There are no legal proceedings to which the Depositor, the Separate Account or the principal underwriter is a party or to which the assets of the Separate Account are subject that are likely to have a material adverse effect on the Separate Account or the ability of the principal underwriter to perform its contract with the Separate Account or of the Depositor to meet its obligations under the policies.

Principal Underwriter/Distributor

John Hancock Distributors LLC (“JH Distributors”), a Delaware limited liability company affiliated with the Depositor, is the principal distributor and underwriter of the securities offered through the prospectus. JH Distributors acts as the principal distributor of a number of other life insurance and annuity products we and our affiliates offer or maintain. JH

2

Table Of Contents
Distributors also acts as the principal underwriter of John Hancock Variable Insurance Trust (the “Trust”), whose securities are used to fund certain variable investment options under the policies and under other life insurance and annuity products we offer or maintain.

JH Distributors’ principal address is 601 Congress Street, Boston, MA 02210, and it also maintains offices with us at 197 Clarendon Street, Boston, MA 02116. JH Distributors is a broker-dealer registered under the Securities Act of 1934 (the “1934 Act”) and is a member of the Financial Industry Regulatory Authority (“FINRA”).

We offer the policies for sale through individuals who are licensed as insurance agents and who are registered representatives of broker-dealers that have entered into selling agreements with JH Distributors. Our affiliate Signator Investors, Inc. is one such broker-dealer.

The aggregate dollar amount of underwriting commissions paid to JH Distributors by the Depositor and its affiliates in connection with the sale of variable life products in 2013, 2012 and 2011 was $119,574,297, $156,801,522, and $158,741,294 respectively. JH Distributors did not retain any of these amounts during such periods.

The registered representative through whom your policy is sold will be compensated pursuant to the registered representative’s own arrangement with his or her broker-dealer. Compensation to broker-dealers for the promotion and sale of the policies is not paid directly by policy owners but will be recouped through the fees and charges imposed under the policy.

Additional compensation and revenue sharing arrangements may be offered to certain broker-dealer firms and other financial intermediaries. The terms of such arrangements may differ among firms we select based on various factors. In general, the arrangements involve three types of payments or any combination thereof:

Our affiliated broker-dealer, Signator Investors, Inc., may pay its respective registered representatives additional cash incentives, such as bonus payments, expense payments, health and retirement benefits or the waiver of overhead costs or expenses in connection with the sale of the policies that they would not receive in connection with the sale of policies issued by unaffiliated companies.

Additional Information About Charges

A policy will not be issued until the underwriting process has been completed to our satisfaction. The underwriting process generally includes the obtaining of information concerning your age, medical history, occupation and other personal information. This information is then used to determine the cost of insurance charge.

3

Table Of Contents

Reduction in Charges

The policy may be available for purchase by corporations and other groups or sponsoring organizations. Group or sponsored arrangements may include reduction or elimination of withdrawal charges and deductions for employees, officers, directors, agents and immediate family members of the foregoing. We reserve the right to reduce any of the policy’s charges on certain cases where it is expected that the amount or nature of such cases will result in savings of sales, underwriting, administrative, commissions or other costs. Eligibility for these reductions and the amount of reductions will be determined by a number of factors, including the number of lives to be insured, the total premiums expected to be paid, total assets under management for the policyowner, the nature of the relationship among the insured individuals, the purpose for which the policies are being purchased, expected persistency of the individual policies, and any other circumstances which we believe to be relevant to the expected reduction of its expenses. Some of these reductions may be guaranteed and others may be subject to withdrawal or modifications, on a uniform case basis. Reductions in charges will not be unfairly discriminatory to any policyowners. We may modify from time to time, on a uniform basis, both the amounts of reductions and the criteria for qualification.


333-85296 333-131134  
333-88972 333-132905 333-152408
333-33504 333-141693 333-153253
333-100664 333-148992 333-157213
333-127543 333-151631 333-179571
333-131139 333-194819
4


Table of Contents

AUDITED FINANCIAL STATEMENTS

John Hancock Life Insurance Company of New York

For the Years Ended December 31, 2013, 2012 and 2011

With Report of Independent Auditors


Table of Contents

JOHN HANCOCK LIFE INSURANCE COMPANY OF NEW YORK

INDEX TO AUDITED FINANCIAL STATEMENTS

 

Report of Independent Auditors

     F-1   

Audited Consolidated Financial Statements

  

Balance Sheets-
As of December 31, 2013 and 2012

     F-2   

Statements of Operations-
For the Years Ended December 31, 2013, 2012 and 2011

     F-4   

Statements of Comprehensive Income (Loss)-
For the Years Ended December 31, 2013, 2012 and 2011

     F-5   

Statements of Changes in Shareholder’s Equity-
For the Years Ended December 31, 2013, 2012 and 2011

     F-6   

Statements of Cash Flows-
For the Years Ended December 31, 2013, 2012 and 2011

     F-7   

Notes to Financial Statements

     F-9   


Table of Contents

Report of Independent Auditors

The Board of Directors

John Hancock Life Insurance Company of New York

We have audited the accompanying financial statements of John Hancock Life Insurance Company of New York, which comprise the balance sheets as of December 31, 2013 and 2012, and the related statements of operations, comprehensive income (loss), changes in shareholder’s equity and cash flows for each of the three years in the period ended December 31, 2013, and the related notes to the financial statements.

Management’s Responsibility for the Financial Statements

Management is responsible for the preparation and fair presentation of these financial statements in conformity with U.S. generally accepted accounting principles; this includes the design, implementation, and maintenance of internal control relevant to the preparation and fair presentation of financial statements that are free of material misstatement, whether due to fraud or error.

Auditor’s Responsibility

Our responsibility is to express an opinion on these financial statements based on our audits. We conducted our audits in accordance with auditing standards generally accepted in the United States. Those standards require that we plan and perform the audit to obtain reasonable assurance about whether the financial statements are free of material misstatement.

An audit involves performing procedures to obtain audit evidence about the amounts and disclosures in the financial statements. The procedures selected depend on the auditor’s judgment, including the assessment of the risks of material misstatement of the financial statements, whether due to fraud or error. In making those risk assessments, the auditor considers internal control relevant to the entity’s preparation and fair presentation of the financial statements in order to design audit procedures that are appropriate in the circumstances, but not for the purpose of expressing an opinion on the effectiveness of the entity’s internal control. Accordingly, we express no such opinion. An audit also includes evaluating the appropriateness of accounting policies used and the reasonableness of significant accounting estimates made by management, as well as evaluating the overall presentation of the financial statements.

We believe that the audit evidence we have obtained is sufficient and appropriate to provide a basis for our audit opinion.

Opinion

In our opinion, the financial statements referred to above present fairly, in all material respects, the financial position of John Hancock Life Insurance Company of New York at December 31, 2013 and 2012, and the results of its operations and its cash flows for each of the three years in the period ended December 31, 2013, in conformity with U.S. generally accepted accounting principles.

/s/ Ernst & Young LLP

Boston, Massachusetts

March 27, 2014

 

F-1


Table of Contents

JOHN HANCOCK LIFE INSURANCE COMPANY OF NEW YORK

BALANCE SHEETS

     December 31,  
     2013      2012  
  

 

 

 
     (in millions)  

Assets

     

Investments

     

Fixed maturities:

     

Available-for-sale—at fair value
(amortized cost: 2013—$5,829; 2012—$6,079)

       $ 5,871           $ 6,629   

Held-for-trading—at fair value
(cost: 2013—$325; 2012—$332)

     338         372   

Equity securities:

     

Available-for-sale—at fair value
(cost: 2013—$0; 2012—$1)

     -         1   

Investment in unconsolidated affiliate

     1         1   

Mortgage loans on real estate

     1,155         977   

Investment real estate, agriculture, and timber

     270         81   

Policy loans

     143         138   

Short-term investments

     1         38   

Other invested assets

     72         5   
  

 

 

    

 

 

 

Total Investments

     7,851         8,242   

Cash and cash equivalents

     59         495   

Accrued investment income

     110         118   

Value of business acquired

     6         12   

Deferred policy acquisition costs and deferred sales inducements

     495         428   

Amounts due from and held for affiliates

     898         286   

Reinsurance recoverable

     450         417   

Derivative assets

     435         654   

Amounts on deposit with reinsurers

     1,586         1,701   

Deferred tax asset

     37         -   

Other assets

     105         61   

Separate account assets

     8,313         7,687   
  

 

 

    

 

 

 

Total Assets

       $   20,345           $   20,101   
  

 

 

    

 

 

 

The accompanying notes are an integral part of these financial statements.

 

F-2


Table of Contents

JOHN HANCOCK LIFE INSURANCE COMPANY OF NEW YORK

BALANCE SHEETS – (CONTINUED)

 

     December 31,  
     2013      2012  
  

 

 

 
     (in millions)  

Liabilities and Shareholder’s Equity

     

Liabilities

     

Future policy benefits

       $ 3,942           $ 3,960   

Policyholders’ funds

     2,295         2,473   

Unearned revenue

     70         40   

Unpaid claims and claim expense reserves

     40         37   

Policyholder dividends payable

     1         2   

Amounts due to affiliates

     378         166   

Current income tax payable

     46         85   

Deferred income tax liability

     -         69   

Coinsurance funds withheld

     2,418         2,329   

Payables for collateral on derivatives

     51         158   

Derivative liabilities

     508         698   

Deferred gains

     112         117   

Other liabilities

     87         89   

Separate account liabilities

     8,313         7,687   
  

 

 

    

 

 

 

Total Liabilities

     18,261         17,910   

Shareholder’s Equity

     

Common stock ($1.00 par value; 3,000,000 shares authorized; 2,000,003 shares issued and outstanding at December 31, 2013 and 2012)

     2         2   

Additional paid-in capital

     895         895   

Retained earnings

     1,179         938   

Accumulated other comprehensive income

     8         356   
  

 

 

    

 

 

 

Total Company Shareholder’s Equity

     2,084         2,191   
  

 

 

    

 

 

 

Total Liabilities and Shareholder’s Equity

       $   20,345           $   20,101   
  

 

 

    

 

 

 

 

The accompanying notes are an integral part of these financial statements.

 

F-3


Table of Contents

JOHN HANCOCK LIFE INSURANCE COMPANY OF NEW YORK

STATEMENTS OF OPERATIONS

 

     Years ended December 31,  
     2013     2012     2011  
  

 

 

 
     (in millions)  

Revenues

      

Premiums

       $ 55          $ 207          $ 74   

Fee income

     252        257        413   

Net investment income

     540        587        597   

Net realized investment and other gains (losses)

     (133     (52     289   

Other revenue

     (1     5        -   
  

 

 

   

 

 

   

 

 

 

Total revenues

        713           1,004           1,373   

Benefits and expenses

      

Benefits to policyholders

     155        511        640   

Policyholder dividends

     5        6        6   

Amortization of deferred policy acquisition costs, deferred sales
inducements, and value of business acquired

     13        53        139   

Other operating costs and expenses

     183        221        237   
  

 

 

   

 

 

   

 

 

 

Total benefits and expenses

     356        791        1,022   
  

 

 

   

 

 

   

 

 

 

Income (loss) before income taxes

     357        213        351   

Income tax expense (benefit)

     116        53        121   
  

 

 

   

 

 

   

 

 

 

Net income (loss)

       $ 241          $ 160          $ 230   
  

 

 

   

 

 

   

 

 

 

 

 

The accompanying notes are an integral part of these financial statements.

 

F-4


Table of Contents

JOHN HANCOCK LIFE INSURANCE COMPANY OF NEW YORK

STATEMENTS OF COMPREHENSIVE INCOME (LOSS)

 

     Years ended December 31,  
     2013     2012     2011  
  

 

 

 
     (in millions)  

Net income (loss)

       $    241      $ 160      $ 230   
  

 

 

 

Other comprehensive income (loss), net of tax

      

Change in unrealized investment gains (losses):

      

Unrealized investment gains (losses) arising during the period

     (356     126        322   

Reclassification adjustment for (gains) losses realized in net income

     57        (102     (208

Change in unrealized gains (losses) on derivative instruments designated as cash flow hedges:

      

Unrealized gains (losses) on the effective portion of the change in fair value of cash flow hedges

     (42     (2     97   

Reclassification of net cash flow hedge (gains) losses to net income

     (7     (4     -   
  

 

 

 

Total other comprehensive income (loss), net of tax

     (348     18        211   
  

 

 

 

Total comprehensive income (loss)

       $ (107   $    178      $    441   
  

 

 

 

Income taxes included in other comprehensive income (loss)

      

Change in unrealized investment gains (losses):

      

Income tax expense (benefit) from unrealized investment gains arising during the period

     (192     67        172   

Income tax (expense) benefit related to reclassification adjustment for gains realized in net income (loss)

     31        (55     (111

Change in unrealized gains (losses) on derivative instruments designated as cash flow hedges:

      

Income tax expense (benefit) from unrealized gains on the effective portion of the change in fair value cash flow hedges

     (23     (1     52   

Income tax (expense) benefit related to reclassification of net cash flow hedge gains to net income (loss)

     (4     (2     -   
  

 

 

 

Total income tax expense (benefit) in other comprehensive income (loss)

       $ (188   $   9      $   113   
  

 

 

 

 

The accompanying notes are an integral part of these financial statements.

 

F-5


Table of Contents

JOHN HANCOCK LIFE INSURANCE COMPANY OF NEW YORK

STATEMENTS OF CHANGES IN SHAREHOLDER’S EQUITY

 

    Common
Stock
    Additional
Paid-in
Capital
    Retained
Earnings
    Accumulated
Other
Comprehensive
Income (Loss)
    Total
Shareholder’s
Equity
attributable
to the
Company
    Outstanding
Shares
 
 

 

 

 
    (in millions, except for shares outstanding)     (in thousands)  

Balance at January 1, 2011

      $   2      $ 895      $ 548      $ 127      $ 1,572        2,000   

Net income (loss)

    -        -        230        -        230     

Other comprehensive income (loss), net of tax

    -        -        -        211        211     
 

 

 

 

Balance at December 31, 2011

      $   2      $   895      $   778      $   338      $   2,013        2,000   
 

 

 

 

Net income (loss)

        160          160     

Other comprehensive income (loss), net of tax

          18        18     
 

 

 

 

Balance at December 31, 2012

      $   2      $   895      $   938      $   356      $   2,191        2,000   
 

 

 

 

Net income (loss)

        241          241     

Other comprehensive income (loss), net of tax

          (348     (348  
 

 

 

 

Balance at December 31, 2013

      $   2      $   895      $   1,179      $   8      $   2,084        2,000   
 

 

 

 

 

The accompanying notes are an integral part of these financial statements.

 

F-6


Table of Contents

JOHN HANCOCK LIFE INSURANCE COMPANY OF NEW YORK

STATEMENTS OF CASH FLOWS

 

     Years ended December 31,  
     2013     2012     2011  
  

 

 

 
     (in millions)  

Cash flows from operating activities:

      

Net income (loss)

       $ 241      $ 160      $ 230   

Adjustments to reconcile net income (loss) to net cash provided by (used in) operating activities:

      

Amortization of premiums and accretion of discounts associated with investments, net

     25        43        74   

Net realized investments and other (gains) losses

     133        52        (289

Amortization of deferred policy acquisition costs, deferred sales
inducements, and value of business acquired

     13        53        139   

Capitalization of deferred policy acquisition costs and deferred sales inducements

     (39     (40     (48

Depreciation and amortization

     2        -        -   

Net cash flows from trading securities

     6        12        54   

(Increase) decrease in accrued investment income

     8        (4     (6

(Increase) decrease in other assets and other liabilities, net

     (74     (294     284   

Increase (decrease) in policyholder liabilities and accruals, net

     (97     211        304   

Interest credited to policyholder liabilities

     142        112        110   

Increase (decrease) in deferred income taxes

     81        (17     (10
  

 

 

 

Net cash provided by (used in) operating activities

     441        288        842   

Cash flows from investing activities:

      

Sales of:

      

Fixed maturities

        3,302           4,321           5,367   

Equity securities

     1        -        -   

Mortgage loans on real estate

     68        74        76   

Investment real estate, agriculture, and timber

     -        6        -   

Maturities, prepayments, and scheduled redemptions of:

      

Fixed maturities

     303        278        551   

Mortgage loans on real estate

     24        25        23   

Other invested assets

     1        -        -   

Purchases of:

      

Fixed maturities

     (3,448     (4,434     (5,911

Equity securities

     -        (1     -   

Investment real estate, agriculture, and timber

     (191     (1     (3

Other invested assets

     (66     (4     -   

Mortgage loans on real estate issued

     (280     (64     (330

Net (purchases) redemptions of short-term investments

     (1     16        13   

Policy loans advanced, net

     (5     (14     (12

Net change in payable for undelivered securities

     (27     (4     3   

Net change in amount due from liquidity pool

     (381     -        -   

Other, net

     -        3        -   
  

 

 

 

Net cash provided by (used in) investing activities

     (700     201        (223

 

The accompanying notes are an integral part of these financial statements.

 

F-7


Table of Contents

JOHN HANCOCK LIFE INSURANCE COMPANY OF NEW YORK

STATEMENTS OF CASH FLOWS – (CONTINUED)

 

     Years ended December 31,  
     2013     2012     2011  
  

 

 

 
     (in millions)  

Cash flows from financing activities:

      

Universal life and investment-type contract deposits

     281        169        341   

Universal life and investment-type contract maturities and withdrawals

     (431     (378     (1,082

Net transfers from (to) separate accounts related to universal life and investment-type contracts

     21        14        12   

Unearned revenue on financial reinsurance

     (48     (49     (89

Net reinsurance recoverable

     -        -        4   
  

 

 

 

Net cash provided by (used in) financing activities

     (177     (244     (814

Net increase (decrease) in cash and cash equivalents

     (436     245        (195

Cash and cash equivalents at beginning of year

        495        250        445   
  

 

 

 

Cash and cash equivalents at end of year

       $ 59      $       495      $       250   
  

 

 

 

Non-cash financing activities during the year:

      

Transfer of assets to First Allmerica Financial Life Insurance Company

       $ -      $ (1,717   $ -   

 

The accompanying notes are an integral part of these financial statements.

 

F-8


Table of Contents

JOHN HANCOCK LIFE INSURANCE COMPANY OF NEW YORK

NOTES TO FINANCIAL STATEMENTS

 

Note 1 — Summary of Significant Accounting Policies

Business. John Hancock Life Insurance Company of New York (the “Company”) is a life insurance company organized on February 10, 1992 under the laws of the State of New York. The New York State Department of Financial Services (the “Department”) granted the Company a license to operate on July 22, 1992. The Company is a wholly-owned subsidiary of John Hancock Life Insurance Company (U.S.A.) (“JHUSA”). JHUSA is a wholly-owned subsidiary of The Manufacturers Investment Corporation (“MIC”). MIC is a wholly-owned subsidiary of John Hancock Financial Corporation (“JHFC”). JHFC is an indirect, wholly-owned subsidiary of The Manufacturers Life Insurance Company (“MLI”). MLI, in turn, is a wholly-owned subsidiary of Manulife Financial Corporation (“MFC”), a Canadian-based, publicly traded financial services holding company.

The Company provides a wide range of financial protection and wealth management products and services to both individual and institutional customers located exclusively in the State of New York (“NY”). Through its insurance operations, the Company offers a variety of individual life insurance that are distributed through multiple distribution channels, including insurance agents, brokers, banks, financial planners, and direct marketing. The Company also offers a variety of retirement products to retirement plans. The Company distributes products through multiple distribution channels, including insurance agents and affiliated brokers, securities brokerage firms, financial planners, pension plan sponsors, pension plan consultants, and banks. In 2013, the Company discontinued sales of its structured settlements and single premium immediate annuity products. In 2012, the Company suspended new sales of its individual fixed and variable annuity products.

The Company manages individual and group fixed and variable annuity, and individual life insurance contracts (collectively, the contracts) for both individual and institutional customers exclusively in the State of New York. Amounts invested in the fixed portion of the contracts are allocated to the general account of the Company. Amounts invested in the variable portion of the contracts are allocated to the separate accounts of the Company. Each of these separate accounts invests in shares of one of the various portfolios of the John Hancock Variable Insurance Trust (“JHVIT”), a no-load, open-end investment management company organized as a Massachusetts business trust, or in open-end investment management companies offered and managed by unaffiliated third parties.

Effective January 1, 2014, the John Hancock Funds Board of Trustees approved John Hancock Advisers, LLC (“JHA”) as the investment adviser to John Hancock Funds II (“JHF II”) and John Hancock Funds III (“JHF III”) replacing John Hancock Investment Management Services, LLC (“JHIMS”). JHF II funds are offered to retail investors, other affiliated John Hancock Funds and separate accounts of JHUSA and JHNY as investment options for 401(k) plans sold by Retirement Plan Services. JHF III funds are offered to retail investors and other affiliated John Hancock Funds. This change transferred approximately $86 billion of assets from JHIMS to JHA. JHIMS will continue as the investment adviser for the John Hancock Variable Insurance Trust funds.

Basis of Presentation. These financial statements have been prepared in conformity with U.S. generally accepted accounting principles (“U.S. GAAP”), which require management to make estimates and assumptions that affect the amounts reported in the financial statements and accompanying notes. Actual results could differ from these estimates.

The Company’s 36% investment in John Hancock Investment Management Services, LLC (“JHIMS”), an affiliated company, is accounted for using the equity method of accounting and is included in investment in unconsolidated affiliate.

Reclassifications. The Company reclassified its fixed deferred annuity liabilities balance of $1,855 million at December 31, 2012 to policyholder funds on the Consolidated Balance Sheets to conform to the current year presentation. Certain other amounts have also been reclassified to conform to the current year presentation.

Investments. The Company determines the classification of its financial assets at initial recognition. Fixed maturity and equity securities are recognized initially at fair value plus, in the case of investments not held for trading, directly attributable transaction costs. The Company classifies its fixed maturity securities as either available-for-sale or held-for-trading and records these securities at fair value. The change in fair value related to available-for-sale securities is reflected in accumulated other comprehensive income (“AOCI”), net of policyholder related amounts and deferred income taxes. The change in fair value related to held-for-trading securities is reflected in net realized investment and other gains (losses).

Interest income on fixed maturity securities, other than mortgage-backed securities, is generally recognized on the accrual basis. The amortized cost of fixed maturity securities is adjusted for other-than-temporary impairments, amortization of premiums, and accretion of discounts to maturity. Amortization of premiums and accretion of discounts is on an effective

 

F-9


Table of Contents

JOHN HANCOCK LIFE INSURANCE COMPANY OF NEW YORK

NOTES TO FINANCIAL STATEMENTS – (CONTINUED)

 

Note 1 — Summary of Significant Accounting Policies - (continued)

 

yield basis and is included in net investment income. The Company recognizes an impairment loss only when management does not expect to recover the amortized cost of the fixed maturity security.

For mortgage-backed securities, the Company recognizes income using a constant effective yield based on anticipated prepayments and the estimated economic life of the securities. When actual prepayments differ significantly from anticipated prepayments, the effective yield is recalculated to reflect actual payments to date plus anticipated future payments, and any resulting adjustment is included in net investment income.

Equity securities primarily include common stock. Dividends are recorded as income on the ex-dividend date. The Company recognizes an impairment loss only when management does not expect to recover the cost of the equity security. In determining whether an equity security is impaired, the Company considers its intent and ability to hold a particular equity security for a period of time sufficient to allow for the recovery of its value. Equity securities that do not have readily determinable fair values are included in other invested assets.

Mortgage loans on real estate are carried at unpaid principal balances and are adjusted for amortization of premiums or accretion of discounts, less an allowance for probable losses. Premiums or discounts are amortized over the life of the mortgage loan contract in a manner that results in a constant effective yield. Interest income and amortization amounts and other costs that are recognized as an adjustment of yield are included as components of net investment income. When contractual payments of mortgage investments are more than 90 days in arrears or when loans are considered impaired, interest is no longer accrued. Mortgage loans on real estate are evaluated periodically as part of the Company’s loan review procedures and are considered impaired when it is probable that the Company will be unable to collect all amounts of principal and interest due according to the contractual terms of the mortgage loan agreement. The valuation allowance established as a result of impairment is based on the present value of the expected future cash flows, discounted at the loan’s original effective interest rate, or is based on the collateral value of the loan if the loan is collateral dependent. The Company estimates this level to be adequate to absorb estimated probable credit losses that exist at the balance sheet date. Any change to the valuation allowance for mortgage loans on real estate is reported as a component of net realized investment and other gains (losses). Interest received on impaired mortgage loans on real estate is applied to reduce the outstanding investment balance. Interest received on other mortgage loans that are in non-accrual status is recorded as interest income on a cash basis. If foreclosure becomes probable, the measurement method used is based on the collateral’s fair value. Foreclosed real estate is recorded at the collateral’s fair value at the date of foreclosure, which establishes a new cost basis.

Investment real estate and agriculture, which the Company has the intent to hold for the production of income, is carried at depreciated cost, using the straight-line method of depreciation, less adjustments for impairments in value. In those cases where it is determined that the carrying amount of investment real estate and agriculture is not recoverable, an impairment loss is recognized based on the difference between the depreciated cost and fair value of the asset. The Company reports impairment losses as part of net realized investment and other gains (losses).

Policy loans are carried at unpaid principal balances.

Other invested assets primarily represent investments in which the Company does not have a controlling financial interest, but has significant influence, and are recorded using the equity method of accounting. The Company records its share of earnings using the most recent financial information available, which is generally on a three month lag. Depending on the timing of receipt of the audited financial statements of these other invested assets, the investee level financial data may be up to one year in arrears.

Short-term investments, which include investments with remaining maturities of one year or less, but greater than three months, at the time of purchase, are reported at fair value.

Net realized investment and other gains (losses), other than those related to separate accounts for which the Company does not bear the investment risk, are determined on a specific identification method and are reported net of amounts credited to participating contract holder accounts.

Derivative Financial Instruments. The Company uses derivative financial instruments (“derivatives”) to manage exposures to interest rate, equity price movements, and other market risks arising from on-balance sheet financial instruments, certain insurance contract liabilities, and selected anticipated transactions. Derivatives are recorded at fair value. Derivatives with unrealized gains are reported as derivative assets and derivatives with unrealized losses are reported as derivative liabilities. Derivatives embedded in other instruments (“host instruments”), such as investment securities, reinsurance contracts, and

 

F-10


Table of Contents

JOHN HANCOCK LIFE INSURANCE COMPANY OF NEW YORK

NOTES TO FINANCIAL STATEMENTS – (CONTINUED)

 

Note 1 — Summary of Significant Accounting Policies - (continued)

 

certain benefit guarantees, are separately recorded as derivatives when their economic characteristics and risks are not closely related to those of the host instrument, the terms of the embedded derivative are the same as those of a stand-alone derivative, and the host instrument is not held-for-trading or carried at fair value.

A determination is made for each relationship as to whether hedge accounting can be applied. Where hedge accounting is not applied, changes in fair value of derivatives are recorded in net realized investment and other gains (losses).

Where the Company has elected to use hedge accounting, a hedge relationship is designated and documented at inception. Hedge effectiveness is evaluated at inception and throughout the term of the hedge, and hedge accounting is only applied when the Company expects that each hedging instrument will be highly effective in achieving offsetting changes in fair value or changes in cash flows attributable to the risk being hedged. Hedge effectiveness is assessed quarterly using a variety of consistently applied techniques, including regression analysis and cumulative dollar offset. When it is determined that the hedging relationship is no longer effective or the hedged item has been sold or terminated, the Company discontinues hedge accounting prospectively. In such cases, if the derivative hedging instruments are not sold or terminated, any subsequent changes in fair value of the derivative are recognized in net realized investment and other gains (losses).

For derivatives that are designated as hedging instruments, changes in fair value are recognized according to the nature of the risks being hedged, as discussed below.

Fair Value Hedges. In a fair value hedging relationship, changes in the fair value of the hedging derivatives are recorded in net realized investment and other gains (losses), along with changes in fair value attributable to the hedged risk. The carrying value of the hedged item is adjusted for changes in fair value attributable to the hedged risk. To the extent the changes in the fair value of derivatives do not offset the changes in the fair value of the hedged item attributable to the hedged risk in net realized investment and other gains (losses), any ineffectiveness will remain in net realized investment and other gains (losses). When hedge accounting is discontinued, the carrying value of the hedged item is no longer adjusted and the cumulative fair value adjustments are amortized to net investment income over the remaining term of the hedged item unless the hedged item is sold, at which time the balance is recognized immediately in net investment income.

Cash Flow Hedges. In a cash flow hedge relationship, the effective portion of the changes in the fair value of the hedging instrument is recorded in AOCI, while the ineffective portion is recognized in net realized investment and other gains (losses). Unrealized gains and losses recorded in AOCI are recognized in income during the same periods as the variability in the cash flows hedged or the hedged forecasted transactions are recognized.

Unrealized gains and losses on cash flow hedges recorded in AOCI are reclassified immediately to income when the hedged item is sold or the forecasted transaction is no longer expected to occur. When a hedge is discontinued, but the hedged forecasted transaction remains highly probable to occur, the amounts in AOCI are reclassified to net realized investment and other gains (losses) in the periods during which variability in the cash flows hedged or the hedged forecasted transaction is recognized in income.

Cash and Cash Equivalents. Cash and cash equivalents include cash and all highly liquid debt investments with a remaining maturity of three months or less when purchased.

Value of Business Acquired. Value of business acquired (VOBA”) is the present value of estimated future profits of insurance policies in-force. The Company amortizes VOBA using the same methodology and assumptions used to amortize deferred policy acquisition costs (“DAC”) and tests for recoverability at least annually.

Deferred Policy Acquisition Costs, Deferred Sales Inducements and Unearned Revenue. DAC are costs that are directly related to the successful acquisition or renewal of insurance contracts. Such costs include: (1) incremental direct costs of contract acquisition, such as commissions; (2) the portion of an employee’s total compensation and benefits directly related to underwriting, policy issuance and processing, medical inspection, and contract selling of new and renewal insurance contracts with respect to actual policies acquired or renewed; (3) other costs directly related to acquisition or renewal activities that would not have been incurred had a policy not been acquired or renewed; and (4) in limited circumstances, the costs of direct response advertising whose primary purpose is to elicit sales to customers who could be shown to have responded specifically to the advertising and that results in contract acquisition. All other acquisition-related costs, including those related to general advertising and solicitation, market research, agent training, product development, unsuccessful sales and underwriting efforts, as well as all indirect costs, are expensed as incurred. Similarly, any amounts assessed as initiation fees or front-end loads are recorded as unearned revenue. The Company tests the recoverability of DAC at least annually.

 

F-11


Table of Contents

JOHN HANCOCK LIFE INSURANCE COMPANY OF NEW YORK

NOTES TO FINANCIAL STATEMENTS – (CONTINUED)

 

Note 1 — Summary of Significant Accounting Policies - (continued)

 

DAC related to participating traditional life insurance is amortized over the life of the policies at a constant rate based on the present value of the estimated gross margin amounts expected to be realized over the lives of the policies. Estimated gross margin amounts include anticipated premiums and investment results less claims and administrative expenses, changes in the net level premium reserve, and expected annual policyholder dividends. For annuity, universal life insurance, and investment-type products, DAC and unearned revenue are amortized generally in proportion to the change in present value of estimated gross profits arising principally from surrender charges, investment results, including realized investment and other gains (losses), and mortality and expense margins. In situations where using gross profits is not the best basis for amortizing DAC, the Company amortizes DAC and unearned revenue based on the amount of insurance in force. DAC amortization includes retrospective adjustments when estimates are revised. For annuity, universal life insurance, and investment-type products, the DAC asset is adjusted for the impact of unrealized gains (losses) on available for sale investments as if these gains (losses) had been realized, with corresponding credits or charges included in AOCI.

DAC and unearned revenue related to non-participating traditional life insurance are amortized over the premium-paying period of the related policies using assumptions consistent with those used in computing future policy benefits.

The Company offers sales inducements, including enhanced crediting rates or bonus payments, to contract holders on certain of its individual life insurance and individual and group annuity products. The Company’s deferred sales inducements (“DSI”) are amortized over the life of the underlying contracts using the same methodology and assumptions used to amortize DAC.

Reinsurance. Assets and liabilities related to reinsurance ceded contracts are reported on a gross basis. The accompanying Statements of Operations reflect premiums, benefits, and settlement expenses net of reinsurance ceded. Reinsurance premiums, commissions, expense reimbursements, benefits, and reserves related to reinsured business are accounted for on a basis consistent with those used in accounting for the original policies issued and the terms of the reinsurance contracts.

The Company utilizes reinsurance agreements to provide for greater diversification of business, allowing management to control exposure to potential losses arising from large risks, and provide additional capacity for growth. Reinsurance ceded contracts do not relieve the Company from its obligations to policyholders. The Company remains liable to its contract holders to the extent that counterparties to reinsurance ceded contracts do not meet their contractual obligations. Failure of the reinsurers to honor their obligations could result in losses to the Company; consequently, estimates are established for amounts deemed or estimated to be uncollectible. To minimize its exposure to significant losses from reinsurance insolvencies, the Company evaluates the financial condition of its reinsurers and monitors concentration of credit risk arising from similar characteristics among the reinsurers.

When a reinsurance agreement does not subject the reinsurer to the reasonable possibility of significant loss, the Company accounts for the agreement as financial reinsurance and uses deposit-type accounting treatment with only the reinsurance risk fee being reported in other operating costs and expenses.

Separate Account Assets and Liabilities. Separate account assets and liabilities reported on the Company’s Balance Sheets represent funds that are administered and invested by the Company to meet specific investment objectives of contract holders. Net investment income and net realized investment and other gains (losses) generally accrue directly to such contract holders who bear the investment risk, subject, in some cases, to principal guarantees and minimum guaranteed rates of income. The assets of each separate account are legally segregated and are not subject to claims that arise out of any other business of the Company. Separate account assets are reported at fair value, and separate account liabilities are set equal to the fair value of the separate account assets. Deposits, surrenders, net investment income, net realized investment and other gains (losses), and the related liability changes of separate accounts are offset within the same line item in the Statements of Operations. Fees charged to contract holders, principally mortality, policy administration, investment management, and surrender charges, are included in the revenues of the Company. For the years ended December 31, 2013, 2012 and 2011 there were no gains or losses on transfers of assets from the general account to the separate account.

Future Policy Benefits and Policyholders’ Funds. Future policy benefits for participating traditional life insurance policies are based on the net level premium method. The net level premium reserve is calculated using the guaranteed mortality and dividend fund interest rates. The liability for annual dividends represents the accrual of annual dividends earned. Settlement dividends are accrued in proportion to gross margins over the life of the policies. Participating business represented 55% and 57% of the Company’s traditional life net insurance in-force at December 31, 2013 and 2012,

 

F-12


Table of Contents

JOHN HANCOCK LIFE INSURANCE COMPANY OF NEW YORK

NOTES TO FINANCIAL STATEMENTS – (CONTINUED)

 

Note 1 — Summary of Significant Accounting Policies - (continued)

 

respectively, and 24%, 24%, and 23% of the Company’s traditional life net insurance premiums for the years ended December 31, 2013, 2012 and 2011, respectively.

For non-participating traditional life insurance policies, future policy benefits are estimated using a net level premium method based upon actuarial assumptions as to mortality, persistency, interest, and expenses established at the policy issue or acquisition date. Assumptions established at policy issue as to mortality and persistency are based on the Company’s experience, which, together with interest and expense assumptions, include a margin for adverse deviation.

For universal life insurance products, the basic policy reserve is account value. An additional liability is established for product features which result in a pattern of profits followed by losses. The benefits covered by this liability include benefits paid under no-lapse guarantee features as well as certain other death benefits. The additional liability is calculated by multiplying the benefit ratio by the assessments recorded from contract inception accumulated with interest and subtracting the excess benefits paid from contract inception accumulated with interest. If experience or assumption changes result in a new benefit ratio, the reserves are adjusted to reflect the changes in a manner similar to the retrospective adjustment of DAC, VOBA, and unearned revenue. The assumptions used in estimating the additional liability are consistent with those used for amortizing DAC. The no-lapse guarantee benefits used in calculating the liability are based on the average benefits payable over a range of scenarios.

Policyholders’ funds are generally equal to the total of the policyholder account values before surrender charges, additional reserves established to adjust for lower market interest rates as of the acquisition date, and additional reserves established on certain guarantees offered in certain investment-type products. Fixed annuity liabilities during the accumulation period are based on the accumulated contract holders’ fund balances and after annuitization are equal to the present value of expected future payments. Policyholder account values include deposits plus credited interest or change in investment value less expense and mortality fees, as applicable, and withdrawals. Policy benefits are charged to expense and include benefit claims incurred in the period in excess of related policy account balances and interest credited to policyholders’ account balances.

Liabilities for unpaid claims and claim expense reserves include estimates of payments to be made on reported life insurance claims and estimates of incurred but not reported claims based on historical claim development patterns.

Estimates of future policy benefit reserves, claim reserves, and expenses are reviewed on a regular basis and adjusted as necessary. Any changes in estimates are reflected in current earnings.

Deferred Gains. The Company amortizes the deferred gains over 10 years using the effective interest method.

Revenue Recognition. Premiums from non-participating traditional life insurance and annuity policies with life contingencies are recognized as revenue when due. When premiums are due over a significantly shorter period than the period over which benefits are provided, any excess profit is deferred and recognized into income in a constant relationship to insurance in-force or, for annuities, the amount of expected future benefit payments.

Deposits related to universal life and investment-type products are credited to policyholders’ account balances. Revenues from these contracts, as well as annuity contracts, consist of amounts assessed against policyholders’ account balances for mortality, policy administration, and surrender charges and are recorded in fee income in the period in which the services are provided.

Fee income also includes advisory fees and administrative service fees collected from the separate accounts. Such fees are recognized in the period in which the services are performed.

Income Taxes. The provision for federal income taxes includes amounts currently payable or recoverable and deferred income taxes, computed under the liability method, resulting from temporary differences between the tax and financial statement bases of assets and liabilities. A valuation allowance is established for deferred tax assets when it is more likely than not that an amount will not be realized. In accordance with the income tax sharing agreements in effect for the applicable tax years, the Company’s income tax expense (benefit) is computed as if the Company filed separate federal income tax returns with tax benefits provided for operating losses and tax credits when utilized and settled by the consolidated group. Intercompany settlements of income taxes are made through an increase or reduction in amounts due to or from affiliates. Such settlements occur on a periodic basis in accordance with the tax sharing agreements.

 

F-13


Table of Contents

JOHN HANCOCK LIFE INSURANCE COMPANY OF NEW YORK

NOTES TO FINANCIAL STATEMENTS – (CONTINUED)

 

Note 1 — Summary of Significant Accounting Policies - (continued)

 

Adoption of Recent Accounting Pronouncements

Offsetting Assets and Liabilities

In December 2011 and January 2013, the Financial Accounting Standards Board (“FASB”) issued updated guidance regarding the disclosure of recognized derivative instruments (including bifurcated embedded derivatives), repurchase agreements and securities borrowing/lending transactions that are offset in the statement of financial position or are subject to an enforceable master netting arrangement or similar arrangement (irrespective of whether they are offset in the balance sheet). This new guidance requires an entity to disclose information, on both a gross and net basis, about instruments and transactions within the scope of the guidance. The Company adopted the revised accounting standard effective January 1, 2013 via retrospective adoption, as required. The expanded disclosures required by this guidance are included in the Investments Note. The adoption of the guidance did not impact the Company’s financial position or results of operations.

Fed Funds as Benchmark Interest Rate

In July 2013, the FASB issued new guidance regarding derivatives. The new guidance permits a company to designate the Fed Funds Effective Swap Rate (also referred to as the “Overnight Index Swap Rate” or “OIS”) as the hedged risk (or benchmark interest rate) in both cash flow and fair value hedges. The new guidance also removed the requirement that similar hedges designate the same benchmark rate. The new guidance is effective prospectively for qualifying new or redesignated hedging relationships commencing on or after July 17, 2013. The adoption of the guidance did not impact the Company’s financial position or results of operations.

Comprehensive Income

In February 2013, the FASB issued updated guidance regarding the presentation of comprehensive income. Under the guidance, the Company is required to separately present information about significant items reclassified out of accumulated other comprehensive income by component as well as changes in accumulated other comprehensive income balances by component in either the financial statements or the notes to the financial statements. The guidance does not change the items that are reported in other comprehensive income, does not change when an item of other comprehensive income must be reclassified to net income, and does not amend any existing requirements for reporting net income or other comprehensive income. The Company’s adoption was prospective and the disclosures required by this guidance are included in the Shareholder’s Equity Note.

Income Taxes

In July 2013, the FASB issued updated guidance regarding the presentation of an unrecognized tax benefit when a net operating loss carryforward, similar tax losses, or a tax credit carryforward exist. This guidance requires liabilities for uncertain tax positions to be presented in the financial statements as a reduction to deferred assets to the extent that the deferred tax assets are available to reduce resulting taxes payable within the same jurisdiction. The guidance is generally effective for 2014. The Company retrospectively early adopted this new guidance for its 2013 reporting. The adoption of this guidance did not impact the Company’s financial position or results of operations.

Future Adoption of Recent Accounting Pronouncements

Investment Companies

In June 2013, the FASB issued updated guidance clarifying the characteristics of an investment company and requiring new disclosures. The new guidance changes the way in which a company assesses whether it should be considered an investment company. Once deemed an investment company, the new guidelines require additional disclosures as well as changes to the reporting of interests in other investment companies. The provisions of the new guidance are effective for annual and interim reporting periods in fiscal years beginning after December 15, 2013. Upon adoption, the new guidance is not expected to materially impact the Company’s financial position or results of operations.

 

F-14


Table of Contents

JOHN HANCOCK LIFE INSURANCE COMPANY OF NEW YORK

NOTES TO FINANCIAL STATEMENTS – (CONTINUED)

 

Note 2 — Investments

Fixed Maturity and Equity Securities

The Company’s investments in available-for-sale fixed maturity and equity securities are summarized below:

 

     December 31, 2013  
     Amortized Cost      Gross
Unrealized
Gains
     Gross
Unrealized
Losses
    Fair Value      Other-Than-
Temporary
Impairments
in AOCI
 
  

 

 

 
     (in millions)  

Fixed maturity and equity securities

             

Corporate debt securities

       $ 3,578       $ 228       $ (66   $ 3,740       $ -   

Commercial mortgage-backed securities

     57         2         -        59         -   

Residential mortgage-backed securities

     -         -         -        -         -   

Collateralized debt obligations

     -         -                  -        -         -   

Other asset-backed securities

     72         3         (2     73           -   

U.S. Treasury securities and obligations of U.S. government corporations and agencies

     1,776         6         (145     1,637         -   

Obligations of states and political subdivisions

     246         16         (5     257         -   

Debt securities issued by foreign governments

     100         5         -        105         -   
  

 

 

 

Fixed maturity securities

       5,829           260         (218       5,871         -   

Other fixed maturity securities

     -         -         -        -         -   
  

 

 

 

Total fixed maturity securities available-for-sale

     5,829         260         (218     5,871         -   

Equity securities available-for-sale

     -         -         -        -         -   
  

 

 

 

Total fixed maturity and equity securities available-for-sale

       $ 5,829       $ 260       $ (218   $ 5,871       $   -   
  

 

 

 

 

F-15


Table of Contents

JOHN HANCOCK LIFE INSURANCE COMPANY OF NEW YORK

NOTES TO FINANCIAL STATEMENTS – (CONTINUED)

 

Note 2 — Investments - (continued)

 

     December 31, 2012  
     Amortized Cost      Gross
Unrealized
Gains
     Gross
Unrealized
Losses
    Fair Value      Other-Than-
Temporary
Impairments
in AOCI
 
  

 

 

 
     (in millions)  

Fixed maturity and equity securities

             

Corporate debt securities

       $ 3,470       $ 406       $ (5   $ 3,871       $ -   

Commercial mortgage-backed securities

     222         8         -        230         -   

Residential mortgage-backed securities

     -         -         -        -         -   

Collateralized debt obligations

     -         -         -        -         -   

Other asset-backed securities

     42         4         -        45         -   

U.S. Treasury securities and obligations of U.S. government corporations and agencies

     2,052         99         (13     2,137         -   

Obligations of states and political subdivisions

     236         51         -        287         -   

Debt securities issued by foreign governments

     57         2         -        59           -   
  

 

 

 

Fixed maturity securities

       6,079           570         (18       6,629         -   

Other fixed maturity securities

     -         -                -        -         -   
  

 

 

 

Total fixed maturity securities available-for-sale

     6,079         570         (18     6,629         -   

Equity securities available-for-sale

     1         -         -        1         -   
  

 

 

 

Total fixed maturity and equity securities available-for-sale

       $ 6,080       $ 570       $ (18   $ 6,630       $ -   
  

 

 

 

The amortized cost and fair value of available-for-sale fixed maturity securities at December 31, 2013, by contractual maturity, are shown below:

 

     Amortized Cost      Fair Value  
  

 

 

 
     (in millions)  

Fixed maturity securities

     

Due in one year or less

       $ 185       $ 188   

Due after one year through five years

     1,043         1,086   

Due after five years through ten years

     1,029         1,070   

Due after ten years

     3,443         3,395   
  

 

 

 
       5,700           5,739   

Asset-backed and mortgage-backed securities

     129         132   
  

 

 

 

Total

       $ 5,829       $ 5,871   
  

 

 

 

Expected maturities may differ from contractual maturities because eligible borrowers may exercise their right to call or prepay obligations with or without call or prepayment penalties. Asset-backed and mortgage-backed securities are shown separately in the table above, as they are not due at a single maturity date.

Fixed Maturity Securities Impairment Review

The Company has a process in place to identify securities that could potentially have an impairment that is other-than-temporary. This process involves monitoring market events that could impact issuers’ credit ratings, business climate, management changes, litigation and government actions, and other similar factors. This process also involves monitoring late payments, downgrades by rating agencies, key financial ratios, financial statements, revenue forecasts, and cash flow projections as indicators of credit issues.

At the end of each quarter, the MFC Loan Review Committee reviews all fixed maturity securities where there is evidence of impairment or a significant unrealized loss at the balance sheet date. Generally, securities with market value less than 60 percent of amortized cost for six months or more indicate an impairment is present. Accordingly, securities in this category are normally deemed impaired unless there is clear evidence they should not be impaired. The analysis focuses on each

 

F-16


Table of Contents

JOHN HANCOCK LIFE INSURANCE COMPANY OF NEW YORK

NOTES TO FINANCIAL STATEMENTS – (CONTINUED)

 

Note 2 — Investments - (continued)

 

company’s or project’s ability to service its debts in a timely fashion and the length of time the security has been trading below amortized cost. The results of this analysis are reviewed by the Transaction and Portfolio Review Committee at MFC. This committee includes MFC’s Chief Financial Officer, Chief Investment Officer, Chief Risk Officer, Chief Credit Officer, and other senior management. This quarterly process includes a fresh assessment of the credit quality of each investment in the entire fixed maturity security portfolio.

The Company considers relevant facts and circumstances in evaluating whether the impairment of a fixed maturity security is other-than-temporary. Relevant facts and circumstances considered include (1) the length of time the fair value has been below cost; (2) the financial position of the issuer, including the current and future impact of any specific events; and (3) the Company’s ability and intent to hold the fixed maturity security to maturity or until it recovers in value. If the Company intends to sell, or if it is more likely than not that it will be required to sell an impaired fixed maturity security prior to recovery of its cost basis, the security is considered other-than-temporarily impaired, and the Company records a charge to earnings for the full amount of impairment (the difference between the current carrying amount and fair value of the security). For fixed maturity securities in an unrealized loss position where the Company does not intend to sell or is not more likely than not to be required to sell, the Company determines its ability to recover the amortized cost of the security by comparing the net present value of the projected future cash flows to the amortized cost of the security. If the net present value of the cash flow is less than the security’s amortized cost, then the difference is recorded as a credit loss. The difference between the estimates of the credit loss and the overall unrealized loss on the security is the non-credit-related component. The credit loss portion is charged to net realized investment and other gains (losses) on the Statements of Operations, while the non-credit loss is charged to AOCI on the Balance Sheets.

The net present value used to determine the credit loss is calculated by discounting the Company’s best estimate of projected future cash flows at the effective interest rate implicit in the fixed maturity security prior to impairment. The Company may use the estimated fair value of collateral as a proxy for the net present value if it believes that the security is dependent on the liquidation of collateral for recovery of its investment. The projection of future cash flows is subject to the same analysis the Company applies to its overall impairment evaluation process, as noted above, which incorporates security specific information such as late payments, downgrades by rating agencies, key financial ratios, investee financial statements, and fundamentals of the industry and geographic area in which the issuer operates, as well as overall macroeconomic conditions. The projections are estimated using assumptions regarding probability of default and estimates regarding timing and amount of recoveries associated with a default.

Similarly, management evaluates all facts and circumstances and exercises professional judgment in determining whether an other-than-temporary impairment of equity securities exists. The MFC Transaction and Portfolio Review Committee reviews and approves the proposed impairments based on an analysis of the evidence, including the current market price, the length of time the security has been in an unrealized loss position, forecasted earnings per share, consensus price targets, projected P/E ratios, overall financial health of each issuer, liquidity or solvency issues, announced changes in ownership structure, changes to issuer debt ratings, changes to dividend payments, changes in products, markets or competition, and other industry specific or macroeconomic factors.

There are a number of significant risks and uncertainties inherent in the process of monitoring impairments and determining if an impairment is other-than-temporary. These risks and uncertainties include (1) the risk that the Company’s assessment of an issuer’s ability to meet all of its contractual obligations will change based on changes in the credit characteristics of that issuer; (2) the risk that the economic outlook will be worse than expected or have more of an impact on the issuer than anticipated; (3) the risk that fraudulent information could be provided to the Company’s investment professionals who determine the fair value estimates and other-than-temporary impairments; and (4) the risk that new information obtained by the Company or changes in other facts and circumstances lead it to change its intent to hold the security to maturity or until it recovers in value. Any of these situations could result in a charge to earnings in a future period.

The cost amounts for fixed maturity securities are net of other-than-temporary impairment charges.

The following table shows the carrying value and gross unrealized losses aggregated by investment category and length of time that individual available-for-sale fixed maturity and equity securities have been in a continuous unrealized loss position:

 

F-17


Table of Contents

JOHN HANCOCK LIFE INSURANCE COMPANY OF NEW YORK

NOTES TO FINANCIAL STATEMENTS – (CONTINUED)

 

Note 2 — Investments - (continued)

 

Unrealized Losses on Fixed Maturity and Equity Securities — By Investment Age

 

    December 31, 2013  
    Less than 12 months     12 months or more     Total  
   
    Carrying
Value
    Unrealized
Losses
    Carrying
Value
    Unrealized
Losses
    Carrying
Value
    Unrealized
Losses
 
   
                (in millions)              

Corporate debt securities

      $ 859      $ (48   $ 118      $ (18   $ 977      $ (66)    

Commercial mortgage-backed securities

    4        -        3        -        7        -     

Residential mortgage-backed securities

    -                -        -        -        -        -     

Collateralized debt obligations

    -        -        -        -        -        -     

Other asset-backed securities

    25        (2     -        -          25        (2)    

US Treasury securities and obligations of US government corps and agencies

      1,199        (64       338        (81     1,537        (145)    

Obligations of states and political subdivisions

    57        (3     10        (2     67        (5)    

Debt securities issued by foreign governments

    -        -        -        -        -        -     
 

 

 

 

Total fixed maturity securities available-for-sale

    2,144        (117       469        (101           2,613        (218)    

Equity securities available-for-sale

    -        -        -        -        -        -     
 

 

 

 

Total

      $ 2,144      $ (117   $ 469      $ (101   $ 2,613      $ (218)    
 

 

 

 
    December 31, 2012  
    Less than 12 months     12 months or more     Total  
   
    Carrying
Value
    Unrealized
Losses
    Carrying
Value
    Unrealized
Losses
    Carrying
Value
    Unrealized
Losses
 
   
                (in millions)              

Corporate debt securities

      $ 186      $ (4   $ 32      $ (1   $ 218      $ (5)    

Commercial mortgage-backed securities

    10        -        -        -        10        -     

Residential mortgage-backed securities

    -        -        -        -        -        -     

Collateralized debt obligations

    -        -        -        -        -        -     

Other asset-backed securities

    -        -        -        -        -        -     

US Treasury securities and obligations of US government corps and agencies

    643        (13     -        -        643        (13)    

Obligations of states and political subdivisions

    12        -        -        -        12        -     

Debt securities issued by foreign governments

    3        -        18        -        21        -     
 

 

 

 

Total fixed maturity securities available-for-sale

    854        (17     50        (1     904        (18)    

Equity securities available-for-sale

    -        -        -        -        -        -     
 

 

 

 

Total

      $ 854      $ (17   $ 50      $ (1   $ 904      $ (18)    
 

 

 

 

Unrealized losses can be created by rising interest rates or by rising credit concerns and hence widening credit spreads. Credit concerns are apt to play a larger role in the unrealized loss on below investment grade securities. Unrealized losses on investment grade securities principally relate to changes in interest rates or changes in credit spreads since the securities were acquired. Credit rating agencies’ statistics indicate that investment grade securities have been found to be less likely to develop credit concerns. The gross unrealized losses on below investment grade available-for-sale fixed maturity securities decreased to $1 million at December 31, 2013 from $1 million at December 31, 2012.

 

F-18


Table of Contents

JOHN HANCOCK LIFE INSURANCE COMPANY OF NEW YORK

NOTES TO FINANCIAL STATEMENTS – (CONTINUED)

 

Note 2 — Investments - (continued)

 

At December 31, 2013 and 2012, there were 306 and 62 fixed maturity securities with aggregate gross unrealized losses of $218 million and $18 million, respectively, of which the single largest unrealized loss was $78 million and $12 million, respectively. The Company anticipates that these fixed maturity securities will perform in accordance with their contractual terms and currently has the ability and intent to hold these securities until they recover or mature.

Available-for-sale securities with amortized cost of $1 million were non-income producing for the year ended December 31, 2013. Non-income producing assets represent investments that have not produced income for the twelve months preceding December 31, 2013.

Assets on Deposit and Pledged as Collateral

The Company maintains assets which are pledged as collateral in connection with various agreements and transactions. Additionally, the Company holds assets on deposit with government authorities as required by state law. The following table summarizes the fair value of the pledged or deposited assets:

 

     December 31,  
     2013      2012  
  

 

 

 
     (in millions)  

Bonds pledged in support of over-the-counter derivative instruments

       $   28       $   1   

Bonds pledged in support of exchange-traded futures and cleared derivatives

     24         24   

Bonds on deposit with government authorities

     1         1   

Mortgage loans pledged in support of real estate

     -         -   

Bonds held in trust

     -         -   

Pledged collateral under reinsurance agreements

     -         -   
  

 

 

 

Total

       $   53       $   26   
  

 

 

 

Offsetting Financial Assets and Financial Liabilities

The Company does not offset financial instruments in the Consolidated Balance Sheets, as the rights of offset are conditional.

In the case of derivatives, collateral is collected from and pledged to counterparties to manage credit exposure in accordance with Credit Support Annex agreements. Under master netting agreements, the Company has a right of offset in the event of default, insolvency, bankruptcy or other early termination.

In the case of reverse repurchase and repurchase transactions, additional collateral may be collected from or pledged to counterparties to manage credit exposure according to bilateral reverse repurchase agreements or repurchase agreements. In the event of default by a counterparty, the Company is entitled to liquidate the assets the Company holds as collateral to offset against obligations to the same counterparty.

The following table presents the effects of conditional master netting and similar arrangements. Similar arrangements may include global master repurchase agreements, global master securities lending agreements, and any related rights to financial collateral.

 

F-19


Table of Contents

JOHN HANCOCK LIFE INSURANCE COMPANY OF NEW YORK

NOTES TO FINANCIAL STATEMENTS – (CONTINUED)

 

Note 2 — Investments - (continued)

 

           Related Amounts Not Set Off
in the Consolidated Balance
Sheets
        
Year ended December 31, 2013   

Gross

Amounts of
Financial
Instruments
presented in

the

Consolidated
Balance
Sheets(1)

   

Amounts
Subject to an
Enforceable
Master

Netting
Arrangement

or Similar
Agreements

    Financial and
Cash
Collateral
Pledged
(Received)(2)
    Net Amount
Including
Financing
Trusts(3)
     Net Amount
Excluding
Financing
Trusts
 
     (in millions)  

Financial assets

           

Derivative assets

       $    432      $ (305   $ (127   $ -       $ -   

Securities lending

     -        -        -        -         -   

Reverse repurchase agreements

     -        -        -        -         -   
  

 

 

 

Total financial assets

     432        (305     (127     -         -   
  

 

 

 

Financial liabilities

           

Derivative liabilities

     (335     305        30        -         -   

Repurchase agreements

     -        -        -        -         -   
  

 

 

 

Total financial liabilities

       $ (335   $ 305      $ 30      $ -       $ -   
  

 

 

 
Year ended December 31, 2012    Gross
Amounts of
Financial
Instruments
presented in
the
Consolidated
Balance
Sheets(1)
    Amounts
Subject to an
Enforceable
Master
Netting
Arrangement
or Similar
Agreements
    Financial and
Cash
Collateral
Pledged
(Received)(2)
    Net Amount
Including
Financing
Trusts(3)
     Net Amount
Excluding
Financing
Trusts
 
     (in millions)  

Financial assets

           

Derivative assets

       $    669      $ (353   $ (316   $ -       $ -   

Securities lending

           

Reverse repurchase agreements

           
  

 

 

 

Total financial assets

     669        (353     (316     -         -   
  

 

 

 

Financial liabilities

           

Derivative liabilities

     (355     353        2        

Repurchase agreements

           
  

 

 

 

Total financial liabilities

       $ (355   $ 353      $ 2      $ -       $ -   
  

 

 

 

 

F-20


Table of Contents

JOHN HANCOCK LIFE INSURANCE COMPANY OF NEW YORK

NOTES TO FINANCIAL STATEMENTS – (CONTINUED)

 

Note 2 — Investments - (continued)

 

(1) The Company does not offset financial instruments. Financial assets and liabilities in the table above include accrued interest of $(5) million and $12 million, respectively December 31, 2013 (December 31, 2012 — $15 million and $5 million, respectively).
(2) Financial and cash collateral excludes over-collateralization. As at December 31, 2013 the Company was over-collateralized on OTC derivative assets and OTC derivative liabilities in the amounts of $25 million and $4 million, respectively (December 31, 2012 — $29 million and $0 million, respectively). Collateral pledged (received) does not include collateral in transit on OTC instruments or include initial margin on exchange traded contracts.
(3) The net amount includes derivative contracts entered into between the Company and its financing trusts which it does not consolidate. The Company does not exchange collateral on derivative contracts entered into with these trusts.

Mortgage Loans on Real Estate

At December 31, 2013 and 2012, the mortgage portfolio was diversified by specific collateral property type and geographic region as displayed below:

December 31, 2013:

 

Collateral

Property Type

   Carrying
Amount
      

Geographic

Concentration

   Carrying
Amount
 

 

      

 

 
     (in millions)             (in millions)  

Apartments

       $ 292         East North Central        $ 175   

Industrial

     123         East South Central      7   

Office buildings

     376         Middle Atlantic      165   

Retail

     266         Mountain      54   

Mixed use

     -         New England      35   

Agricultural

     -         Pacific      419   

Agribusiness

     10         South Atlantic      208   

Other

     88         West North Central      42   
        West South Central      50   
        Canada/other      -   

Provision for losses

     -         Provision for losses      -   
  

 

 

         

 

 

 

Total

       $   1,155         Total        $   1,155   
  

 

 

         

 

 

 

December 31, 2012:

 

Collateral

Property Type

   Carrying
Amount
      

Geographic

Concentration

   Carrying
Amount
 

 

      

 

 
     (in millions)             (in millions)  

Apartments

       $ 201         East North Central        $ 146   

Industrial

     130         East South Central      2   

Office buildings

     322         Middle Atlantic      114   

Retail

        251         Mountain         48   

Mixed use

     -         New England      37   

Agricultural

     -         Pacific      333   

Agribusiness

     2         South Atlantic      193   

Other

     71         West North Central      39   
        West South Central      65   
        Canada/other      -   

Provision for losses

     -         Provision for losses      -   
  

 

 

         

 

 

 

Total

       $ 977         Total        $ 977   
  

 

 

         

 

 

 

At the end of each quarter, the MFC Loan Review Committee reviews all mortgage loans rated BB or lower, as determined by review of the underlying collateral, and decides whether an allowance for credit loss is needed. The Company considers

 

F-21


Table of Contents

JOHN HANCOCK LIFE INSURANCE COMPANY OF NEW YORK

NOTES TO FINANCIAL STATEMENTS – (CONTINUED)

 

Note 2 — Investments - (continued)

 

collateral value, the borrower’s ability to pay, normal historical credit loss levels, and future expectations in evaluating whether an allowance for credit losses is required for impaired loans.

Changes in the allowance for probable losses on mortgage loans on real estate are summarized below:

 

     Balance at Beginning
of Period
     Additions      Recoveries     

Charge-

offs and

Disposals

    Balance at End of
Period
 
  

 

 

 
     (in millions)  

Year ended December 31, 2013

       $ -       $ -       $ -       $ -      $ -   

Year ended December 31, 2012

     7         -         -         (7     -   

Year ended December 31, 2011

     2         9         -         (4     7   

A mortgage loan charge-off is recorded when the impaired loan is disposed or when an impaired loan is determined to be a full loss with no possibility of recovery. Charge-offs are deducted from the allowance for probable losses.

As of December 31, 2013, the carrying value for certain mortgage loans is as follows:

 

     December 31,  
     2013      2012  
  

 

 

 
     (in millions)  

Non-income producing

       $   -       $   -   

Delinquent less than 90 days

     -         -   

Delinquent greater than 90 days

     -         -   

The Company provides for credit risk on mortgage loans by establishing allowances against the carrying value of the impaired loans. The total recorded investment in mortgage loans that is considered to be impaired along with the related allowance for credit losses was as follows:

 

     December 31,  
     2013      2012  
  

 

 

 
     (in millions)  

Impaired mortgage loans on real estate with provision for losses

       $   -       $   -   

Allowance for credit losses

     -         -   
  

 

 

    

 

 

 

Net impaired mortgage loans on real estate

       $ -       $ -   
  

 

 

    

 

 

 

The average recorded investment in impaired loans and the interest income recognized on impaired loans were as follows:

 

     December 31,  
     2013      2012      2011  
  

 

 

 
     (in millions)  

Average recorded investment in impaired loans

       $   -       $   9       $   20   

Interest income recognized on impaired loans

     -         -         -   

For mortgage loans, the Company evaluates credit quality through regular monitoring of credit related exposures, considering both qualitative and quantitative factors in assigning an internal risk rating (IRR). These ratings are updated at least annually.

 

F-22


Table of Contents

JOHN HANCOCK LIFE INSURANCE COMPANY OF NEW YORK

NOTES TO FINANCIAL STATEMENTS – (CONTINUED)

 

Note 2 — Investments - (continued)

 

The carrying value of mortgage loans by IRR was as follows:

 

     December 31,  
     2013      2012  
  

 

 

 
     (in millions)  

AAA

       $ 68           $ 30   

AA

     175         125   

A

     376         238   

BBB

         530             562   

BB

     6         22   

B and lower and unrated

     -         -   
  

 

 

    

 

 

 

Total

       $   1,155           $ 977   
  

 

 

    

 

 

 

Investment Real Estate and Agriculture

Investment real estate and agriculture of $18 million was non-income producing for the year ended December 31, 2013. Depreciation expense on investment real estate and agriculture was $2 million, $2 million, and $2 million for the years ended December 31, 2013, 2012 and 2011 respectively. Accumulated depreciation was $6 million and $5 million at December 31, 2013 and 2012, respectively.

Other Invested Assets

The following tables summarize the Company’s investments accounted for using the equity method of accounting:

 

     December 31,  
     2013      2012  
  

 

 

 
     (in millions)  

Carrying value

       $ 66           $ 6   

Combined assets

       675           272   

Combined liabilities

     161         100   

Debt included in combined liabilities

     55         -   

 

     December 31,  
     2013      2012      2011  
  

 

 

 
     (in millions)  

Net investment income on the investments

       $ 198       $ 183       $ 175   

Combined revenues

       1,050           894           818   

Combined expenses

     470         366         337   

Combined income (loss) from operations

     580         528         481   

 

F-23


Table of Contents

JOHN HANCOCK LIFE INSURANCE COMPANY OF NEW YORK

NOTES TO FINANCIAL STATEMENTS – (CONTINUED)

 

Note 2 — Investments - (continued)

 

Net Investment Income and Net Realized Investment and Other Gains (Losses)

The following information summarizes the components of net investment income and net realized investment and other gains (losses):

 

     December 31,  
     2013     2012     2011  
  

 

 

 
     (in millions)  

Net investment income

      

Fixed maturity securities

       $ 273      $ 333      $ 366   

Equity securities

     -        -        -   

Mortgage loans on real estate

     51        49        40   

Investment real estate, agriculture, and timber

     12        17        10   

Policy loans

     7        6        6   

Short-term investments

     -        1        1   

Derivatives

     23        25        23   

Equity method investments and other (1)

     199        183        175   
  

 

 

   

 

 

   

 

 

 

Gross investment income

       565          614          621   

Investment expenses

     (25     (27     (24
  

 

 

 

Net investment income

       $ 540      $ 587      $ 597   
  

 

 

 

 

     December 31,  
     2013     2012     2011  
  

 

 

 
     (in millions)  

Net realized investment and other gains (losses)

      

Fixed maturity securities

       $ (115       $    170          $ 337   

Equity securities

       -          -          -   

Mortgage loans on real estate

     1        3        (7

Derivatives

     (47     (211     (24

Other invested assets

     -        1           -   

Amounts credited to participating contract holders

          28        (15     (17
  

 

 

 

Net realized investment and other gains (losses)

       $ (133       $ (52       $   289   
  

 

 

 
(1) Primarily represents income earned from the Company’s investment in JHIMS.

 

F-24


Table of Contents

JOHN HANCOCK LIFE INSURANCE COMPANY OF NEW YORK

NOTES TO FINANCIAL STATEMENTS – (CONTINUED)

 

Note 2 — Investments - (continued)

 

     December 31,  
     2013     2012     2011  
  

 

 

 
     (in millions)  

Certain investment related activity:

      

Net investment income passed through to participating contract holders as interest credited to policyholders’ account balances

       $ 20          $ 23      $ 30   

Change in unrealized gains (losses) included in net realized investment and other gains (losses):

      

Fixed maturity securities held-for-trading

     (27     10        13   

Equity securities held-for-trading

     -        -        -   

Derivatives

     27        (134     14   

Gross gains on sales of available-for-sale securities

        41           190           345   

Gross losses on sales of available-for-sale securities

     134        51        26   

Other-than-temporary impairments on available-for-sale securities

     2        -        -   

Note 3 — Value of Business Acquired

The balance of and changes in VOBA were as follows:

 

     December 31,  
     2013     2012     2011  
  

 

 

 
     (in millions)  

Balance, beginning of year

       $   12      $    30      $   42   

Amortization

     (5     (28     (8

Change due to unrealized investment gains (losses)

     (1     10        (4
  

 

 

 

Balance, end of year

       $ 6      $ 12      $   30   
  

 

 

 

The following table provides estimated future amortization for the periods indicated:

 

     VOBA
Amortization
 
     (in millions)  

2014

       $   2   

2015

     2   

2016

     1   

2017

     1   

2018

     1   

 

F-25


Table of Contents

JOHN HANCOCK LIFE INSURANCE COMPANY OF NEW YORK

NOTES TO FINANCIAL STATEMENTS – (CONTINUED)

 

Note 4 — Deferred Policy Acquisition Costs and Deferred Sales Inducements

The balance of and changes in deferred policy acquisition costs were as follows:

 

     December 31,  
     2013     2012     2011  
  

 

 

 
     (in millions)  

Balance, beginning of year

       $ 405      $   397      $   499   

Capitalization

     38        40        47   

Amortization

     (10     (24     (124

Change due to unrealized investment gains

     34        (8     (25
  

 

 

 

Balance, end of year

       $   467      $   405      $    397   
  

 

 

 

The balance of and changes in deferred sales inducements (“DSI”) were as follows:

 

     December 31,  
     2013      2012     2011  
  

 

 

 
     (in millions)  

Balance, beginning of year

       $   23       $   24      $   32   

Capitalization

     1         -        1   

Amortization

     2         (1     (7

Change due to unrealized investment gains

     2         -        (2
  

 

 

 

Balance, end of year

       $   28       $   23      $   24   
  

 

 

 

Note 5 — Related Party Transactions

Service Agreements

The Company has formal service agreements with JHUSA. Under these agreements, the Company will pay investment and operating expenses incurred by JHUSA on behalf of the Company. Services provided under the agreements include legal, personnel, marketing, investment, and certain other administrative services and are billed based on intercompany cost allocations. Costs incurred under the agreements were $65 million, $65 million, and $66 million for the years ended December 31, 2013, 2012 and 2011, respectively. As of December 31, 2013 and 2012, the Company had amounts payable of $15 million and $14 million, respectively.

Management believes the allocation methods used are reasonable and appropriate in the circumstances; however, the Company’s Balance Sheets and Statements of Operations may not necessarily be indicative of the financial condition that would have existed if the Company operated as an unaffiliated entity.

 

F-26


Table of Contents

JOHN HANCOCK LIFE INSURANCE COMPANY OF NEW YORK

NOTES TO FINANCIAL STATEMENTS – (CONTINUED)

 

Note 5 — Related Party Transactions - (continued)

 

Other

The Company entered into an Amended and Restated Underwriting and Distribution Agreement with John Hancock Distributors, LLC (“JHD”), effective December 1, 2009, pursuant to which JHD is appointed as the principal underwriter and exclusive distributor of the variable annuities, variable life and other products issued by the Company. For the years ended December 31, 2013, 2012 and 2011, the Company was billed by JHD for underwriting commissions of $68 million, $67 million, and $75 million, respectively. The Company had amounts payable for services provided of $4 million and $4 million at December 31, 2013 and 2012, respectively.

The Company had receivables from JHIMS relating to distributions of $17 million and $16 million, which were included in accrued investment income at December 31, 2013 and 2012, respectively.

The Company is party to the Second Restated and Amended Liquidity Pool and Loan Facility Agreement effective January 1, 2010 with JHUSA. Pursuant to the agreement, participating affiliates are permitted to invest their excess cash in the liquidity pool and earn interest calculated at a rate that is reset daily to the one-month U.S. Dollar London Inter-Bank Bid Rate (“LIBID”), subject to an aggregate limit of $5 billion and an amount not to exceed 10% of the Company’s admitted assets as shown in the last financial statement filed with the Insurance Division. The Company had $381 million and $333 million invested in this pool at December 31, 2013 and 2012, respectively.

The Company also has certain reinsurance agreements with affiliates. These are more fully described in the Reinsurance note.

Note 6 — Reinsurance

Certain premiums and benefits are assumed from or ceded to affiliate and other insurance companies under various reinsurance agreements. The Company entered into these reinsurance agreements to transfer underlying risk on certain of its products, and to improve cash flow and statutory capital. The ceded reinsurance agreements provide the Company with increased capacity to write larger risks and maintain its exposure to loss within its capital resources.

Total reinsurance amounts included in the Company’s accompanying financial statements were as follows:

 

     Years ended December 31,  
     2013     2012     2011  
  

 

 

 
     (in millions)  

Premiums earned

      

Direct

       $   67      $   89      $   110   

Assumed

     30        158        22   

Ceded

     (42     (40     (58
  

 

 

 

Net

       $   55      $   207      $   74   
  

 

 

 

Benefits to policyholders ceded

       $   224      $   104      $   95   

Affiliated Reinsurance

The below table consists of the impact of the reinsurance agreements with its parents, JHUSA:

 

F-27


Table of Contents

JOHN HANCOCK LIFE INSURANCE COMPANY OF NEW YORK

NOTES TO FINANCIAL STATEMENTS – (CONTINUED)

 

Note 6 — Reinsurance - (continued)

 

     Years ended December 31,
     2013      2012      2011
  

 

 

     (in millions)

Amounts due from and held for affiliates

       $   404       $   271      

Reinsurance recoverable

     21         27      

Amounts due to affiliates

     66         67      

Coinsurance funds withheld

       2,418           2,329      

On January 1, 2010, the assets supporting the policyholders who reside in the state of New York (“NY business”) were transferred from JHUSA to the Company. The transfer included participating traditional life insurance, universal life insurance, fixed deferred and immediate annuities, participating pension contracts, and variable annuities. The NY business was transferred using assumption reinsurance, modified coinsurance and coinsurance with cut-through provisions.

The NY business related to the participating traditional life insurance policies were transferred from JHUSA to JHNY under a coinsurance agreement and was immediately retroceded back to JHUSA using a coinsurance funds withheld agreement. As the reinsurance agreements do not subject the reinsurer to reasonable possibility of significant loss, they are classified as structured reinsurance and given deposit-type accounting treatment. The Company retained the invested assets supporting this block of business. The NY business related to variable universal life was reinsured through coinsurance and modified coinsurance. The NY business related to universal life was transferred from JHUSA to JHNY under coinsurance agreements.

The NY business related to a majority of the fixed deferred annuity business was transferred from JHUSA to JHNY under an assumption reinsurance agreement. The NY business related to variable annuities and some participating pension contracts where assets were held in separate accounts were reinsured through modified coinsurance. The NY business related to fixed deferred and immediate annuities and participating pension contracts was transferred from JHUSA to JHNY under a coinsurance agreement.

The table and commentary below summarizes the impact of the reinsurance agreements with an affiliate, John Hancock Reassurance Company Limited (“JHRECO”), a wholly-owned subsidiary of MFC:

 

     Years ended December 31,  
     2013      2012      2011  
  

 

 

 
     (in millions)  

Premiums ceded

       $ -       $ -       $   15   

Benefits ceded

     63         34         44   

Amounts due from and held for affiliates

     -         1      

Reinsurance recoverable

       36           52      

Amounts due to affiliates

     31         51      

Other payables

     1         8      

Effective January 1, 2010, the Company entered into a partition and novation reinsurance agreement with an affiliate, JHRECO, to reinsure 100% of the mortality risk arising from no lapse guarantee benefits for single and survivorship joint Universal Life policies issued from 2002 to New York residents. The reinsurance agreement is written on a coinsurance funds withheld basis.

Effective January 1, 2010, the Company entered into a partition and novation reinsurance agreement with an affiliate, JHRECO, to reinsure 20% of the risk related to payout annuity policies issued January 1, 2008 through September 30, 2008 and 65% of the risk related to payout annuity policies issued prior to January 1, 2008. The reinsurance agreement is written on a modified coinsurance basis where the assets supporting the reinsured policies remain invested with the Company. In 2013, there was a partial recapture of the payout annuity policy agreement by the Company. This recapture did not have a material impact on the Company’s results of operations.

 

F-28


Table of Contents

JOHN HANCOCK LIFE INSURANCE COMPANY OF NEW YORK

NOTES TO FINANCIAL STATEMENTS – (CONTINUED)

 

Note 6 — Reinsurance - (continued)

 

At December 31, 2013, any material recoveries were secured by letters of credit or assets placed in trust by the assuming company.

Included in other operating costs and expenses for the years ended December 31, 2013, 2012 and 2011, respectively is $116 million, $123 million and $129 million of separate account fee income, net investment income and realized investment and other gains (losses), which was ceded to the affiliated reinsurers noted above.

Non-Affiliated Reinsurance

The Company also entered into a coinsurance agreement with Commonwealth Annuity to reinsure 90% of its fixed deferred annuity business effective July 1, 2012. The transaction was structured such that the Company transferred the actuarial liabilities and related invested assets which included $231 million in cash and $1,481 million in fixed maturity securities. The Company incurred a pre-tax gain of $46 million in connection with the transaction. Under the terms of the agreement, the Company will maintain responsibility for servicing of the policies. In addition, the agreement does not meet the criteria for reinsurance accounting and was given deposit-type accounting treatment that resulted in the recognition of an asset for amounts on deposit with reinsurers on the Balance Sheets.

At December 31, 2013, the Company had treaties with 27 reinsurers for its life insurance business (24 non-affiliated and 3 affiliated). The per policy life risk retained by the Company is capped at a maximum of $30 million on single life policies and $35 million on survivorship life policies. The previous limit of $100 thousand, which was revised as a consequence of the transfer of NY business, continues to apply to policies and reinsurance agreements in-force as at December 31, 2009. In 2013, recoveries under these agreements totaled $182 million on $204 million of death claims. In 2012, recoveries under these agreements totaled $70 million on $92 million of death claims. In 2011, recoveries under these agreements totaled $50 million on $69 million of death claims.

Note 7 — Derivatives and Hedging Instruments

Derivatives are financial contracts, the value of which is derived from underlying interest rates, foreign exchange rates, credit, equity price movements, indices or other market risks arising from on-balance sheet financial instruments and selected anticipated transactions. The Company uses derivatives including swaps and futures agreements to manage current and anticipated exposures to changes in interest rates and equity market prices.

Over-the-counter (“OTC”) swaps are contractual agreements between the Company and a counterparty to exchange a series of cash flows based upon rates applied to a notional amount. For interest rate swaps, counterparties generally exchange fixed or floating interest rate payments based on a notional value in a single currency.

Cleared interest rate swaps are contractual agreements between the Company and a counterparty whereby the transaction must be cleared through a central clearing house, and subject to mandatory margin and reporting requirements.

Futures agreements are contractual obligations to buy or sell a financial instrument or foreign currency on a predetermined future date at a specified price. Futures agreements are contracts with standard amounts and settlement dates that are traded on regulated exchanges.

Types of Derivatives and Derivative Strategies

Interest Rate Contracts. The Company uses interest rate futures contracts, OTC interest rate swap agreements and cleared interest rate swap agreements as part of its overall strategies of managing the duration of assets and liabilities or the average life of certain asset portfolios to specified targets. Interest rate swap agreements are contracts with counterparties to exchange interest rate payments of a differing character (i.e., fixed-rate payments exchanged for variable-rate payments) based on an underlying principal balance (notional principal). The net differential to be paid or received on interest rate swap agreements is accrued and recognized as a component of net investment income.

The Company uses interest rate swap agreements in effective hedge accounting relationships. These derivatives hedge the variable cash flows associated with future fixed income asset acquisitions, which will support the Company’s life insurance business. These agreements will reduce the impact of future interest rates changes on the cost of acquiring adequate assets to support the investment income assumptions used in pricing these products. During future periods when the acquired assets

 

F-29


Table of Contents

JOHN HANCOCK LIFE INSURANCE COMPANY OF NEW YORK

NOTES TO FINANCIAL STATEMENTS – (CONTINUED)

 

Note 7 — Derivatives and Hedging Instruments - (continued)

 

are held by the Company, the accumulated other comprehensive income will be amortized into investment income as a yield adjustment on the assets.

In addition, the Company uses interest rate swap agreements in effective hedge accounting relationships to hedge the risk of changes in fair value of fixed rate assets and liabilities arising from changes in benchmark interest rates. The Company reclassifies the effective portion of the change in fair value of the hedged item due to interest rate risk to earnings and amortizes the basis adjustment over the life of the hedged item.

The Company also enters into basis swaps to better match the cash flows from assets and related liabilities. Basis swaps are included in interest rate swaps for disclosure purposes. The Company utilizes basis swaps in qualifying and non-qualifying hedge accounting relationships.

The Company uses exchange-traded interest rate futures primarily to hedge mismatches between the duration of assets in a portfolio and the duration of liabilities supported by those assets, to hedge against changes in value of securities the Company owns or anticipates acquiring, and to hedge against changes in interest rates on anticipated liability issuances by replicating U.S. Treasury or swap curve performance. The Company utilizes exchange-traded interest rate futures in non-qualifying hedge accounting relationships.

Equity Market Contracts. Equity index futures contracts are contractual obligations to buy or sell a specified amount of an underlying equity index at an agreed contract price on a specified date. Equity index futures are contracts with standard amounts and settlement dates that are traded on regulated exchanges. The Company utilizes equity index futures in non-qualifying hedge accounting relationships.

 

F-30


Table of Contents

JOHN HANCOCK LIFE INSURANCE COMPANY OF NEW YORK

NOTES TO FINANCIAL STATEMENTS – (CONTINUED)

 

Note 7 — Derivatives and Hedging Instruments - (continued)

 

The table below provides a summary of the gross notional amount and fair value of derivatives contracts for all derivatives in qualifying and non-qualifying hedge accounting relationships:

 

          December 31, 2013      December 31, 2012  
          Notional
Amount
     Fair
Value
Assets
     Fair
Value
Liabilities
     Notional
Amount
     Fair
Value
Assets
     Fair
Value
Liabilities
 
     

 

 

    

 

 

 
          (in millions)  

Qualifying Hedge Accounting Relationships

                 

Fair value hedges

  

Interest rate swaps

       $ 212       $ 45       $ 3           $ 212       $ 32       $ -   
  

Foreign currency swaps

     -         -         -         -         -         -   

Cash flow hedges

  

Interest rate swaps

     298           12         17           311         78         3   
  

Foreign currency swaps

     -         -         -         -         -         -   
  

Foreign currency forwards

     -         -         -         -         -         -   
  

Equity total return swaps

     -         -         -         -         -         -   
     

 

 

    

 

 

 

Total Derivatives in Hedge Accounting Relationships

       $ 510       $ 57       $ 20           $ 523       $ 110       $ 3   
     

 

 

    

 

 

 

Non-Qualifying Hedge Accounting Relationships

                 
  

Interest rate swaps

       $ 8,175       $ 378       $ 325           $ 7,385       $ 544       $ 347   
  

Interest rate treasury locks

     -         -         -         -         -         -   
  

Interest rate options

     -         -         -         -         -         -   
  

Interest rate futures

     252         -         -         284         -         -   
  

Foreign currency swaps

     -         -         -         -         -         -   
  

Foreign currency forwards

     -         -         -         -         -         -   
  

Foreign currency futures

     -         -         -         -         -         -   
  

Equity total return swaps

     -         -         -         -         -         -   
  

Equity options

     -         -         -         -         -         -   
  

Equity index futures

     304         -         -         394         -         -   
  

Credit default swaps

     -         -         -         -         -         -   
  

Embedded derivatives – fixed maturity securities

     -         -         -         -         -         -   
  

Embedded derivatives – reinsurance contracts

     -         -         163         -         -         348   
  

Embedded derivatives – participating pension contracts (1)

     -         -         32         -         -         37   
  

Embedded derivatives – benefit
guarantees (1)

     -         49         13         -         75         108   
     

 

 

    

 

 

 

Total Derivatives in Non-Qualifying Hedge Accounting Relationships

     8,731         427         533         8,063         619         840   
     

 

 

    

 

 

 

Total Derivatives (2)

       $   9,241       $   484       $   553           $   8,586       $   729       $   843   
     

 

 

    

 

 

 
(1) Embedded derivatives related to participating pension contracts are reported as part of future policy benefits and embedded derivatives related to benefit guarantees are reported as part of reinsurance recoverable or future policy benefits on the Balance Sheets.
(2) The fair values of all derivatives in an asset position are reported within derivative assets on the Balance Sheets, and derivatives in a liability position are reported within derivative liabilities on the Balance Sheets, excluding embedded derivatives related to participating pension contracts and benefit guarantees.

 

F-31


Table of Contents

JOHN HANCOCK LIFE INSURANCE COMPANY OF NEW YORK

NOTES TO FINANCIAL STATEMENTS – (CONTINUED)

 

Note 7 — Derivatives and Hedging Instruments - (continued)

 

Hedging Relationships

The Company generally does not enter into derivative contracts for speculative purposes. In certain circumstances, these hedges also meet the requirements for hedge accounting. Hedging relationships eligible for hedge accounting are designated as either fair value hedges or cash flow hedges, as described below.

Fair Value Hedges. The Company uses interest rate swaps to manage its exposure to changes in fair value of fixed-rate financial instruments caused by changes in interest rates.

For the years ended December 31, 2013, 2012 and 2011, the Company did not recognize any gains or losses related to the portion of the hedging instruments that were excluded from the assessment of hedge effectiveness. At December 31, 2013, the Company had no hedges of firm commitments.

The following tables show the investment gains (losses) recognized:

Year ended December 31, 2013

 

Derivatives in Qualifying Fair Value

Hedging Relationships

  

Hedged Items in Qualifying Fair

Value Hedging

Relationships

   Gains (Losses)
Recognized on
Derivatives
    Gains (Losses)
Recognized for
Hedged Items
    Ineffectiveness
Recognized
 
          (in millions)  

Interest rate swaps

  

Fixed-rate assets

   $ 23      $ (27   $ (4
  

Fixed-rate liabilities

     (13     13        -   

Foreign currency swaps

  

Fixed-rate assets

     -        -        -   
  

Fixed-rate liabilities

     -        -        -   

 

 

Total

      $ 10      $ (14   $ (4

 

 

Year ended December 31, 2012

 

Derivatives in Qualifying Fair

Value Hedging Relationships

  

Hedged Items in Qualifying Fair

Value Hedging

Relationships

   Gains (Losses)
Recognized on
Derivatives
     Gains (Losses)
Recognized for
Hedged Items
    Ineffectiveness
Recognized
 
          (in millions)  

Interest rate swaps

  

Fixed-rate assets

   $ 7       $ (6   $ 1   
  

Fixed-rate liabilities

     -         -        -   

Foreign currency swaps

  

Fixed-rate assets

     -         -        -   
  

Fixed-rate liabilities

     -         -        -   

 

 

Total

      $ 7       $ (6   $ 1   

 

 

 

F-32


Table of Contents

JOHN HANCOCK LIFE INSURANCE COMPANY OF NEW YORK

NOTES TO FINANCIAL STATEMENTS – (CONTINUED)

 

Note 7 — Derivatives and Hedging Instruments - (continued)

 

Year ended December 31, 2011

 

Derivatives in Qualifying Fair

Value Hedging Relationships

  

Hedged Items in Qualifying Fair

Value Hedging
Relationships

   Gains (Losses)
Recognized on
Derivatives
     Gains (Losses)
Recognized for
Hedged Items
    Ineffectiveness
Recognized
 
          (in millions)  

Interest rate swaps

  

Fixed-rate assets

   $ -       $ -      $ -   
  

Fixed-rate liabilities

     10         (12     (2

Foreign currency swaps

  

Fixed-rate assets

     -         -        -   
  

Fixed-rate liabilities

     -         -        -   

 

 

Total

      $ 10       $ (12   $ (2

 

 

Cash Flow Hedges. The Company uses interest rate swaps to hedge the variability in cash flows from variable rate financial instruments and forecasted transactions.

For the year ended December 31, 2011, all of the Company’s hedged forecast transactions qualified as cash flow hedges. During 2012 the Company completed a review of the investment strategy for the universal life (“UL”) business. As part of this review, it was determined that it was appropriate for the UL business to begin investing in non-fixed income assets. Under the revised investment strategy, new UL cash flows will be invested in a combination of fixed income and non-fixed income assets, potentially resulting in lower cash flows available for reinvestment in fixed income assets than originally anticipated for the UL cash flow hedging program. The Company voluntarily de-designated $150 million (notional principal) of forward-starting interest rate swaps in 2012; the accumulated other comprehensive income related to these de-designated swaps continues to be deferred. During 2012, the deferred OCI related to the de-designated swaps amounted to $30 million, net of tax. If the forecasted transactions do occur as expected, these amounts will be allocated to the acquired fixed income assets in the periods during which the hedged forecasted transactions occur and amortized to earnings over the life of the underlying fixed income assets acquired. If the forecasted transactions become probable not to occur, the amounts will be reclassified to earnings in the period.

For the year ended December 31, 2013, all of the Company’s hedged forecast transactions qualified as cash flow hedges and no cash flow hedges were discontinued because it was probable that the original forecasted transactions would occur by the end of the originally specified time period documented at inception of the hedging relationship.

 

F-33


Table of Contents

JOHN HANCOCK LIFE INSURANCE COMPANY OF NEW YORK

NOTES TO FINANCIAL STATEMENTS – (CONTINUED)

 

Note 7 — Derivatives and Hedging Instruments - (continued)

 

The following tables present the effects of derivatives in qualifying cash flow hedging relationships on the Statements of Operations, the Statements of Comprehensive Income (Loss) and the Statements of Changes in Shareholder’s Equity:

Year ended December 31, 2013

 

Derivatives in Qualifying Cash

Flow Hedging Relationships

  

Hedged Items in Qualifying

Cash Flow Hedging

Relationships

   Gains (Losses)
Deferred in AOCI on
Derivatives  (Net of Tax)
   

Gains Reclassified from
AOCI into Net Realized
Investment and Other
Gains (Losses)

(Net of Tax)

     Ineffectiveness
Recognized in Net
Realized  Investment
and Other Gains
(Losses)
 
     (in millions)  

Interest rate swaps

  

Forecasted fixed-rate assets

   $ -      $ -       $ -   
  

Floating rate assets

     (42     7         -   
  

Inflation indexed liabilities

     -        -         -   
  

Forecasted fixed-rate liabilities

     -        -         -   

Foreign currency swaps

  

Fixed-rate assets

     -        -         -   
  

Floating rate assets

     -        -         -   
  

Floating rate liabilities

     -        -         -   

Foreign currency forwards

  

Forecasted expenses

     -        -         -   
  

Foreign currency assets

     -        -         -   

Equity total return swaps

  

Share-based payments

     -        -         -   

 

 

Total

      $ (42   $ 7       $ -   

 

 

Year ended December 31, 2012

 

Derivatives in Qualifying Cash

Flow Hedging Relationships

  

Hedged Items in Qualifying

Cash Flow Hedging

Relationships

   Gains (Losses)
Deferred in AOCI on
Derivatives  (Net of Tax)
   

Gains Reclassified from
AOCI into Net Realized
Investment and Other
Gains (Losses)

(Net of Tax)

     Ineffectiveness
Recognized in Net
Realized  Investment
and Other Gains
(Losses)
 
     (in millions)  

Interest rate swaps

  

Forecasted fixed-rate assets

   $ (2   $ 4       $ -   
  

Floating rate assets

     -        -         -   
  

Inflation indexed liabilities

     -        -         -   
  

Forecasted fixed-rate liabilities

     -        -         -   

Foreign currency swaps

  

Fixed-rate assets

     -        -         -   
  

Floating rate assets

     -        -         -   
  

Floating rate liabilities

     -        -         -   

Foreign currency forwards

  

Forecasted expenses

     -        -         -   
  

Foreign currency assets

     -        -         -   

Equity total return swaps

  

Share-based payments

    

 

-

-

  

  

    -         -   

 

 

Total

      $ (2   $ 4       $ -   

 

 

 

F-34


Table of Contents

JOHN HANCOCK LIFE INSURANCE COMPANY OF NEW YORK

NOTES TO FINANCIAL STATEMENTS – (CONTINUED)

 

Note 7 — Derivatives and Hedging Instruments - (continued)

 

Year ended December 31, 2011

 

Derivatives in Qualifying Cash

Flow Hedging Relationships

  

Hedged Items in Qualifying

Cash Flow Hedging

Relationships

   Gains (Losses)
Deferred in AOCI  on
Derivatives
(Net of Tax)
    

Gains Reclassified from
AOCI into Net Realized
Investment and Other
Gains (Losses)

(Net of Tax)

     Ineffectiveness
Recognized in Net
Realized  Investment
and Other Gains
(Losses)
 
     (in millions)  

Interest rate swaps

  

Forecasted fixed-rate assets

   $ 97       $ -       $ -   
  

Floating rate assets

     -         -         -   
  

Inflation indexed liabilities

     -         -         -   
  

Forecasted fixed-rate liabilities

     -         -         -   

Foreign currency swaps

  

Fixed-rate assets

     -         -         -   
  

Floating rate assets

     -         -         -   
  

Floating rate liabilities

     -         -         -   

Foreign currency forwards

  

Forecasted expenses

     -         -         -   
  

Foreign currency assets

     -         -         -   

Equity total return swaps

  

Share-based payments

     -         -         -   

 

 

Total

      $ 97       $ -       $ -   

 

 

The Company anticipates that pre-tax net gains of $2 million will be reclassified from accumulated other comprehensive income to earnings within the next 12 months. The maximum time frame for which variable cash flows are hedged is 7 years.

For a roll forward of the net accumulated gains (losses) on cash flow hedges see Shareholder’s Equity Note.

Derivatives Not Designated in Qualifying Hedge Accounting Relationships. The Company enters into interest rate swap agreements and interest rate futures contracts to manage exposure to interest rates without designating the derivatives as hedging instruments.

The Company offers certain variable annuity products with a guaranteed minimum withdrawal benefit (“GMWB”) rider. This rider is effectively an embedded option on the basket of mutual funds which is offered to contract holders. Beginning in July 2010, for certain contracts, the Company implemented a hedging program to reduce its exposure to the GMWB rider. This dynamic hedging program uses interest rate swap agreements, equity index futures (including but not limited to the Dow Jones Industrial, Standard & Poor’s 500, Russell 2000, and Dow Jones Euro Stoxx 50 indices), and foreign currency futures to match the sensitivities of the GMWB rider liability to the market risk factors.

 

F-35


Table of Contents

JOHN HANCOCK LIFE INSURANCE COMPANY OF NEW YORK

NOTES TO FINANCIAL STATEMENTS – (CONTINUED)

 

Note 7 — Derivatives and Hedging Instruments - (continued)

 

For the years ended December 31, 2013, 2012 and 2011, gains and losses related to derivatives in a non-qualifying hedge accounting relationship were recognized by the Company and the components were recorded in net realized investment and other gains (losses) as follows:

 

Years ended December 31,    2013     2012     2011  
     (in millions)  

Non-Qualifying Hedge Accounting Relationships

      

Interest rate swaps

       $ (152   $ (28   $    187   

Interest rate treasury locks

     -        -        -   

Interest rate options

     -        -        -   

Interest rate futures

            5        (5     (14

Foreign currency swaps

     -        -        -   

Foreign currency forwards

     -        -        -   

Foreign currency futures

     -        -        -   

Equity total return swaps

     -        -        -   

Equity options

     -        -        -   

Equity index futures

     (90     (81     (23

Credit default swaps

     -                -        -   

Embedded derivatives

       258        (104     (172
  

 

 

 

Total Investment Gains (Losses) from Derivatives in Non-Qualifying Hedge Accounting Relationships

       $ 21      $ (218   $ (22
  

 

 

 

Embedded Derivatives. The Company has certain embedded derivatives that are required to be separated from their host contracts and accounted for as derivatives. These host contracts include fixed maturity securities, reinsurance contracts, participating pension contracts, and certain benefit guarantees.

For more details on the Company’s embedded derivatives, see the Fair Value Measurements Note.

Credit Risk. The Company’s exposure to loss on derivatives is limited to the amount of any net gains that may have accrued with a particular counterparty. Gross derivative counterparty exposure is measured as the total fair value (including accrued interest) of all outstanding contracts in a gain position excluding any offsetting contracts in negative positions and the impact of collateral on hand. The Company may be exposed to credit-related losses in the event of nonperformance by counterparties to the derivative financial instruments. The current credit exposure of the Company’s derivative contracts is limited to the fair value in excess of the collateral held at the reporting date.

The Company manages its credit risk by entering into transactions with creditworthy counterparties, obtaining collateral where appropriate, and entering into master netting agreements that provide for a netting of payments and receipts with a single counterparty. The Company enters into credit support annexes with its OTC derivative dealers in order to manage its credit exposure to those counterparties. As part of the terms and conditions of those agreements, the pledging and accepting of collateral in connection with the Company’s derivative usage is required. As of December 31, 2013 and 2012, the Company had accepted collateral consisting of cash of $57 million and $158 million and various securities with a fair value of $94 million and $187 million, respectively, which is held in separate custodial accounts. In addition, the Company has pledged collateral to support both the OTC derivative instruments, exchange traded futures and cleared interest rate swap transactions. For further details regarding pledged collateral see the Investments Note.

In June 2013, under US regulations, certain interest rate swap agreements were required to be cleared through central clearing houses. These transactions are contractual agreements that require initial and variation margin collateral postings and are settled on a daily basis through a clearing house. As such, they reduce the credit risk exposure in the event of default by a counterparty.

 

F-36


Table of Contents

JOHN HANCOCK LIFE INSURANCE COMPANY OF NEW YORK

NOTES TO FINANCIAL STATEMENTS – (CONTINUED)

 

Note 8 — Certain Separate Accounts

The deposits related to the variable life insurance contracts are invested in separate accounts, and the Company guarantees a specified death benefit on certain policies if specified premiums on these policies are paid by the policyholder, regardless of separate account performance.

The following table reflects variable life insurance contracts with guarantees held by the Company:

 

     December 31,  
     2013      2012  
  

 

 

 
     (in millions, except for age)  

Life insurance contracts with guaranteed benefits

     

In the event of death

     

Account value

       $   136           $   104   

Net amount at risk related to deposits

     5         5   

Average attained age of contract holders

     50         49   

Many of the variable annuity contracts issued by the Company offer various guaranteed minimum death, income, and/or withdrawal benefits. Guaranteed Minimum Death Benefit (“GMDB”) features guarantee the contract holder either (a) a return of no less than total deposits made to the contract less any partial withdrawals; (b) total deposits made to the contract less any partial withdrawals plus a minimum return; (c) the highest contract value on a specified anniversary date minus any withdrawals following the contract anniversary, or (d) a combination of (b) and (c) above.

Contracts with Guaranteed Minimum Income Benefit (“GMIB”) riders provide a guaranteed lifetime annuity, which may be elected by the contract holder after a stipulated waiting period (ten years), and which may be larger than what the contract account balance would purchase at then-current annuity purchase rates.

Multiple variations of an optional GMWB rider have also been offered by the Company. The GMWB rider provides contract holders a guaranteed annual withdrawal amount over a specified time period or in some cases for as long as they live. In general, guaranteed annual withdrawal amounts are based on deposits and may be reduced if withdrawals exceed allowed amounts. Guaranteed amounts may also be increased as a result of “step-up” provisions, which increase the benefit base to higher account values at specified intervals. Guaranteed amounts may also be increased if withdrawals are deferred over a specified period. In addition, certain versions of the GMWB rider extend lifetime guarantees to spouses.

Unaffiliated reinsurance has been utilized to mitigate risk related to some of the guarantee benefit riders. Hedging has also been utilized to mitigate risk related to some of the GMWB riders.

For GMDB, the net amount at risk is defined as the current guaranteed minimum death benefit in excess of the current account balance. For GMIB, the net amount at risk is defined as the excess of the current annuitization income base over the current account value. For GMWB, the net amount at risk is defined as the current guaranteed withdrawal amount minus the current account value. For all the guarantees, the net amount at risk is floored at zero at the single contract level.

The Company had the following variable annuity contracts with guarantees. Amounts at risk are shown net of reinsurance. Note that the Company’s variable annuity contracts with guarantees may offer more than one type of guarantee in each contract; therefore, the amounts listed are not mutually exclusive.

 

F-37


Table of Contents

JOHN HANCOCK LIFE INSURANCE COMPANY OF NEW YORK

NOTES TO FINANCIAL STATEMENTS – (CONTINUED)

 

Note 8 — Certain Separate Accounts - (continued)

 

     December 31,  
     2013     2012  
  

 

 

 
     (in millions, except for ages and percentages)  

Guaranteed Minimum Death Benefit

    

Return of net deposits

    

In the event of death

    

Account value

       $   1,519      $   1,463   

Net amount at risk — net of reinsurance

     4        12   

Average attained age of contract holders

     67        66   

Return of net deposits plus a minimum return

    

In the event of death

    

Account value

       $ -      $ -   

Net amount at risk — net of reinsurance

     -        -   

Average attained age of contract holders

     -        -   

Guaranteed minimum return rate

     0     0

Highest specified anniversary account value minus withdrawals post anniversary

    

In the event of death

    

Account value

       $ 2,506      $ 2,493   

Net amount at risk — net of reinsurance

     28        67   

Average attained age of contract holders

     66        66   

Guaranteed Minimum Income Benefit

    

Account value

       $ 415      $ 421   

Net amount at risk — net of reinsurance

     -        -   

Average attained age of contract holders

     64        63   

Guaranteed Minimum Withdrawal Benefit

    

Account value

       $ 3,031      $ 2,944   

Net amount at risk

     164        334   

Average attained age of contract holders

     66        65   

Account balances of variable contracts with guarantees were invested in various separate accounts with the following characteristics:

 

     December 31,  
     2013      2012  
  

 

 

 
     (in millions)  

Type of Fund

     

Equity

       $   2,012       $   2,160   

Balanced

     1,708         1,379   

Bond

       478         535   

Money Market

     44         65   
  

 

 

 

Total

       $ 4,242       $ 4,139   
  

 

 

 

 

F-38


Table of Contents

JOHN HANCOCK LIFE INSURANCE COMPANY OF NEW YORK

NOTES TO FINANCIAL STATEMENTS – (CONTINUED)

 

Note 8 — Certain Separate Accounts - (continued)

 

The following table summarizes the liabilities for guarantees on variable life and annuity contracts reflected in future policy benefits in the general account:

 

    

Guaranteed
Minimum
Death

Benefit
(GMDB)

    Guaranteed
Minimum
Income
Benefit
(GMIB)
    Guaranteed
Minimum
Withdrawal
Benefit
(GMWB)
    Total  
  

 

 

 
     (in millions)  

Balance at January 1, 2013

       $         28      $       11      $       118      $       157   

Incurred guarantee benefits

     (1     (1     -        (2

Other reserve changes

     (1     (3     (100     (104
  

 

 

 

Balance at December 31, 2013

     26        7        18        51   

Reinsurance recoverable

     (1     (49     -        (50
  

 

 

 

Net balance at December 31, 2013

       $ 25      $ (42   $ 18      $ 1   
  

 

 

 

Balance at January 1, 2012

       $ 28      $ 10      $ 106      $ 144   

Incurred guarantee benefits

     (3     -        -        (3

Other reserve changes

     3        1        12        16   
  

 

 

 

Balance at December 31, 2012

     28        11        118        157   

Reinsurance recoverable

     (1     (75     -        (76
  

 

 

 

Net balance at December 31, 2012

       $ 27      $ (64   $ 118      $ 81   
  

 

 

 

The GMDB gross and ceded reserves, the GMIB gross reserves, and the life contingent portion of the GMWB reserves were determined in accordance with ASC 944, “Financial Services — Insurance”, and the GMIB reinsurance recoverable and non-life contingent GMWB gross reserves were determined in accordance with ASC 815 “Derivatives and Hedging.”

The Company regularly evaluates estimates used and adjusts the additional liability balance, with a related charge or credit to benefits to policyholders, if actual experience or other evidence suggests that earlier assumptions should be revised.

The following assumptions and methodology were used to determine the amounts above at December 31, 2013 and 2012:

 

   

Data used included 1,000 stochastically generated investment performance scenarios. For the GMIB reinsurance recoverable and non-life contingent GMWB gross reserve calculations, risk neutral scenarios were used.

 

   

Mean return and volatility assumptions were determined by asset class. Market consistent observed volatilities were used where available for ASC 815 calculations.

 

   

Annuity mortality is based on a combination of the Ruark Variable Annuity table and the Company’s actual experience between 2006 and 2010. The Ruark table is based on an industry study of variable annuity deaths in 2005 and 2006.

 

   

Annuity base lapse rates vary by contract type, duration, type of living benefit or death benefit rider, and whether guaranteed withdrawals are being taken. The lapse rates range from 0.5% to 40%.

 

   

The discount rates used in the GMDB gross and ceded reserves, the GMIB gross reserves, and the life contingent portion of the GMWB reserve calculations range from 6.4% to 7%. The discount rates used in the GMIB reinsurance recoverable and non-life contingent GMWB gross reserve calculations were based on the term structure of swap curves with a credit spread based on the credit standing of MFC (for GMWB) and the reinsurers (for GMIB).

 

F-39


Table of Contents

JOHN HANCOCK LIFE INSURANCE COMPANY OF NEW YORK

NOTES TO FINANCIAL STATEMENTS – (CONTINUED)

 

Note 9 — Income Taxes

The Company is included in the consolidated federal income tax return of JHFC. Prior to the merger, the Company filed tax returns as part of the MHDLLC consolidated group.

The components of income taxes were as follows:

 

     Years ended December 31,  
     2013      2012     2011  
  

 

 

 
     (in millions)  

Current taxes:

       

Federal

       $ 35       $    70      $    131   

Deferred taxes:

       

Federal

     81         (17     (10
  

 

 

 

Total income tax expense (benefit)

       $   116       $ 53      $ 121   
  

 

 

 

A reconciliation of income taxes at the federal income tax rate to income tax expense (benefit) charged to operations follows:

 

     Years ended December 31,  
     2013     2012     2011  
  

 

 

 
     (in millions)  

Tax at 35%

       $   125      $    75      $   123   

Add (deduct):

      

Prior year taxes

     1        (4     2   

Tax credits

     (1     (2     (1

Dividend received deduction

     (7     (7     (6

Change in tax reserves

     (2     (9     3   

Tax-exempt investment income

     -        -        -   

Foreign tax expense gross-up

     1        1        -   

Other

     (1     (1     -   
  

 

 

 

Total income tax expense (benefit)

       $ 116      $ 53      $ 121   
  

 

 

 

 

F-40


Table of Contents

JOHN HANCOCK LIFE INSURANCE COMPANY OF NEW YORK

NOTES TO FINANCIAL STATEMENTS – (CONTINUED)

 

Note 9 — Income Taxes - (continued)

 

Deferred income tax assets and liabilities result from tax affecting the differences between the financial statement values and income tax values of assets and liabilities at each Balance Sheet date. Deferred tax assets and liabilities consisted of the following:

 

     December 31,  
     2013      2012  
  

 

 

 
     (in millions)  

Deferred tax assets:

     

Policy reserves

       $   99       $   202   

Tax credits

     7         10   

Unearned revenue

     23         7   

Securities and other investments

     23         -   

Other

     1         3   
  

 

 

 

Total deferred tax assets

     153         222   
  

 

 

 

Deferred tax liabilities:

     

Unrealized investment gains on securities

     4         192   

Deferred policy acquisition costs

     92         73   

Deferred sales inducements

     10         9   

Securities and other investments

     -         13   

Intangibles

     2         4   

Premiums receivable

     1         -   

Other

     7         -   
  

 

 

 

Total deferred tax liabilities

     116         291   
  

 

 

 

Net deferred tax assets (liabilities)

       $ 37       $ (69
  

 

 

 

At December 31, 2013 the Company had no operating loss carry forwards. At December 31, 2013, the Company had $7 million of tax credits, which consist of $1 million of alternative minimum tax credits and $6 million of foreign tax credits. The foreign tax credits begin to expire in tax year 2016 through tax year 2023. The alternative minimum tax credits do not have an expiration date.

The Company has not recorded a valuation allowance with respect to the realizability of its deferred tax assets. In assessing the need for a valuation allowance, management considered the future reversal of taxable temporary differences, future taxable income exclusive of reversing temporary differences, taxable income in the carry back period, as well as tax planning strategies. Tax planning strategies were considered to the extent they were both prudent and feasible and if implemented, would result in the realization of deferred tax assets. Based on management’s assessment of all available information, management believes that it is more likely than not that the Company will realize the full benefit of its deferred tax assets.

Under the terms of its intercompany tax sharing agreement, the Company made federal income tax payments to its parent, JHUSA, of $73 million, $152 million, and $69 million in 2013, 2012 and 2011, respectively. In 2013 the Company made income tax payments of $1 million to the Internal Revenue Service (“IRS”).

The Company files income tax returns in the U.S. federal jurisdiction and in NY. The Company is under continuous examination by the IRS. Effective for 2010, the Company’s common parent JHFC merged into MHDLLC resulting in a new combined group. The returns for the new combined group have not yet been examined by the IRS. With respect to the legacy MHDLLC consolidated return group, the IRS audit for tax years prior to 2008 have been closed. For tax years 2008 and 2009, a refund claim is pending with the IRS Joint Committee.

 

F-41


Table of Contents

JOHN HANCOCK LIFE INSURANCE COMPANY OF NEW YORK

NOTES TO FINANCIAL STATEMENTS – (CONTINUED)

 

Note 9 — Income Taxes - (continued)

 

A reconciliation of the beginning and ending amount of unrecognized tax benefits is as follows:

 

     December 31,  
     2013     2012  
  

 

 

 
     (in millions)  

Balance, beginning of year

       $    9      $    18   

Additions based on tax positions related to the current year

     1        2   

Payments

     (2     -   

Reductions for tax positions of prior years

     (3     (11
  

 

 

 

Balance, end of year

       $ 5      $ 9   
  

 

 

 

Included in the balances as of December 31, 2013 and 2012, respectively, are $5 million and $9 million of unrecognized benefits that, if recognized, would affect the Company’s effective tax rate. There are no tax positions for which the ultimate deductibility is highly certain but for which there is uncertainty about the timing of such deductibility.

The Company has no unrecognized tax benefits that will significantly increase or decrease in the next twelve months.

The Company recognizes interest accrued and penalties in income tax expense. For the years ended December 31, 2013 and 2012 the Company recognized approximately $2 million and $3 million of interest benefit, respectively. For the year ended December 31, 2011 the Company recognized approximately $1 million of interest expense. The Company had approximately $0 million and $1 million accrued for interest as of December 31, 2013 and 2012, respectively. The Company did not recognize material penalties for the years ended December 31, 2013, 2012 and 2011.

Note 10 — Commitments and Legal Proceedings

Commitments. The Company has extended commitments to purchase U.S. private debt and to issue mortgage loans on real estate totaling $230 million and $16 million, respectively, at December 31, 2013. The Company monitors the creditworthiness of borrowers under long-term bond commitments and requires collateral as deemed necessary. Approximately 53% of these commitments expire in 2014 and the majority of the remainder expires by 2018.

The Company leases office space under an operating lease agreement, which will expire in March 2015. Rental expenses were $61 thousand, $48 thousand, and $63 thousand for each of the years ended December 31, 2013, 2012 and 2011, respectively.

The future minimum lease payments by year and in the aggregate, under the remaining operating lease are presented below:

 

     Operating Leases  
     (in thousands)  

2014

       $   56   

2015

     14   

2016

     -   
  

 

 

 

Total minimum lease payments

       $ 70   
  

 

 

 

The Company does not have any sublease income related to its office space.

Legal Proceedings. The Company is regularly involved in litigation, both as a defendant and as a plaintiff. The litigation naming the Company as a defendant ordinarily involves its activities as a provider of insurance protection and wealth management products, and as a taxpayer. In addition, the NY State Department of Financial Services, the NY Attorney General, the SEC, the Financial Regulatory Authority, and other government and regulatory bodies regularly make inquiries and, from time to time, require the production of information or conduct examinations concerning the Company’s compliance with, among other things, insurance laws, securities laws, and laws governing the activities of broker-dealers. An estimation of the range of potential outcomes in any given matter is often unavailable until such matters have developed and sufficient information emerges to support an assessment of the range of possible loss, such as quantification of a damage demand from

 

F-42


Table of Contents

JOHN HANCOCK LIFE INSURANCE COMPANY OF NEW YORK

NOTES TO FINANCIAL STATEMENTS – (CONTINUED)

 

Note 10 — Commitments and Legal Proceedings - (continued)

 

plaintiffs, discovery from other parties and investigation of factual allegations, rulings by the court on motions or appeals, analysis by experts, and the progress of settlement negotiations. On a quarterly and annual basis, the Company reviews relevant information with respect to litigation contingencies and updates its accruals and estimates of reasonably possible losses or ranges of loss based on such reviews.

Note 11 — Shareholder’s Equity

Capital Stock

The Company has one class of capital stock, common stock. All of the outstanding common stock of the Company is owned by its parent, JHUSA.

Accumulated Other Comprehensive Income

The components of accumulated other comprehensive income (loss) were as follows:

 

     Net Unrealized
Investment
Gains (Losses)
    Net
Accumulated
Gain (loss)
on Cash
Flow Hedges
     Foreign
Currency
Translation
Adjustment
     Accumulated
Other
Comprehensive
Income (Loss)
 
  

 

 

 
     (in millions)  

Balance at January 1, 2011

       $ 127      $ -       $   -       $ 127   

Gross unrealized investment gains (net of deferred income tax expense of $212)

        395                 395   

Reclassification adjustment for gains realized in net income (net of deferred income tax expense of $111)

     (208           (208

Adjustment for policyholder liabilities (net of deferred income tax benefit of $23)

     (42           (42

Adjustment for deferred policy acquisition costs, deferred sales inducements, value of business acquired, and unearned revenue liability (net of deferred income tax benefit of $17)

     (31           (31
  

 

 

 

Net unrealized investment gains

     114              114   

Foreign currency translation adjustment (net of deferred income tax benefit of $0)

          -         -   

Net gains on the effective portion of the change in fair value of cash flow hedges (net of deferred income tax expense of $52)

         97            97   

Reclassification of net cash flow hedge losses to net income (net of deferred income tax benefit of $0)

       -            -   
  

 

 

 

Balance at December 31, 2011

       $ 241      $ 97       $ -       $ 338   
  

 

 

 

 

F-43


Table of Contents

JOHN HANCOCK LIFE INSURANCE COMPANY OF NEW YORK

NOTES TO FINANCIAL STATEMENTS – (CONTINUED)

 

Note 11 — Shareholder’s Equity - (continued)

 

     Net Unrealized
Investment
Gains (Losses)
    Net
Accumulated
Gain (loss)
on Cash
Flow Hedges
    Foreign
Currency
Translation
Adjustment
     Accumulated
Other
Comprehensive
Income (Loss)
 
  

 

 

 
     (in millions)  

Balance at January 1, 2012

       $ 241      $    97      $ -       $ 338   

Gross unrealized investment gains (net of deferred income tax expense of $70)

        132                132   

Reclassification adjustment for gains realized in net income (net of deferred income tax expense of $55)

     (102          (102

Adjustment for policyholder liabilities (net of deferred income tax benefit of $3)

     (6          (6

Adjustment for deferred policy acquisition costs, deferred sales inducements, value of business acquired, and unearned revenue liability (net of deferred income tax benefit of $0)

     -             -   
  

 

 

 

Net unrealized investment gains

     24             24   

Foreign currency translation adjustment (net of deferred income tax benefit of $0)

         -         -   

Net losses on the effective portion of the change in fair value of cash flow hedges (net of deferred income tax benefit of $1)

       (2        (2

Reclassification of net cash flow hedge gains to net income (net of deferred income tax expense of $2)

       (4        (4
  

 

 

 

Balance at December 31, 2012

       $ 265      $ 91      $ -       $ 356   
  

 

 

 

 

F-44


Table of Contents

JOHN HANCOCK LIFE INSURANCE COMPANY OF NEW YORK

NOTES TO FINANCIAL STATEMENTS – (CONTINUED)

 

Note 11 — Shareholder’s Equity - (continued)

 

     Net Unrealized
Investment
Gains (Losses)
    Net
Accumulated
Gain (loss)
on Cash
Flow Hedges
    Foreign
Currency
Translation
Adjustment
     Accumulated
Other
Comprehensive
Income (Loss)
 
  

 

 

 
     (in millions)  

Balance at January 1, 2013

       $ 265      $    91      $   -       $    356   

Gross unrealized investment losses (net of deferred income tax benefit of $208)

     (386          (386

Reclassification adjustment for losses realized in net income (net of deferred income tax benefit of $31)

     57             57   

Adjustment for policyholder liabilities (net of deferred income tax benefit of $1)

     (2          (2

Adjustment for deferred policy acquisition costs, deferred sales inducements, value of business acquired, and unearned revenue liability (net of deferred income tax expense of $17)

     32             32   
  

 

 

 

Net unrealized investment losses

     (299          (299

Foreign currency translation adjustment (net of deferred income tax benefit of $0)

         -         -   

Net losses on the effective portion of the change in fair value of cash flow hedges (net of deferred income tax benefit of $23)

       (42        (42

Reclassification of net cash flow hedge gains to net income (net of deferred income tax expense of $4)

       (7        (7
  

 

 

 

Balance at December 31, 2013

       $ (34   $ 42      $ -       $ 8   
  

 

 

 

 

F-45


Table of Contents

JOHN HANCOCK LIFE INSURANCE COMPANY OF NEW YORK

NOTES TO FINANCIAL STATEMENTS – (CONTINUED)

 

Note 11 — Shareholder’s Equity - (continued)

 

Information regarding amounts reclassified out of each component of AOCI was as follows:

 

     Amounts      
     Reclassified from      
     AOCI (1)      
     Year Ended     Affected Line Item in
     December 31,     Statement
     2013     of Operations
  

 

 

Unrealized investment gains (losses): (2) (3)

    

Net unrealized gains (losses)

   $ (88   Other net realized investment and other gains (losses)

OTTI

     -      Portion of loss recognized in other comprehensive income
  

 

 

   

Net realized gains (losses) before income tax

     (88  

Income tax (expense) benefit

     31     
  

 

 

   

Net realized gains (losses), net of income tax

   $ (57  
  

 

 

   

Unrealized gains (losses) on derivatives - cash flow hedges:

    

Interest rate swaps

   $ 11      Other net realized investment and other gains (losses)

Foreign currency swaps

     -      Other net realized investment and other gains (losses)

Foreign currency forwards

     -      Other net realized investment and other gains (losses)

Equity market contracts

     -      Other net realized investment and other gains (losses)
  

 

 

   

Net gains (losses) on cash flow hedges, before income tax

     11     

Income tax (expense) benefit

     (4  
  

 

 

   

Net gains (losses) on cash flow hedges, net of income tax

   $ 7     
  

 

 

   

Total reclassifications for the year, net of income tax

   $ (50  
  

 

 

   
(1) Positive amounts indicate gains/benefits reclassified out of AOCI. Negative amounts indicate losses/costs reclassified out of AOCI.
(2) Amounts reflect investment gains (losses) that were previously unrealized and reclassified to the Consolidated Statements of Operations during the period as realized.
(3) See table below for additional information on unrealized investment gains (losses), including the impact on deferred policy acquisition costs, deferred sales inducements, value of business acquired, unearned revenue liability, and policyholder liabilities.

 

F-46


Table of Contents

JOHN HANCOCK LIFE INSURANCE COMPANY OF NEW YORK

NOTES TO FINANCIAL STATEMENTS – (CONTINUED)

 

Note 11 — Shareholder’s Equity - (continued)

 

Net unrealized investment gains (losses) included on the Company’s Balance Sheets as a component of shareholder’s equity are summarized below:

 

     Years ended December 31,  
     2013     2012     2011  
  

 

 

 
     (in millions)  

Balance, end of year comprises:

      

Unrealized investment gains (losses) on:

      

Fixed maturity securities

       $ 43      $ 552      $ 507   

Equity securities

     -        -        -   

Other investments

     2        -        -   
  

 

 

 

Total

        45           552        507   

Amounts of unrealized investment gains (losses) attributable to:

      

Deferred policy acquisition costs, deferred sales inducements, value of business acquired, and unearned revenue liability

     (19     (70     (70

Policyholder liabilities

     (78     (75     (66

Deferred income taxes

     18        (142     (130
  

 

 

 

Total

     (79     (287     (266
  

 

 

 

Net unrealized investment gains (losses)

       $ (34   $ 265      $    241   
  

 

 

 

Statutory Results

The Company is required to prepare financial statements in accordance with accounting practices prescribed or permitted by the insurance department of its state of domicile, which is New York.

The principal differences between statutory financial statements and financial statements prepared in accordance with USGAAP are that statutory financial statements do not reflect DAC, bonds may be carried at amortized cost, assets and liabilities are presented net of reinsurance, policy and contract obligations are generally valued using more conservative assumptions and certain assets are non-admitted.

Life and health insurance companies are subject to certain risk-based capital (“RBC”) requirements as specified by the NAIC. Under those requirements, the amount of capital and surplus maintained by a life and health insurance company is to be determined based on the various risk factors related to it. At December 31, 2013, the Company met the minimum RBC requirements.

The Company’s statutory net income (loss) for the years ended December 31, 2013, 2012 and 2011 was $466 million, $69 million, and $(282) million, respectively.

The Company’s statutory capital and surplus as of December 31, 2013 and 2012 was $1,284 million and $1,005 million, respectively.

Under New York State insurance laws, no insurer may pay any shareholder dividends from any source other than statutory earned surplus without the prior approval of the Superintendent of Financial Services (the “Superintendent”). New York State law also limits the aggregate amount of dividends a life insurer may pay in any calendar year, without the prior permission of the Superintendent, to the lesser of (i) 10% of its statutory policyholders’ surplus as of the immediately preceding calendar year or (ii) the company’s statutory net gain from operations for the immediately preceding calendar year, not including realized capital gains. JHNY paid no shareholder dividends to JHUSA for the years ended December 31, 2013, 2012 and 2011.

 

F-47


Table of Contents

JOHN HANCOCK LIFE INSURANCE COMPANY OF NEW YORK

NOTES TO FINANCIAL STATEMENTS - (CONTINUED)

 

Note 12 — Pension and Other Postretirement Benefit Plans

The Company participates in the John Hancock Pension Plan (the “Plan”), a qualified defined benefit plan sponsored by MIC. The Company also participates in the John Hancock Non-Qualified Pension Plan, a non-qualified defined benefit plan for employees whose qualified cash balance benefit is restricted by the Internal Revenue Code. The non-qualified defined benefit plan was frozen except for grandfathered participants as of January 1, 2008, and the benefits accrued under this plan continue to be subject to the plan’s provisions. The expense for these plans was charged to the Company and was not material for the years ended December 31, 2013, 2012 and 2011, respectively.

The Company participates in the John Hancock Employee Welfare Plan (the “Welfare Plan”), a postretirement medical and life insurance benefit plan for its retired employees and their spouses. The Welfare Plan is sponsored by MIC. The expense for other postretirement benefits was charged to the Company and was not material for the years ended December 31, 2013, 2012 and 2011, respectively.

The Company participates in The Investment-Incentive Plan for John Hancock Employees, a qualified defined contribution plan for its employees who meet certain eligibility requirements. The plan is sponsored by JHUSA. The expense for the defined contribution plan was charged to the Company and was not material for the years ended December 31, 2013, 2012 and 2011, respectively.

Note 13 — Fair Value Measurements

Fair value is defined as the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date; that is, an exit value. The exit value assumes the asset or liability is exchanged in an orderly transaction; it is not a forced liquidation or distressed sale.

The Company categorizes its fair value measurements according to a three-level hierarchy. The hierarchy prioritizes the inputs used by the Company’s valuation techniques. A level is assigned to each fair value measurement based on the lowest level input significant to the fair value measurement in its entirety. The three levels of the fair value hierarchy are defined as follows:

 

 

Level 1 – Fair value measurements that reflect unadjusted, quoted prices in active markets for identical assets and liabilities that the Company has the ability to access at the measurement date. Active markets are defined as having the following characteristics for the measured asset/liability; (i) many transactions, (ii) current prices, (iii) price quotes not varying substantially among market makers, (iv) narrow bid/ask spreads, and (v) most information is publicly available. Valuations are based on quoted prices reflecting market transactions involving assets or liabilities identical to those being measured. Level 1 assets primarily include separate account assets.

 

 

Level 2 – Fair value measurements using inputs other than quoted prices included within Level 1 that are observable for the asset or liability, either directly or indirectly. These include quoted prices for similar assets and liabilities in active markets, quoted prices for identical or similar assets and liabilities in inactive markets, inputs that are observable that are not prices (such as interest rates, credit risks, etc.), and inputs that are derived from or corroborated by observable market data. Most fixed maturity securities and some short-term investments are classified within Level 2. Also included in the Level 2 category are financial instruments that are priced using models with observable market inputs, including most derivative financial instruments.

 

 

Level 3 – Fair value measurements using significant nonmarket observable inputs. These include valuations for assets and liabilities that are derived using data, some or all of which is not market observable data, including assumptions about risk. Level 3 securities include less liquid securities. Embedded derivatives related to reinsurance agreements or product guarantees are included in this category.

Determination of Fair Value

The valuation methodologies used to determine the fair values of assets and liabilities reflect market participant assumptions and are based on the application of the fair value hierarchy that prioritizes observable market inputs over unobservable inputs. When available, the Company uses quoted market prices to determine fair value and classifies such items within Level 1 or 2. If quoted market prices are not available, fair value is based upon valuation techniques, which discount expected cash flows utilizing independent market observable interest rates based on the credit quality and duration of the instrument. Items valued

 

F-48


Table of Contents

JOHN HANCOCK LIFE INSURANCE COMPANY OF NEW YORK

NOTES TO FINANCIAL STATEMENTS – (CONTINUED)

 

Note 13 — Fair Value Measurements - (continued)

 

using models are classified according to the lowest level input that is significant to the valuation. Thus, an item may be classified in Level 3 even though significant market observable inputs are used.

The Company utilizes a Valuation Quality Assurance (“VQA”) team of security analysts. The MFC Chief Investment Officer has ultimate responsibility over the VQA team. The team ensures quality and completeness of all daily and monthly prices. Prices are received from external pricing vendors and brokers and are put through a quality assurance process which includes review of price movements relative to the market, comparison of prices between vendors, and internal matrix pricing. All inputs to our pricing matrix are external observable inputs extracted and entered by the VQA team. Broker quotes are used only when no external public vendor prices are available.

The following is a description of the valuation techniques used to measure fair value and the general classification of these instruments pursuant to the fair value hierarchy:

 

 

Assets and Liabilities Measured and Disclosed at Fair Value on a Recurring Basis and Reported in the Balance Sheets – This category includes assets and liabilities measured at fair value on a recurring and nonrecurring basis. Financial instruments measured on a recurring basis include fixed maturity securities, short-term investments, real estate joint ventures and other limited partnership interests, derivatives, and separate account assets and liabilities. Assets measured at fair value on a nonrecurring basis include limited partnership interests, which are reported at fair value only in the period in which an impairment is recognized.

 

Assets and Liabilities Disclosed at Fair Value on a Recurring Basis – This category includes mortgage loans on real estate, policy loans, cash and cash equivalents, and policyholders’ funds.

Assets and Liabilities Measured and Disclosed at Fair Value on a Recurring Basis

Fixed Maturity Securities

For fixed maturity securities, including corporate debt, U.S. Treasury, commercial mortgage-backed securities, asset-backed securities, issuances by foreign governments, and obligations of state and political subdivisions, fair values are based on quoted market prices when available. When market prices are not available, fair value is generally estimated using discounted cash flow analyses, incorporating current market inputs for similar financial instruments with comparable terms and credit quality (matrix pricing). The significant inputs into these models include, but are not limited to, yield curves, credit risks and spreads, measures of volatility, and prepayment speeds. These fixed maturity securities are classified within Level 2. Fixed maturity securities with significant pricing inputs which are unobservable are classified within Level 3.

Equity Securities

Equity securities are comprised of common stock and are classified within Level 1, as fair values are based on quoted market prices in active markets. Common stocks not traded in active markets are classified within Level 3.

Short-Term Investments

Short-term investments are comprised of securities due to mature within one year of the date of purchase. Those that are traded in active markets are classified within Level 1, as fair values are based on quoted market prices. Securities such as commercial paper and discount notes are classified within Level 2 because these securities are typically not actively traded due to their short maturities and, as such, their cost generally approximates fair value.

Real Estate Joint Ventures and Other Limited Partnership Interests

The amounts disclosed in the following tables consist of those investments accounted for using the cost method. The estimated fair values for such cost method investments are generally based on the Company’s share of the NAV as provided in the financial statements of the investees. In certain circumstances, management may adjust the NAV by a premium or discount when it has sufficient evidence to support applying such adjustments.

 

F-49


Table of Contents

JOHN HANCOCK LIFE INSURANCE COMPANY OF NEW YORK

NOTES TO FINANCIAL STATEMENTS – (CONTINUED)

 

Note 13 — Fair Value Measurements - (continued)

 

Derivatives

The fair value of derivatives is determined through the use of quoted market prices for exchange-traded derivatives or through the use of pricing models for OTC derivatives. The pricing models used are based on market standard valuation methodologies, and the inputs to these models are consistent with what a market participant would use when pricing the instruments. Derivative valuations can be affected by changes in interest rates, currency exchange rates, financial indices, credit spreads, default risk (including the counterparties to the contract), and volatility. The Company’s derivatives are generally classified within Level 2 given the significant inputs to the pricing models for most OTC derivatives are observable or can be corroborated by observable market data. Inputs that are observable generally include interest rates, foreign currency exchange rates, and interest rate curves; however, certain OTC derivatives may rely on inputs that are significant to the fair value, but are unobservable in the market or cannot be derived principally from or corroborated by observable market data and would be classified within Level 3. Inputs that are unobservable generally include broker quotes, volatilities, and inputs that are outside of the observable portion of the interest rate curve or other relevant market measures. These unobservable inputs may involve significant management judgment or estimation.

Even though unobservable, these inputs are based on assumptions deemed appropriate given the circumstances and consistent with what market participants would use when pricing such instruments. The credit risk of both the counterparty and the Company are considered in determining the fair value for all OTC derivatives after taking into account the effects of netting agreements and collateral arrangements.

Embedded Derivatives

The Company holds assets and liabilities classified as embedded derivatives on the Balance Sheets. These assets include guaranteed minimum income benefits that are ceded under modified coinsurance reinsurance arrangements (“Reinsurance GMIB Assets”). Liabilities include policyholder benefits offered under variable annuity contracts such as GMWB with a term certain and embedded reinsurance derivatives.

Embedded derivatives are recorded on the Balance Sheets at fair value, separately from their host contract, and the change in their fair value is reflected in net income. Many observable factors including, but not limited to, market conditions, credit ratings, and risk margins related to non-capital market inputs may result in significant fluctuations in the fair value of embedded derivatives that could materially affect net income. Embedded derivatives which are valued using observable market inputs are classified within Level 2 of the fair value hierarchy. Some embedded derivatives, mainly benefit guarantees for variable annuity products, utilize significant pricing inputs which are unobservable. These unobservable inputs are received from third party valuation experts and include equity volatility, mortality rates, lapse rates and utilization rates. Embedded derivatives with significant unobservable inputs are classified within Level 3.

The fair value of embedded derivatives related to GMIB and GMWB is estimated as the present value of future benefits less the present value of future fees. The fair value calculation includes assumptions for risk margins including nonperformance risk.

Risk margins are established to capture the risks of the instrument which represent the additional compensation a market participant would require to assume the risks related to the uncertainties of such actuarial assumptions as annuitization, persistency, partial withdrawal, and surrenders. The establishment of these actuarial assumptions, risk margins, nonperformance risk, and other inputs requires the use of significant judgment.

Nonperformance risk refers to the risk that the obligation will not be fulfilled and affects the value of the liability. The fair value measurement assumes that the nonperformance risk is the same before and after the transfer; therefore, fair value reflects the reporting entity’s own credit risk.

Nonperformance risk for liabilities held by the Company is based on MFC’s own credit risk, which is determined by taking into consideration publicly available information relating to MFC’s debt, as well as its claims paying ability. Nonperformance risk is also reflected in the reinsurance GMIB assets held by the Company. The credit risk of the reinsurance companies is most representative of the nonperformance risk for the reinsurance GMIB assets and is derived from publicly available information relating to the reinsurance companies’ publicly issued debt. As such, the reinsurance contract embedded derivatives are classified within Level 2.

The fair value of embedded derivatives related to reinsurance agreements is determined based on a total return swap methodology. These total return swaps are reflected as assets or liabilities on the Balance Sheets representing the difference between the adjusted statutory book value and fair value of the related modified coinsurance assets with ongoing changes in

 

F-50


Table of Contents

JOHN HANCOCK LIFE INSURANCE COMPANY OF NEW YORK

NOTES TO FINANCIAL STATEMENTS – (CONTINUED)

 

Note 13 — Fair Value Measurements - (continued)

 

fair value recorded in net realized investment and other gains (losses). The fair value of the underlying assets is based on the valuation approach for similar assets described herein.

Separate Account Assets and Liabilities

Separate account assets are carried at fair value and reported as a summarized total on the Balance Sheets. Assets owned by the Company’s separate accounts primarily include investments in funds, short-term investments, and cash and cash equivalents. For separate accounts structured as a unitized fund, the fair value of separate account assets is based on the fair value of the underlying funds owned by the separate account. Investment performance related to separate account assets is fully offset by corresponding amounts credited to contract holders whose interest in the separate account assets is recorded by the Company as separate account liabilities. Separate account liabilities are set equal to the fair value of separate account assets.

The fair value of fund investments is based upon quoted market prices or reported NAV. Fund investments that are traded in an active market and have a NAV that the Company can access at the measurement date are classified within Level 1. The fair values of fixed maturity securities, equity securities, short-term investments, and cash equivalents held by separate accounts are determined on a basis consistent with the methodologies described herein for similar financial instruments held within the Company’s general account and may be classified within Level 1, 2, or 3, accordingly.

Assets and Liabilities Disclosed at Fair Value on a Recurring Basis

Mortgage Loans on Real Estate

The fair value of unimpaired mortgage loans is estimated using discounted cash flows and takes into account the contractual maturities and discount rates, which were based on current market rates for similar maturity ranges and adjusted for risk due to the property type.

Policy Loans

These loans are carried at unpaid principal balances, which approximate their fair values.

Cash and Cash Equivalents

The carrying values for cash and cash equivalents approximate fair value due to the short-term maturities of these instruments.

Policyholders’ Funds

Policyholders’ funds include guaranteed investment contracts, fixed-rate deferred annuities, term certain and supplementary contracts without life contingencies, and certain balances that can be withdrawn by the policyholder at any time without prior notice or penalty. The fair values associated with guaranteed investment contracts, term certain and supplementary contracts without life contingencies are determined by projecting cash flows and discounting the cash flows at current corporate rates, defined as U.S. Treasury rates plus MFC’s corporate spread. The fair value attributable to credit risk represents the present value of the spread. The fair value of fixed-rate deferred annuities is estimated by projecting multiple stochastically generated interest rate scenarios under a risk neutral environment reflecting inputs (interest rate, volatility, etc.) observable at the valuation date. For those balances that can be withdrawn by the policyholder at any time without prior notice or penalty, the fair value is the amount estimated to be payable to the policyholder as of the reporting date, which is generally the carrying value.

 

F-51


Table of Contents

JOHN HANCOCK LIFE INSURANCE COMPANY OF NEW YORK

NOTES TO FINANCIAL STATEMENTS – (CONTINUED)

 

Note 13 — Fair Value Measurements - (continued)

 

The table below presents the fair value by fair value hierarchy level for assets and liabilities that are reported at fair value in the Balance Sheets:

 

     December 31, 2013  
     Carrying
Value
     Total Fair
Value
     Level 1      Level 2      Level 3  
  

 

 

 
     (in millions)  

Assets:

              

Fixed maturity securities available-for-sale:

              

Corporate debt securities (4)

       $ 3,740       $ 3,740       $ -       $ 3,446       $ 294   

Commercial mortgage-backed securities

     59         59         -         49         10   

Residential mortgage-backed securities

     -         -         -         -         -   

Collateralized debt obligations

     -         -         -         -         -   

Other asset-backed securities

     73         73         -         73         -   

U.S. Treasury and agency securities

     1,637         1,637         -         1,637         -   

Obligations of states and political subdivisions (5)

     257         257         -         250         7   

Debt securities issued by foreign governments

     105         105         -         105         -   
  

 

 

 

Total fixed maturity securities available-for-sale

     5,871         5,871         -           5,560           311   

Fixed maturity securities held-for-trading:

              

Corporate debt securities (4)

     281         281         -         274         7   

Commercial mortgage-backed securities

     25         25         -         25         -   

Residential mortgage-backed securities

     -         -         -         -         -   

Collateralized debt obligations

     -         -         -         -         -   

Other asset-backed securities

     12         12         -         12         -   

U.S. Treasury and agency securities

     5         5         -         5         -   

Obligations of states and political subdivisions (5)

     14         14         -         12         2   

Debt securities issued by foreign governments

     1         1         -         1         -   
  

 

 

 

Total fixed maturity securities held-for-trading

     338         338         -         329         9   

Equity securities available-for-sale

     -         -         -         -         -   

Equity securities held-for-trading

     -         -         -         -         -   

Short-term investments

     1         1         -         1         -   

Other invested assets (2)

     7         7         -         -         7   

Derivative assets (1):

              

Interest rate swaps

     435         435         -         435         -   

Interest rate treasury locks

     -         -         -         -         -   

Interest rate options

     -         -         -         -         -   

Interest rate futures

     -         -         -         -         -   

Foreign currency swaps

     -         -         -         -         -   

Foreign currency forwards

     -         -         -         -         -   

Foreign currency futures

     -         -         -         -         -   

Equity total return swaps

     -         -         -         -         -   

Equity options

     -         -         -         -         -   

Embedded derivatives (3):

              

Reinsurance contracts

     -         -         -         -         -   

Benefit guarantees (6)

     49         49         -         -         49   

Separate account assets

       8,313           8,313         8,313         -         -   
  

 

 

 

Total assets at fair value

       $   15,014       $   15,014       $   8,313       $   6,325       $   376   
  

 

 

 

Liabilities:

              

Derivatives liabilities (1):

              

Interest rate swaps

       $ 345       $ 345       $ -       $ 345       $ -   

Interest rate treasury locks

     -         -         -         -         -   

Interest rate options

     -         -         -         -         -   

Interest rate futures

     -         -         -         -         -   

Foreign currency swaps

     -         -         -         -         -   

Foreign currency forwards

     -         -         -         -         -   

Foreign currency futures

     -         -         -         -         -   

Equity total return swaps

     -         -         -         -         -   

Equity options

     -         -         -         -         -   

Embedded derivatives (3):

              

Reinsurance contracts

     163         163         -         163         -   

Participating pension contracts

     32         32         -         32         -   

Benefit guarantees (6)

     13         13         -         -         13   

Separate account liabilities

     8,313         8,313         8,313         -         -   
  

 

 

 

Total liabilities at fair value

       $ 8,866       $ 8,866       $ 8,313       $ 540       $ 13   
  

 

 

 

 

F-52


Table of Contents

JOHN HANCOCK LIFE INSURANCE COMPANY OF NEW YORK

NOTES TO FINANCIAL STATEMENTS – (CONTINUED)

 

Note 13 — Fair Value Measurements - (continued)

 

     December 31, 2012  
     Carrying
Value
     Total Fair
Value
     Level 1      Level 2      Level 3  
  

 

 

 
     (in millions)  

Assets:

              

Fixed maturity securities available-for-sale:

              

Corporate debt securities (4)

       $ 3,871       $ 3,871       $ -       $ 3,547       $ 324   

Commercial mortgage-backed securities

     230         230         -         227         3   

Residential mortgage-backed securities

     -         -         -         -         -   

Collateralized debt obligations

     -         -         -         -         -   

Other asset-backed securities

     45         45         -         45         -   

U.S. Treasury and agency securities

     2,137         2,137         -         2,137         -   

Obligations of states and political subdivisions (5)

     287         287         -         271         16   

Debt securities issued by foreign governments

     59         59         -         59         -   
  

 

 

 

Total fixed maturity securities available-for-sale

     6,629         6,629         -         6,286         343   

Fixed maturity securities held-for-trading:

              

Corporate debt securities (4)

     259         259         -         249         10   

Commercial mortgage-backed securities

     63         63         -         63         -   

Residential mortgage-backed securities

     -         -         -         -         -   

Collateralized debt obligations

     -         -         -         -         -   

Other asset-backed securities

     9         9         -         9         -   

U.S. Treasury and agency securities

     24         24         -         24         -   

Obligations of states and political subdivisions (5)

     16         16         -         14         2   

Debt securities issued by foreign governments

     1         1         -         1         -   
  

 

 

 

Total fixed maturity securities held-for-trading

     372         372         -           360           12   

Equity securities available-for-sale

     1         1         1         -         -   

Equity securities held-for-trading

     -         -         -         -         -   

Short-term investments

     38         38         -         38         -   

Other invested assets (2)

     -         -         -         -         -   

Derivative assets (1):

              

Interest rate swaps

     654         654         -         654         -   

Interest rate treasury locks

     -         -         -         -         -   

Interest rate options

     -         -         -         -         -   

Interest rate futures

     -         -         -         -         -   

Foreign currency swaps

     -         -         -         -         -   

Foreign currency forwards

     -         -         -         -         -   

Foreign currency futures

     -         -         -         -         -   

Equity total return swaps

     -         -         -         -         -   

Equity options

     -         -         -         -         -   

Equity index futures

     -         -         -         -         -   

Credit default swaps

     -         -         -         -         -   

Embedded derivatives (3):

              

Reinsurance contracts

     -         -         -         -         -   

Benefit guarantees (6)

     75         75         -         -         75   

Separate account assets

       7,687           7,687         7,687         -         -   
  

 

 

 

Total assets at fair value

       $   15,456       $   15,456       $   7,688       $   7,338       $   430   
  

 

 

 

Liabilities:

              

Derivatives liabilities (1):

              

Interest rate swaps

       $ 350       $ 350       $ -       $ 350       $ -   

Interest rate treasury locks

     -         -         -         -         -   

Interest rate options

     -         -         -         -         -   

Interest rate futures

     -         -         -         -         -   

Foreign currency swaps

     -         -         -         -         -   

Foreign currency forwards

     -         -         -         -         -   

Foreign currency futures

     -         -         -         -         -   

Equity total return swaps

     -         -         -         -         -   

Equity options

     -         -         -         -         -   

Equity index futures

     -         -         -         -         -   

Credit default swaps

     -         -         -         -         -   

Embedded derivatives (3):

              

Reinsurance contracts

     348         348         -         348         -   

Participating pension contracts

     37         37         -         37         -   

Benefit guarantees (6)

     108         108         -         -         108   

Separate account liabilities

     7,687         7,687         7,687         -         -   
  

 

 

 

Total liabilities at fair value

       $ 8,530       $ 8,530       $ 7,687       $ 735       $ 108   
  

 

 

 

 

F-53


Table of Contents

JOHN HANCOCK LIFE INSURANCE COMPANY OF NEW YORK

NOTES TO FINANCIAL STATEMENTS – (CONTINUED)

 

Note 13 — Fair Value Measurements - (continued)

 

(1) Derivative assets and liabilities are presented gross to reflect the presentation in the Balance Sheets, but are presented net for purposes of the Level 3 rollforward.
(2) Other invested assets exclude equity method and cost accounted investments of $65 million and $5 million at December 31, 2013 and 2012, respectively.
(3) Embedded derivatives related to fixed maturity securities and reinsurance contracts are reported as part of the derivative asset or liability on the Balance Sheets. Embedded derivatives related to benefit guarantees are reported as part of the reinsurance recoverable or future policy benefits on the Balance Sheets. Embedded derivatives related to participating pension contracts are reported as part of future policy benefits on the Balance Sheets.
(4) Fair value of the Level 3 corporate debt securities is determined based on discounted cash flow models using discount rates based on credit spreads, yields, or price levels of publicly traded debt of the issuer or other comparable securities, considering illiquidity and structure. The significant unobservable input is the yield at or beyond the 30 year point and ranged from 0 to 61 basis points and 0 to 61 basis points during 2013 and 2012, respectively.
(5) Fair value of the Level 3 obligations of states and political subdivisions is determined based on discounted cash flow models using discount rates based on credit spreads, yields, or price levels of publicly traded debt of the issuer or other comparable securities, considering illiquidity and structure. The significant unobservable input is the yield at or beyond the 30 year point and ranged from 0 to 361 basis points and 97 to 364 basis points during 2013 and 2012, respectively.
(6) Fair value of the Level 3 benefit guarantees is determined based on discounted cash flow models. The significant unobservable inputs are equity implied volatility, base lapse rates, dynamic lapse rates, mortality rates, and 0% utilization rates. These inputs ranged from 0% to 37%, 1% to 40%, 0% to 50%, 0% to 40%, and 80% to 100% in 2013, respectively. These inputs ranged from 0% to 35%, 1% to 35%, 0% to 70%, 0% to 38%, and 80% to 100% in 2012, respectively.

The table below presents the fair value by fair value hierarchy level for certain assets and liabilities that are not reported at fair value in the Balance Sheet, but are disclosed at fair value.

 

     December 31, 2013  
     Carrying
Value
     Total Fair
Value
     Level 1      Level 2      Level 3  
  

 

 

 
     (in millions)  

Assets

              

Mortgage loans on real estate

       $ 1,155       $ 1,233       $ -       $ -       $ 1,233   

Policy loans

     143         143         -         143         -   

Cash and cash equivalents

     59         59         59         -         -   

Affiliated debt

     -         -         -         -         -   
  

 

 

 

Total Assets

       $ 1,357       $ 1,435       $   59       $ 143       $ 1,233   
  

 

 

 

Liabilities

              

Consumer notes

       $ -       $ -       $ -       $ -       $ -   

Debt

     -         -         -         -         -   

Policyholders’ funds

       2,291           2,317         -           151           2,166   

Affiliated debt

     -         -         -         -         -   
  

 

 

 

Total Liabilities

       $ 2,291       $ 2,317       $ -       $ 151       $ 2,166   
  

 

 

 

 

F-54


Table of Contents

JOHN HANCOCK LIFE INSURANCE COMPANY OF NEW YORK

NOTES TO FINANCIAL STATEMENTS – (CONTINUED)

 

Note 13 — Fair Value Measurements - (continued)

 

     December 31, 2012  
     Carrying
Value
     Total Fair
Value
     Level 1      Level 2      Level 3  
  

 

 

 
     (in millions)  

Assets

              

Mortgage loans on real estate

       $ 977       $ 1,106       $ -       $ -       $ 1,106   

Policy loans

     138         138         -         138         -   

Cash and cash equivalents

     495         495           495         -         -   

Affiliated debt

     -         -         -         -         -   
  

 

 

 

Total Assets

       $ 1,610       $ 1,739       $ 495       $ 138       $ 1,106   
  

 

 

 

Liabilities

              

Consumer notes

       $ -       $ -       $ -       $ -       $ -   

Debt

     -         -         -         -         -   

Policyholders’ funds

       2,470           2,507         -           153           2,354   

Affiliated debt

     -         -         -         -         -   
  

 

 

 

Total Liabilities

       $ 2,470       $ 2,507       $ -       $ 153       $ 2,354   
  

 

 

 

Transfers of Level 1 and Level 2 Assets and Liabilities

The Company’s policy is to record transfers of assets and liabilities between Level 1 and Level 2 at their fair values as of the end of each reporting period, consistent with the date of the determination of fair value. Assets are transferred out of Level 1 when they are no longer transacted with sufficient frequency and volume in an active market. During the years ended December 31, 2013 and 2012, the Company did not have any transfers from Level 1 to Level 2. Conversely, assets are transferred from Level 2 to Level 1 when transaction volume and frequency are indicative of an active market. The Company did not transfer assets from Level 2 to Level 1 during the years ended December 31, 2013 and 2012.

 

F-55


Table of Contents

JOHN HANCOCK LIFE INSURANCE COMPANY OF NEW YORK

NOTES TO FINANCIAL STATEMENTS – (CONTINUED)

 

Note 13 — Fair Value Measurements - (continued)

 

Level 3 Assets and Liabilities

The changes in Level 3 financial instruments measured at fair value on a recurring basis for the years ended December 31, 2013, 2012 and 2011 are summarized as follows:

 

   

Balance at
January 1,
2013

    Net realized/unrealized
gains (losses) included in:
   

Purchases

   

Issuances

   

Sales

   

Settlements

    Transfers    

Balance at
December 31,
2013

   

Change in
unrealized gains
(losses) included in
earnings on
instruments still
held

 
     

Earnings

(1)

   

AOCI

(2)

            Into
Level 3
(3)
    Out of
Level 3
(3)
     
 

 

 

 
    (in millions)  

Fixed maturity securities available-for-sale:

                     

Corporate debt securities

      $ 324      $ (1   $ (29   $ 57      $ -      $ -      $ (2   $ 57      $ (112   $ 294      $ -   

Commercial mortgage-backed securities

    3        -        -        7        -        -        -        -        -        10        -   

Residential mortgage-backed securities

    -        -        -        -        -        -        -        -        -        -        -   

Collateralized debt obligations

    -        -        -        -        -        -        -        -        -        -        -   

Other asset-backed securities

    -        -        -        -        -        -        -        -        -        -        -   

US Treasury securities and obligations of US govt corporation and agencies (AFS)

    -        -        -        -        -        -        -        -                -        -        -   

Obligations of states and political subdivisions

    16        -        (1     -        -        -        -        -        (8     7        -   
 

 

 

 

Total fixed maturity securities available-for-sale

      343        (1     (30     64        -        -        (2        57        (120     311        -   

Fixed maturity securities held-for-trading:

                     

Corporate debt securities

    10        (1     -        2        -        -        -        -        (4     7        (1

Commercial mortgage-backed securities

    -        -        -        -        -        -        -        -        -        -        -   

Residential mortgage-backed securities

    -        -        -        -        -        -        -        -        -        -        -   

Collateralized debt obligations

    -        -        -        -        -        -        -        -        -        -        -   

Other asset-backed securities

    -        -        -        -        -        -        -        -        -        -        -   

Obligations of states and political subdivisions

    2        -        -        -        -        -        -        -        -        2        -   
 

 

 

 

Total fixed maturity securities held-for-trading

    12        (1     -        2        -        -        -        -        (4     9        (1

Other invested assets

    -        -            2        5        -        -        -        -        -        7        -   

Net derivatives

    -        -        -        -        -        -        -        -        -        -        -   

Net embedded derivatives (4)

    (33     69        -        -        -        -        -        -        -        36        69   

Assets held in trust

    -        -        -        -        -        -        -        -        -        -        -   

Separate account assets/liabilities (5)

    -        -        -        -        -        -        -        -        -        -        -   
 

 

 

 

Total

      $ 322      $   67      $ (28   $   71      $   -      $   -      $ (2   $   57      $ (124   $   363      $   68   
 

 

 

 

 

F-56


Table of Contents

JOHN HANCOCK LIFE INSURANCE COMPANY OF NEW YORK

NOTES TO FINANCIAL STATEMENTS – (CONTINUED)

 

Note 13 — Fair Value Measurements - (continued)

 

   

Balance at
January 1,
2012

    Net realized/unrealized
gains  (losses) included in:
   

Purchases

   

Issuances

   

Sales

   

Settlements

    Transfers    

Balance at
December 31,
2012

   

Change in
unrealized gains
(losses) included in
earnings on
instruments still
held

 
     

Earnings

(1)

   

AOCI

(2)

            Into
Level 3
(3)
    Out of
Level 3
(3)
     
 

 

 

 
    (in millions)  

Fixed maturity securities available-for-sale:

                     

Corporate debt securities

      $ 371      $ 1      $ 5      $ 106      $ -      $ (96   $ (6   $ 6      $ (63   $ 324      $ -   

Commercial mortgage-backed securities

    -        -        -        3        -        -        -        -        -        3        -   

Residential mortgage-backed securities

    -        -        -        -        -        -        -        -        -        -        -   

Collateralized debt obligations

    -        -        -        -        -        -        -        -        -        -        -   

Other asset-backed securities

    -        -        -        -        -        -        -        -        -        -        -   

Obligations of states and political subdivisions

    12        -        -        11        -        (7     -        -        -        16        -   
 

 

 

 

Total fixed maturity securities available-for-sale

      383        1        5        120               -        (103     (6     6        (63     343        -   

Fixed maturity securities held-for-trading

                     

Corporate debt securities

    7        -        -        5        -        -        -        -        (2     10        -   

Commercial mortgage-backed securities

    -        -        -        -        -        -        -        -        -        -        -   

Residential mortgage-backed securities

    -        -        -        -        -        -        -        -        -        -        -   

Collateralized debt obligations

    -        -        -        -        -        -        -        -        -        -        -   

Other asset-backed securities

    -        -        -        -        -        -        -        -        -        -        -   

Obligations of states and political subdivisions

    2        -        -        -        -                -        -        -                -        2        -   
 

 

 

 

Total fixed maturity securities held-for-trading

    9        -        -        5        -        -        -        -        (2     12        -   

Other invested assets

    -        -        -        -        -        -        -        -        -        -        -   

Net derivatives

    37        -        -        -        -        -        -        -        (37     -        -   

Net embedded derivatives (4)

    (28     (5     -        -        -        -        -        -        -        (33     (5

Assets held in trust

    -        -        -        -        -        -        -        -        -        -        -   

Separate account
assets/liabilities (5)

    -        -        -        -        -        -        -        -        -        -        -   
 

 

 

 

Total

      $   401      $ (4   $   5      $   125      $   -      $ (103   $ (6   $   6      $ (102   $   322      $ (5
 

 

 

 

 

F-57


Table of Contents

JOHN HANCOCK LIFE INSURANCE COMPANY OF NEW YORK

NOTES TO FINANCIAL STATEMENTS – (CONTINUED)

 

Note 13 — Fair Value Measurements - (continued)

 

          Net realized/unrealized
gains (losses) included in:
                            Transfers          

Change in
unrealized gains
(losses) included
in earnings on
instruments still
held

 
    Balance at
January 1,
2011
   

Earnings

(1)

   

AOCI

(2)

    Purchases     Issuances     Sales     Settlements    

Into

Level 3
(3)

    Out of
Level 3
(3)
    Balance at
December 31,
2011
   
 

 

 

 
    (in millions)  

Fixed maturity securities available-for-sale:

                     

Corporate debt securities

      $ 255      $ -      $ 19      $ 66      $ -      $ -      $ (6   $ 41      $ (4   $ 371      $ -   

Commercial mortgage-backed securities

    10        -        -        -        -        -        (10     -        -        -        -   

Residential mortgage-backed securities

    -        -        -        -        -        -        -        -        -        -        -   

Collateralized debt obligations

    -        -        -        -        -        -        -        -        -        -        -   

Other asset-backed securities

    -        -        -        -        -        -        -        -        -        -        -   

Obligations of states and political subdivisions

    7        -        1        4        -        -        -        -        -        12        -   
 

 

 

 

Total fixed maturity securities available-for-sale

    272        -        20        70        -        -        (16     41        (4     383        -   

Fixed maturity securities held-for-trading

                     

Corporate debt securities

    3        1        -        5        -        -        -        -        (2     7        1   

Commercial mortgage-backed securities

    -        -        -        -        -        -        -        -        -        -        -   

Residential mortgage-backed securities

    -        -        -        -        -        -        -        -        -        -        -   

Collateralized debt obligations

    -        -        -        -        -        -        -        -        -        -        -   

Other asset-backed securities

    -        -        -        -        -        -        -        -        -        -        -   

Obligations of states and political subdivisions

    -        -        -        2        -        -        -        -        -        2        -   
 

 

 

 

Total fixed maturity securities held-for-trading

    3            1        -        7        -        -            -        -        (2     9        1   

Other invested assets

    -        -        -        -        -        -        -        -            -        -            -   

Net derivatives

    -        -        37        -        -        -        -        -        -        37        -   

Net embedded derivatives (4)

    10        (38     -        -        -        -        -        -        -        (28     (38

Assets held in trust

    -        -        -        -        -        -        -        -        -        -        -   

Separate account assets/liabilities (5)

    -        -        -        -        -        -        -        -        -        -        -   
 

 

 

 

Total

      $ 285      $ (37   $   57      $   77      $   -      $   -      $ (16   $   41      $ (6   $   401      $ (37
 

 

 

 

 

F-58


Table of Contents

JOHN HANCOCK LIFE INSURANCE COMPANY OF NEW YORK

NOTES TO FINANCIAL STATEMENTS – (CONTINUED)

 

Note 13 — Fair Value Measurements - (continued)

 

(1) This amount is included in net realized investment and other gains (losses) on the Statements of Operations.
(2) This amount is included in net unrealized investment gains (losses) within AOCI on the Balance Sheets.
(3) For financial assets that are transferred into and/or out of Level 3, the Company uses the fair value of the assets at the beginning of the reporting period.
(4) The earnings amount is included in benefits to policyholders on the Statements of Operations.
(5) Investment performance related to separate account assets is fully offset by corresponding amounts credited to contract holders whose liability is reflected within separate account liabilities.

The Company may hedge positions with offsetting positions that are classified in a different level. For example, the gains and losses for assets and liabilities in the Level 3 category presented in the tables above may not reflect the effect of offsetting gains and losses on hedging instruments that have been classified by the Company in the Level 1 and Level 2 categories.

The transfers into Level 3 primarily result from securities that were impaired during the year or securities where a lack of observable market data (versus the previous year) resulted in reclassifying assets into Level 3. The transfers out of Level 3 primarily result from observable market data becoming available for that asset, thus eliminating the need to extrapolate market data beyond observable points.

Assets Measured at Fair Value on a Nonrecurring Basis

Certain assets are reported at fair value on a nonrecurring basis, including investments such as, limited partnership interests, which are reported at fair value only in the period in which an impairment is recognized. The fair is calculated using models that are widely accepted in the financial services industry. During the reporting period, there were no assets measured at fair value on a nonrecurring basis.

Note 14 — Segment Information

The Company operates in the following three business segments: (1) Insurance and (2) Wealth Management, which primarily serve retail and institutional customers and (3) Corporate.

The Company’s reportable segments are strategic business units offering different products and services. The reportable segments are managed separately, as they focus on different products, markets, and distribution channels.

Insurance Segment. Offers a variety of individual life insurance products. Products are distributed through multiple distribution channels, including insurance agents, brokers, banks, financial planners, and direct marketing.

Wealth Management Segment. Offers annuities and a variety of retirement products to group benefit plans. Annuity contracts provide non-guaranteed, partially guaranteed, and fully guaranteed investment options through general and separate account products. These businesses distribute products through multiple distribution channels, including insurance agents and brokers affiliated with the Company, securities brokerage firms, financial planners, pension plan sponsors, pension plan consultants, and banks. As discussed in the Summary of Significant Accounting Policies Note, the Company suspended sales of all its individual and group fixed and variable annuities.

Corporate. Includes corporate operations primarily related to certain financing activities and income on capital not specifically allocated to the operating segments.

The accounting policies of the segments are the same as those described in the Summary of Significant Accounting Policies Note. Allocations of net investment income are based on the amount of assets allocated to each segment. Other costs and operating expenses are allocated to each segment based on a review of the nature of such costs, cost allocations utilizing time studies, and other relevant allocation methodologies.

 

F-59


Table of Contents

JOHN HANCOCK LIFE INSURANCE COMPANY OF NEW YORK

NOTES TO FINANCIAL STATEMENTS – (CONTINUED)

 

Note 14 — Segment Information - (continued)

 

The following table summarizes selected financial information by segment for the periods indicated:

 

     Insurance     Wealth
Management
    Corporate
and Other
    Total  
  

 

 

 
     (in millions)  

2013

        

Revenues from external customers

       $ 181      $ 127      $ (2   $ 306   

Net investment income

     185        148        207        540   

Net realized investment and other gains (losses)

     (200     (154     221        (133

Inter-segment

     -        -        -        -   
  

 

 

 

Revenues

       $ 166      $ 121      $ 426      $ 713   
  

 

 

 

Net income (loss)

       $ (43   $ 7      $ 277      $ 241   
  

 

 

 

Supplemental Information:

        

Equity in net income (loss) of investees accounted for under the equity method

       $ 1      $ 28      $ 169      $ 198   

Carrying value of investments under the equity method

     55        10        1        66   

Amortization of deferred policy acquisition costs, deferred sales inducements, and value of business acquired

     (16     28        1        13   

Goodwill impairment

     -        -        -        -   

Interest expense

     -        -        -        -   

Income tax expense (benefit)

     (24     (10     150        116   

Segment assets

     5,387        12,164        2,794        20,345   
     Insurance     Wealth
Management
    Corporate
and Other
    Total  
  

 

 

 
     (in millions)  

2012

        

Revenues from external customers

       $ 187      $ 283      $ (1   $ 469   

Net investment income

     167        204        216        587   

Net realized investment and other gains (losses)

     (73     (18     39        (52

Inter-segment

     -        -        -        -   
  

 

 

 

Revenues

       $ 281      $ 469      $ 254      $ 1,004   
  

 

 

 

Net income (loss)

       $ (56   $ 48      $ 168      $ 160   
  

 

 

 

Supplemental Information:

        

Equity in net income (loss) of investees accounted for under the equity method

       $ 1      $ 26      $ 156      $ 183   

Carrying value of investments under the equity method

     4        1        1        6   

Amortization of deferred policy acquisition costs, deferred sales inducements, and value of business acquired

     24        29        -        53   

Goodwill impairment

     -        -        -        -   

Interest expense

     -        -        -        -   

Income tax expense (benefit)

     (31     (1     85        53   

Segment assets

       5,553          11,989          2,559          20,101   

 

F-60


Table of Contents

JOHN HANCOCK LIFE INSURANCE COMPANY OF NEW YORK

NOTES TO FINANCIAL STATEMENTS – (CONTINUED)

 

Note 14 — Segment Information - (continued)

 

     Insurance      Wealth
Management
     Corporate
and Other
    Total  
  

 

 

 
     (in millions)  

2011

          

Revenues from external customers

       $   340       $   144       $ 3      $ 487   

Net investment income

     161         235         201        597   

Net realized investment and other gains (losses)

     229         65         (5     289   

Inter-segment revenues

     -         -         -        -   
  

 

 

 

Revenues

       $ 730       $ 444       $ 199      $ 1,373   
  

 

 

 

Net income (loss)

       $ 90       $ 14       $ 126      $ 230   
  

 

 

 

Supplemental Information:

          

Equity in net income (loss) of investees accounted for under the equity method

       $ -       $ 25       $ 150      $ 175   

Amortization of deferred policy acquisition costs, deferred sales inducements, and value of business acquired

           61         78         -        139   

Goodwill impairment

     -         -         -        -   

Interest expense

     -         -         -        -   

Income tax expense (benefit)

     48         1         72        121   

The Company operates primarily in the United States and has no reportable major customers.

Note 15 — Subsequent Events

The Company evaluated the recognition and disclosure of subsequent events for its December 31, 2013 financial statements through the date on which the financial statements were issued. The Company did not have any subsequent events requiring disclosure.

 

F-61


Table of Contents

 

 

John Hancock Life Insurance Company of New York Separate Account B

Audited Financial Statements

Year ended December 31, 2013 with Report of Independent Registered Public Accounting Firm


Table of Contents


Table of Contents

John Hancock Life Insurance Company of New York Separate Account B

Audited Financial Statements

Year ended December 31, 2013

Contents

 

Report of Independent Registered Public Accounting Firm

     5   

Statements of Assets and Contract Owners’ Equity

     8   

Statements of Operations and Changes in Contract Owners’ Equity

     12   

Notes to Financial Statements

     66   

Organization

     66   

Significant Accounting Policies

     67   

Contract Charges

     69   

Federal Income Taxes

     69   

Purchases and Sales of Investments

     69   

Transaction with Affiliates

     72   

Diversification Requirements

     72   

Subsequent Events

     73   

Financial Highlights

     74   


Table of Contents


Table of Contents

Report of Independent Registered Public Accounting Firm

 

Board of Directors of the John Hancock Life Insurance Company New York and Contract Owners of John Hancock Life Insurance Company New York Separate Account B

 

“Active” sub-accounts

  
500 Index Trust B Series 0    Global Bond Trust Series 0
Active Bond Trust Series 0    Global Bond Trust Series 1
Active Bond Trust Series 1    Global Trust Series 0
All Cap Core Trust Series 0    Global Trust Series 1
All Cap Core Trust Series 1    Health Sciences Trust Series 0
Alpha Opportunities Trust Series 0    Health Sciences Trust Series 1
American Asset Allocation Trust Series 1    High Yield Trust Series 0
American Global Growth Trust Series 1    High Yield Trust Series 1
American Growth Trust Series 1    International Core Trust Series 0
American Growth-Income Trust Series 1    International Core Trust Series 1
American International Trust Series 1    International Equity Index Trust B Series 0
American New World Trust Series 1    International Equity Index Trust B Series 1
Blue Chip Growth Trust Series 0    International Growth Stock Trust Series 0
Blue Chip Growth Trust Series 1    International Growth Stock Trust Series 1
Bond Trust Series 0    International Small Company Trust Series 0
Bond Trust Series 1    International Small Company Trust Series 1
Capital Appreciation Trust Series 0    International Value Trust Series 0
Capital Appreciation Trust Series 1    International Value Trust Series 1
Capital Appreciation Value Trust Series 0    Investment Quality Bond Trust Series 0
Core Bond Trust Series 0    Investment Quality Bond Trust Series 1
Core Bond Trust Series 1    Lifestyle Aggressive Trust Series 0
Core Strategy Trust Series 0    Lifestyle Aggressive Trust Series 1
Emerging Markets Value Trust Series 0    Lifestyle Balanced Trust Series 0
Emerging Markets Value Trust Series 1    Lifestyle Balanced Trust Series 1
Equity-Income Trust Series 0    Lifestyle Conservative Trust Series 0
Equity-Income Trust Series 1    Lifestyle Conservative Trust Series 1
Financial Services Trust Series 0    Lifestyle Growth Trust Series 0
Financial Services Trust Series 1    Lifestyle Growth Trust Series 1
Franklin Templeton Founding Allocation Trust Series 0    Lifestyle Moderate Trust Series 0
Franklin Templeton Founding Allocation Trust Series 1    Lifestyle Moderate Trust Series 1
Fundamental All Cap Core Trust Series 0    Mid Cap Index Trust Series 0
Fundamental All Cap Core Trust Series 1    Mid Cap Index Trust Series 1
Fundamental Large Cap Value Trust Series 0    Mid Cap Stock Trust Series 0
Fundamental Large Cap Value Trust Series 1    Mid Cap Stock Trust Series 1
Fundamental Value Trust Series 0    Mid Value Trust Series 0
Fundamental Value Trust Series 1    Mid Value Trust Series 1

 

5


Table of Contents

Report of Independent Registered Public Accounting Firm

 

 

Money Market Trust B Series 0    Small Company Value Trust Series 1
Money Market Trust Series 1    Strategic Income Opportunities Trust Series 0
Natural Resources Trust Series 0    Strategic Income Opportunities Trust Series 1
Natural Resources Trust Series 1    Total Bond Market Trust B Series 0
Real Estate Securities Trust Series 0    Total Return Trust Series 0
Real Estate Securities Trust Series 1    Total Return Trust Series 1
Real Return Bond Trust Series 0    Total Stock Market Index Trust Series 0
Real Return Bond Trust Series 1    Total Stock Market Index Trust Series 1
Science & Technology Trust Series 0    Ultra Short Term Bond Trust Series 0
Science & Technology Trust Series 1    U.S. Equity Trust Series 0
Short Term Government Income Trust Series 0    U.S. Equity Trust Series 1
Short Term Government Income Trust Series 1    Utilities Trust Series 0
Small Cap Growth Trust Series 0    Utilities Trust Series 1
Small Cap Growth Trust Series 1    Value Trust Series 0
Small Cap Index Trust Series 0    Value Trust Series 1
Small Cap Index Trust Series 1    All Asset Portfolio
Small Cap Opportunities Trust Series 0    Brandes International Equity
Small Cap Opportunities Trust Series 1    Frontier Capital Appreciation
Small Cap Value Trust Series 0    Large Cap Growth
Small Cap Value Trust Series 1    Large Cap Value
Small Company Value Trust Series 0   

“Closed” sub-accounts

  
All Cap Value Trust Series 0    Disciplined Diversification Trust Series 0
All Cap Value Trust Series 1    Fundamental Holdings Trust Series 1
American Global Small Capitalization Trust Series 1    Global Diversification Trust Series 1
American High-Income Bond Trust Series 1    Smaller Company Growth Trust Series 0
Core Allocation Plus Trust Series 0    Smaller Company Growth Trust Series 1

 

6


Table of Contents

Report of Independent Registered Public Accounting Firm

 

We have audited the accompanying statements of assets and contract owners’ equity of John Hancock Life Insurance Company of New York Separate Account B (the “Account”), comprised of the active sub-accounts as of December 31, 2013, and the related statements of operations and changes in contract owners’ equity of the active and closed sub-accounts for each of the two years in the period then ended (or years since inception), and the financial highlights for each of the five years in the period then ended (or years since inception). These financial statements and financial highlights are the responsibility of the Account’s management. Our responsibility is to express an opinion on these financial statements and financial highlights based on our audits.

We conducted our audits in accordance with the standards of the Public Company Accounting Oversight Board (United States). Those standards require that we plan and perform the audit to obtain reasonable assurance about whether the financial statements and financial highlights are free of material misstatement. We were not engaged to perform an audit of the Account’s internal control over financial reporting. Our audits included consideration of internal control over financial reporting as a basis for designing audit procedures that are appropriate in the circumstances, but not for the purpose of expressing an opinion on the effectiveness of the Account’s internal control over financial reporting. Accordingly, we express no such opinion. An audit also includes examining, on a test basis, evidence supporting the amounts and disclosures in the financial statements and financial highlights, assessing the accounting principles used and significant estimates made by management, and evaluating the overall financial statement presentation. Our procedures included confirmation of securities owned as of December 31, 2013, by correspondence with the custodian or fund manager of the underlying portfolios. We believe that our audits provide a reasonable basis for our opinion.

In our opinion, the financial statements and financial highlights referred to above present fairly, in all material respects, the financial position of each of the active sub-accounts constituting John Hancock Life Insurance Company of New York Separate Account B at December 31, 2013, and the results of its operations and changes in contract owners’ equity of the active and closed sub-accounts for each of the two years in the period then ended (or years since inception), and the financial highlights for each of the five years in the period then ended (or years since inception), in conformity with U.S. generally accepted accounting principles.

/s/ ERNST & YOUNG LLP

Chartered Accountants

Licensed Public Accountants

Toronto, Canada

March 28, 2014

 

7


Table of Contents

John Hancock Life Insurance Company of New York Separate Account B

Statements of Assets and Contract Owners’ Equity

December 31, 2013

 

Assets

  

Investments at fair value:

  

Sub-accounts invested in John Hancock Variable Insurance Trust portfolios:

  

500 Index Trust B Series 0 - 289,932 shares (cost $5,297,145)

   $ 6,764,116   

Active Bond Trust Series 0 - 68,105 shares (cost $684,679)

     653,806   

Active Bond Trust Series 1 - 32,818 shares (cost $315,049)

     315,051   

All Cap Core Trust Series 0 - 3,289 shares (cost $56,092)

     82,745   

All Cap Core Trust Series 1 - 11,882 shares (cost $177,312)

     298,820   

All Cap Value Trust Series 0

     —     

All Cap Value Trust Series 1

     —     

Alpha Opportunities Trust Series 0 - 5,763 shares (cost $82,628)

     93,480   

American Asset Allocation Trust Series 1 - 98,968 shares (cost $1,167,997)

     1,506,292   

American Global Growth Trust Series 1 - 5,218 shares (cost $62,855)

     81,821   

American Global Small Capitalization Trust Series 1

     —     

American Growth Trust Series 1 - 111,386 shares (cost $1,705,515)

     2,499,497   

American Growth-Income Trust Series 1 - 127,419 shares (cost $1,910,017)

     2,798,113   

American High-Income Bond Trust Series 1

     —     

American International Trust Series 1 - 89,582 shares (cost $1,387,542)

     1,722,671   

American New World Trust Series 1 - 23,192 shares (cost $305,584)

     345,333   

Blue Chip Growth Trust Series 0 - 81,742 shares (cost $1,602,744)

     2,795,578   

Blue Chip Growth Trust Series 1 - 29,260 shares (cost $556,599)

     1,001,567   

Bond Trust Series 0 - 13,887 shares (cost $192,719)

     184,560   

Bond Trust Series 1

     —     

Capital Appreciation Trust Series 0 - 303,838 shares (cost $3,583,868)

     4,797,597   

Capital Appreciation Trust Series 1 - 21,747 shares (cost $243,265)

     343,169   

Capital Appreciation Value Trust Series 0 - 85,386 shares (cost $1,030,130)

     1,110,013   

Core Allocation Plus Trust Series 0

     —     

Core Bond Trust Series 0 - 39,333 shares (cost $547,320)

     503,461   

Core Bond Trust Series 1 - 10,562 shares (cost $134,336)

     135,720   

Core Strategy Trust Series 0 - 389,023 shares (cost $5,360,832)

     5,636,940   

Disciplined Diversification Trust Series 0

     —     

Emerging Markets Value Trust Series 0 - 298,564 shares (cost $3,613,984)

     2,955,779   

Emerging Markets Value Trust Series 1 - 611 shares (cost $7,019)

     6,059   

Equity-Income Trust Series 0 - 350,273 shares (cost $5,209,051)

     6,921,388   

Equity-Income Trust Series 1 - 40,672 shares (cost $604,851)

     806,115   

Financial Services Trust Series 0 - 28,263 shares (cost $329,226)

     447,400   

Financial Services Trust Series 1 - 8,965 shares (cost $104,463)

     142,093   

Franklin Templeton Founding Allocation Trust Series 0 - 145,000 shares (cost $1,566,504)

     1,890,794   

Franklin Templeton Founding Allocation Trust Series 1 - 165 shares (cost $2,164)

     2,156   

Fundamental All Cap Core Trust Series 0 - 25,676 shares (cost $400,532)

     530,987   

Fundamental All Cap Core Trust Series 1 - 1,704 shares (cost $34,058)

     35,115   

Fundamental Holdings Trust Series 1

     —     

Fundamental Large Cap Value Trust Series 0 - 78,575 shares (cost $1,174,600)

     1,252,483   

Fundamental Large Cap Value Trust Series 1 - 8,477 shares (cost $131,425)

     135,126   

Fundamental Value Trust Series 0 - 14,371 shares (cost $206,390)

     289,723   

 

8


Table of Contents

John Hancock Life Insurance Company of New York Separate Account B

Statements of Assets and Contract Owners’ Equity

December 31, 2013

 

Assets (continued)

  

Investments at fair value:

  

Sub-accounts invested in John Hancock Variable Insurance Trust portfolios:

  

Fundamental Value Trust Series 1 - 30,546 shares (cost $380,089)

   $ 617,642   

Global Bond Trust Series 0 - 74,721 shares (cost $958,243)

     921,315   

Global Bond Trust Series 1 - 13,739 shares (cost $168,751)

     170,232   

Global Diversification Trust Series 1

     —     

Global Trust Series 0 - 6,361 shares (cost $95,557)

     130,202   

Global Trust Series 1 - 5,040 shares (cost $71,414)

     103,317   

Health Sciences Trust Series 0 - 28,361 shares (cost $623,546)

     832,668   

Health Sciences Trust Series 1 - 10,027 shares (cost $176,074)

     292,696   

High Yield Trust Series 0 - 260,065 shares (cost $1,593,059)

     1,570,793   

High Yield Trust Series 1 - 37,632 shares (cost $246,180)

     229,554   

International Core Trust Series 0 - 32,006 shares (cost $305,196)

     373,513   

International Core Trust Series 1 - 6,699 shares (cost $55,266)

     78,377   

International Equity Index Trust B Series 0 - 271,580 shares (cost $4,221,266)

     4,652,174   

International Equity Index Trust B Series 1 - 16,259 shares (cost $240,184)

     278,688   

International Growth Stock Trust Series 0 - 37,927 shares (cost $530,745)

     639,451   

International Growth Stock Trust Series 1 - 12,477 shares (cost $174,128)

     210,237   

International Small Company Trust Series 0 - 36,897 shares (cost $362,042)

     464,898   

International Small Company Trust Series 1 - 3,957 shares (cost $36,856)

     49,900   

International Value Trust Series 0 - 29,206 shares (cost $351,333)

     428,737   

International Value Trust Series 1 - 22,408 shares (cost $269,672)

     331,196   

Investment Quality Bond Trust Series 0 - 13,818 shares (cost $163,866)

     157,106   

Investment Quality Bond Trust Series 1 - 19,467 shares (cost $224,260)

     222,114   

Lifestyle Aggressive Trust Series 0 - 896,506 shares (cost $7,465,114)

     9,780,876   

Lifestyle Aggressive Trust Series 1 - 55,631 shares (cost $415,183)

     606,938   

Lifestyle Balanced Trust Series 0 - 1,907,424 shares (cost $22,858,936)

     26,169,856   

Lifestyle Balanced Trust Series 1 - 368,766 shares (cost $4,472,986)

     5,048,408   

Lifestyle Conservative Trust Series 0 - 265,374 shares (cost $3,425,814)

     3,346,371   

Lifestyle Conservative Trust Series 1 - 11,884 shares (cost $143,676)

     149,499   

Lifestyle Growth Trust Series 0 - 2,011,508 shares (cost $23,429,345)

     28,643,878   

Lifestyle Growth Trust Series 1 - 159,666 shares (cost $1,913,668)

     2,272,044   

Lifestyle Moderate Trust Series 0 - 415,144 shares (cost $5,266,295)

     5,683,325   

Lifestyle Moderate Trust Series 1 - 70,244 shares (cost $825,589)

     960,936   

Mid Cap Index Trust Series 0 - 167,394 shares (cost $3,126,017)

     3,652,538   

Mid Cap Index Trust Series 1 - 15,316 shares (cost $246,596)

     334,200   

Mid Cap Stock Trust Series 0 - 43,022 shares (cost $640,903)

     911,647   

Mid Cap Stock Trust Series 1 - 18,601 shares (cost $249,155)

     391,932   

Mid Value Trust Series 0 - 68,089 shares (cost $747,590)

     949,157   

Mid Value Trust Series 1 - 16,211 shares (cost $164,880)

     226,791   

Money Market Trust B Series 0 - 6,536,519 shares (cost $6,536,519)

     6,536,519   

Money Market Trust Series 1 - 2,730,900 shares (cost $2,730,900)

     2,730,900   

Natural Resources Trust Series 0 - 111,007 shares (cost $1,131,127)

     1,127,832   

Natural Resources Trust Series 1 - 15,773 shares (cost $157,887)

     162,934   

 

9


Table of Contents

John Hancock Life Insurance Company of New York Separate Account B

Statements of Assets and Contract Owners’ Equity

December 31, 2013

 

Assets (continued)

  

Investments at fair value:

  

Sub-accounts invested in John Hancock Variable Insurance Trust portfolios:

  

Real Estate Securities Trust Series 0 - 215,064 shares (cost $2,610,418)

   $ 2,959,281   

Real Estate Securities Trust Series 1 - 36,528 shares (cost $457,299)

     505,546   

Real Return Bond Trust Series 0 - 78,192 shares (cost $986,833)

     910,159   

Real Return Bond Trust Series 1 - 3,005 shares (cost $36,481)

     35,456   

Science & Technology Trust Series 0 - 27,695 shares (cost $476,354)

     688,221   

Science & Technology Trust Series 1 - 9,217 shares (cost $122,933)

     227,926   

Short Term Government Income Trust Series 0 - 34,452 shares (cost $446,394)

     430,654   

Short Term Government Income Trust Series 1 - 31,954 shares (cost $412,283)

     399,419   

Small Cap Growth Trust Series 0 - 37,346 shares (cost $381,699)

     481,384   

Small Cap Growth Trust Series 1 - 2,238 shares (cost $21,464)

     28,691   

Small Cap Index Trust Series 0 - 183,810 shares (cost $2,433,421)

     2,911,545   

Small Cap Index Trust Series 1 - 9,703 shares (cost $124,302)

     153,601   

Small Cap Opportunities Trust Series 0 - 32,913 shares (cost $936,855)

     1,010,418   

Small Cap Opportunities Trust Series 1 - 4,110 shares (cost $81,776)

     126,761   

Small Cap Value Trust Series 0 - 28,449 shares (cost $569,644)

     740,817   

Small Cap Value Trust Series 1 - 2,398 shares (cost $57,212)

     62,567   

Small Company Value Trust Series 0 - 33,190 shares (cost $561,954)

     837,044   

Small Company Value Trust Series 1 - 13,759 shares (cost $205,802)

     347,540   

Smaller Company Growth Trust Series 0

     —     

Smaller Company Growth Trust Series 1

     —     

Strategic Income Opportunities Trust Series 0 - 328,119 shares (cost $4,423,686)

     4,311,480   

Strategic Income Opportunities Trust Series 1 - 21,487 shares (cost $295,077)

     283,198   

Total Bond Market Trust B Series 0 - 35,140 shares (cost $370,460)

     354,564   

Total Return Trust Series 0 - 148,355 shares (cost $2,121,842)

     2,010,204   

Total Return Trust Series 1 - 47,986 shares (cost $674,369)

     652,605   

Total Stock Market Index Trust Series 0 - 62,908 shares (cost $827,519)

     1,074,462   

Total Stock Market Index Trust Series 1 - 10,270 shares (cost $119,615)

     175,418   

Ultra Short Term Bond Trust Series 0 - 11,868 shares (cost $143,749)

     142,183   

U.S. Equity Trust Series 0 - 46,889 shares (cost $657,356)

     830,873   

U.S. Equity Trust Series 1 - 3,887 shares (cost $54,453)

     68,841   

Utilities Trust Series 0 - 53,759 shares (cost $660,759)

     828,969   

Utilities Trust Series 1 - 4,584 shares (cost $55,068)

     70,782   

Value Trust Series 0 - 23,476 shares (cost $443,682)

     608,489   

Value Trust Series 1 - 12,447 shares (cost $169,186)

     323,011   

 

10


Table of Contents

John Hancock Life Insurance Company of New York Separate Account B

Statements of Assets and Contract Owners’ Equity

December 31, 2013

 

Assets (continued)

  

Investments at fair value:

  

Sub-accounts invested in Outside Trust portfolios:

  

All Asset Portfolio - 442,848 shares (cost $4,954,957)

   $ 4,889,041   

Brandes International Equity - 8,440 shares (cost $102,812)

     110,980   

Frontier Capital Appreciation - 1,841 shares (cost $53,646)

     54,710   

Large Cap Growth - 5,511 shares (cost $111,114)

     136,344   

Large Cap Value - 6,147 shares (cost $79,452)

     84,641   
  

 

 

 

Total Assets

   $ 191,394,784   
  

 

 

 

Contract Owners’ Equity

  
  

 

 

 

Variable universal life insurance contracts

   $ 191,394,784   
  

 

 

 

 

See accompanying notes.

 

11


Table of Contents

John Hancock Life Insurance Company of New York Separate Account B

Statements of Operations and Changes in Contract Owners’ Equity

 

     Sub-Account  
     500 Index Trust B Series 0     500 Index Trust Series 1  
     Year Ended     Year Ended     Year Ended  
     Dec. 31/13     Dec. 31/12     Dec. 31/12 (y)  

Income:

      

Dividend income distribution

   $ 108,176      $ 37,737      $ 25,942   
  

 

 

   

 

 

   

 

 

 

Net investment income (loss)

     108,176        37,737        25,942   
  

 

 

   

 

 

   

 

 

 

Realized gains (losses) on investments:

      

Capital gain distributions

     11,849        —          55,467   

Net realized gains (losses)

     223,636        107,664        (8,858
  

 

 

   

 

 

   

 

 

 

Realized gains (losses)

     235,485        107,664        46,609   

Unrealized appreciation (depreciation) during the period

     1,062,289        339,246        (1,306
  

 

 

   

 

 

   

 

 

 

Net increase (decrease) in assets from operations

     1,405,950        484,647        71,245   
  

 

 

   

 

 

   

 

 

 

Changes from principal transactions:

      

Transfer of net premiums

     487,089        495,381        32,904   

Transfer on terminations

     (936,885     (185,940     (28,620

Transfer on policy loans

     (34,708     (17,916     (3,445

Net interfund transfers

     1,491,960        626,019        (583,863
  

 

 

   

 

 

   

 

 

 

Net increase (decrease) in assets from principal transactions

     1,007,456        917,544        (583,024
  

 

 

   

 

 

   

 

 

 

Total increase (decrease) in assets

     2,413,406        1,402,191        (511,779

Assets, beginning of period

     4,350,710        2,948,519        511,779   
  

 

 

   

 

 

   

 

 

 

Assets, end of period

   $ 6,764,116      $ 4,350,710        —     
  

 

 

   

 

 

   

 

 

 

 

(y) Terminated as an investment option and funds transferred to 500 Index Trust B Series 0 on November 5, 2012.
(bg) Fund has no Series. Previously presented as Series 0 and Series 1.

 

See accompanying notes.

 

12


Table of Contents
Sub-Account  
Active Bond Trust Series 0     Active Bond Trust Series 1     All Asset Portfolio  
Year Ended
Dec. 31/13
    Year Ended
Dec. 31/12
    Year Ended
Dec. 31/13
    Year Ended
Dec. 31/12
    Year Ended
Dec. 31/13 (bg)
    Year Ended
Dec. 31/12 (bg)
 
         
$ 38,679      $ 24,942      $ 17,777      $ 10,908      $ 208,525      $ 160,170   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 
  38,679        24,942        17,777        10,908        208,525        160,170   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 
         
  —          3,923        —          1,765        —          —     
  1,707        1,011        568        1,332        5,979        6,320   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 
  1,707        4,934        568        3,097        5,979        6,320   
  (39,231     13,052        (17,898     9,903        (220,102     159,654   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 
  1,155        42,928        447        23,908        (5,598     326,144   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 
         
  33,074        31,156        13,105        14,948        57,614        68,780   
  (24,842     (15,681     (12,741     (12,761     (152,419     (68,367
  2,051        (657     260        (4,905     (289     (273
  32,508        256,052        45,768        3,008        21,475        4,387,526   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 
  42,791        270,870        46,392        290        (73,619     4,387,666   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 
  43,946        313,798        46,839        24,198        (79,217     4,713,810   
  609,860        296,062        268,212        244,014        4,968,258        254,448   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 
$ 653,806      $ 609,860      $ 315,051      $ 268,212      $ 4,889,041      $ 4,968,258   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

 

13


Table of Contents

John Hancock Life Insurance Company of New York Separate Account B

Statements of Operations and Changes in Contract Owners’ Equity

(continued)

 

     Sub-Account  
     All Cap Core Trust Series 0     All Cap Core Trust Series 1  
     Year Ended
Dec. 31/13
    Year Ended
Dec. 31/12
    Year Ended
Dec. 31/13
    Year Ended
Dec. 31/12
 

Income:

        

Dividend income distribution

   $ 1,004      $ 616      $ 6,611      $ 4,684   
  

 

 

   

 

 

   

 

 

   

 

 

 

Net investment income (loss)

     1,004        616        6,611        4,684   
  

 

 

   

 

 

   

 

 

   

 

 

 

Realized gains (losses) on investments:

        

Capital gain distributions

     —          —          —          —     

Net realized gains (losses)

     4,601        22,940        45,028        (1,487
  

 

 

   

 

 

   

 

 

   

 

 

 

Realized gains (losses)

     4,601        22,940        45,028        (1,487

Unrealized appreciation (depreciation) during the period

     15,175        98,654        85,963        58,163   
  

 

 

   

 

 

   

 

 

   

 

 

 

Net increase (decrease) in assets from operations

     20,780        122,210        137,602        61,360   
  

 

 

   

 

 

   

 

 

   

 

 

 

Changes from principal transactions:

        

Transfer of net premiums

     14,426        9,324        9,553        8,716   

Transfer on terminations

     (7,820     (11,740     (13,365     (12,576

Transfer on policy loans

     (7,349     (1,799     (251,756     7   

Net interfund transfers

     7,313        (1,041,889     (11,819     (234
  

 

 

   

 

 

   

 

 

   

 

 

 

Net increase (decrease) in assets from principal transactions

     6,570        (1,046,104     (267,387     (4,087
  

 

 

   

 

 

   

 

 

   

 

 

 

Total increase (decrease) in assets

     27,350        (923,894     (129,785     57,273   

Assets, beginning of period

     55,395        979,289        428,605        371,332   
  

 

 

   

 

 

   

 

 

   

 

 

 

Assets, end of period

   $ 82,745      $ 55,395      $ 298,820      $ 428,605   
  

 

 

   

 

 

   

 

 

   

 

 

 

 

(m) Terminated as an investment option and funds transferred to Fundamental Large Cap Value Trust on December 9, 2013.

 

See accompanying notes.

 

14


Table of Contents
Sub-Account  
All Cap Value Trust Series 0     All Cap Value Trust Series 1     Alpha Opportunities Trust Series 0  
Year Ended
Dec. 31/13 (m)
    Year Ended
Dec. 31/12
    Year Ended
Dec. 31/13 (m)
    Year Ended
Dec. 31/12
    Year Ended
Dec. 31/13
    Year Ended
Dec. 31/12
 
         
$ 10,367      $ 4,449      $ 2,293      $ 1,412      $ 545      $ 273   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 
  10,367        4,449        2,293        1,412        545        273   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 
         
  401,391        19,775        82,624        6,706        5,700        2,981   
  (216,104     1,181        (11,198     (9,132     390        (102,348

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 
  185,287        20,956        71,426        (2,426     6,090        (99,367
  (21,405     21,011        (15,917     25,157        11,584        246,898   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 
  174,249        46,416        57,802        24,143        18,219        147,804   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 
         
  93,683        104,568        5,615        5,354        6,120        6,055   
  (31,905     (25,119     (40,905     (8,339     (3,634     (6,416
  —          —          —          (21,643     —          —     
  (749,492     5,943        (170,866     (101,634     24,238        (961,902

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 
  (687,714     85,392        (206,156     (126,262     26,724        (962,263

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 
  (513,465     131,808        (148,354     (102,119     44,943        (814,459
  513,465        381,657        148,354        250,473        48,537        862,996   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 
  —        $ 513,465        —        $ 148,354      $ 93,480      $ 48,537   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

 

15


Table of Contents

John Hancock Life Insurance Company of New York Separate Account B

Statements of Operations and Changes in Contract Owners’ Equity

(continued)

 

    Sub-Account  
    American Asset Allocation Trust Series 1     American Blue Chip Income and Growth Trust Series 1  
    Year Ended     Year Ended         Year Ended  
    Dec. 31/13     Dec. 31/12                    Dec. 31/12 (v)  

Income:

       

Dividend income distribution

  $ 15,134      $ 15,780          —     
 

 

 

   

 

 

     

 

 

 

Net investment income (loss)

    15,134        15,780          —     
 

 

 

   

 

 

     

 

 

 

Realized gains (losses) on investments:

       

Capital gain distributions

    —          —            104,496   

Net realized gains (losses)

    30,194        14,086          (33,533
 

 

 

   

 

 

     

 

 

 

Realized gains (losses)

    30,194        14,086          70,963   

Unrealized appreciation (depreciation) during the period

    210,494        79,861          (16,479
 

 

 

   

 

 

     

 

 

 

Net increase (decrease) in assets from operations

    255,822        109,727          54,484   
 

 

 

   

 

 

     

 

 

 

Changes from principal transactions:

       

Transfer of net premiums

    205,615        189,870          54,991   

Transfer on terminations

    (117,857     (71,989       (41,608

Transfer on policy loans

    (1,714     (5,271       (119

Net interfund transfers

    132,229        240,768          (363,264
 

 

 

   

 

 

     

 

 

 

Net increase (decrease) in assets from principal transactions

    218,273        353,378          (350,000
 

 

 

   

 

 

     

 

 

 

Total increase (decrease) in assets

    474,095        463,105          (295,516

Assets, beginning of period

    1,032,197        569,092          295,516   
 

 

 

   

 

 

     

 

 

 

Assets, end of period

  $ 1,506,292      $ 1,032,197          —     
 

 

 

   

 

 

     

 

 

 

 

(v) Terminated as an investment option and funds transferred to American Growth-Income Trust Series 1 on November 5, 2012.
(bh) Terminated as an investment option and funds transferred to American Global Growth Trust Series 1 on April 29, 2013.

 

See accompanying notes.

 

16


Table of Contents
Sub-Account  
American Global Growth Trust Series 1     American Global Small
Capitalization Trust Series 1
    American Growth Trust Series 1  
Year Ended
Dec. 31/13
    Year Ended
Dec. 31/12
    Year Ended
Dec. 31/13 (bh)
    Year Ended
Dec. 31/12
    Year Ended
Dec. 31/13
    Year Ended
Dec. 31/12
 
         
$ 656      $ 180      $ 46      $ 164      $ 12,267      $ 7,791   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 
  656        180        46        164        12,267        7,791   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 
         
  —          —          —          —          —          —     
  1,812        (2     2,196        (85     101,324        75,326   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 
  1,812        (2     2,196        (85     101,324        75,326   
  13,796        6,136        (213     2,863        451,233        327,805   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 
  16,264        6,314        2,029        2,942        564,824        410,922   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 
         
  8,078        18,212        69        641        213,598        318,626   
  (5,683     (3,237     (342     (855     (167,428     (362,764
  —          —          —          —          (3,325     (2,120
  23,922        3,074        (21,208     332        (59,893     (782,593

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 
  26,317        18,049        (21,481     118        (17,048     (828,851

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 
  42,581        24,363        (19,452     3,060        547,776        (417,929
  39,240        14,877        19,452        16,392        1,951,721        2,369,650   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 
$ 81,821      $ 39,240        —        $ 19,452      $ 2,499,497      $ 1,951,721   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

 

17


Table of Contents

John Hancock Life Insurance Company of New York Separate Account B

Statements of Operations and Changes in Contract Owners’ Equity

(continued)

 

    Sub-Account  
    American Growth-Income Trust Series  1     American High-Income Bond Trust Series  1  
    Year Ended
Dec. 31/13
    Year Ended
Dec. 31/12
    Year Ended
Dec. 31/13 (l)
    Year Ended
Dec. 31/12
 

Income:

       

Dividend income distribution

  $ 25,148      $ 26,448      $ 128      $ 9,917   
 

 

 

   

 

 

   

 

 

   

 

 

 

Net investment income (loss)

    25,148        26,448        128        9,917   
 

 

 

   

 

 

   

 

 

   

 

 

 

Realized gains (losses) on investments:

       

Capital gain distributions

    —          —          3,986        —     

Net realized gains (losses)

    83,364        33,188        389        223   
 

 

 

   

 

 

   

 

 

   

 

 

 

Realized gains (losses)

    83,364        33,188        4,375        223   

Unrealized appreciation (depreciation) during the period

    595,570        149,339        199        1,754   
 

 

 

   

 

 

   

 

 

   

 

 

 

Net increase (decrease) in assets from operations

    704,082        208,975        4,702        11,894   
 

 

 

   

 

 

   

 

 

   

 

 

 

Changes from principal transactions:

       

Transfer of net premiums

    182,414        125,999        4,415        9,541   

Transfer on terminations

    (175,680     (114,259     (3,675     (6,760

Transfer on policy loans

    (17,127     (8,124     (150     —     

Net interfund transfers

    (26,925     954,850        (162,316     118,822   
 

 

 

   

 

 

   

 

 

   

 

 

 

Net increase (decrease) in assets from principal transactions

    (37,318     958,466        (161,726     121,603   
 

 

 

   

 

 

   

 

 

   

 

 

 

Total increase (decrease) in assets

    666,764        1,167,441        (157,024     133,497   

Assets, beginning of period

    2,131,349        963,908        157,024        23,527   
 

 

 

   

 

 

   

 

 

   

 

 

 

Assets, end of period

  $ 2,798,113      $ 2,131,349        —        $ 157,024   
 

 

 

   

 

 

   

 

 

   

 

 

 

 

(l) Terminated as an investment option and funds transferred to High Yield Trust Series 1 on April 29, 2013.
(e) Terminated as an investment option and funds transferred to Lifestyle Growth Trust on April 30, 2012.

 

See accompanying notes.

 

18


Table of Contents
Sub-Account  
American International Trust Series 1     American New World Trust Series 1     Balanced Trust Series 0  
Year Ended
Dec. 31/13
    Year Ended
Dec. 31/12
    Year Ended
Dec. 31/13
    Year Ended
Dec. 31/12
    Year Ended
Dec. 31/12 (e)
 
       
$ 15,339      $ 14,745      $ 3,093      $ 1,224      $ 3,685   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 
  15,339        14,745        3,093        1,224        3,685   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 
       
  —          —          —          —          84,208   
  67,910        (37,967     517        337        (81,763

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 
  67,910        (37,967     517        337        2,445   
  222,797        248,174        24,926        29,858        14,926   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 
  306,046        224,952        28,536        31,419        21,056   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 
       
  83,540        197,860        23,109        31,520        922   
  (493,773     (238,686     (15,468     (14,538     (2,299
  (2,028     (791     —          —          —     
  401,643        (88,137     89,716        (1,059     (265,602

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 
  (10,618     (129,754     97,357        15,923        (266,979

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 
  295,428        95,198        125,893        47,342        (245,923
  1,427,243        1,332,045        219,440        172,098        245,923   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 
$ 1,722,671      $ 1,427,243      $ 345,333      $ 219,440        —     

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

 

19


Table of Contents

John Hancock Life Insurance Company of New York Separate Account B

Statements of Operations and Changes in Contract Owners’ Equity

(continued)

 

     Sub-Account  
     Balanced Trust Series 1     Blue Chip Growth Trust Series 0  
     Year Ended     Year Ended     Year Ended  
     Dec. 31/12 (e)     Dec. 31/13     Dec. 31/12  

Income:

      

Dividend income distribution

   $ 22      $ 7,544      $ 3,807   
  

 

 

   

 

 

   

 

 

 

Net investment income (loss)

     22        7,544        3,807   
  

 

 

   

 

 

   

 

 

 

Realized gains (losses) on investments:

      

Capital gain distributions

     524        —          —     

Net realized gains (losses)

     (424     233,627        230,513   
  

 

 

   

 

 

   

 

 

 

Realized gains (losses)

     100        233,627        230,513   

Unrealized appreciation (depreciation) during the period

     13        621,444        396,479   
  

 

 

   

 

 

   

 

 

 

Net increase (decrease) in assets from operations

     135        862,615        630,799   
  

 

 

   

 

 

   

 

 

 

Changes from principal transactions:

      

Transfer of net premiums

     —          162,806        295,106   

Transfer on terminations

     (70     (1,130,590     (301,267

Transfer on policy loans

     —          (19,312     (1,412

Net interfund transfers

     (1,653     24,485        (1,055,105
  

 

 

   

 

 

   

 

 

 

Net increase (decrease) in assets from principal transactions

     (1,723     (962,611     (1,062,678
  

 

 

   

 

 

   

 

 

 

Total increase (decrease) in assets

     (1,588     (99,996     (431,879

Assets, beginning of period

     1,588        2,895,574        3,327,453   
  

 

 

   

 

 

   

 

 

 

Assets, end of period

     —        $ 2,795,578      $ 2,895,574   
  

 

 

   

 

 

   

 

 

 

 

(e) Terminated as an investment option and funds transferred to Lifestyle Growth Trust on April 30, 2012.

 

See accompanying notes.

 

20


Table of Contents
Sub-Account  
Blue Chip Growth Trust Series 1     Bond Trust Series 0     Bond Trust Series 1  
Year Ended
Dec. 31/13
    Year Ended
Dec. 31/12
    Year Ended
Dec. 31/13
    Year Ended
Dec. 31/12
    Year Ended
Dec. 31/13
    Year Ended
Dec. 31/12
 
         
$ 2,534      $ 654      $ 5,709      $ 5,391        —        $ 577   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 
  2,534        654        5,709        5,391        —          577   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 
         
  —          —          1,434        1,265        —          142   
  52,826        35,959        13        218        141        4   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 
  52,826        35,959        1,447        1,483        141        146   
  255,420        86,179        (9,357     4,095        (157     157   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 
  310,780        122,792        (2,201     10,969        (16     880   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 
         
  36,525        35,013        24,405        25,150        —          —     
  (49,275     (87,078     (22,581     (13,618     (59     (279
  (36,519     (28,692     (56     (5,309     —          —     
  54,386        (61,957     (12,693     13,108        (21,011     20,485   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 
  5,117        (142,714     (10,925     19,331        (21,070     20,206   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 
  315,897        (19,922     (13,126     30,300        (21,086     21,086   
  685,670        705,592        197,686        167,386        21,086        —     

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 
$ 1,001,567      $ 685,670      $ 184,560      $ 197,686        —        $ 21,086   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

 

21


Table of Contents

John Hancock Life Insurance Company of New York Separate Account B

Statements of Operations and Changes in Contract Owners’ Equity

(continued)

 

     Sub-Account  
     Brandes International Equity     Capital Appreciation Trust Series 0  
     Year Ended
Dec. 31/13
    Year Ended
Dec. 31/12
    Year Ended
Dec. 31/13
    Year Ended
Dec. 31/12
 

Income:

        

Dividend income distribution

   $ 2,259      $ 758      $ 10,417      $ 7,253   
  

 

 

   

 

 

   

 

 

   

 

 

 

Net investment income (loss)

     2,259        758        10,417        7,253   
  

 

 

   

 

 

   

 

 

   

 

 

 

Realized gains (losses) on investments:

        

Capital gain distributions

     —          —          —          —     

Net realized gains (losses)

     251        (80     46,663        (72,321
  

 

 

   

 

 

   

 

 

   

 

 

 

Realized gains (losses)

     251        (80     46,663        (72,321

Unrealized appreciation (depreciation) during the period

     5,713        5,505        1,246,404        (38,106
  

 

 

   

 

 

   

 

 

   

 

 

 

Net increase (decrease) in assets from operations

     8,223        6,183        1,303,484        (103,174
  

 

 

   

 

 

   

 

 

   

 

 

 

Changes from principal transactions:

        

Transfer of net premiums

     10,407        10,667        25,678        27,676   

Transfer on terminations

     (1,939     (4,061     (79,981     (74,226

Transfer on policy loans

     —          —          —          —     

Net interfund transfers

     54,791        251        (65,034     3,489,141   
  

 

 

   

 

 

   

 

 

   

 

 

 

Net increase (decrease) in assets from principal transactions

     63,259        6,857        (119,337     3,442,591   
  

 

 

   

 

 

   

 

 

   

 

 

 

Total increase (decrease) in assets

     71,482        13,040        1,184,147        3,339,417   

Assets, beginning of period

     39,498        26,458        3,613,450        274,033   
  

 

 

   

 

 

   

 

 

   

 

 

 

Assets, end of period

   $ 110,980      $ 39,498      $ 4,797,597      $ 3,613,450   
  

 

 

   

 

 

   

 

 

   

 

 

 

 

(z) Terminated as an investment option and funds transferred to Core Strategy Trust on December 9, 2013.

 

See accompanying notes.

 

22


Table of Contents
Sub-Account  
Capital Appreciation Trust Series 1     Capital Appreciation Value Trust Series 0     Core Allocation Plus Trust Series 0  
Year Ended
Dec. 31/13
    Year Ended
Dec. 31/12
    Year Ended
Dec. 31/13
    Year Ended
Dec. 31/12
    Year Ended
Dec. 31/13 (z)
    Year Ended
Dec. 31/12
 
         
$ 741      $ 582      $ 13,847      $ 12,245      $ 28,663      $ 9,206   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 
  741        582        13,847        12,245        28,663        9,206   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 
         
  —          —          89,178        77,176        294,959        38,780   
  60,293        18,317        7,016        1,744        (202,039     (135

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 
  60,293        18,317        96,194        78,920        92,920        38,645   
  41,364        22,340        86,598        1,409        23,954        21,509   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 
  102,398        41,239        196,639        92,574        145,537        69,360   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 
         
  24,705        27,536        130,894        111,080        139,011        108,358   
  (58,703     (56,574     (79,744     (49,131     (36,500     (29,689
  98        (4,767     (6,655     (3,052     (1,004     (424
  (83,602     106,738        28,517        137,726        (918,946     41,493   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 
  (117,502     72,933        73,012        196,623        (817,439     119,738   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 
  (15,104     114,172        269,651        289,197        (671,902     189,098   
  358,273        244,101        840,362        551,165        671,902        482,804   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 
$ 343,169      $ 358,273      $ 1,110,013      $ 840,362        —        $ 671,902   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

 

23


Table of Contents

John Hancock Life Insurance Company of New York Separate Account B

Statements of Operations and Changes in Contract Owners’ Equity

(continued)

 

     Sub-Account  
     Core Bond Trust Series 0     Core Bond Trust Series 1  
     Year Ended
Dec. 31/13
    Year Ended
Dec. 31/12
    Year Ended
Dec. 31/13
    Year Ended
Dec. 31/12
 

Income:

        

Dividend income distribution

   $ 10,784      $ 11,972      $ 2,943      $ 3,807   
  

 

 

   

 

 

   

 

 

   

 

 

 

Net investment income (loss)

     10,784        11,972        2,943        3,807   
  

 

 

   

 

 

   

 

 

   

 

 

 

Realized gains (losses) on investments:

        

Capital gain distributions

     18,987        9,928        5,281        3,745   

Net realized gains (losses)

     (2,192     43,119        273        1,391   
  

 

 

   

 

 

   

 

 

   

 

 

 

Realized gains (losses)

     16,795        53,047        5,554        5,136   

Unrealized appreciation (depreciation) during the period

     (37,644     (5,047     (11,527     (19
  

 

 

   

 

 

   

 

 

   

 

 

 

Net increase (decrease) in assets from operations

     (10,065     59,972        (3,030     8,924   
  

 

 

   

 

 

   

 

 

   

 

 

 

Changes from principal transactions:

        

Transfer of net premiums

     38,629        46,042        —          —     

Transfer on terminations

     (18,079     (20,904     (2,650     (3,739

Transfer on policy loans

     (2,058     (7,431     —          —     

Net interfund transfers

     24,896        215,445        —          (9,594
  

 

 

   

 

 

   

 

 

   

 

 

 

Net increase (decrease) in assets from principal transactions

     43,388        233,152        (2,650     (13,333
  

 

 

   

 

 

   

 

 

   

 

 

 

Total increase (decrease) in assets

     33,323        293,124        (5,680     (4,409

Assets, beginning of period

     470,138        177,014        141,400        145,809   
  

 

 

   

 

 

   

 

 

   

 

 

 

Assets, end of period

   $ 503,461      $ 470,138      $ 135,720      $ 141,400   
  

 

 

   

 

 

   

 

 

   

 

 

 

 

(z) Terminated as an investment option and funds transferred to Core Strategy Trust on December 9, 2013.

 

See accompanying notes.

 

24


Table of Contents
Sub-Account  
Core Strategy Trust Series 0     Disciplined Diversification Trust Series 0     Emerging Markets Value Trust Series 0  
Year Ended
Dec. 31/13
    Year Ended
Dec. 31/12
    Year Ended
Dec. 31/13 (z)
    Year Ended
Dec. 31/12
    Year Ended
Dec. 31/13
    Year Ended
Dec. 31/12
 
         
$ 35,171      $ 70,005      $ 23,057      $ 11,570      $ 39,627      $ 30,299   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 
  35,171        70,005        23,057        11,570        39,627        30,299   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 
         
  310,312        —          264,402        5,954        101,028        186,981   
  33,119        132,969        (165,433     3,229        (45,954     (100,657

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 
  343,431        132,969        98,969        9,183        55,074        86,324   
  173,080        236,612        (44,219     32,695        (191,614     245,927   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 
  551,682        439,586        77,807        53,448        (96,913     362,550   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 
         
  378,869        260,161        43,660        37,964        117,372        103,211   
  (329,052     (195,602     (31,280     (29,330     (92,796     (77,900
  (9,154     (1,487     (4,109     (1,277     (2,144     (1,742
  2,464,153        (1,855,121     (586,715     28,408        60,142        731,362   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 
  2,504,816        (1,792,049     (578,444     35,765        82,574        754,931   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 
  3,056,498        (1,352,463     (500,637     89,213        (14,339     1,117,481   
  2,580,442        3,932,905        500,637        411,424        2,970,118        1,852,637   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 
$ 5,636,940      $ 2,580,442        —        $ 500,637      $ 2,955,779      $ 2,970,118   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

 

25


Table of Contents

John Hancock Life Insurance Company of New York Separate Account B

Statements of Operations and Changes in Contract Owners’ Equity

(continued)

 

     Sub-Account  
     Emerging Markets Value Trust Series 1     Equity-Income Trust Series 0  
     Year Ended
Dec. 31/13
    Year Ended
Dec. 31/12
    Year Ended
Dec. 31/13
    Year Ended
Dec. 31/12
 

Income:

        

Dividend income distribution

   $ 79      $ 70      $ 123,309      $ 124,224   
  

 

 

   

 

 

   

 

 

   

 

 

 

Net investment income (loss)

     79        70        123,309        124,224   
  

 

 

   

 

 

   

 

 

   

 

 

 

Realized gains (losses) on investments:

        

Capital gain distributions

     209        462        —          —     

Net realized gains (losses)

     (50     (7,513     152,807        (11,333
  

 

 

   

 

 

   

 

 

   

 

 

 

Realized gains (losses)

     159        (7,051     152,807        (11,333

Unrealized appreciation (depreciation) during the period

     (439     8,930        1,347,859        360,237   
  

 

 

   

 

 

   

 

 

   

 

 

 

Net increase (decrease) in assets from operations

     (201     1,949        1,623,975        473,128   
  

 

 

   

 

 

   

 

 

   

 

 

 

Changes from principal transactions:

        

Transfer of net premiums

     —          59        172,781        406,980   

Transfer on terminations

     (383     (10,210     (831,703     (338,332

Transfer on policy loans

     —          —          (14,747     (324

Net interfund transfers

     122        (10,952     (44,846     3,639,456   
  

 

 

   

 

 

   

 

 

   

 

 

 

Net increase (decrease) in assets from principal transactions

     (261     (21,103     (718,515     3,707,780   
  

 

 

   

 

 

   

 

 

   

 

 

 

Total increase (decrease) in assets

     (462     (19,154     905,460        4,180,908   

Assets, beginning of period

     6,521        25,675        6,015,928        1,835,020   
  

 

 

   

 

 

   

 

 

   

 

 

 

Assets, end of period

   $ 6,059      $ 6,521      $ 6,921,388      $ 6,015,928   
  

 

 

   

 

 

   

 

 

   

 

 

 

 

See accompanying notes.

 

26


Table of Contents
Sub-Account  
Equity-Income Trust Series 1     Financial Services Trust Series 0     Financial Services Trust Series 1  
Year Ended
Dec. 31/13
    Year Ended
Dec. 31/12
    Year Ended
Dec. 31/13
    Year Ended
Dec. 31/12
    Year Ended
Dec. 31/13
    Year Ended
Dec. 31/12
 
         
$ 15,080      $ 14,008      $ 2,773      $ 2,502      $ 827      $ 851   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 
  15,080        14,008        2,773        2,502        827        851   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 
         
  —          —          4,213        —          1,368        —     
  91,548        14,801        8,646        63,967        (1,413     (2,153

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 
  91,548        14,801        12,859        63,967        (45     (2,153
  103,365        75,635        84,638        23,403        33,053        18,683   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 
  209,993        104,444        100,270        89,872        33,835        17,381   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 
         
  52,014        59,077        41,037        52,294        1,173        1,031   
  (116,461     (48,467     (40,685     (36,261     (3,982     (4,418
  —          (95     322        (49     —          —     
  (37,722     (5,820     33,983        (149,508     (48     (37

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 
  (102,169     4,695        34,657        (133,524     (2,857     (3,424

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 
  107,824        109,139        134,927        (43,652     30,978        13,957   
  698,291        589,152        312,473        356,125        111,115        97,158   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 
$ 806,115      $ 698,291      $ 447,400      $ 312,473      $ 142,093      $ 111,115   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

 

27


Table of Contents

John Hancock Life Insurance Company of New York Separate Account B

Statements of Operations and Changes in Contract Owners’ Equity

(continued)

 

     Sub-Account  
     Franklin Templeton Founding
Allocation Trust Series 0
    Franklin Templeton Founding
Allocation Trust Series 1
 
     Year Ended
Dec. 31/13
    Year Ended
Dec. 31/12
    Year Ended
Dec. 31/13
    Year Ended
Dec. 31/12 (r)
 

Income:

        

Dividend income distribution

   $ 43,350      $ 36,409      $ 48        —     
  

 

 

   

 

 

   

 

 

   

 

 

 

Net investment income (loss)

     43,350        36,409        48        —     
  

 

 

   

 

 

   

 

 

   

 

 

 

Realized gains (losses) on investments:

        

Capital gain distributions

     —          —          —          —     

Net realized gains (losses)

     21,845        3,411        —          —     
  

 

 

   

 

 

   

 

 

   

 

 

 

Realized gains (losses)

     21,845        3,411        —          —     

Unrealized appreciation (depreciation) during the period

     265,970        98,419        (8     —     
  

 

 

   

 

 

   

 

 

   

 

 

 

Net increase (decrease) in assets from operations

     331,165        138,239        40        —     
  

 

 

   

 

 

   

 

 

   

 

 

 

Changes from principal transactions:

        

Transfer of net premiums

     309,406        275,782        —          —     

Transfer on terminations

     (122,258     (74,932     (31     —     

Transfer on policy loans

     (6,219     (6,470     —          —     

Net interfund transfers

     162,229        267,395        2,147        —     
  

 

 

   

 

 

   

 

 

   

 

 

 

Net increase (decrease) in assets from principal transactions

     343,158        461,775        2,116        —     
  

 

 

   

 

 

   

 

 

   

 

 

 

Total increase (decrease) in assets

     674,323        600,014        2,156        —     

Assets, beginning of period

     1,216,471        616,457        —          —     
  

 

 

   

 

 

   

 

 

   

 

 

 

Assets, end of period

   $ 1,890,794      $ 1,216,471      $ 2,156        —     
  

 

 

   

 

 

   

 

 

   

 

 

 

 

(r) Fund available but no activity.

 

See accompanying notes.

 

28


Table of Contents
Sub-Account  
Frontier Capital Appreciation     Fundamental All Cap Core Trust Series 0     Fundamental All Cap Core Trust Series 1  
Year Ended
Dec. 31/13
    Year Ended
Dec. 31/12
    Year Ended
Dec. 31/13
    Year Ended
Dec. 31/12
    Year Ended
Dec. 31/13
    Year Ended
Dec. 31/12
 
         
  —        $ 14      $ 4,329      $ 1,290      $ 11      $ 3   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 
  —          14        4,329        1,290        11        3   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 
         
  4,105        274        —          —          —          —     
  73        (4     17,070        45,829        132        88   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 
  4,178        270        17,070        45,829        132        88   
  1,180        265        96,360        110,860        1,044        (21

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 
  5,358        549        117,759        157,979        1,187        70   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 
         
  1,666        1,498        24,725        25,479        2,119        2,133   
  (557     (343     (29,215     (30,149     (1,596     (2,402
  —          —          1,373        (590     —          (96
  43,738        97        243,029        (1,023,578     33,009        —     

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 
  44,847        1,252        239,912        (1,028,838     33,532        (365

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 
  50,205        1,801        357,671        (870,859     34,719        (295
  4,505        2,704        173,316        1,044,175        396        691   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 
$ 54,710      $ 4,505      $ 530,987      $ 173,316      $ 35,115      $ 396   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

 

29


Table of Contents

John Hancock Life Insurance Company of New York Separate Account B

Statements of Operations and Changes in Contract Owners’ Equity

(continued)

 

     Sub-Account  
     Fundamental Holdings Trust Series 1     Fundamental Large Cap Value Trust Series 0  
     Year Ended
Dec. 31/13 (z)
    Year Ended
Dec. 31/12
    Year Ended
Dec. 31/13
    Year Ended
Dec. 31/12
 

Income:

        

Dividend income distribution

   $ 3,860      $ 2,846      $ 4,371      $ 385   
  

 

 

   

 

 

   

 

 

   

 

 

 

Net investment income (loss)

     3,860        2,846        4,371        385   
  

 

 

   

 

 

   

 

 

   

 

 

 

Realized gains (losses) on investments:

        

Capital gain distributions

     74,040        —          —          —     

Net realized gains (losses)

     (43,649     995        5,349        324   
  

 

 

   

 

 

   

 

 

   

 

 

 

Realized gains (losses)

     30,391        995        5,349        324   

Unrealized appreciation (depreciation) during the period

     (10,369     13,164        76,131        3,344   
  

 

 

   

 

 

   

 

 

   

 

 

 

Net increase (decrease) in assets from operations

     23,882        17,005        85,851        4,053   
  

 

 

   

 

 

   

 

 

   

 

 

 

Changes from principal transactions:

        

Transfer of net premiums

     28,081        25,120        28,493        2,758   

Transfer on terminations

     (39,480     (14,842     (24,822     (3,013

Transfer on policy loans

     (2,939     (4,909     (7,164     —     

Net interfund transfers

     (177,470     15,752        1,134,681        19,124   
  

 

 

   

 

 

   

 

 

   

 

 

 

Net increase (decrease) in assets from principal transactions

     (191,808     21,121        1,131,188        18,869   
  

 

 

   

 

 

   

 

 

   

 

 

 

Total increase (decrease) in assets

     (167,926     38,126        1,217,039        22,922   

Assets, beginning of period

     167,926        129,800        35,444        12,522   
  

 

 

   

 

 

   

 

 

   

 

 

 

Assets, end of period

     —        $ 167,926      $ 1,252,483      $ 35,444   
  

 

 

   

 

 

   

 

 

   

 

 

 

 

(z) Terminated as an investment option and funds transferred to Core Strategy Trust on December 9, 2013.
(n) Fund available in prior year but no activity.

 

See accompanying notes.

 

30


Table of Contents
Sub-Account  
Fundamental Large Cap Value Trust Series 1     Fundamental Value Trust Series 0     Fundamental Value Trust Series 1  
Year Ended
Dec. 31/13
    Year Ended
Dec. 31/12 (n)
    Year Ended
Dec. 31/13
    Year Ended
Dec. 31/12
    Year Ended
Dec. 31/13
    Year Ended
Dec. 31/12
 
         
  —          —        $ 3,521      $ 3,347      $ 7,633      $ 4,502   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 
  —          —          3,521        3,347        7,633        4,502   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 
         
  —          —          —          —          —          —     
  3        357        35,391        17,647        30,135        66,513   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 
  3        357        35,391        17,647        30,135        66,513   
  3,701        —          41,763        17,553        125,374        1,457   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 
  3,704        357        80,675        38,547        163,142        72,472   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 
         
  97        111        42,458        75,917        41,608        47,108   
  (320     (24,707     (181,480     (47,459     (77,680     (173,634
  —          —          (2,759     (1     (263     (365
  131,645        24,239        (2,134     (3,617     215        (63,157

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 
  131,422        (357     (143,915     24,840        (36,120     (190,048

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 
  135,126        —          (63,240     63,387        127,022        (117,576
  —          —          352,963        289,576        490,620        608,196   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 
$ 135,126        —        $ 289,723      $ 352,963      $ 617,642      $ 490,620   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

 

31


Table of Contents

John Hancock Life Insurance Company of New York Separate Account B

Statements of Operations and Changes in Contract Owners’ Equity

(continued)

 

     Sub-Account  
     Global Bond Trust Series 0     Global Bond Trust Series 1  
     Year Ended
Dec. 31/13
    Year Ended
Dec. 31/12
    Year Ended
Dec. 31/13
    Year Ended
Dec. 31/12
 

Income:

        

Dividend income distribution

   $ 4,809      $ 124,872      $ 838      $ 16,084   
  

 

 

   

 

 

   

 

 

   

 

 

 

Net investment income (loss)

     4,809        124,872        838        16,084   
  

 

 

   

 

 

   

 

 

   

 

 

 

Realized gains (losses) on investments:

        

Capital gain distributions

     —          —          —          —     

Net realized gains (losses)

     (45,803     1,429        1,436        (7,158
  

 

 

   

 

 

   

 

 

   

 

 

 

Realized gains (losses)

     (45,803     1,429        1,436        (7,158

Unrealized appreciation (depreciation) during the period

     (62,403     (419     (14,038     7,104   
  

 

 

   

 

 

   

 

 

   

 

 

 

Net increase (decrease) in assets from operations

     (103,397     125,882        (11,764     16,030   
  

 

 

   

 

 

   

 

 

   

 

 

 

Changes from principal transactions:

        

Transfer of net premiums

     82,960        89,939        9,107        9,196   

Transfer on terminations

     (72,010     (82,955     (56,212     (10,181

Transfer on policy loans

     (5,828     (2,641     —          —     

Net interfund transfers

     (763,526     933,784        (6,309     (53,711
  

 

 

   

 

 

   

 

 

   

 

 

 

Net increase (decrease) in assets from principal transactions

     (758,404     938,127        (53,414     (54,696
  

 

 

   

 

 

   

 

 

   

 

 

 

Total increase (decrease) in assets

     (861,801     1,064,009        (65,178     (38,666

Assets, beginning of period

     1,783,116        719,107        235,410        274,076   
  

 

 

   

 

 

   

 

 

   

 

 

 

Assets, end of period

   $ 921,315      $ 1,783,116      $ 170,232      $ 235,410   
  

 

 

   

 

 

   

 

 

   

 

 

 

 

(z) Terminated as an investment option and funds transferred to Core Strategy Trust on December 9, 2013.

 

See accompanying notes.

 

32


Table of Contents
Sub-Account  
Global Diversification Trust Series 1     Global Trust Series 0     Global Trust Series 1  
Year Ended
Dec. 31/13 (z)
    Year Ended
Dec. 31/12
    Year Ended
Dec. 31/13
    Year Ended
Dec. 31/12
    Year Ended
Dec. 31/13
    Year Ended
Dec. 31/12
 
         
$ 7,469      $ 4,859      $ 1,828      $ 1,430      $ 1,424      $ 19,267   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 
  7,469        4,859        1,828        1,430        1,424        19,267   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 
         
  104,512        —          —          —          —          —     
  (46,006     1,112        2,384        1,430        186,652        3,040   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 
  58,506        1,112        2,384        1,430        186,652        3,040   
  (22,528     31,757        24,185        10,067        (87,485     151,944   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 
  43,447        37,728        28,397        12,927        100,591        174,251   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 
         
  57,702        39,760        15,984        13,587        589        633   
  (63,616     (32,902     (9,349     (8,934     (10,679     (31,087
  (5,522     (1,295     —          —          —          (386
  (325,881     25,826        26,412        (14,039     (944,520     —     

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 
  (337,317     31,389        33,047        (9,386     (954,610     (30,840

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 
  (293,870     69,117        61,444        3,541        (854,019     143,411   
  293,870        224,753        68,758        65,217        957,336        813,925   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 
  —        $ 293,870      $ 130,202      $ 68,758      $ 103,317      $ 957,336   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

 

33


Table of Contents

John Hancock Life Insurance Company of New York Separate Account B

Statements of Operations and Changes in Contract Owners’ Equity

(continued)

 

     Sub-Account  
     Health Sciences Trust Series 0     Health Sciences Trust Series 1  
     Year Ended
Dec. 31/13
    Year Ended
Dec. 31/12
    Year Ended
Dec. 31/13
    Year Ended
Dec. 31/12
 

Income:

        

Dividend income distribution

     —          —          —          —     
  

 

 

   

 

 

   

 

 

   

 

 

 

Net investment income (loss)

     —          —          —          —     
  

 

 

   

 

 

   

 

 

   

 

 

 

Realized gains (losses) on investments:

        

Capital gain distributions

     55,120        25,345        21,030        15,376   

Net realized gains (losses)

     16,597        42,990        18,428        17,158   
  

 

 

   

 

 

   

 

 

   

 

 

 

Realized gains (losses)

     71,717        68,335        39,458        32,534   

Unrealized appreciation (depreciation) during the period

     168,342        10,237        60,864        27,649   
  

 

 

   

 

 

   

 

 

   

 

 

 

Net increase (decrease) in assets from operations

     240,059        78,572        100,322        60,183   
  

 

 

   

 

 

   

 

 

   

 

 

 

Changes from principal transactions:

        

Transfer of net premiums

     38,658        41,544        3,278        3,771   

Transfer on terminations

     (44,168     (22,678     (18,940     (15,307

Transfer on policy loans

     (8,363     (59     (22,311     (32,771

Net interfund transfers

     172,099        164,567        20,714        10,196   
  

 

 

   

 

 

   

 

 

   

 

 

 

Net increase (decrease) in assets from principal transactions

     158,226        183,374        (17,259     (34,111
  

 

 

   

 

 

   

 

 

   

 

 

 

Total increase (decrease) in assets

     398,285        261,946        83,063        26,072   

Assets, beginning of period

     434,383        172,437        209,633        183,561   
  

 

 

   

 

 

   

 

 

   

 

 

 

Assets, end of period

   $ 832,668      $ 434,383      $ 292,696      $ 209,633   
  

 

 

   

 

 

   

 

 

   

 

 

 

 

See accompanying notes.

 

34


Table of Contents
Sub-Account  
High Yield Trust Series 0     High Yield Trust Series 1     International Core Trust Series 0  
Year Ended
Dec. 31/13
    Year Ended
Dec. 31/12
    Year Ended
Dec. 31/13
    Year Ended
Dec. 31/12
    Year Ended
Dec. 31/13
    Year Ended
Dec. 31/12
 
         
$ 94,016      $ 433,187      $ 16,825      $ 17,372      $ 9,462      $ 14,925   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 
  94,016        433,187        16,825        17,372        9,462        14,925   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 
         
  —          —          —          —          —          —     
  213,969        (55,761     (23,426     (6,347     33,315        2,241   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 
  213,969        (55,761     (23,426     (6,347     33,315        2,241   
  (48,715     356,285        26,649        26,705        35,429        56,552   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 
  259,270        733,711        20,048        37,730        78,206        73,718   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 
         
  120,001        109,509        7,966        9,123        23,252        72,366   
  (332,464     (140,798     (26,163     (10,896     (358,036     (21,685
  (3,451     (5,491     —          —          (7,587     —     
  (4,308,247     2,928,548        (7,281     803        79,168        (184,635

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 
  (4,524,161     2,891,768        (25,478     (970     (263,203     (133,954

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 
  (4,264,891     3,625,479        (5,430     36,760        (184,997     (60,236
  5,835,684        2,210,205        234,984        198,224        558,510        618,746   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 
$ 1,570,793      $ 5,835,684      $ 229,554      $ 234,984      $ 373,513      $ 558,510   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

 

35


Table of Contents

John Hancock Life Insurance Company of New York Separate Account B

Statements of Operations and Changes in Contract Owners’ Equity

(continued)

 

    Sub-Account  
    International Core Trust Series 1     International Equity Index Trust A Series 0  
    Year Ended
Dec. 31/13
    Year Ended
Dec. 31/12
   

        

  Year Ended
Dec. 31/12 (u)
 

Income:

       

Dividend income distribution

  $ 2,395      $ 2,203        $ 11,000   
 

 

 

   

 

 

     

 

 

 

Net investment income (loss)

    2,395        2,203          11,000   
 

 

 

   

 

 

     

 

 

 

Realized gains (losses) on investments:

       

Capital gain distributions

    —          —            19,485   

Net realized gains (losses)

    6,789        (2,685       (130,662
 

 

 

   

 

 

     

 

 

 

Realized gains (losses)

    6,789        (2,685       (111,177

Unrealized appreciation (depreciation) during the period

    9,724        10,903          141,923   
 

 

 

   

 

 

     

 

 

 

Net increase (decrease) in assets from operations

    18,908        10,421          41,746   
 

 

 

   

 

 

     

 

 

 

Changes from principal transactions:

       

Transfer of net premiums

    4,616        6,292          30,772   

Transfer on terminations

    (20,412     (7,711       (21,119

Transfer on policy loans

    (4,323     11          (10

Net interfund transfers

    (594     13          (425,904
 

 

 

   

 

 

     

 

 

 

Net increase (decrease) in assets from principal transactions

    (20,713     (1,395       (416,261
 

 

 

   

 

 

     

 

 

 

Total increase (decrease) in assets

    (1,805     9,026          (374,515

Assets, beginning of period

    80,182        71,156          374,515   
 

 

 

   

 

 

     

 

 

 

Assets, end of period

  $ 78,377      $ 80,182          —     
 

 

 

   

 

 

     

 

 

 

 

(u) Terminated as an investment option and funds transferred to International Equity Index Trust B on November 5, 2012.
(s) Reflects the period from commencement of operations on November 5, 2012 through December 31, 2012.

 

See accompanying notes.

 

36


Table of Contents
Sub-Account  
International Equity Index Trust A Series 1     International Equity Index Trust B Series 0     International Equity Index Trust B Series 1  
                           Year Ended
Dec. 31/12 (u)
    Year Ended
Dec. 31/13
    Year Ended
Dec. 31/12
    Year Ended
Dec. 31/13
    Year Ended
Dec. 31/12 (s)
 
         
  $ 6,621      $ 106,275      $ 48,154      $ 6,366      $ 2,797   
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 
    6,621        106,275        48,154        6,366        2,797   
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 
         
    11,740        —          —          —          —     
    (88,158     53,848        (159,639     2,684        12   
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 
    (76,418     53,848        (159,639     2,684        12   
    97,105        418,558        773,701        26,449        12,054   
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 
    27,308        578,681        662,216        35,499        14,863   
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 
         
    9,877        192,792        180,702        10,998        1,386   
    (8,052     (154,861     (123,250     (7,722     (1,934
    —          (6,576     (9,902     —          —     
    (288,640     (180,027     (450,958     (22,313     247,911   
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 
    (286,815     (148,672     (403,408     (19,037     247,363   
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 
    (259,507     430,009        258,808        16,462        262,226   
    259,507        4,222,165        3,963,357        262,226        —     
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 
    —        $ 4,652,174      $ 4,222,165      $ 278,688      $ 262,226   
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

 

37


Table of Contents

John Hancock Life Insurance Company of New York Separate Account B

Statements of Operations and Changes in Contract Owners’ Equity

(continued)

 

    Sub-Account  
    International Growth Stock Trust Series 0     International Growth Stock Trust Series 1  
    Year Ended
Dec. 31/13
    Year Ended
Dec. 31/12 (s)
    Year Ended
Dec. 31/13
    Year Ended
Dec. 31/12 (s)
 

Income:

       

Dividend income distribution

  $ 7,141      $ 3,660      $ 2,329      $ 1,052   
 

 

 

   

 

 

   

 

 

   

 

 

 

Net investment income (loss)

    7,141        3,660        2,329        1,052   
 

 

 

   

 

 

   

 

 

   

 

 

 

Realized gains (losses) on investments:

       

Capital gain distributions

    —          —          —          —     

Net realized gains (losses)

    4,458        10        422        3   
 

 

 

   

 

 

   

 

 

   

 

 

 

Realized gains (losses)

    4,458        10        422        3   

Unrealized appreciation (depreciation) during the period

    90,465        18,240        30,551        5,558   
 

 

 

   

 

 

   

 

 

   

 

 

 

Net increase (decrease) in assets from operations

    102,064        21,910        33,302        6,613   
 

 

 

   

 

 

   

 

 

   

 

 

 

Changes from principal transactions:

       

Transfer of net premiums

    46,072        9,108        11,275        1,549   

Transfer on terminations

    (50,320     (3,292     (5,095     (805

Transfer on policy loans

    (1,959     (111     —          —     

Net interfund transfers

    (13,533     529,512        1,299        162,099   
 

 

 

   

 

 

   

 

 

   

 

 

 

Net increase (decrease) in assets from principal transactions

    (19,740     535,217        7,479        162,843   
 

 

 

   

 

 

   

 

 

   

 

 

 

Total increase (decrease) in assets

    82,324        557,127        40,781        169,456   

Assets, beginning of period

    557,127        —          169,456        —     
 

 

 

   

 

 

   

 

 

   

 

 

 

Assets, end of period

  $ 639,451      $ 557,127      $ 210,237      $ 169,456   
 

 

 

   

 

 

   

 

 

   

 

 

 

 

(s) Reflects the period from commencement of operations on November 5, 2012 through December 31, 2012.
(t) Terminated as an investment option and funds transferred to International Growth Stock Trust on November 5, 2012.

 

See accompanying notes.

 

38


Table of Contents
Sub-Account  
International Opportunities Trust Series 0     International Opportunities Trust Series 1     International Small Company Trust Series 0  
                       Year Ended
Dec. 31/12 (t)
                           Year Ended
Dec. 31/12 (t)
    Year Ended
Dec. 31/13
    Year Ended
Dec. 31/12
 
         
  $ 10,664        $ 3,185      $ 7,743      $ 4,108   
 

 

 

     

 

 

   

 

 

   

 

 

 
    10,664          3,185        7,743        4,108   
 

 

 

     

 

 

   

 

 

   

 

 

 
         
    —            —          —          —     
    9,239          (44,355     5,804        (59,498
 

 

 

     

 

 

   

 

 

   

 

 

 
    9,239          (44,355     5,804        (59,498
    4,135          53,310        75,986        196,179   
 

 

 

     

 

 

   

 

 

   

 

 

 
    24,038          12,140        89,533        140,789   
 

 

 

     

 

 

   

 

 

   

 

 

 
         
    40,910          9,852        32,479        48,301   
    (31,611       (4,011     (23,933     (25,687
    (143       —          (2,908     (854
    (305,904       (161,070     44,338        (715,814
 

 

 

     

 

 

   

 

 

   

 

 

 
    (296,748       (155,229     49,976        (694,054
 

 

 

     

 

 

   

 

 

   

 

 

 
    (272,710       (143,089     139,509        (553,265
    272,710          143,089        325,389        878,654   
 

 

 

     

 

 

   

 

 

   

 

 

 
    —            —        $ 464,898      $ 325,389   
 

 

 

     

 

 

   

 

 

   

 

 

 

 

39


Table of Contents

John Hancock Life Insurance Company of New York Separate Account B

Statements of Operations and Changes in Contract Owners’ Equity

(continued)

 

     Sub-Account  
     International Small Company Trust Series 1     International Value Trust Series 0  
     Year Ended
Dec. 31/13
    Year Ended
Dec. 31/12
    Year Ended
Dec. 31/13
    Year Ended
Dec. 31/12
 

Income:

        

Dividend income distribution

   $ 908      $ 524      $ 6,132      $ 9,056   
  

 

 

   

 

 

   

 

 

   

 

 

 

Net investment income (loss)

     908        524        6,132        9,056   
  

 

 

   

 

 

   

 

 

   

 

 

 

Realized gains (losses) on investments:

        

Capital gain distributions

     —          —          —          —     

Net realized gains (losses)

     1,617        2,353        13,939        (6,461
  

 

 

   

 

 

   

 

 

   

 

 

 

Realized gains (losses)

     1,617        2,353        13,939        (6,461

Unrealized appreciation (depreciation) during the period

     8,705        7,106        53,163        56,391   
  

 

 

   

 

 

   

 

 

   

 

 

 

Net increase (decrease) in assets from operations

     11,230        9,983        73,234        58,986   
  

 

 

   

 

 

   

 

 

   

 

 

 

Changes from principal transactions:

        

Transfer of net premiums

     4,708        4,198        38,028        47,629   

Transfer on terminations

     (1,950     (1,918     (50,662     (109,503

Transfer on policy loans

     (183     (178     (10,724     (466

Net interfund transfers

     (5,969     (25,895     93,593        (37,759
  

 

 

   

 

 

   

 

 

   

 

 

 

Net increase (decrease) in assets from principal transactions

     (3,394     (23,793     70,235        (100,099
  

 

 

   

 

 

   

 

 

   

 

 

 

Total increase (decrease) in assets

     7,836        (13,810     143,469        (41,113

Assets, beginning of period

     42,064        55,874        285,268        326,381   
  

 

 

   

 

 

   

 

 

   

 

 

 

Assets, end of period

   $ 49,900      $ 42,064      $ 428,737      $ 285,268   
  

 

 

   

 

 

   

 

 

   

 

 

 

 

See accompanying notes.

 

40


Table of Contents
Sub-Account  
International Value Trust Series 1     Investment Quality Bond Trust Series 0     Investment Quality Bond Trust Series 1  
Year Ended
Dec. 31/13
    Year Ended
Dec. 31/12
    Year Ended
Dec. 31/13
    Year Ended
Dec. 31/12
    Year Ended
Dec. 31/13
    Year Ended
Dec. 31/12
 
         
$ 5,204      $ 25,731      $ 6,396      $ 51,559      $ 8,498      $ 4,432   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 
  5,204        25,731        6,396        51,559        8,498        4,432   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 
         
  —          —          3,186        —          4,187        —     
  49,640        (12,287     (33,851     1,379        370        6,313   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 
  49,640        (12,287     (30,665     1,379        4,557        6,313   
  26,387        153,609        (52,283     44,553        (17,334     5,448   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 
  81,231        167,053        (76,552     97,491        (4,279     16,193   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 
         
  22,377        24,922        28,091        25,097        7,050        4,882   
  (45,770     (54,050     (52,679     (49,049     (6,355     (110,704
  119        183        (2,220     (1,896     225        (12,835
  (765,066     37,879        (2,178,689     2,238,256        7,621        79,053   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 
  (788,340     8,934        (2,205,497     2,212,408        8,541        (39,604

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 
  (707,109     175,987        (2,282,049     2,309,899        4,262        (23,411
  1,038,305        862,318        2,439,155        129,256        217,852        241,263   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 
$ 331,196      $ 1,038,305      $ 157,106      $ 2,439,155      $ 222,114      $ 217,852   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

 

41


Table of Contents

John Hancock Life Insurance Company of New York Separate Account B

Statements of Operations and Changes in Contract Owners’ Equity

(continued)

 

     Sub-Account  
     Large Cap Growth     Large Cap Trust Series 0  
     Year Ended
Dec. 31/13
    Year Ended
Dec. 31/12
                        Year Ended
Dec. 31/12  (f)
 

Income:

         

Dividend income distribution

   $ 553      $ 27         $ 2,112   
  

 

 

   

 

 

      

 

 

 

Net investment income (loss)

     553        27           2,112   
  

 

 

   

 

 

      

 

 

 

Realized gains (losses) on investments:

         

Capital gain distributions

     6,520        —             —     

Net realized gains (losses)

     3,596        1,204           45,268   
  

 

 

   

 

 

      

 

 

 

Realized gains (losses)

     10,116        1,204           45,268   

Unrealized appreciation (depreciation) during the period

     18,252        7,321           (62
  

 

 

   

 

 

      

 

 

 

Net increase (decrease) in assets from operations

     28,921        8,552           47,318   
  

 

 

   

 

 

      

 

 

 

Changes from principal transactions:

         

Transfer of net premiums

     22,726        22,693           15,818   

Transfer on terminations

     (9,304     (8,377        (9,703

Transfer on policy loans

     —          —             (1

Net interfund transfers

     38,154        (77        (388,635
  

 

 

   

 

 

      

 

 

 

Net increase (decrease) in assets from principal transactions

     51,576        14,239           (382,521
  

 

 

   

 

 

      

 

 

 

Total increase (decrease) in assets

     80,497        22,791           (335,203

Assets, beginning of period

     55,847        33,056           335,203   
  

 

 

   

 

 

      

 

 

 

Assets, end of period

   $ 136,344      $ 55,847           —     
  

 

 

   

 

 

      

 

 

 

 

(f) Terminated as an investment option and funds transferred to U.S. Equity Trust on April 30, 2012.
(ag) Renamed on April 29, 2013. Previously known as Business Opportunity Value.

 

See accompanying notes.

 

42


Table of Contents
Sub-Account  
Large Cap Trust Series 1     Large Cap Value     Lifestyle Aggressive Trust Series 0  
                   Year Ended
Dec. 31/12 (f)
    Year Ended
Dec. 31/13 (ag)
    Year Ended
Dec. 31/12
    Year Ended
Dec. 31/13
    Year Ended
Dec. 31/12
 
         
  $ 378      $ 1,444      $ 163      $ 225,358      $ 115,148   
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 
    378        1,444        163        225,358        115,148   
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 
         
    —          6,574        —          —          —     
    6,205        2,093        337        366,943        (47,214
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 
    6,205        8,667        337        366,943        (47,214
    2,640        2,236        2,509        1,416,586        917,828   
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 
    9,223        12,347        3,009        2,008,887        985,762   
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 
         
    2,306        5,532        5,255        1,531,534        1,638,827   
    (2,091     (1,277     (1,422     (2,139,249     (534,252
    —          —          —          (78,293     (42,075
    (76,687     46,577        (210     209,690        1,294,203   
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 
    (76,472     50,832        3,623        (476,318     2,356,703   
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 
    (67,249     63,179        6,632        1,532,569        3,342,465   
    67,249        21,462        14,830        8,248,307        4,905,842   
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 
    —        $ 84,641      $ 21,462      $ 9,780,876      $ 8,248,307   
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

 

43


Table of Contents

John Hancock Life Insurance Company of New York Separate Account B

Statements of Operations and Changes in Contract Owners’ Equity

(continued)

 

     Sub-Account  
     Lifestyle Aggressive Trust Series 1     Lifestyle Balanced Trust Series 0  
     Year Ended
Dec. 31/13
    Year Ended
Dec. 31/12
    Year Ended
Dec. 31/13
    Year Ended
Dec. 31/12
 

Income:

        

Dividend income distribution

   $ 13,725      $ 6,154      $ 708,124      $ 473,372   
  

 

 

   

 

 

   

 

 

   

 

 

 

Net investment income (loss)

     13,725        6,154        708,124        473,372   
  

 

 

   

 

 

   

 

 

   

 

 

 

Realized gains (losses) on investments:

        

Capital gain distributions

     —          —          —          —     

Net realized gains (losses)

     4,723        (1,495     544,396        143,339   
  

 

 

   

 

 

   

 

 

   

 

 

 

Realized gains (losses)

     4,723        (1,495     544,396        143,339   

Unrealized appreciation (depreciation) during the period

     106,914        56,778        1,537,162        1,254,838   
  

 

 

   

 

 

   

 

 

   

 

 

 

Net increase (decrease) in assets from operations

     125,362        61,437        2,789,682        1,871,549   
  

 

 

   

 

 

   

 

 

   

 

 

 

Changes from principal transactions:

        

Transfer of net premiums

     55,167        68,092        2,819,331        2,335,658   

Transfer on terminations

     (17,890     (16,772     (2,480,571     (1,531,256

Transfer on policy loans

     (8,036     (2,550     (93,347     (170,918

Net interfund transfers

     —          —          1,891,725        4,884,895   
  

 

 

   

 

 

   

 

 

   

 

 

 

Net increase (decrease) in assets from principal transactions

     29,241        48,770        2,137,138        5,518,379   
  

 

 

   

 

 

   

 

 

   

 

 

 

Total increase (decrease) in assets

     154,603        110,207        4,926,820        7,389,928   

Assets, beginning of period

     452,335        342,128        21,243,036        13,853,108   
  

 

 

   

 

 

   

 

 

   

 

 

 

Assets, end of period

   $ 606,938      $ 452,335      $ 26,169,856      $ 21,243,036   
  

 

 

   

 

 

   

 

 

   

 

 

 

 

See accompanying notes.

 

44


Table of Contents
Sub-Account  
Lifestyle Balanced Trust Series 1     Lifestyle Conservative Trust Series 0     Lifestyle Conservative Trust Series 1  
Year Ended
Dec. 31/13
    Year Ended
Dec. 31/12
    Year Ended
Dec. 31/13
    Year Ended
Dec. 31/12
    Year Ended
Dec. 31/13
    Year Ended
Dec. 31/12
 
         
$ 137,801      $ 101,840      $ 117,616      $ 98,208      $ 5,194      $ 4,151   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 
  137,801        101,840        117,616        98,208        5,194        4,151   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 
         
  —          —          109,843        67,053        4,798        3,143   
  9,534        (7,186     25,960        24,686        61        (88

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 
  9,534        (7,186     135,803        91,739        4,859        3,055   
  432,583        400,993        (121,378     43,647        (4,400     4,562   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 
  579,918        495,647        132,041        233,594        5,653        11,768   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 
         
  44,990        41,200        344,345        501,612        —          —     
  (160,023     (147,230     (881,229     (209,152     (4,996     (5,631
  (11,774     (56,093     4,750        (17,557     —          (100
  3,220        289        264,576        749,827        1,758        1,443   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 
  (123,587     (161,834     (267,558     1,024,730        (3,238     (4,288

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 
  456,331        333,813        (135,517     1,258,324        2,415        7,480   
  4,592,077        4,258,264        3,481,888        2,223,564        147,084        139,604   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 
$ 5,048,408      $ 4,592,077      $ 3,346,371      $ 3,481,888      $ 149,499      $ 147,084   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

 

45


Table of Contents

John Hancock Life Insurance Company of New York Separate Account B

Statements of Operations and Changes in Contract Owners’ Equity

(continued)

 

     Sub-Account  
     Lifestyle Growth Trust Series 0     Lifestyle Growth Trust Series 1  
     Year Ended
Dec. 31/13
    Year Ended
Dec. 31/12
    Year Ended
Dec. 31/13
    Year Ended
Dec. 31/12
 

Income:

        

Dividend income distribution

   $ 678,193      $ 399,475      $ 53,092      $ 34,116   
  

 

 

   

 

 

   

 

 

   

 

 

 

Net investment income (loss)

     678,193        399,475        53,092        34,116   
  

 

 

   

 

 

   

 

 

   

 

 

 

Realized gains (losses) on investments:

        

Capital gain distributions

     —          —          —          —     

Net realized gains (losses)

     507,881        373,264        (4,364     (14,796
  

 

 

   

 

 

   

 

 

   

 

 

 

Realized gains (losses)

     507,881        373,264        (4,364     (14,796

Unrealized appreciation (depreciation) during the period

     3,243,650        1,874,699        319,982        213,504   
  

 

 

   

 

 

   

 

 

   

 

 

 

Net increase (decrease) in assets from operations

     4,429,724        2,647,438        368,710        232,824   
  

 

 

   

 

 

   

 

 

   

 

 

 

Changes from principal transactions:

        

Transfer of net premiums

     3,184,960        3,214,879        104,723        95,921   

Transfer on terminations

     (2,186,250     (3,090,575     (81,691     (78,099

Transfer on policy loans

     (261,388     (188,888     (6,924     (22,617

Net interfund transfers

     1,631,124        431,707        (10,245     1,958   
  

 

 

   

 

 

   

 

 

   

 

 

 

Net increase (decrease) in assets from principal transactions

     2,368,446        367,123        5,863        (2,837
  

 

 

   

 

 

   

 

 

   

 

 

 

Total increase (decrease) in assets

     6,798,170        3,014,561        374,573        229,987   

Assets, beginning of period

     21,845,708        18,831,147        1,897,471        1,667,484   
  

 

 

   

 

 

   

 

 

   

 

 

 

Assets, end of period

   $ 28,643,878      $ 21,845,708      $ 2,272,044      $ 1,897,471   
  

 

 

   

 

 

   

 

 

   

 

 

 

 

See accompanying notes.

 

46


Table of Contents
Sub-Account  
Lifestyle Moderate Trust Series 0     Lifestyle Moderate Trust Series 1     Mid Cap Index Trust Series 0  
Year Ended
Dec. 31/13
    Year Ended
Dec. 31/12
    Year Ended
Dec. 31/13
    Year Ended
Dec. 31/12
    Year Ended
Dec. 31/13
    Year Ended
Dec. 31/12
 
         
$ 171,212      $ 100,854      $ 27,659      $ 22,378      $ 36,721      $ 37,331   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 
  171,212        100,854        27,659        22,378        36,721        37,331   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 
         
  —          —          —          —          176,442        236,979   
  78,474        10,746        773        (13,890     54,220        25,170   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 
  78,474        10,746        773        (13,890     230,662        262,149   
  210,097        909,809        63,503        83,932        608,852        (79,917

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 
  459,783        1,021,409        91,935        92,420        876,235        219,563   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 
         
  507,916        611,959        10,802        25,680        157,628        183,707   
  (674,094     (392,594     (49,825     (26,328     (120,974     (87,705
  (13,970     (27,983     (1,626     (133,569     (11,651     (5,333
  1,368,386        (12,535,903     —          —          121,595        1,187,222   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 
  1,188,238        (12,344,521     (40,649     (134,217     146,598        1,277,891   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 
  1,648,021        (11,323,112     51,286        (41,797     1,022,833        1,497,454   
  4,035,304        15,358,416        909,650        951,447        2,629,705        1,132,251   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 
$ 5,683,325      $ 4,035,304      $ 960,936      $ 909,650      $ 3,652,538      $ 2,629,705   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

 

47


Table of Contents

John Hancock Life Insurance Company of New York Separate Account B

Statements of Operations and Changes in Contract Owners’ Equity

(continued)

 

     Sub-Account  
     Mid Cap Index Trust Series 1     Mid Cap Stock Trust Series 0  
     Year Ended
Dec. 31/13
    Year Ended
Dec. 31/12
    Year Ended
Dec. 31/13
    Year Ended
Dec. 31/12
 

Income:

        

Dividend income distribution

   $ 3,075      $ 3,403      $ 481        —     
  

 

 

   

 

 

   

 

 

   

 

 

 

Net investment income (loss)

     3,075        3,403        481        —     
  

 

 

   

 

 

   

 

 

   

 

 

 

Realized gains (losses) on investments:

        

Capital gain distributions

     15,241        23,023        13,126        —     

Net realized gains (losses)

     2,771        924        72,814        13,828   
  

 

 

   

 

 

   

 

 

   

 

 

 

Realized gains (losses)

     18,012        23,947        85,940        13,828   

Unrealized appreciation (depreciation) during the period

     59,075        9,528        155,407        127,050   
  

 

 

   

 

 

   

 

 

   

 

 

 

Net increase (decrease) in assets from operations

     80,162        36,878        241,828        140,878   
  

 

 

   

 

 

   

 

 

   

 

 

 

Changes from principal transactions:

        

Transfer of net premiums

     11,822        7,495        57,662        119,585   

Transfer on terminations

     (10,432     (11,844     (412,206     (64,448

Transfer on policy loans

     —          (5     (2,798     (916

Net interfund transfers

     9,955        (2,706     140,485        60,886   
  

 

 

   

 

 

   

 

 

   

 

 

 

Net increase (decrease) in assets from principal transactions

     11,345        (7,060     (216,857     115,107   
  

 

 

   

 

 

   

 

 

   

 

 

 

Total increase (decrease) in assets

     91,507        29,818        24,971        255,985   

Assets, beginning of period

     242,693        212,875        886,676        630,691   
  

 

 

   

 

 

   

 

 

   

 

 

 

Assets, end of period

   $ 334,200      $ 242,693      $ 911,647      $ 886,676   
  

 

 

   

 

 

   

 

 

   

 

 

 

 

See accompanying notes.

 

48


Table of Contents
Sub-Account  
Mid Cap Stock Trust Series 1     Mid Value Trust Series 0     Mid Value Trust Series 1  
Year Ended
Dec. 31/13
    Year Ended
Dec. 31/12
    Year Ended
Dec. 31/13
    Year Ended
Dec. 31/12
    Year Ended
Dec. 31/13
    Year Ended
Dec. 31/12
 
         
$ 129        —        $ 9,314      $ 10,691      $ 2,478      $ 1,659   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 
  129        —          9,314        10,691        2,478        1,659   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 
         
  6,443        —          58,094        91,886        16,190        15,001   
  4,188        (2,455     62,046        14,061        24,272        28,021   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 
  10,631        (2,455     120,140        105,947        40,462        43,022   
  97,629        59,034        118,368        68,582        19,359        (5,623

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 
  108,389        56,579        247,822        185,220        62,299        39,058   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 
         
  16,461        17,817        45,989        146,914        16,291        16,956   
  (24,967     (34,651     (586,821     (133,833     (52,552     (18,915
  (1,366     (387     (3,985     (782     (158     (139
  (2,465     280        49,759        186,349        (3,528     (60,981

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 
  (12,337     (16,941     (495,058     198,648        (39,947     (63,079

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 
  96,052        39,638        (247,236     383,868        22,352        (24,021
  295,880        256,242        1,196,393        812,525        204,439        228,460   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 
$ 391,932      $ 295,880      $ 949,157      $ 1,196,393      $ 226,791      $ 204,439   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

 

49


Table of Contents

John Hancock Life Insurance Company of New York Separate Account B

Statements of Operations and Changes in Contract Owners’ Equity

(continued)

 

     Sub-Account  
     Money Market Trust B Series 0     Money Market Trust Series 1  
     Year Ended
Dec. 31/13
    Year Ended
Dec. 31/12
    Year Ended
Dec. 31/13
    Year Ended
Dec. 31/12
 

Income:

        

Dividend income distribution

   $ 520      $ 2,931        —          —     
  

 

 

   

 

 

   

 

 

   

 

 

 

Net investment income (loss)

     520        2,931        —          —     
  

 

 

   

 

 

   

 

 

   

 

 

 

Realized gains (losses) on investments:

        

Capital gain distributions

     299        513        193        121   

Net realized gains (losses)

     —          —          —          —     
  

 

 

   

 

 

   

 

 

   

 

 

 

Realized gains (losses)

     299        513        193        121   

Unrealized appreciation (depreciation) during the period

     —          —          —          —     
  

 

 

   

 

 

   

 

 

   

 

 

 

Net increase (decrease) in assets from operations

     819        3,444        193        121   
  

 

 

   

 

 

   

 

 

   

 

 

 

Changes from principal transactions:

        

Transfer of net premiums

     14,085,184        16,791,909        103,803        113,061   

Transfer on terminations

     (2,646,786     (919,757     (131,400     (592,394

Transfer on policy loans

     (14,679     (50,671     —          1,873   

Net interfund transfers

     (12,498,312     (16,750,304     1,756,676        27,698   
  

 

 

   

 

 

   

 

 

   

 

 

 

Net increase (decrease) in assets from principal transactions

     (1,074,593     (928,823     1,729,079        (449,762
  

 

 

   

 

 

   

 

 

   

 

 

 

Total increase (decrease) in assets

     (1,073,774     (925,379     1,729,272        (449,641

Assets, beginning of period

     7,610,293        8,535,672        1,001,628        1,451,269   
  

 

 

   

 

 

   

 

 

   

 

 

 

Assets, end of period

   $ 6,536,519      $ 7,610,293      $ 2,730,900      $ 1,001,628   
  

 

 

   

 

 

   

 

 

   

 

 

 

 

See accompanying notes.

 

50


Table of Contents
Sub-Account  
Natural Resources Trust Series 0     Natural Resources Trust Series 1     Real Estate Securities Trust Series 0  
Year Ended
Dec. 31/13
    Year Ended
Dec. 31/12
    Year Ended
Dec. 31/13
    Year Ended
Dec. 31/12
    Year Ended
Dec. 31/13
    Year Ended
Dec. 31/12
 
         
$ 7,037      $ 22,458      $ 904      $ 1,266      $ 60,874      $ 54,523   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 
  7,037        22,458        904        1,266        60,874        54,523   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 
         
  —          —          —          —          —          —     
  (1,748     (145,468     13,614        (27,572     159,013        77,743   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 
  (1,748     (145,468     13,614        (27,572     159,013        77,743   
  26,790        75,543        (10,567     28,157        (210,236     259,499   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 
  32,079        (47,467     3,951        1,851        9,651        391,765   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 
         
  179,561        168,338        6,858        7,079        113,231        160,363   
  (117,618     (118,027     (23,169     (7,721     (488,904     (116,146
  (9,983     (2,784     (9,711     (23     (13,977     (2,288
  (66,224     (476,324     24,229        (20,367     101,147        764,883   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 
  (14,264     (428,797     (1,793     (21,032     (288,503     806,812   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 
  17,815        (476,264     2,158        (19,181     (278,852     1,198,577   
  1,110,017        1,586,281        160,776        179,957        3,238,133        2,039,556   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 
$ 1,127,832      $ 1,110,017      $ 162,934      $ 160,776      $ 2,959,281      $ 3,238,133   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

 

51


Table of Contents

John Hancock Life Insurance Company of New York Separate Account B

Statements of Operations and Changes in Contract Owners’ Equity

(continued)

 

     Sub-Account  
     Real Estate Securities Trust Series 1     Real Return Bond Trust Series 0  
     Year Ended
Dec. 31/13
    Year Ended
Dec. 31/12
    Year Ended
Dec. 31/13
    Year Ended
Dec. 31/12
 

Income:

        

Dividend income distribution

   $ 9,889      $ 7,962      $ 26,096      $ 19,891   
  

 

 

   

 

 

   

 

 

   

 

 

 

Net investment income (loss)

     9,889        7,962        26,096        19,891   
  

 

 

   

 

 

   

 

 

   

 

 

 

Realized gains (losses) on investments:

        

Capital gain distributions

     —          —          —          —     

Net realized gains (losses)

     (9,818     (22,761     8,182        29,651   
  

 

 

   

 

 

   

 

 

   

 

 

 

Realized gains (losses)

     (9,818     (22,761     8,182        29,651   

Unrealized appreciation (depreciation) during the period

     (434     84,501        (128,483     44,991   
  

 

 

   

 

 

   

 

 

   

 

 

 

Net increase (decrease) in assets from operations

     (363     69,702        (94,205     94,533   
  

 

 

   

 

 

   

 

 

   

 

 

 

Changes from principal transactions:

        

Transfer of net premiums

     14,600        15,227        60,627        120,641   

Transfer on terminations

     (15,816     (12,979     (387,802     (52,745

Transfer on policy loans

     (52     1,154        (3,343     (23

Net interfund transfers

     27,136        1,383        82,474        152,393   
  

 

 

   

 

 

   

 

 

   

 

 

 

Net increase (decrease) in assets from principal transactions

     25,868        4,785        (248,044     220,266   
  

 

 

   

 

 

   

 

 

   

 

 

 

Total increase (decrease) in assets

     25,505        74,487        (342,249     314,799   

Assets, beginning of period

     480,041        405,554        1,252,408        937,609   
  

 

 

   

 

 

   

 

 

   

 

 

 

Assets, end of period

   $ 505,546      $ 480,041      $ 910,159      $ 1,252,408   
  

 

 

   

 

 

   

 

 

   

 

 

 

 

See accompanying notes.

 

52


Table of Contents
Sub-Account  
Real Return Bond Trust Series 1     Science & Technology Trust Series 0     Science & Technology Trust Series 1  
Year Ended
Dec. 31/13
    Year Ended
Dec. 31/12
    Year Ended
Dec. 31/13
    Year Ended
Dec. 31/12
    Year Ended
Dec. 31/13
    Year Ended
Dec. 31/12
 
         
$ 968      $ 729        —          —          —          —     

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 
  968        729        —          —          —          —     

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 
         
  —          —          —          —          —          —     
  264        209        51,210        5,045        16,066        9,210   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 
  264        209        51,210        5,045        16,066        9,210   
  (4,883     2,542        164,926        23,903        58,939        9,534   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 
  (3,651     3,480        216,136        28,948        75,005        18,744   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 
         
  1,379        1,491        56,352        51,322        22,515        19,236   
  (4,519     (3,070     (58,947     (40,298     (35,239     (26,371
  —          —          (2,317     (3,647     (8,873     454   
  841        —          (749     191,939        (672     (33,267

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 
  (2,299     (1,579     (5,661     199,316        (22,269     (39,948

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 
  (5,950     1,901        210,475        228,264        52,736        (21,204
  41,406        39,505        477,746        249,482        175,190        196,394   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 
$ 35,456      $ 41,406      $ 688,221      $ 477,746      $ 227,926      $ 175,190   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

 

53


Table of Contents

John Hancock Life Insurance Company of New York Separate Account B

Statements of Operations and Changes in Contract Owners’ Equity

(continued)

 

    Sub-Account  
    Short Term Government Income Trust Series 0     Short Term Government Income Trust Series 1  
    Year Ended
Dec. 31/13
    Year Ended
Dec. 31/12
    Year Ended
Dec. 31/13
    Year Ended
Dec. 31/12
 

Income:

       

Dividend income distribution

  $ 9,886      $ 8,538      $ 8,118      $ 6,369   
 

 

 

   

 

 

   

 

 

   

 

 

 

Net investment income (loss)

    9,886        8,538        8,118        6,369   
 

 

 

   

 

 

   

 

 

   

 

 

 

Realized gains (losses) on investments:

       

Capital gain distributions

    —          —          —          —     

Net realized gains (losses)

    (2,714     651        (169     316   
 

 

 

   

 

 

   

 

 

   

 

 

 

Realized gains (losses)

    (2,714     651        (169     316   

Unrealized appreciation (depreciation) during the period

    (10,634     (3,358     (11,413     (2,062
 

 

 

   

 

 

   

 

 

   

 

 

 

Net increase (decrease) in assets from operations

    (3,462     5,831        (3,464     4,623   
 

 

 

   

 

 

   

 

 

   

 

 

 

Changes from principal transactions:

       

Transfer of net premiums

    70,844        63,186        28,247        20,045   

Transfer on terminations

    (53,577     (43,375     (17,752     (35,793

Transfer on policy loans

    (60     (149     134        (4,722

Net interfund transfers

    (81,745     3,993        6,672        2,863   
 

 

 

   

 

 

   

 

 

   

 

 

 

Net increase (decrease) in assets from principal transactions

    (64,538     23,655        17,301        (17,607
 

 

 

   

 

 

   

 

 

   

 

 

 

Total increase (decrease) in assets

    (68,000     29,486        13,837        (12,984

Assets, beginning of period

    498,654        469,168        385,582        398,566   
 

 

 

   

 

 

   

 

 

   

 

 

 

Assets, end of period

  $ 430,654      $ 498,654      $ 399,419      $ 385,582   
 

 

 

   

 

 

   

 

 

   

 

 

 

 

See accompanying notes.

 

54


Table of Contents
Sub-Account  
Small Cap Growth Trust Series 0     Small Cap Growth Trust Series 1     Small Cap Index Trust Series 0  
Year Ended
Dec. 31/13
    Year Ended
Dec. 31/12
    Year Ended
Dec. 31/13
    Year Ended
Dec. 31/12
    Year Ended
Dec. 31/13
    Year Ended
Dec. 31/12
 
         
  —          —          —          —        $ 38,718      $ 47,255   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 
  —          —          —          —          38,718        47,255   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 
         
  16,834        30,217        1,032        1,949        181,903        382,835   
  13,195        8,583        1,786        808        3,228        (3,499

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 
  30,029        38,800        2,818        2,757        185,131        379,336   
  96,964        (10,254     5,047        (514     600,791        (115,824

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 
  126,993        28,546        7,865        2,243        824,640        310,767   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 
         
  47,951        63,743        4,769        1,291        70,075        115,196   
  (38,981     (27,654     (1,706     (2,037     (448,340     (60,793
  (2,511     (3,349     —          —          (5,109     (1,805
  86,866        43,958        2,581        (36     79,217        1,402,022   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 
  93,325        76,698        5,644        (782     (304,157     1,454,620   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 
  220,318        105,244        13,509        1,461        520,483        1,765,387   
  261,066        155,822        15,182        13,721        2,391,062        625,675   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 
$ 481,384      $ 261,066      $ 28,691      $ 15,182      $ 2,911,545      $ 2,391,062   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

 

55


Table of Contents

John Hancock Life Insurance Company of New York Separate Account B

Statements of Operations and Changes in Contract Owners’ Equity

(continued)

 

     Sub-Account  
     Small Cap Index Trust Series 1     Small Cap Opportunities Trust Series 0  
     Year Ended
Dec. 31/13
    Year Ended
Dec. 31/12
    Year Ended
Dec. 31/13
    Year Ended
Dec. 31/12
 

Income:

        

Dividend income distribution

   $ 1,983      $ 2,233      $ 876        —     
  

 

 

   

 

 

   

 

 

   

 

 

 

Net investment income (loss)

     1,983        2,233        876        —     
  

 

 

   

 

 

   

 

 

   

 

 

 

Realized gains (losses) on investments:

        

Capital gain distributions

     9,541        18,694        —          —     

Net realized gains (losses)

     (446     (1,185     3,782        2,185   
  

 

 

   

 

 

   

 

 

   

 

 

 

Realized gains (losses)

     9,095        17,509        3,782        2,185   

Unrealized appreciation (depreciation) during the period

     32,599        (2,889     58,634        10,179   
  

 

 

   

 

 

   

 

 

   

 

 

 

Net increase (decrease) in assets from operations

     43,677        16,853        63,292        12,364   
  

 

 

   

 

 

   

 

 

   

 

 

 

Changes from principal transactions:

        

Transfer of net premiums

     4,172        4,058        18,054        16,392   

Transfer on terminations

     (5,914     (6,101     (12,674     (8,702

Transfer on policy loans

     —          (5     (676     —     

Net interfund transfers

     (2,886     (7,212     852,872        444   
  

 

 

   

 

 

   

 

 

   

 

 

 

Net increase (decrease) in assets from principal transactions

     (4,628     (9,260     857,576        8,134   
  

 

 

   

 

 

   

 

 

   

 

 

 

Total increase (decrease) in assets

     39,049        7,593        920,868        20,498   

Assets, beginning of period

     114,552        106,959        89,550        69,052   
  

 

 

   

 

 

   

 

 

   

 

 

 

Assets, end of period

   $ 153,601      $ 114,552      $ 1,010,418      $ 89,550   
  

 

 

   

 

 

   

 

 

   

 

 

 

 

See accompanying notes.

 

56


Table of Contents
Sub-Account  
Small Cap Opportunities Trust Series 1     Small Cap Value Trust Series 0     Small Cap Value Trust Series 1  
Year Ended
Dec. 31/13
    Year Ended
Dec. 31/12
    Year Ended
Dec. 31/13
    Year Ended
Dec. 31/12
    Year Ended
Dec. 31/13
    Year Ended
Dec. 31/12
 
         
$ 801        —        $ 3,726      $ 3,554      $ 411      $ 331   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 
  801        —          3,726        3,554        411        331   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 
         
  —          —          33,852        17,361        3,767        1,744   
  14,786        (2,385     16,581        5,191        10,337        13,153   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 
  14,786        (2,385     50,433        22,552        14,104        14,897   
  26,609        19,134        108,043        25,553        2,980        (10,098

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 
  42,196        16,749        162,202        51,659        17,495        5,130   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 
         
  6,631        7,199        51,073        56,930        1,146        1,295   
  (57,984     (18,804     (34,688     (26,166     (41,131     (27,207
  47        —          (13,387     (50     —          —     
  28,946        (503     160,403        38,708        44,818        26,663   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 
  (22,360     (12,108     163,401        69,422        4,833        751   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 
  19,836        4,641        325,603        121,081        22,328        5,881   
  106,925        102,284        415,214        294,133        40,239        34,358   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 
$ 126,761      $ 106,925      $ 740,817      $ 415,214      $ 62,567      $ 40,239   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

 

57


Table of Contents

John Hancock Life Insurance Company of New York Separate Account B

Statements of Operations and Changes in Contract Owners’ Equity

(continued)

 

     Sub-Account  
     Small Company Value Trust Series 0     Small Company Value Trust Series 1  
     Year Ended
Dec. 31/13
    Year Ended
Dec. 31/12
    Year Ended
Dec. 31/13
    Year Ended
Dec. 31/12
 

Income:

        

Dividend income distribution

   $ 12,800      $ 1,663      $ 5,798      $ 783   
  

 

 

   

 

 

   

 

 

   

 

 

 

Net investment income (loss)

     12,800        1,663        5,798        783   
  

 

 

   

 

 

   

 

 

   

 

 

 

Realized gains (losses) on investments:

        

Capital gain distributions

     —          —          —          —     

Net realized gains (losses)

     13,728        (148,563     27,091        (695
  

 

 

   

 

 

   

 

 

   

 

 

 

Realized gains (losses)

     13,728        (148,563     27,091        (695

Unrealized appreciation (depreciation) during the period

     170,156        60,495        58,567        46,021   
  

 

 

   

 

 

   

 

 

   

 

 

 

Net increase (decrease) in assets from operations

     196,684        (86,405     91,456        46,109   
  

 

 

   

 

 

   

 

 

   

 

 

 

Changes from principal transactions:

        

Transfer of net premiums

     38,404        40,132        27,192        25,211   

Transfer on terminations

     (41,928     (153,414     (58,344     (25,239

Transfer on policy loans

     (7,673     (2,684     450        (30,132

Net interfund transfers

     38,270        452,165        (5,694     (20,777
  

 

 

   

 

 

   

 

 

   

 

 

 

Net increase (decrease) in assets from principal transactions

     27,073        336,199        (36,396     (50,937
  

 

 

   

 

 

   

 

 

   

 

 

 

Total increase (decrease) in assets

     223,757        249,794        55,060        (4,828

Assets, beginning of period

     613,287        363,493        292,480        297,308   
  

 

 

   

 

 

   

 

 

   

 

 

 

Assets, end of period

   $ 837,044      $ 613,287      $ 347,540      $ 292,480   
  

 

 

   

 

 

   

 

 

   

 

 

 

 

(af) Terminated as an investment option and funds transferred to Small Cap Opportunities Trust on December 9, 2013.

 

See accompanying notes.

 

58


Table of Contents
Sub-Account  
Smaller Company Growth Trust Series 0     Smaller Company Growth Trust Series 1     Strategic Income Opportunities Trust Series 0  
Year Ended
Dec. 31/13 (af)
    Year Ended
Dec. 31/12
    Year Ended
Dec. 31/13 (af)
    Year Ended
Dec. 31/12
    Year Ended
Dec. 31/13
    Year Ended
Dec. 31/12
 
         
  —          —          —          —        $ 241,672      $ 263,802   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 
  —          —          —          —          241,672        263,802   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 
         
  50,804        51,944        1,845        3,612        —          —     
  232,469        3,382        11,638        359        42,395        (23,764

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 
  283,273        55,326        13,483        3,971        42,395        (23,764
  (65,620     35,199        (3,259     493        (101,538     41,544   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 
  217,653        90,525        10,224        4,464        182,529        281,582   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 
         
  14,070        14,976        800        1,647        104,973        99,914   
  (31,849     (25,829     (1,826     (1,859     (122,017     (98,557
  (1,055     (75     (1,572     195        (5,701     (5,509
  (839,231     (463     (52,809     20,210        1,043,660        2,291,128   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 
  (858,065     (11,391     (55,407     20,193        1,020,915        2,286,976   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 
  (640,412     79,134        (45,183     24,657        1,203,444        2,568,558   
  640,412        561,278        45,183        20,526        3,108,036        539,478   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 
  —        $ 640,412        —        $ 45,183      $ 4,311,480      $ 3,108,036   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

 

59


Table of Contents

John Hancock Life Insurance Company of New York Separate Account B

Statements of Operations and Changes in Contract Owners’ Equity

(continued)

 

     Sub-Account  
     Strategic Income Opportunities Trust Series 1     Total Bond Market Trust B Series 0  
     Year Ended
Dec. 31/13
    Year Ended
Dec. 31/12
    Year Ended
Dec. 31/13
    Year Ended
Dec. 31/12
 

Income:

        

Dividend income distribution

   $ 16,771      $ 20,426      $ 12,499      $ 3,638   
  

 

 

   

 

 

   

 

 

   

 

 

 

Net investment income (loss)

     16,771        20,426        12,499        3,638   
  

 

 

   

 

 

   

 

 

   

 

 

 

Realized gains (losses) on investments:

        

Capital gain distributions

     —          —          —          —     

Net realized gains (losses)

     (5,422     (1,385     (16,582     8,775   
  

 

 

   

 

 

   

 

 

   

 

 

 

Realized gains (losses)

     (5,422     (1,385     (16,582     8,775   

Unrealized appreciation (depreciation) during the period

     110        16,813        (19,011     2,175   
  

 

 

   

 

 

   

 

 

   

 

 

 

Net increase (decrease) in assets from operations

     11,459        35,854        (23,094     14,588   
  

 

 

   

 

 

   

 

 

   

 

 

 

Changes from principal transactions:

        

Transfer of net premiums

     9,090        10,071        27,804        36,838   

Transfer on terminations

     (51,841     (15,099     (23,863     (19,122

Transfer on policy loans

     —          (404     4,221        (2,136

Net interfund transfers

     2,654        619        (785,735     905,346   
  

 

 

   

 

 

   

 

 

   

 

 

 

Net increase (decrease) in assets from principal transactions

     (40,097     (4,813     (777,573     920,926   
  

 

 

   

 

 

   

 

 

   

 

 

 

Total increase (decrease) in assets

     (28,638     31,041        (800,667     935,514   

Assets, beginning of period

     311,836        280,795        1,155,231        219,717   
  

 

 

   

 

 

   

 

 

   

 

 

 

Assets, end of period

   $ 283,198      $ 311,836      $ 354,564      $ 1,155,231   
  

 

 

   

 

 

   

 

 

   

 

 

 

 

See accompanying notes.

 

60


Table of Contents
Sub-Account  
Total Return Trust Series 0     Total Return Trust Series 1     Total Stock Market Index Trust Series 0  
Year Ended
Dec. 31/13
    Year Ended
Dec. 31/12
    Year Ended
Dec. 31/13
    Year Ended
Dec. 31/12
    Year Ended
Dec. 31/13
    Year Ended
Dec. 31/12
 
         
$ 72,282      $ 43,507      $ 21,327      $ 14,482      $ 14,320      $ 8,500   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 
  72,282        43,507        21,327        14,482        14,320        8,500   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 
         
  52,217        —          15,619        —          13,617        1,374   
  (2,595     431        8,566        2,626        40,230        8,810   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 
  49,622        431        24,185        2,626        53,847        10,184   
  (160,510     120,665        (59,798     42,395        159,243        44,999   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 
  (38,606     164,603        (14,286     59,503        227,410        63,683   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 
         
  276,094        339,025        36,478        37,850        95,502        98,973   
  (461,974     (215,675     (107,474     (65,782     (66,499     (45,306
  (17,288     (14,630     —          1        4,859        (76
  50,149        30,125        1,900        270        255,216        77,067   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 
  (153,019     138,845        (69,096     (27,661     289,078        130,658   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 
  (191,625     303,448        (83,382     31,842        516,488        194,341   
  2,201,829        1,898,381        735,987        704,145        557,974        363,633   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 
$ 2,010,204      $ 2,201,829      $ 652,605      $ 735,987      $ 1,074,462      $ 557,974   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

 

61


Table of Contents

John Hancock Life Insurance Company of New York Separate Account B

Statements of Operations and Changes in Contract Owners’ Equity

(continued)

 

     Sub-Account  
     Total Stock Market Index Trust Series 1     Ultra Short Term Bond Trust Series 0  
     Year Ended
Dec. 31/13
    Year Ended
Dec. 31/12
    Year Ended
Dec. 31/13
    Year Ended
Dec. 31/12
 

Income:

        

Dividend income distribution

   $ 2,245      $ 2,046      $ 1,742      $ 637   
  

 

 

   

 

 

   

 

 

   

 

 

 

Net investment income (loss)

     2,245        2,046        1,742        637   
  

 

 

   

 

 

   

 

 

   

 

 

 

Realized gains (losses) on investments:

        

Capital gain distributions

     2,208        346        —          —     

Net realized gains (losses)

     1,729        5,726        (729     9   
  

 

 

   

 

 

   

 

 

   

 

 

 

Realized gains (losses)

     3,937        6,072        (729     9   

Unrealized appreciation (depreciation) during the period

     38,695        11,228        (980     (560
  

 

 

   

 

 

   

 

 

   

 

 

 

Net increase (decrease) in assets from operations

     44,877        19,346        33        86   
  

 

 

   

 

 

   

 

 

   

 

 

 

Changes from principal transactions:

        

Transfer of net premiums

     1,329        1,014        68,083        3,993   

Transfer on terminations

     (6,043     (54,449     (12,798     (4,620

Transfer on policy loans

     —          (5     —          —     

Net interfund transfers

     (2,304     46,941        22,351        63,471   
  

 

 

   

 

 

   

 

 

   

 

 

 

Net increase (decrease) in assets from principal transactions

     (7,018     (6,499     77,636        62,844   
  

 

 

   

 

 

   

 

 

   

 

 

 

Total increase (decrease) in assets

     37,859        12,847        77,669        62,930   

Assets, beginning of period

     137,559        124,712        64,514        1,584   
  

 

 

   

 

 

   

 

 

   

 

 

 

Assets, end of period

   $ 175,418      $ 137,559      $ 142,183      $ 64,514   
  

 

 

   

 

 

   

 

 

   

 

 

 

 

(g) Reflects the period from commencement of operations on April 30, 2012 through December 31, 2012.

 

See accompanying notes.

 

62


Table of Contents
Sub-Account  
U.S. Equity Trust Series 0     U.S. Equity Trust Series 1     Utilities Trust Series 0  
Year Ended
Dec. 31/13
    Year Ended
Dec. 31/12 (g)
    Year Ended
Dec. 31/13
    Year Ended
Dec. 31/12 (g)
    Year Ended
Dec. 31/13
    Year Ended
Dec. 31/12
 
         
$ 13,023      $ 9,205      $ 1,450      $ 1,104      $ 16,064      $ 21,565   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 
  13,023        9,205        1,450        1,104        16,064        21,565   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 
         
  —          —          —          —          —          —     
  6,318        280        6,030        36        35,333        (3,170

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 
  6,318        280        6,030        36        35,333        (3,170
  163,403        10,114        13,437        952        80,270        101,220   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 
  182,744        19,599        20,917        2,092        131,667        119,615   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 
         
  47,015        43,934        3,421        3,044        69,657        77,999   
  (45,169     (27,714     (22,646     (4,946     (77,011     (60,697
  (2,760     (103     —          153        (12,499     (778
  4,334        608,993        (9,826     76,632        89,217        (960,113

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 
  3,420        625,110        (29,051     74,883        69,364        (943,589

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 
  186,164        644,709        (8,134     76,975        201,031        (823,974
  644,709        —          76,975        —          627,938        1,451,912   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 
$ 830,873      $ 644,709      $ 68,841      $ 76,975      $ 828,969      $ 627,938   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

 

63


Table of Contents

John Hancock Life Insurance Company of New York Separate Account B

Statements of Operations and Changes in Contract Owners’ Equity

(continued)

 

     Sub-Account  
     Utilities Trust Series 1     Value Trust Series 0  
     Year Ended
Dec. 31/13
    Year Ended
Dec. 31/12
    Year Ended
Dec. 31/13
    Year Ended
Dec. 31/12
 

Income:

        

Dividend income distribution

   $ 1,713      $ 3,320      $ 4,585      $ 2,930   
  

 

 

   

 

 

   

 

 

   

 

 

 

Net investment income (loss)

     1,713        3,320        4,585        2,930   
  

 

 

   

 

 

   

 

 

   

 

 

 

Realized gains (losses) on investments:

        

Capital gain distributions

     —          —          —          —     

Net realized gains (losses)

     2,658        (253     15,574        4,959   
  

 

 

   

 

 

   

 

 

   

 

 

 

Realized gains (losses)

     2,658        (253     15,574        4,959   

Unrealized appreciation (depreciation) during the period

     12,873        8,452        117,660        30,031   
  

 

 

   

 

 

   

 

 

   

 

 

 

Net increase (decrease) in assets from operations

     17,244        11,519        137,819        37,920   
  

 

 

   

 

 

   

 

 

   

 

 

 

Changes from principal transactions:

        

Transfer of net premiums

     2,740        2,596        29,988        30,683   

Transfer on terminations

     (7,669     (4,128     (25,375     (16,654

Transfer on policy loans

     (16,934     (182     (9,190     (3,136

Net interfund transfers

     (19,634     (29     122,111        138,604   
  

 

 

   

 

 

   

 

 

   

 

 

 

Net increase (decrease) in assets from principal transactions

     (41,497     (1,743     117,534        149,497   
  

 

 

   

 

 

   

 

 

   

 

 

 

Total increase (decrease) in assets

     (24,253     9,776        255,353        187,417   

Assets, beginning of period

     95,035        85,259        353,136        165,719   
  

 

 

   

 

 

   

 

 

   

 

 

 

Assets, end of period

   $ 70,782      $ 95,035      $ 608,489      $ 353,136   
  

 

 

   

 

 

   

 

 

   

 

 

 

 

See accompanying notes.

 

64


Table of Contents
Sub-Account        
Value Trust Series 1     Total  
Year Ended
Dec. 31/13
    Year Ended
Dec. 31/12
    Year Ended
Dec. 31/13
    Year Ended
Dec. 31/12
 
     
$ 2,567      $ 2,196      $ 3,958,167      $ 3,515,712   

 

 

   

 

 

   

 

 

   

 

 

 
  2,567        2,196        3,958,167        3,515,712   

 

 

   

 

 

   

 

 

   

 

 

 
     
  —          —          2,660,103        1,624,293   
  22,164        726        3,640,195        398,999   

 

 

   

 

 

   

 

 

   

 

 

 
  22,164        726        6,300,298        2,023,292   
  65,867        37,064        17,018,126        12,813,931   

 

 

   

 

 

   

 

 

   

 

 

 
  90,598        39,986        27,276,591        18,352,935   

 

 

   

 

 

   

 

 

   

 

 

 
     
  2,849        4,570        28,818,159        32,366,430   
  (50,015     (12,471     (22,751,339     (13,317,889
  (20,892     236        (1,172,152     (999,605
  25,432        18,530        (9,157,394     (3,538,031

 

 

   

 

 

   

 

 

   

 

 

 
  (42,626     10,865        (4,262,726     14,510,905   

 

 

   

 

 

   

 

 

   

 

 

 
  47,972        50,851        23,013,865        32,863,840   
  275,039        224,188        168,380,919        135,517,079   

 

 

   

 

 

   

 

 

   

 

 

 
$ 323,011      $ 275,039      $ 191,394,784      $ 168,380,919   

 

 

   

 

 

   

 

 

   

 

 

 

 

65


Table of Contents

John Hancock Life Insurance Company of New York Separate Account B

Notes to Financial Statements

December 31, 2013

 

1. Organization

John Hancock Life Insurance Company of New York Separate Account B (the “Account”) is a separate account administered and sponsored by John Hancock Life Insurance Company of New York (the “Company”). The Account operates as a Unit Investment Trust registered under the Investment Company Act of 1940, as amended (the “Act”) and has 108 active investment sub-accounts that invest in shares of a particular John Hancock Variable Insurance Trust (the “Trust”), which was formerly known as the John Hancock Trust, portfolio and 5 sub-accounts that invest in shares of other outside investment trusts as of December 31, 2013. The Trust is registered under the Act as an open-end management investment company, commonly known as a mutual fund, which does not transact with the general public. Instead, the Trust deals primarily with insurance companies by providing the investment medium for variable contracts. The Account is a funding vehicle for the allocation of net premiums under single premium variable life and variable universal life insurance contracts (the “Contracts”) issued by the Company.

The Company is a wholly owned subsidiary of John Hancock Life Insurance Company (U.S.A.) (“JHUSA”) which in turn is an indirect, wholly owned subsidiary of Manulife Financial Corporation (“MFC”), a Canadian-based publicly traded stock life insurance company.

The Company is required to maintain assets in the Account with a total fair value at least equal to the reserves and other liabilities relating to the variable benefits under all Contracts participating in the Account. These assets may not be charged with liabilities which arise from any other business the Company conducts. However, all obligations under the Contracts are general corporate obligations of the Company.

Additional assets are held in the Company’s general account to cover the contingency that the guaranteed minimum death benefit might exceed the death benefit which would have been payable in the absence of such guarantee.

Each sub-account that invests in portfolios of the Trust may offer two classes of units to fund the Contracts issued by the Company. These classes, Series 1 and Series 0, represent an interest in the same Trust portfolio but in different share classes of that portfolio. Series 1 represents interests in Series 1 shares of the Trust’s portfolio and Series 0 represents interests in Series NAV shares of the Trust’s portfolio. Series 1 and Series NAV shares differ in the level of 12b-1 fees and other expenses assessed against the portfolio’s assets.

As the result of a portfolio change, the following sub-account of the Account was renamed as follows:

 

Previous Name

  

New Name

  

Effective Date

Business Opportunity Value    Large Cap Value    April 29, 2013

 

66


Table of Contents

John Hancock Life Insurance Company of New York Separate Account B

Notes to Financial Statements (continued)

 

The following sub-accounts of the Account were commenced as investment options:

 

New Sub-Accounts

  

Effective Date

Lifestyle Aggressive Trust PS Series NAV    December 9, 2013
Lifestyle Balanced Trust PS Series NAV    December 9, 2013
Lifestyle Conservative Trust PS Series NAV    December 9, 2013
Lifestyle Growth Trust PS Series NAV    December 9, 2013
Lifestyle Moderate Trust PS Series NAV    December 9, 2013

The following sub-accounts of the Account were terminated as investment options and the funds were transferred to existing sub-accounts as follows:

 

Terminated

 

Transferred To

 

Effective Date

All Cap Value Trust   Fundamental Large Cap Value Trust   December 9, 2013
American Global Small Capitalization Trust Series 1   American Global Growth Trust Series 1   April 29, 2013
American High Income Bond Trust Series 1   High Yield Trust Series 1   April 29, 2013
Core Allocation Plus Trust   Core Strategy Trust   December 9, 2013
Disciplined Diversification Trust   Core Strategy Trust   December 9, 2013
Fundamental Holdings Trust Series 1   Core Strategy Trust Series 1   December 9, 2013
Global Diversification Trust Series 1   Core Strategy Trust Series 1   December 9, 2013
Smaller Company Growth Trust   Small Cap Opportunities Trust   December 9, 2013

Where a sub-account has two series, the changes noted above apply to both Series 0 and Series 1.

 

2. Significant Accounting Policies

Investments of each sub-account consist of shares in the respective portfolios of the Trust. These shares are carried at fair value which is calculated using the fair value of the investment securities underlying each Trust portfolio. Transactions are recorded on the trade date. Income from dividends is recorded on the ex-dividend date. Realized gains and losses on the sale of investments are computed on the basis of the specifically identified cost of the investment sold.

In addition to the Account, a contract holder may also allocate funds to the fixed account contained within the Company’s general account. Because of exemptive and exclusionary provisions, interests in the fixed account have not been registered under the Securities Act of 1933 and the Company’s general account has not been registered as an investment company under the Act. Net interfund transfers include interfund transfers between separate and general accounts.

 

67


Table of Contents

John Hancock Life Insurance Company of New York Separate Account B

Notes to Financial Statements (continued)

 

The operations of the Account are included in the federal income tax return of the Company, which is taxed as a life insurance company under the provisions of the Internal Revenue Code (the “Code”). Under the current provisions of the Code, the Company does not expect to incur federal income taxes on the earnings of the Account to the extent the earnings are credited under the Contracts. Based on this, no charge is being made currently to the Account for federal income taxes. The Company will periodically reassess this position taking into account changes in the tax law. Such a charge may be made in future years for any federal income taxes that would be attributable to the Contracts.

FASB ASC Topic 820 - Fair Value Measurement and Disclosure (“ASC 820”) provides a single definition of fair value for accounting purposes, establishes a consistent framework for measuring fair value and expands disclosure requirements about fair value measurements. ASC 820 defines fair value as the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date; that is, an exit value. An exit value is not a forced liquidation or distressed sale. Assets not measured at fair value are excluded from ASC 820 note disclosure, including Policy Loans which are held to maturity and accounted for at cost.

Following ASC 820 guidance, the Account has categorized its fair value measurements according to a three-level hierarchy. The hierarchy prioritizes the inputs used by the Account’s valuation techniques. A level is assigned to each fair value measurement based on the lowest level input significant to the fair value measurement in its entirety. The three levels of the fair value hierarchy are defined as follows:

 

 

Level 1 – Fair value measurements that reflect unadjusted, quoted prices in active markets for identical assets and liabilities that the Account has the ability to access at the measurement date.

 

 

Level 2 – Fair value measurements using inputs other than quoted prices included within Level 1 that are observable, either directly or indirectly.

 

 

Level 3 – Fair value measurements using significant non-market observable inputs.

Assets owned by the Account are primarily open-ended mutual fund investments issued by the Trust. These are classified within Level 1, as fair values of the underlying funds are based upon reported net asset values (“NAV”), which represent the values at which each sub-account can redeem its investments.

The following table presents the Account’s assets that are measured at fair value on a recurring basis by fair value hierarchy level under ASC 820, as of December 31, 2013.

 

     Mutual Funds  

Level 1

   $ 191,394,784   

Level 2

     —     

Level 3

     —     
  

 

 

 
   $ 191,394,784   
  

 

 

 

The preparation of financial statements in conformity with accounting principles generally accepted in the United States requires management to make estimates and assumptions that affect the amounts reported herein. Actual results could differ from those estimates.

 

68


Table of Contents

John Hancock Life Insurance Company of New York Separate Account B

Notes to Financial Statements (continued)

 

3. Contract Charges

The Company deducts certain charges from gross premiums before placing the remaining net premiums in the sub-account. In the event of a surrender by the contract holder, surrender charges may be levied by the Company against the contract value at the time of termination to cover sales and administrative expenses associated with the underwriting and issuing of the Contract. Additionally, each month a deduction consisting of an administration charge, a charge for cost of insurance, a charge for mortality and expense risks and charges for supplementary benefits is deducted from the contract value. Contract charges are paid through the redemption of sub-account units and are reflected as terminations.

 

4. Federal Income Taxes

The Account does not file separate tax returns. The taxable income of the Account is consolidated with that of the Company within the consolidated federal tax return. Any tax contingencies arising from the taxable income generated by the Account are the responsibility of the Company and the Company holds any and all tax contingencies on its financial statements. The Account is not a party to the consolidated tax sharing agreement thus no amount of income taxes or tax contingencies are passed through to the Account. The legal form of the Account is not taxable in any state or foreign jurisdictions.

The Income Taxes topic of the FASB Accounting Standard Codification establishes a minimum threshold for financial statement recognition of the benefit of positions taken, or expected to be taken, in filing tax returns (including whether the Account is taxable in certain jurisdictions). The topic requires the evaluation of tax positions taken or expected to be taken in the course of preparing the Company’s tax returns to determine whether tax positions are “more-likely-than not” of being sustained by the applicable tax authority. Tax positions deemed to meet the more-likely-than-not threshold would be recorded as tax expense or benefit.

The Account complies with the provisions of FASB ASC Topic 740, Income Taxes. As of December 31, 2013, the Account did not have a liability for any uncertain tax positions. The Account recognizes interest and penalties, if any, related to tax liabilities as income tax expense in the Statements of Operations.

 

5. Purchases and Sales of Investments

The cost of purchases and proceeds from sales of investments for the year ended December 31, 2013 were as follows:

 

     Purchases      Sales  

Sub-accounts:

     

500 Index Trust B Series 0

   $ 2,278,406       $ 1,150,926   

Active Bond Trust Series 0

     104,962         23,491   

Active Bond Trust Series 1

     75,364         11,194   

All Cap Core Trust Series 0

     21,136         13,562   

All Cap Core Trust Series 1

     13,854         274,629   

All Cap Value Trust Series 0

     608,934         884,890   

All Cap Value Trust Series 1

     156,773         278,013   

Alpha Opportunities Trust Series 0

     42,316         9,347   

 

69


Table of Contents

John Hancock Life Insurance Company of New York Separate Account B

Notes to Financial Statements (continued)

 

     Purchases      Sales  

Sub-accounts:

     

American Asset Allocation Trust Series 1

   $ 348,772       $ 115,365   

American Global Growth Trust Series 1

     35,121         8,147   

American Global Small Capitalization Trust Series 1

     1,524         22,959   

American Growth Trust Series 1

     290,248         295,030   

American Growth-Income Trust Series 1

     195,057         207,228   

American High-Income Bond Trust Series 1

     14,917         172,530   

American International Trust Series 1

     603,047         598,326   

American New World Trust Series 1

     111,328         10,878   

Blue Chip Growth Trust Series 0

     278,658         1,233,726   

Blue Chip Growth Trust Series 1

     175,609         167,957   

Bond Trust Series 0

     34,443         38,226   

Bond Trust Series 1

     —           21,071   

Capital Appreciation Trust Series 0

     164,541         273,461   

Capital Appreciation Trust Series 1

     53,164         169,924   

Capital Appreciation Value Trust Series 0

     261,102         85,065   

Core Allocation Plus Trust Series 0

     539,040         1,032,857   

Core Bond Trust Series 0

     107,059         33,900   

Core Bond Trust Series 1

     8,224         2,650   

Core Strategy Trust Series 0

     3,149,438         299,138   

Disciplined Diversification Trust Series 0

     390,280         681,265   

Emerging Markets Value Trust Series 0

     384,760         161,532   

Emerging Markets Value Trust Series 1

     408         382   

Equity-Income Trust Series 0

     483,232         1,078,438   

Equity-Income Trust Series 1

     114,429         201,518   

Financial Services Trust Series 0

     77,673         36,031   

Financial Services Trust Series 1

     4,303         4,965   

Franklin Templeton Founding Allocation Trust Series 0

     503,633         117,126   

Franklin Templeton Founding Allocation Trust Series 1

     2,185         21   

Fundamental All Cap Core Trust Series 0

     291,411         47,169   

Fundamental All Cap Core Trust Series 1

     34,950         1,407   

Fundamental Holdings Trust Series 1

     133,384         247,292   

Fundamental Large Cap Value Trust Series 0

     1,164,847         29,289   

Fundamental Large Cap Value Trust Series 1

     131,664         241   

Fundamental Value Trust Series 0

     43,857         184,252   

Fundamental Value Trust Series 1

     40,586         69,073   

Global Bond Trust Series 0

     157,772         911,367   

Global Bond Trust Series 1

     13,541         66,117   

Global Diversification Trust Series 1

     292,514         517,850   

Global Trust Series 0

     42,785         7,910   

Global Trust Series 1

     1,966         955,153   

Health Sciences Trust Series 0

     262,267         48,922   

Health Sciences Trust Series 1

     54,416         50,645   

High Yield Trust Series 0

     657,833         5,087,979   

High Yield Trust Series 1

     27,835         36,489   

International Core Trust Series 0

     116,483         370,223   

International Core Trust Series 1

     6,101         24,419   

International Equity Index Trust B Series 0

     593,347         635,745   

International Equity Index Trust B Series 1

     21,807         34,478   

International Growth Stock Trust Series 0

     56,693         69,292   

International Growth Stock Trust Series 1

     14,214         4,407   

 

70


Table of Contents

John Hancock Life Insurance Company of New York Separate Account B

Notes to Financial Statements (continued)

 

     Purchases      Sales  

Sub-accounts:

     

International Small Company Trust Series 0

   $ 86,488       $ 28,769   

International Small Company Trust Series 1

     4,043         6,530   

International Value Trust Series 0

     135,544         59,176   

International Value Trust Series 1

     56,051         839,186   

Investment Quality Bond Trust Series 0

     50,369         2,246,283   

Investment Quality Bond Trust Series 1

     26,866         5,639   

Lifestyle Aggressive Trust Series 0

     1,903,753         2,154,713   

Lifestyle Aggressive Trust Series 1

     64,518         21,553   

Lifestyle Balanced Trust Series 0

     6,277,552         3,432,290   

Lifestyle Balanced Trust Series 1

     176,424         162,211   

Lifestyle Conservative Trust Series 0

     1,173,572         1,213,671   

Lifestyle Conservative Trust Series 1

     11,462         4,708   

Lifestyle Growth Trust Series 0

     6,153,764         3,107,125   

Lifestyle Growth Trust Series 1

     145,957         87,002   

Lifestyle Moderate Trust Series 0

     1,989,767         630,318   

Lifestyle Moderate Trust Series 1

     34,211         47,201   

Mid Cap Index Trust Series 0

     727,400         367,639   

Mid Cap Index Trust Series 1

     45,488         15,826   

Mid Cap Stock Trust Series 0

     223,061         426,312   

Mid Cap Stock Trust Series 1

     20,652         26,417   

Mid Value Trust Series 0

     169,090         596,740   

Mid Value Trust Series 1

     31,966         53,244   

Money Market Trust B Series 0

     13,191,007         14,264,781   

Money Market Trust Series 1

     1,872,571         143,299   

Natural Resources Trust Series 0

     169,909         177,136   

Natural Resources Trust Series 1

     33,787         34,677   

Real Estate Securities Trust Series 0

     267,464         495,093   

Real Estate Securities Trust Series 1

     62,602         26,846   

Real Return Bond Trust Series 0

     230,130         452,077   

Real Return Bond Trust Series 1

     3,053         4,382   

Science & Technology Trust Series 0

     116,373         122,032   

Science & Technology Trust Series 1

     17,584         39,854   

Short Term Government Income Trust Series 0

     94,253         148,905   

Short Term Government Income Trust Series 1

     42,622         17,202   

Small Cap Growth Trust Series 0

     150,795         40,636   

Small Cap Growth Trust Series 1

     10,303         3,626   

Small Cap Index Trust Series 0

     495,227         578,763   

Small Cap Index Trust Series 1

     14,218         7,322   

Small Cap Opportunities Trust Series 0

     870,334         11,884   

Small Cap Opportunities Trust Series 1

     36,786         58,345   

Small Cap Value Trust Series 0

     255,659         54,680   

Small Cap Value Trust Series 1

     53,439         44,429   

Small Company Value Trust Series 0

     85,296         45,424   

Small Company Value Trust Series 1

     29,710         60,308   

Smaller Company Growth Trust Series 0

     62,681         869,942   

Smaller Company Growth Trust Series 1

     2,640         56,203   

Strategic Income Opportunities Trust Series 0

     6,310,205         5,047,618   

Strategic Income Opportunities Trust Series 1

     31,792         55,117   

Total Bond Market Trust B Series 0

     3,959,313         4,724,388   

 

71


Table of Contents

John Hancock Life Insurance Company of New York Separate Account B

Notes to Financial Statements (continued)

 

     Purchases      Sales  

Sub-accounts:

     

Total Return Trust Series 0

   $ 875,042       $ 903,563   

Total Return Trust Series 1

     74,701         106,851   

Total Stock Market Index Trust Series 0

     464,172         147,158   

Total Stock Market Index Trust Series 1

     5,768         8,331   

Ultra Short Term Bond Trust Series 0

     134,851         55,473   

U.S. Equity Trust Series 0

     63,216         46,774   

U.S. Equity Trust Series 1

     3,994         31,594   

Utilities Trust Series 0

     179,451         94,023   

Utilities Trust Series 1

     3,885         43,671   

Value Trust Series 0

     181,039         58,921   

Value Trust Series 1

     34,195         74,254   

All Asset Portfolio

     295,566         160,660   

Brandes International Equity

     68,107         2,588   

Frontier Capital Appreciation

     49,520         568   

Large Cap Growth

     73,319         14,670   

Large Cap Value

     65,819         6,970   
  

 

 

    

 

 

 
   $ 66,344,609       $ 63,989,078   
  

 

 

    

 

 

 

 

6. Transaction with Affiliates

John Hancock Distributors LLC, a registered broker-dealer and wholly owned subsidiary of JHUSA, acts as the principal underwriter of the Contracts pursuant to a distribution agreement with the Company. Contracts are sold by registered representatives of either John Hancock Distributors LLC or other broker-dealers having distribution agreements with John Hancock Distributors LLC who are also authorized as variable life insurance agents under applicable state insurance laws. Registered representatives are compensated on a commission basis.

JHUSA has a formal service agreement with its ultimate parent company, MFC, which can be terminated by either party upon two months’ notice. Under this agreement, JHUSA pays for legal, actuarial, investment and certain other administrative services.

The majority of the investments held by the Account are invested in the Trust (Note 1).

 

7. Diversification Requirements

The Internal Revenue Service has issued regulations under Section 817(h) of the Internal Revenue Code (the “Code”). Under the provisions of Section 817(h) of the Code, a variable life contract will not be treated as a life contract for federal tax purposes for any period for which the investments of the Account on which the contract is based are not adequately diversified. The Code provides that the “adequately diversified” requirement may be met if the underlying investments satisfy either a statutory safe harbour test or diversification requirements set forth in regulations issued by the Secretary of Treasury. JHUSA believes that the Account satisfies the current requirements of the regulations, and the Account will continue to meet such requirements.

 

72


Table of Contents

John Hancock Life Insurance Company of New York Separate Account B

Notes to Financial Statements (continued)

 

8. Subsequent Events

In accordance with the provision set forth in FASB ASC Topic 855 - Subsequent Events (“ASC 855”), management has evaluated the possibility of subsequent events existing in the Account’s financial statements through March 28, 2014 and has determined that no events have occurred that require additional disclosure.

 

73


Table of Contents

John Hancock Life Insurance Company of New York Separate Account B

Notes to Financial Statements (continued)

 

9. Financial Highlights

 

    Sub-Account  
    500 Index Trust B Series 0  
    Year Ended
Dec. 31/13
    Year Ended
Dec. 31/12
    Year Ended
Dec. 31/11
    Year Ended
Dec. 31/10
    Year Ended
Dec. 31/09
 

Units, beginning of period

    164,881        119,719        79,667        87,318        38,794   

Units issued

    66,058        78,636        64,579        54,685        80,467   

Units redeemed

    (37,728     (33,474     (24,527     (62,336     (31,943
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Units, end of period

    193,211        164,881        119,719        79,667        87,318   
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Unit value, end of period $

    23.54 to 37.65        17.83 to 28.52        15.40 to 24.63        15.12 to 24.18        21.05   

Assets, end of period $

    6,764,116        4,350,710        2,948,519        1,914,656        1,828,011   

Investment income ratio*

    2.17     1.13     2.13     1.59     2.37

Total return, lowest to highest**

    32.02% to 32.03     8.03% to 15.80     1.86% to 1.87     14.85% to 14.86     24.08% to 31.02
    Sub-Account  
    Active Bond Trust Series 0  
    Year Ended
Dec. 31/13
    Year Ended
Dec. 31/12
    Year Ended
Dec. 31/11
    Year Ended
Dec. 31/10
    Year Ended
Dec. 31/09
 

Units, beginning of period

    9,197        4,900        1,410        975        334   

Units issued

    997        4,521        3,631        1,681        707   

Units redeemed

    (354     (224     (141     (1,246     (66
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Units, end of period

    9,840        9,197        4,900        1,410        975   
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Unit value, end of period $

    66.44        66.31        60.42        57.02        50.05   

Assets, end of period $

    653,806        609,860        296,062        80,380        48,772   

Investment income ratio*

    5.99     5.15     11.40     7.43     8.48

Total return, lowest to highest**

    0.19     5.32% to 9.76     5.97     13.91     18.30% to 24.86

 

74


Table of Contents

John Hancock Life Insurance Company of New York Separate Account B

Notes to Financial Statements (continued)

 

9. Financial Highlights

 

    Sub-Account  
    Active Bond Trust Series 1  
    Year Ended
Dec. 31/13
    Year Ended
Dec. 31/12
    Year Ended
Dec. 31/11
    Year Ended
Dec. 31/10
    Year Ended
Dec. 31/09
 

Units, beginning of period

    13,176        13,151        13,969        13,951        20,634   

Units issued

    2,813        976        805        759        1,167   

Units redeemed

    (550     (951     (1,623     (741     (7,850
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Units, end of period

    15,439        13,176        13,151        13,969        13,951   
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Unit value, end of period $

    20.41        20.36        18.56        17.54        15.41   

Assets, end of period $

    315,051        268,212        244,014        244,979        214,909   

Investment income ratio*

    6.44     4.20     5.40     7.62     6.87

Total return, lowest to highest**

    0.24     9.71     5.81     13.84     24.81
    Sub-Account  
    All Asset Portfolio  
    Year Ended
Dec. 31/13  (bg)
    Year Ended
Dec. 31/12  (bg)
    Year Ended
Dec. 31/11  (bg)
    Year Ended
Dec. 31/10  (bg)
    Year Ended
Dec. 31/09
 

Units, beginning of period

    313,212        17,548        10,032        9,068        2,123   

Units issued

    5,459        301,263        9,120        3,705        10,323   

Units redeemed

    (9,370     (5,599     (1,604     (2,741     (3,378
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Units, end of period

    309,301        313,212        17,548        10,032        9,068   
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Unit value, end of period $

    15.81 to 22.31        15.82 to 22.34        13.80 to 19.48        13.58 to 19.16        12.05 to 17.00   

Assets, end of period $

    4,889,041        4,968,258        254,448        138,475        116,677   

Investment income ratio*

    4.24     6.73     7.29     6.98     7.71

Total return, lowest to highest**

    (0.10%) to (0.10 %)      9.24% to 14.65     1.66     12.71     14.85% to 21.32

 

(bg) Fund has no Series. Previously presented as Series 0 and Series 1.

 

75


Table of Contents

John Hancock Life Insurance Company of New York Separate Account B

Notes to Financial Statements (continued)

 

9. Financial Highlights

 

    Sub-Account  
    All Cap Core Trust Series 0  
    Year Ended
Dec. 31/13
    Year Ended
Dec. 31/12
    Year Ended
Dec. 31/11
    Year Ended
Dec. 31/10
    Year Ended
Dec. 31/09
 

Units, beginning of period

    4,035        83,259        2,836        2,602        1,325   

Units issued

    1,254        1,655        81,932        596        1,703   

Units redeemed

    (806     (80,879     (1,509     (362     (426
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Units, end of period

    4,483        4,035        83,259        2,836        2,602   
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Unit value, end of period $

    18.44        13.72        11.76        11.71        10.36   

Assets, end of period $

    82,745        55,395        979,289        33,255        26,974   

Investment income ratio*

    1.38     0.24     1.62     1.18     1.70

Total return, lowest to highest**

    34.44     10.44% to 16.62     0.40     13.09     24.46% to 33.05
    Sub-Account  
    All Cap Core Trust Series 1  
    Year Ended
Dec. 31/13
    Year Ended
Dec. 31/12
    Year Ended
Dec. 31/11
    Year Ended
Dec. 31/10
    Year Ended
Dec. 31/09
 

Units, beginning of period

    37,068        37,436        38,944        40,951        34,833   

Units issued

    536        681        876        1,171        8,929   

Units redeemed

    (18,366     (1,049     (2,384     (3,178     (2,811
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Units, end of period

    19,238        37,068        37,436        38,944        40,951   
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Unit value, end of period $

    15.53        11.56        9.92        9.88        8.74   

Assets, end of period $

    298,820        428,605        371,332        384,712        357,886   

Investment income ratio*

    1.34     1.15     1.03     1.07     1.68

Total return, lowest to highest**

    34.31     16.57     0.42     13.03     28.46

 

76


Table of Contents

John Hancock Life Insurance Company of New York Separate Account B

Notes to Financial Statements (continued)

 

9. Financial Highlights

 

    Sub-Account  
    All Cap Value Trust Series 0  
    Year Ended
Dec. 31/13 (m)
    Year Ended
Dec. 31/12
    Year Ended
Dec. 31/11
    Year Ended
Dec. 31/10
    Year Ended
Dec. 31/09
 

Units, beginning of period

    32,924        27,144        11,363        8,332        5,913   

Units issued

    10,547        7,879        18,411        4,022        3,819   

Units redeemed

    (43,471     (2,099     (2,630     (991     (1,400
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Units, end of period

    —          32,924        27,144        11,363        8,332   
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Unit value, end of period $

    20.42        15.60        14.06        14.67        12.38   

Assets, end of period $

    —          513,465        381,657        166,715        103,167   

Investment income ratio*

    1.62     0.96     0.52     0.51     0.63

Total return, lowest to highest**

    30.93     6.24% to 10.92     (4.17 %)      18.50     22.43% to 31.77

(m)   Terminated as an investment option and funds transferred to Fundamental Large Cap Value Trust on December 9, 2013.

      

    Sub-Account  
    All Cap Value Trust Series 1  
    Year Ended
Dec. 31/13 (m)
    Year Ended
Dec. 31/12
    Year Ended
Dec. 31/11
    Year Ended
Dec. 31/10
    Year Ended
Dec. 31/09
 

Units, beginning of period

    6,878        12,885        7,937        8,263        10,031   

Units issued

    2,997        210        5,225        333        501   

Units redeemed

    (9,875     (6,217     (277     (659     (2,269
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Units, end of period

    —          6,878        12,885        7,937        8,263   
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Unit value, end of period $

    28.21        21.57        19.44        20.29        17.15   

Assets, end of period $

    —          148,354        250,473        161,055        141,658   

Investment income ratio*

    1.06     0.76     0.48     0.37     0.52

Total return, lowest to highest**

    30.78     10.95     (4.21 %)      18.35     26.61

 

(m) Terminated as an investment option and funds transferred to Fundamental Large Cap Value Trust on December 9, 2013.

 

77


Table of Contents

John Hancock Life Insurance Company of New York Separate Account B

Notes to Financial Statements (continued)

 

9. Financial Highlights

 

    Sub-Account  
    Alpha Opportunities Trust Series 0  
    Year Ended
Dec. 31/13
    Year Ended
Dec. 31/12
    Year Ended
Dec. 31/11
    Year Ended
Dec. 31/10 (n)
 

Units, beginning of period

    2,919        63,000        1,887        —     

Units issued

    1,711        714        63,239        1,903   

Units redeemed

    (483     (60,795     (2,126     (16
 

 

 

   

 

 

   

 

 

   

 

 

 

Units, end of period

    4,147        2,919        63,000        1,887   
 

 

 

   

 

 

   

 

 

   

 

 

 

Unit value, end of period $

    22.54        16.63        13.70        14.89   

Assets, end of period $

    93,480        48,537        862,996        28,103   

Investment income ratio*

    0.92     0.12     0.28     0.96

Total return, lowest to highest**

    35.58     9.62% to 21.38     (8.02 %)      16.98

 

(n) Fund available in prior year but no activity.

 

    Sub-Account  
    American Asset Allocation Trust Series 1  
    Year Ended
Dec. 31/13
    Year Ended
Dec. 31/12
    Year Ended
Dec. 31/11
    Year Ended
Dec. 31/10
    Year Ended
Dec. 31/09
 

Units, beginning of period

    87,850        56,070        37,305        24,158        157   

Units issued

    24,729        38,456        23,086        15,778        25,418   

Units redeemed

    (8,602     (6,676     (4,321     (2,631     (1,417
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Units, end of period

    103,977        87,850        56,070        37,305        24,158   
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Unit value, end of period $

    14.49        11.75        10.15        10.06        8.98   

Assets, end of period $

    1,506,292        1,032,197        569,092        375,193        216,820   

Investment income ratio*

    1.24     1.94     2.05     2.00     3.54

Total return, lowest to highest**

    23.30     8.80% to 15.77     0.91     12.07     18.28% to 25.85

 

78


Table of Contents

John Hancock Life Insurance Company of New York Separate Account B

Notes to Financial Statements (continued)

 

9. Financial Highlights

 

    Sub-Account  
    American Global Growth Trust Series 1  
    Year Ended
Dec. 31/13
    Year Ended
Dec. 31/12
    Year Ended
Dec. 31/11 (n)
 

Units, beginning of period

    3,506        1,623        —     

Units issued

    2,825        2,434        1,660   

Units redeemed

    (648     (551     (37
 

 

 

   

 

 

   

 

 

 

Units, end of period

    5,683        3,506        1,623   
 

 

 

   

 

 

   

 

 

 

Unit value, end of period $

    14.40        11.19        9.17   

Assets, end of period $

    81,821        39,240        14,877   

Investment income ratio*

    1.04     0.54     2.45

Total return, lowest to highest**

    28.63     13.48% to 22.12     (9.24 %) 

(n)    Fund available in prior year but no activity.

       

    Sub-Account  
    American Global Small Capitalization Trust Series 1  
    Year Ended
Dec. 31/13 (bh)
    Year Ended
Dec. 31/12
    Year Ended
Dec. 31/11 (n)
 

Units, beginning of period

    2,018        2,002        —     

Units issued

    141        105        2,046   

Units redeemed

    (2,159     (89     (44
 

 

 

   

 

 

   

 

 

 

Units, end of period

    —          2,018        2,002   
 

 

 

   

 

 

   

 

 

 

Unit value, end of period $

    10.64        9.64        8.19   

Assets, end of period $

    —          19,452        16,392   

Investment income ratio*

    0.70     0.91     2.24

Total return, lowest to highest**

    10.37     9.07% to 17.71     (19.43 %) 

 

(bh) Terminated as an investment option and funds transferred to American Global Growth Trust Series 1 on April 29, 2013.
(n) Fund available in prior year but no activity.

 

79


Table of Contents

John Hancock Life Insurance Company of New York Separate Account B

Notes to Financial Statements (continued)

 

9. Financial Highlights

 

    Sub-Account  
    American Growth Trust Series 1  
    Year Ended
Dec. 31/13
    Year Ended
Dec. 31/12
    Year Ended
Dec. 31/11
    Year Ended
Dec. 31/10
    Year Ended
Dec. 31/09
 

Units, beginning of period

    116,603        175,103        94,221        91,492        56,137   

Units issued

    15,422        37,768        97,231        59,196        50,848   

Units redeemed

    (14,925     (96,268     (16,349     (56,467     (15,493
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Units, end of period

    117,100        116,603        175,103        94,221        91,492   
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Unit value, end of period $

    19.58 to 29.48        15.11 to 22.75        12.86 to 19.36        13.48 to 20.30        11.40   

Assets, end of period $

    2,499,497        1,951,721        2,369,650        1,421,047        1,153,106   

Investment income ratio*

    0.57     0.38     0.27     0.36     0.34

Total return, lowest to highest**

    29.61% to 29.61     8.11% to 17.49     (4.63 %)      18.23% to 18.24     25.08% to 42.05
    Sub-Account  
    American Growth-Income Trust Series 1  
    Year Ended
Dec. 31/13
    Year Ended
Dec. 31/12
    Year Ended
Dec. 31/11
    Year Ended
Dec. 31/10
    Year Ended
Dec. 31/09
 

Units, beginning of period

    143,577        71,930        70,155        60,898        88,850   

Units issued

    10,133        80,514        12,692        14,882        65,625   

Units redeemed

    (11,625     (8,867     (10,917     (5,625     (93,577
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Units, end of period

    142,085        143,577        71,930        70,155        60,898   
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Unit value, end of period $

    18.11 to 27.04        13.62 to 20.33        11.62 to 17.35        11.87 to 17.72        10.69   

Assets, end of period $

    2,798,113        2,131,349        963,908        998,842        796,589   

Investment income ratio*

    1.02     2.01     1.19     1.22     0.74

Total return, lowest to highest**

    33.01% to 33.02     10.27% to 17.16     (2.10%) to (2.09 %)      11.05% to 11.06     23.68% to 33.69

 

80


Table of Contents

John Hancock Life Insurance Company of New York Separate Account B

Notes to Financial Statements (continued)

 

9. Financial Highlights

 

     Sub-Account  
     American High-Income Bond Trust Series  1  
     Year Ended
Dec. 31/13 (l)
    Year Ended
Dec. 31/12
    Year Ended
Dec. 31/11 (n)
 

Units, beginning of period

     13,661        2,315        —     

Units issued

     926        13,744        2,411   

Units redeemed

     (14,587     (2,398     (96
  

 

 

   

 

 

   

 

 

 

Units, end of period

     —          13,661        2,315   
  

 

 

   

 

 

   

 

 

 

Unit value, end of period $

     11.83        11.49        10.16   

Assets, end of period $

     —          157,024        23,527   

Investment income ratio*

     0.25     10.57     20.05

Total return, lowest to highest**

     2.90     6.30% to 13.11     1.46

 

(l) Terminated as an investment option and funds transferred to High Yield Trust Series 1 on April 29, 2013.
(n) Fund available in prior year but no activity.

 

    Sub-Account  
    American International Trust Series 1  
    Year Ended
Dec. 31/13
    Year Ended
Dec. 31/12
    Year Ended
Dec. 31/11
    Year Ended
Dec. 31/10
    Year Ended
Dec. 31/09
 

Units, beginning of period

    81,137        89,381        76,308        51,505        42,851   

Units issued

    34,067        19,210        34,549        52,695        34,474   

Units redeemed

    (33,108     (27,454     (21,476     (27,892     (25,820
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Units, end of period

    82,096        81,137        89,381        76,308        51,505   
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Unit value, end of period $

    18.85 to 33.19        15.55 to 27.39        13.24 to 23.31        15.45 to 27.21        14.46   

Assets, end of period $

    1,722,671        1,427,243        1,332,045        1,349,296        855,948   

Investment income ratio*

    1.03     1.06     1.51     1.97     1.20

Total return, lowest to highest**

    21.20% to 21.20     13.22% to 17.50     (14.34 %)      6.88     27.67% to 46.99

 

81


Table of Contents

John Hancock Life Insurance Company of New York Separate Account B

Notes to Financial Statements (continued)

 

9. Financial Highlights

 

    Sub-Account  
    American New World Trust Series 1  
    Year Ended
Dec. 31/13
    Year Ended
Dec. 31/12
    Year Ended
Dec. 31/11
    Year Ended
Dec. 31/10
    Year Ended
Dec. 31/09 (a)
 

Units, beginning of period

    13,912        12,806        4,109        11,999        —     

Units issued

    6,499        2,231        11,580        3,543        12,025   

Units redeemed

    (668     (1,125     (2,883     (11,433     (26
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Units, end of period

    19,743        13,912        12,806        4,109        11,999   
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Unit value, end of period $

    17.49        15.77        13.44        15.69        13.36   

Assets, end of period $

    345,333        219,440        172,098        64,457        160,289   

Investment income ratio*

    1.22     0.64     2.18     0.65     7.30

Total return, lowest to highest**

    10.89     12.53% to 17.37     (14.33 %)      17.43     30.38% to 33.58

(a)    Reflects the period from commencement of operations on May 4, 2009 through December 31, 2009.

       

    Sub-Account  
    Blue Chip Growth Trust Series 0  
    Year Ended
Dec. 31/13
    Year Ended
Dec. 31/12
    Year Ended
Dec. 31/11
    Year Ended
Dec. 31/10
    Year Ended
Dec. 31/09
 

Units, beginning of period

    36,543        49,717        31,138        27,629        7,243   

Units issued

    2,924        8,580        32,665        14,495        24,326   

Units redeemed

    (14,522     (21,754     (14,086     (10,986     (3,940
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Units, end of period

    24,945        36,543        49,717        31,138        27,629   
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Unit value, end of period $

    112.07        79.24        66.93        65.97        56.75   

Assets, end of period $

    2,795,578        2,895,574        3,327,453        2,054,232        1,567,863   

Investment income ratio*

    0.32     0.13     0.02     0.09     0.20

Total return, lowest to highest**

    41.43     5.30% to 18.39     1.45     16.25     26.87% to 46.21

 

82


Table of Contents

John Hancock Life Insurance Company of New York Separate Account B

Notes to Financial Statements (continued)

 

9. Financial Highlights

 

    Sub-Account  
    Blue Chip Growth Trust Series 1  
    Year Ended
Dec. 31/13
    Year Ended
Dec. 31/12
    Year Ended
Dec. 31/11
    Year Ended
Dec. 31/10
    Year Ended
Dec. 31/09
 

Units, beginning of period

    44,353        54,004        52,381        51,352        58,485   

Units issued

    10,344        3,448        9,561        4,833        12,872   

Units redeemed

    (8,855     (13,099     (7,938     (3,804     (20,005
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Units, end of period

    45,842        44,353        54,004        52,381        51,352   
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Unit value, end of period $

    21.84        15.46        13.06        12.88        11.09   

Assets, end of period $

    1,001,567        685,670        705,592        674,666        569,454   

Investment income ratio*

    0.28     0.09     0.01     0.08     0.15

Total return, lowest to highest**

    41.33     18.31     1.44     16.15     42.89

 

    Sub-Account  
    Bond Trust Series 0  
    Year Ended
Dec. 31/13
    Year Ended
Dec. 31/12
    Year Ended
Dec. 31/11 (c)
 

Units, beginning of period

    18,444        16,603        —     

Units issued

    2,564        3,451        16,794   

Units redeemed

    (3,559     (1,610     (191
 

 

 

   

 

 

   

 

 

 

Units, end of period

    17,449        18,444        16,603   
 

 

 

   

 

 

   

 

 

 

Unit value, end of period $

    10.58        10.72        10.08   

Assets, end of period $

    184,560        197,686        167,386   

Investment income ratio*

    2.99     2.96     14.80

Total return, lowest to highest**

    (1.32 %)      2.99% to 6.31     0.82

 

(c) Reflects the period from commencement of operations on October 31, 2011 through December 31, 2011.

 

83


Table of Contents

John Hancock Life Insurance Company of New York Separate Account B

Notes to Financial Statements (continued)

 

9. Financial Highlights

 

    Sub-Account  
    Bond Trust Series 1  
    Year Ended
Dec. 31/13
    Year Ended
Dec. 31/12
    Year Ended
Dec. 31/11 (c)
 

Units, beginning of period

    1,967        —          —     

Units issued

    —          1,991        1,851   

Units redeemed

    (1,967     (24     (1,851
 

 

 

   

 

 

   

 

 

 

Units, end of period

    —          1,967        —     
 

 

 

   

 

 

   

 

 

 

Unit value, end of period $

    10.57        10.72        10.08   

Assets, end of period $

    —          21,086        —     

Investment income ratio*

    0.00     3.38     0.00

Total return, lowest to highest**

    (1.36 %)      6.34     0.78

 

(c) Reflects the period from commencement of operations on October 31, 2011 through December 31, 2011.

 

    Sub-Account  
    Brandes International Equity  
    Year Ended
Dec. 31/13
    Year Ended
Dec. 31/12
    Year Ended
Dec. 31/11
    Year Ended
Dec. 31/10
    Year Ended
Dec. 31/09
 

Units, beginning of period

    1,292        1,044        678        815        63   

Units issued

    1,909        405        4,422        712        824   

Units redeemed

    (80     (157     (4,056     (849     (72
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Units, end of period

    3,121        1,292        1,044        678        815   
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Unit value, end of period $

    35.56        30.57        25.33        29.30        28.01   

Assets, end of period $

    110,980        39,498        26,458        19,895        22,847   

Investment income ratio*

    3.81     2.44     2.86     4.07     5.05

Total return, lowest to highest**

    16.32     14.03% to 20.68     (13.56 %)      4.61     19.34% to 25.28

 

84


Table of Contents

John Hancock Life Insurance Company of New York Separate Account B

Notes to Financial Statements (continued)

 

9. Financial Highlights

 

    Sub-Account  
    Capital Appreciation Trust Series 0  
    Year Ended
Dec. 31/13
    Year Ended
Dec. 31/12
    Year Ended
Dec. 31/11
    Year Ended
Dec. 31/10
    Year Ended
Dec. 31/09
 

Units, beginning of period

    224,074        19,715        6,573        3,745        2,731   

Units issued

    7,827        257,019        14,224        3,932        2,202   

Units redeemed

    (15,543     (52,660     (1,082     (1,104     (1,188
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Units, end of period

    216,358        224,074        19,715        6,573        3,745   
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Unit value, end of period $

    22.17        16.13        13.90        13.88        12.41   

Assets, end of period $

    4,797,597        3,613,450        274,033        91,282        46,488   

Investment income ratio*

    0.26     0.24     0.15     0.22     0.34

Total return, lowest to highest**

    37.50     3.07% to 16.03     0.11     11.88     28.49% to 44.66
    Sub-Account  
    Capital Appreciation Trust Series 1  
    Year Ended
Dec. 31/13
    Year Ended
Dec. 31/12
    Year Ended
Dec. 31/11
    Year Ended
Dec. 31/10
    Year Ended
Dec. 31/09
 

Units, beginning of period

    21,787        17,216        24,852        20,403        18,768   

Units issued

    2,618        7,586        1,756        6,440        7,646   

Units redeemed

    (9,218     (3,015     (9,392     (1,991     (6,011
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Units, end of period

    15,187        21,787        17,216        24,852        20,403   
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Unit value, end of period $

    22.60        16.44        14.18        14.17        12.67   

Assets, end of period $

    343,169        358,273        244,101        352,086        258,477   

Investment income ratio*

    0.24     0.16     0.07     0.14     0.28

Total return, lowest to highest**

    37.41     15.98     0.07     11.83     42.28

 

85


Table of Contents

John Hancock Life Insurance Company of New York Separate Account B

Notes to Financial Statements (continued)

 

9. Financial Highlights

 

    Sub-Account  
    Capital Appreciation Value Trust Series 0  
    Year Ended
Dec. 31/13
    Year Ended
Dec. 31/12
    Year Ended
Dec. 31/11
    Year Ended
Dec. 31/10
    Year Ended
Dec. 31/09 (n)
 

Units, beginning of period

    65,861        49,574        7,785        4,309        —     

Units issued

    11,050        21,760        43,226        3,814        4,378   

Units redeemed

    (5,780     (5,473     (1,437     (338     (69
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Units, end of period

    71,131        65,861        49,574        7,785        4,309   
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Unit value, end of period $

    15.60        12.76        11.12        10.79        9.47   

Assets, end of period $

    1,110,013        840,362        551,165        83,962        40,797   

Investment income ratio*

    1.39     1.68     2.52     1.96     4.08

Total return, lowest to highest**

    22.29     7.74% to 14.77     3.09     13.91     19.68% to 30.98

(n)    Fund available in prior year but no activity.

       

    Sub-Account  
    Core Allocation Plus Trust Series 0  
    Year Ended
Dec. 31/13 (z)
    Year Ended
Dec. 31/12
    Year Ended
Dec. 31/11
    Year Ended
Dec. 31/10
    Year Ended
Dec. 31/09
 

Units, beginning of period

    63,214        51,573        12,952        2,056        25   

Units issued

    17,999        14,390        40,590        11,390        2,075   

Units redeemed

    (81,213     (2,749     (1,969     (494     (44
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Units, end of period

    —          63,214        51,573        12,952        2,056   
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Unit value, end of period $

    12.75        10.63        9.36        9.58        8.66   

Assets, end of period $

    —          671,902        482,804        124,047        17,817   

Investment income ratio*

    3.72     1.54     1.66     1.64     3.21

Total return, lowest to highest**

    20.00     7.77% to 13.53     (2.26 %)      10.57     17.53% to 27.67

 

(z) Terminated as an investment option and funds transferred to Core Strategy Trust on December 9, 2013.

 

86


Table of Contents

John Hancock Life Insurance Company of New York Separate Account B

Notes to Financial Statements (continued)

 

9. Financial Highlights

 

    Sub-Account  
    Core Bond Trust Series 0  
    Year Ended
Dec. 31/13
    Year Ended
Dec. 31/12
    Year Ended
Dec. 31/11
    Year Ended
Dec. 31/10
    Year Ended
Dec. 31/09
 

Units, beginning of period

    30,002        12,035        8,084        174        5   

Units issued

    5,022        130,590        6,894        8,238        302   

Units redeemed

    (2,201     (112,623     (2,943     (328     (133
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Units, end of period

    32,823        30,002        12,035        8,084        174   
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Unit value, end of period $

    15.34        15.67        14.71        13.58        12.67   

Assets, end of period $

    503,461        470,138        177,014        109,761        2,208   

Investment income ratio*

    2.25     1.81     3.79     5.76     3.31

Total return, lowest to highest**

    (2.12 %)      3.76% to 6.54     8.32     7.17     5.61% to 9.93
    Sub-Account   
    Core Bond Trust Series 1  
    Year Ended
Dec. 31/13
    Year Ended
Dec. 31/12
    Year Ended
Dec. 31/11
    Year Ended
Dec. 31/10
    Year Ended
Dec. 31/09
 

Units, beginning of period

    7,239        7,947        7,576        7,642        7,548   

Units issued

    —          —          578        138        330   

Units redeemed

    (138     (708     (207     (204     (236
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Units, end of period

    7,101        7,239        7,947        7,576        7,642   
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Unit value, end of period $

    19.11        19.53        18.35        16.94        15.82   

Assets, end of period $

    135,720        141,400        145,809        128,333        120,893   

Investment income ratio*

    2.13     2.67     3.31     2.71     2.42

Total return, lowest to highest**

    (2.15 %)      6.46     8.32     7.08     9.94

 

87


Table of Contents

John Hancock Life Insurance Company of New York Separate Account B

Notes to Financial Statements (continued)

 

9. Financial Highlights

 

    Sub-Account  
    Core Strategy Trust Series 0  
    Year Ended
Dec. 31/13
    Year Ended
Dec. 31/12
    Year Ended
Dec. 31/11
    Year Ended
Dec. 31/10
    Year Ended
Dec. 31/09 (az)
 

Units, beginning of period

    221,775        380,508        33,777        15,262        267   

Units issued

    207,562        105,814        362,230        23,078        32,585   

Units redeemed

    (23,224     (264,547     (15,499     (4,563     (17,590
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Units, end of period

    406,113        221,775        380,508        33,777        15,262   
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Unit value, end of period $

    13.88        11.64        10.34        10.32        9.17   

Assets, end of period $

    5,636,940        2,580,442        3,932,905        348,482        139,885   

Investment income ratio*

    1.15     2.47     2.63     3.19     3.19

Total return, lowest to highest**

    19.29     7.54% to 12.58     0.19     12.57     18.49% to 25.03

(az)  Renamed on May 4, 2009. Previously known as Index Allocation Trust.

     

    Sub-Account  
    Disciplined Diversification Trust Series 0  
    Year Ended
Dec. 31/13 (z)
    Year Ended
Dec. 31/12
    Year Ended
Dec. 31/11
    Year Ended
Dec. 31/10
    Year Ended
Dec. 31/09
 

Units, beginning of period

    43,479        40,301        34,328        30,638        70   

Units issued

    8,168        5,592        8,493        5,086        31,069   

Units redeemed

    (51,647     (2,414     (2,520     (1,396     (501
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Units, end of period

    —          43,479        40,301        34,328        30,638   
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Unit value, end of period $

    13.23        11.51        10.21        10.42        9.19   

Assets, end of period $

    —          500,637        411,424        357,729        281,420   

Investment income ratio*

    4.35     2.60     2.47     1.82     7.40

Total return, lowest to highest**

    14.89     8.54% to 12.79     (2.04 %)      13.45     20.12% to 29.89

 

(z) Terminated as an investment option and funds transferred to Core Strategy Trust on December 9, 2013.

 

88


Table of Contents

John Hancock Life Insurance Company of New York Separate Account B

Notes to Financial Statements (continued)

 

9. Financial Highlights

 

    Sub-Account  
    Emerging Markets Value Trust Series 0  
    Year Ended
Dec. 31/13
    Year Ended
Dec. 31/12
    Year Ended
Dec. 31/11
    Year Ended
Dec. 31/10
    Year Ended
Dec. 31/09
 

Units, beginning of period

    240,299        177,609        98,617        80,233        2,347   

Units issued

    20,447        87,243        164,542        54,370        80,237   

Units redeemed

    (13,757     (24,553     (85,550     (35,986     (2,351
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Units, end of period

    246,989        240,299        177,609        98,617        80,233   
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Unit value, end of period $

    11.97        12.36        10.43        14.29        11.61   

Assets, end of period $

    2,955,779        2,970,118        1,852,637        1,409,515        931,541   

Investment income ratio*

    1.35     1.20     2.45     1.38     0.13

Total return, lowest to highest**

    (3.18 %)      14.09% to 18.49     (27.02 %)      23.11     1.56% to 101.36
    Sub-Account  
    Emerging Markets Value Trust Series 1  
    Year Ended
Dec. 31/13
    Year Ended
Dec. 31/12
    Year Ended
Dec. 31/11
    Year Ended
Dec. 31/10
    Year Ended
Dec. 31/09 (n)
 

Units, beginning of period

    421        1,972        3,889        77        —     

Units issued

    8        621        327        3,931        82   

Units redeemed

    (25     (2,172     (2,244     (119     (5
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Units, end of period

    404        421        1,972        3,889        77   
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Unit value, end of period $

    14.93        15.42        13.01        17.84        14.50   

Assets, end of period $

    6,059        6,521        25,675        69,386        1,128   

Investment income ratio*

    1.28     0.83     1.51     2.32     0.05

Total return, lowest to highest**

    (3.22 %)      18.53     (27.06 %)      23.03     101.12

 

(n) Fund available in prior year but no activity.

 

89


Table of Contents

John Hancock Life Insurance Company of New York Separate Account B

Notes to Financial Statements (continued)

 

9. Financial Highlights

 

    Sub-Account  
    Equity-Income Trust Series 0  
    Year Ended
Dec. 31/13
    Year Ended
Dec. 31/12
    Year Ended
Dec. 31/11
    Year Ended
Dec. 31/10
    Year Ended
Dec. 31/09
 

Units, beginning of period

    183,533        65,762        38,933        38,620        19,617   

Units issued

    9,138        156,871        38,362        18,265        34,992   

Units redeemed

    (30,304     (39,100     (11,533     (17,952     (15,989
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Units, end of period

    162,367        183,533        65,762        38,933        38,620   
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Unit value, end of period $

    42.63        32.78        27.90        28.12        24.40   

Assets, end of period $

    6,921,388        6,015,928        1,835,020        1,094,709        942,394   

Investment income ratio*

    2.00     2.46     2.22     2.01     2.39

Total return, lowest to highest**

    30.05     10.80% to 17.47     (0.76 %)      15.23     24.57% to 30.76
    Sub-Account  
    Equity-Income Trust Series 1  
    Year Ended
Dec. 31/13
    Year Ended
Dec. 31/12
    Year Ended
Dec. 31/11
    Year Ended
Dec. 31/10
    Year Ended
Dec. 31/09
 

Units, beginning of period

    35,163        34,818        21,579        23,852        34,606   

Units issued

    4,304        2,977        18,762        2,793        9,623   

Units redeemed

    (8,253     (2,632     (5,523     (5,066     (20,377
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Units, end of period

    31,214        35,163        34,818        21,579        23,852   
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Unit value, end of period $

    25.82        19.86        16.92        17.06        14.82   

Assets, end of period $

    806,115        698,291        589,152        368,113        353,455   

Investment income ratio*

    1.85     2.12     2.09     1.86     2.06

Total return, lowest to highest**

    30.04     17.36     (0.81 %)      15.11     25.72

 

90


Table of Contents

John Hancock Life Insurance Company of New York Separate Account B

Notes to Financial Statements (continued)

 

9. Financial Highlights

 

    Sub-Account  
    Financial Services Trust Series 0  
    Year Ended
Dec. 31/13
    Year Ended
Dec. 31/12
    Year Ended
Dec. 31/11
    Year Ended
Dec. 31/10
    Year Ended
Dec. 31/09
 

Units, beginning of period

    15,608        20,995        13,850        20,156        5,401   

Units issued

    3,021        49,061        40,001        4,459        16,641   

Units redeemed

    (1,551     (54,448     (32,856     (10,765     (1,886
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Units, end of period

    17,078        15,608        20,995        13,850        20,156   
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Unit value, end of period $

    26.20        20.02        16.96        18.72        16.68   

Assets, end of period $

    447,400        312,473        356,125        259,280        336,237   

Investment income ratio*

    0.74     0.68     1.37     0.32     1.48

Total return, lowest to highest**

    30.86     8.06% to 18.03     (9.39 %)      12.22     25.68% to 49.06
    Sub-Account  
    Financial Services Trust Series 1  
    Year Ended
Dec. 31/13
    Year Ended
Dec. 31/12
    Year Ended
Dec. 31/11
    Year Ended
Dec. 31/10
    Year Ended
Dec. 31/09
 

Units, beginning of period

    6,673        6,888        7,907        8,149        7,699   

Units issued

    117        68        147        807        1,904   

Units redeemed

    (263     (283     (1,166     (1,049     (1,454
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Units, end of period

    6,527        6,673        6,888        7,907        8,149   
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Unit value, end of period $

    21.77        16.65        14.10        15.59        13.89   

Assets, end of period $

    142,093        111,115        97,158        123,250        113,149   

Investment income ratio*

    0.65     0.80     1.61     0.34     0.75

Total return, lowest to highest**

    30.75     18.05     (9.51 %)      12.26     41.41

 

91


Table of Contents

John Hancock Life Insurance Company of New York Separate Account B

Notes to Financial Statements (continued)

 

9. Financial Highlights

 

    Sub-Account  
    Franklin Templeton Founding Allocation Trust Series 0  
    Year Ended
Dec. 31/13
    Year Ended
Dec. 31/12
    Year Ended
Dec. 31/11
    Year Ended
Dec. 31/10
    Year Ended
Dec. 31/09
 

Units, beginning of period

    107,295        63,253        14,641        2,821        204   

Units issued

    35,637        49,595        51,040        12,964        2,762   

Units redeemed

    (8,984     (5,553     (2,428     (1,144     (145
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Units, end of period

    133,948        107,295        63,253        14,641        2,821   
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Unit value, end of period $

    14.12        11.34        9.75        9.89        8.93   

Assets, end of period $

    1,890,794        1,216,471        616,457        144,801        25,206   

Investment income ratio*

    2.82     4.11     4.91     7.41     6.77

Total return, lowest to highest**

    24.51     12.32% to 16.33     (1.45 %)      10.71     25.33% to 32.61
    Sub-Account  
    Franklin Templeton Founding Allocation Trust Series 1  
    Year Ended
Dec. 31/13
    Year Ended
Dec. 31/12  (r)
    Year Ended
Dec. 31/11
    Year Ended
Dec. 31/10 (n)
 

Units, beginning of period

    —          —          346        —     

Units issued

    155        —          —          364   

Units redeemed

    (2     —          (346     (18
 

 

 

   

 

 

   

 

 

   

 

 

 

Units, end of period

    153        —          —          346   
 

 

 

   

 

 

   

 

 

   

 

 

 

Unit value, end of period $

    14.09        11.32        9.74        9.88   

Assets, end of period $

    2,156        —          —          3,420   

Investment income ratio*

    21.24     0.00     0.00     6.97

Total return, lowest to highest**

    24.43     16.26     (1.41 %)      10.66

 

(r) Fund available but no activity.
(n) Fund available in prior year but no activity.

 

 

92


Table of Contents

John Hancock Life Insurance Company of New York Separate Account B

Notes to Financial Statements (continued)

 

9. Financial Highlights

 

    Sub-Account  
    Frontier Capital Appreciation  
    Year Ended     Year Ended     Year Ended     Year Ended     Year Ended  
    Dec. 31/13     Dec. 31/12     Dec. 31/11     Dec. 31/10     Dec. 31/09  

Units, beginning of period

    84        59        6        2        31   

Units issued

    649        29        131        5        2   

Units redeemed

    (9     (4     (78     (1     (31
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Units, end of period

    724        84        59        6        2   
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Unit value, end of period $

    75.67        54.36        46.29        49.89        39.29   

Assets, end of period $

    54,710        4,505        2,704        275        91   

Investment income ratio*

    0.00     0.39     0.00     0.15     0.15

Total return, lowest to highest**

    39.20     8.43% to 17.43     (7.22 %)      27.00     29.61% to 50.68
    Sub-Account  
    Fundamental All Cap Core Trust Series 0  
    Year Ended     Year Ended     Year Ended     Year Ended     Year Ended  
    Dec. 31/13     Dec. 31/12     Dec. 31/11 (j)     Dec. 31/10     Dec. 31/09  

Units, beginning of period

    11,939        88,943        9,318        7,099        6,594   

Units issued

    17,627        3,671        83,048        4,103        3,624   

Units redeemed

    (2,645     (80,675     (3,423     (1,884     (3,119
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Units, end of period

    26,921        11,939        88,943        9,318        7,099   
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Unit value, end of period $

    19.73        14.52        11.74        11.98        10.02   

Assets, end of period $

    530,987        173,316        1,044,175        111,639        71,151   

Investment income ratio*

    1.14     0.35     1.32     1.35     1.44

Total return, lowest to highest**

    35.87     15.03% to 23.67     (2.02 %)      19.55     26.61% to 31.86

 

(j) Renamed on June 27, 2011. Previously known as Optimized All Cap Trust.

 

 

93


Table of Contents

John Hancock Life Insurance Company of New York Separate Account B

Notes to Financial Statements (continued)

 

9. Financial Highlights

 

     Sub-Account  
     Fundamental All Cap Core Trust Series 1  
     Year Ended     Year Ended     Year Ended     Year Ended     Year Ended  
     Dec. 31/13     Dec. 31/12     Dec. 31/11 (j)     Dec. 31/10     Dec. 31/09  

Units, beginning of period

     17        36        66        67        218   

Units issued

     1,091        123        110        119        723   

Units redeemed

     (50     (142     (140     (120     (874
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Units, end of period

     1,058        17        36        66        67   
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Unit value, end of period $

     33.23        24.46        19.80        20.22        16.91   

Assets, end of period $

     35,115        396        691        1,320        1,127   

Investment income ratio*

     0.34     0.47     0.75     1.11     0.28

Total return, lowest to highest**

     35.88     23.52     (2.08 %)      19.55     28.27

 

(j) Renamed on June 27, 2011. Previously known as Optimized All Cap Trust.

 

     Sub-Account  
     Fundamental Holdings Trust Series 1  
     Year Ended     Year Ended     Year Ended     Year Ended     Year Ended  
     Dec. 31/13 (z)     Dec. 31/12     Dec. 31/11 (p)     Dec. 31/10     Dec. 31/09 (a)  

Units, beginning of period

     11,450        9,969        72,846        2,833        —     

Units issued

     3,428        2,529        5,645        71,620        2,841   

Units redeemed

     (14,878     (1,048     (68,522     (1,607     (8
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Units, end of period

     —          11,450        9,969        72,846        2,833   
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Unit value, end of period $

     16.67        14.66        13.02        13.15        11.92   

Assets, end of period $

     —          167,926        129,800        958,309        33,778   

Investment income ratio*

     2.20     1.91     1.38     3.14     12.79

Total return, lowest to highest**

     13.66     7.22% to 12.65     (1.05 %)      10.36     18.47% to 19.20

 

(z) Terminated as an investment option and funds transferred to Core Strategy Trust on December 9, 2013.
(p) Renamed on October 31, 2011. Previously known as American Fundamental Holdings Trust Series 1.
(a) Reflects the period from commencement of operations on May 4, 2009 through December 31, 2009.

 

 

94


Table of Contents

John Hancock Life Insurance Company of New York Separate Account B

Notes to Financial Statements (continued)

 

9. Financial Highlights

 

     Sub-Account  
     Fundamental Large Cap Value Trust Series 0  
     Year Ended     Year Ended     Year Ended     Year Ended     Year Ended  
     Dec. 31/13     Dec. 31/12     Dec. 31/11 (o)     Dec. 31/10     Dec. 31/09  

Units, beginning of period

     2,603        1,145        1,107        711        635   

Units issued

     68,598        1,644        129        458        118   

Units redeemed

     (1,775     (186     (91     (62     (42
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Units, end of period

     69,426        2,603        1,145        1,107        711   
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Unit value, end of period $

     18.04        13.62        10.94        10.74        9.46   

Assets, end of period $

     1,252,483        35,444        12,522        11,885        6,727   

Investment income ratio*

     1.49     2.01     1.09     2.55     2.26

Total return, lowest to highest**

     32.46     16.71% to 24.48     1.90     13.51     22.60% to 28.80

 

(o) Renamed on June 27, 2011. Previously known as Optimized Value Trust.

 

     Sub-Account  
     Fundamental Large Cap Value Trust Series 1  
     Year Ended     Year Ended  
     Dec. 31/13     Dec. 31/12 (n)  

Units, beginning of period

     —          —     

Units issued

     5,280        1,417   

Units redeemed

     (10     (1,417
  

 

 

   

 

 

 

Units, end of period

     5,270        —     
  

 

 

   

 

 

 

Unit value, end of period $

     25.64        19.36   

Assets, end of period $

     135,126        —     

Investment income ratio*

     0.00     0.00

Total return, lowest to highest**

     32.41     24.43

 

(n) Fund available in prior year but no activity.

 

 

95


Table of Contents

John Hancock Life Insurance Company of New York Separate Account B

Notes to Financial Statements (continued)

 

9. Financial Highlights

 

     Sub-Account  
     Fundamental Value Trust Series 0  
     Year Ended
Dec. 31/13
    Year Ended
Dec. 31/12
    Year Ended
Dec. 31/11
    Year Ended
Dec. 31/10
    Year Ended
Dec. 31/09
 

Units, beginning of period

     27,028        25,146        100,018        19,978        12,508   

Units issued

     2,603        7,590        7,502        87,250        15,795   

Units redeemed

     (13,028     (5,708     (82,374     (7,210     (8,325
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Units, end of period

     16,603        27,028        25,146        100,018        19,978   
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Unit value, end of period $

     17.45        13.06        11.52        11.96        10.57   

Assets, end of period $

     289,723        352,963        289,576        1,196,553        211,149   

Investment income ratio*

     1.36     1.06     0.82     2.00     1.18

Total return, lowest to highest**

     33.62     6.37% to 13.40     (3.74 %)      13.20     24.46% to 38.50
     Sub-Account  
     Fundamental Value Trust Series 1  
     Year Ended
Dec. 31/13
    Year Ended
Dec. 31/12
    Year Ended
Dec. 31/11
    Year Ended
Dec. 31/10
    Year Ended
Dec. 31/09
 

Units, beginning of period

     26,876        37,776        36,464        37,304        51,202   

Units issued

     1,580        2,090        5,148        3,423        3,228   

Units redeemed

     (3,115     (12,990     (3,836     (4,263     (17,126
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Units, end of period

     25,341        26,876        37,776        36,464        37,304   
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Unit value, end of period $

     24.37        18.25        16.10        16.73        14.79   

Assets, end of period $

     617,642        490,620        608,196        610,130        551,908   

Investment income ratio*

     1.33     0.85     0.86     1.15     0.87

Total return, lowest to highest**

     33.52     13.38     (3.78 %)      13.10     31.78

 

96


Table of Contents

John Hancock Life Insurance Company of New York Separate Account B

Notes to Financial Statements (continued)

 

9. Financial Highlights

 

     Sub-Account  
     Global Bond Trust Series 0  
     Year Ended
Dec. 31/13
    Year Ended
Dec. 31/12
    Year Ended
Dec. 31/11
    Year Ended
Dec. 31/10
    Year Ended
Dec. 31/09
 

Units, beginning of period

     56,000        24,198        22,412        14,823        16,578   

Units issued

     5,022        37,731        4,734        9,135        24,214   

Units redeemed

     (30,392     (5,929     (2,948     (1,546     (25,969
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Units, end of period

     30,630        56,000        24,198        22,412        14,823   
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Unit value, end of period $

     30.08        31.84        29.72        27.24        24.68   

Assets, end of period $

     921,315        1,783,116        719,107        610,575        365,776   

Investment income ratio*

     0.34     8.14     6.68     4.16     9.15

Total return, lowest to highest**

     (5.54 %)      4.53% to 7.15     9.08     10.40     13.91% to 15.41
     Sub-Account  
     Global Bond Trust Series 1  
     Year Ended
Dec. 31/13
    Year Ended
Dec. 31/12
    Year Ended
Dec. 31/11
    Year Ended
Dec. 31/10
    Year Ended
Dec. 31/09
 

Units, beginning of period

     10,561        13,161        14,516        14,975        21,752   

Units issued

     602        425        1,138        1,011        1,141   

Units redeemed

     (3,089     (3,025     (2,493     (1,470     (7,918
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Units, end of period

     8,074        10,561        13,161        14,516        14,975   
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Unit value, end of period $

     21.08        22.28        20.82        19.09        17.31   

Assets, end of period $

     170,232        235,410        274,076        277,123        259,180   

Investment income ratio*

     0.42     6.83     6.18     3.58     12.39

Total return, lowest to highest**

     (5.42 %)      7.03     9.08     10.30     15.39

 

97


Table of Contents

John Hancock Life Insurance Company of New York Separate Account B

Notes to Financial Statements (continued)

 

9. Financial Highlights

 

    Sub-Account  
    Global Diversification Trust Series 1  
    Year Ended
Dec. 31/13 (z)
    Year Ended
Dec. 31/12
    Year Ended
Dec. 31/11 (q)
    Year Ended
Dec. 31/10
    Year Ended
Dec. 31/09 (a)
 

Units, beginning of period

    19,135        16,953        6,614        2,302        —     

Units issued

    10,687        4,116        11,703        4,740        2,303   

Units redeemed

    (29,822     (1,934     (1,364     (428     (1
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Units, end of period

    —          19,135        16,953        6,614        2,302   
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Unit value, end of period $

    17.42        15.36        13.26        14.18        12.59   

Assets, end of period $

    —          293,870        224,753        93,765        28,990   

Investment income ratio*

    2.29     1.87     3.07     3.98     49.21

Total return, lowest to highest**

    13.46     9.32% to 15.84     (6.49 %)      12.57     23.51% to 25.94

(z)    Terminated as an investment option and funds transferred to Core Strategy Trust on December 9, 2013.

(q)    Renamed on October 31, 2011. Previously known as American Global Diversification Trust Series 1.

(a)    Reflects the period from commencement of operations on May 4, 2009 through December 31, 2009.

       

       

       

    Sub-Account  
    Global Trust Series 0  
    Year Ended
Dec. 31/13
    Year Ended
Dec. 31/12
    Year Ended
Dec. 31/11
    Year Ended
Dec. 31/10
    Year Ended
Dec. 31/09
 

Units, beginning of period

    5,089        5,881        5,566        4,180        6,917   

Units issued

    2,767        1,193        1,408        1,799        1,715   

Units redeemed

    (501     (1,985     (1,093     (413     (4,452
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Units, end of period

    7,355        5,089        5,881        5,566        4,180   
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Unit value, end of period $

    17.70        13.51        11.09        11.79        10.94   

Assets, end of period $

    130,202        68,758        65,217        65,634        45,718   

Investment income ratio*

    1.77     2.10     2.19     1.91     1.68

Total return, lowest to highest**

    31.04     18.78% to 21.82     (5.96 %)      7.82     25.95% to 34.80

 

98


Table of Contents

John Hancock Life Insurance Company of New York Separate Account B

Notes to Financial Statements (continued)

 

9. Financial Highlights

 

     Sub-Account  
     Global Trust Series 1  
     Year Ended
Dec. 31/13
    Year Ended
Dec. 31/12
    Year Ended
Dec. 31/11
    Year Ended
Dec. 31/10
    Year Ended
Dec. 31/09
 

Units, beginning of period

     64,693        66,962        61,120        49,303        14,977   

Units issued

     34        12        11,042        13,256        43,211   

Units redeemed

     (59,402     (2,281     (5,200     (1,439     (8,885
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Units, end of period

     5,325        64,693        66,962        61,120        49,303   
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Unit value, end of period $

     19.40        14.80        12.15        12.93        12.00   

Assets, end of period $

     103,317        957,336        813,925        790,323        591,609   

Investment income ratio*

     0.27     2.18     2.08     1.65     4.69

Total return, lowest to highest**

     31.08     21.75     (6.00 %)      7.76     31.36
     Sub-Account  
     Health Sciences Trust Series 0  
     Year Ended
Dec. 31/13
    Year Ended
Dec. 31/12
    Year Ended
Dec. 31/11
    Year Ended
Dec. 31/10
    Year Ended
Dec. 31/09
 

Units, beginning of period

     16,097        8,430        6,190        23,192        5,783   

Units issued

     5,685        12,370        3,130        3,034        20,674   

Units redeemed

     (1,379     (4,703     (890     (20,036     (3,265
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Units, end of period

     20,403        16,097        8,430        6,190        23,192   
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Unit value, end of period $

     40.81        26.99        20.45        18.48        15.96   

Assets, end of period $

     832,668        434,383        172,437        114,424        370,136   

Investment income ratio*

     0.00     0.00     0.00     0.00     0.00

Total return, lowest to highest**

     51.24     12.19% to 31.93     10.66     15.81     29.89% to 34.30

 

99


Table of Contents

John Hancock Life Insurance Company of New York Separate Account B

Notes to Financial Statements (continued)

 

9. Financial Highlights

 

     Sub-Account  
     Health Sciences Trust Series 1  
     Year Ended
Dec. 31/13
    Year Ended
Dec. 31/12
    Year Ended
Dec. 31/11
    Year Ended
Dec. 31/10
    Year Ended
Dec. 31/09
 

Units, beginning of period

     6,047        6,987        7,361        7,371        11,054   

Units issued

     742        859        106        408        685   

Units redeemed

     (1,201     (1,799     (480     (418     (4,368
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Units, end of period

     5,588        6,047        6,987        7,361        7,371   
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Unit value, end of period $

     52.38        34.67        26.28        23.76        20.54   

Assets, end of period $

     292,696        209,633        183,561        174,926        151,406   

Investment income ratio*

     0.00     0.00     0.00     0.00     0.00

Total return, lowest to highest**

     51.07     31.95     10.57     15.70     31.81
     Sub-Account  
     High Yield Trust Series 0  
     Year Ended
Dec. 31/13
    Year Ended
Dec. 31/12
    Year Ended
Dec. 31/11
    Year Ended
Dec. 31/10
    Year Ended
Dec. 31/09
 

Units, beginning of period

     300,098        135,322        38,750        20,085        25,611   

Units issued

     27,426        192,996        106,412        24,650        38,737   

Units redeemed

     (253,174     (28,220     (9,840     (5,985     (44,263
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Units, end of period

     74,350        300,098        135,322        38,750        20,085   
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Unit value, end of period $

     21.14        19.45        16.33        16.15        14.20   

Assets, end of period $

     1,570,793        5,835,684        2,210,205        625,808        285,178   

Investment income ratio*

     3.08     9.08     10.00     56.47     11.12

Total return, lowest to highest**

     8.68     9.73% to 19.07     1.14     13.75     31.02% to 54.51

 

100


Table of Contents

John Hancock Life Insurance Company of New York Separate Account B

Notes to Financial Statements (continued)

 

9. Financial Highlights

 

    Sub-Account  
    High Yield Trust Series 1  
    Year Ended
Dec. 31/13
    Year Ended
Dec. 31/12
    Year Ended
Dec. 31/11
    Year Ended
Dec. 31/10
    Year Ended
Dec. 31/09
 

Units, beginning of period

    11,431        11,474        11,213        9,668        10,542   

Units issued

    508        434        886        2,428        1,151   

Units redeemed

    (1,650     (477     (625     (883     (2,025
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Units, end of period

    10,289        11,431        11,474        11,213        9,668   
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Unit value, end of period $

    22.30        20.54        17.27        17.11        15.04   

Assets, end of period $

    229,554        234,984        198,224        192,003        145,523   

Investment income ratio*

    6.83     7.93     8.79     44.62     11.71

Total return, lowest to highest**

    8.53     18.98     0.90     13.78     54.51
    Sub-Account  
    International Core Trust Series 0  
    Year Ended
Dec. 31/13
    Year Ended
Dec. 31/12
    Year Ended
Dec. 31/11
    Year Ended
Dec. 31/10
    Year Ended
Dec. 31/09
 

Units, beginning of period

    40,566        51,752        39,058        26,018        15,838   

Units issued

    6,784        14,236        23,871        24,641        31,640   

Units redeemed

    (25,669     (25,422     (11,177     (11,601     (21,460
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Units, end of period

    21,681        40,566        51,752        39,058        26,018   
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Unit value, end of period $

    17.23        13.77        11.96        13.22        12.05   

Assets, end of period $

    373,513        558,510        618,746        516,316        313,626   

Investment income ratio*

    3.16     3.11     3.03     2.23     2.54

Total return, lowest to highest**

    25.13     15.16% to 16.10     (9.55 %)      9.67     18.62% to 22.55

 

101


Table of Contents

John Hancock Life Insurance Company of New York Separate Account B

Notes to Financial Statements (continued)

 

9. Financial Highlights

 

    Sub-Account  
    International Core Trust Series 1  
    Year Ended
Dec. 31/13
    Year Ended
Dec. 31/12
    Year Ended
Dec. 31/11
    Year Ended
Dec. 31/10
    Year Ended
Dec. 31/09
 

Units, beginning of period

    6,183        6,313        7,935        9,009        7,100   

Units issued

    266        376        347        525        3,877   

Units redeemed

    (1,613     (506     (1,969     (1,599     (1,968
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Units, end of period

    4,836        6,183        6,313        7,935        9,009   
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Unit value, end of period $

    16.21        12.97        11.28        12.47        11.38   

Assets, end of period $

    78,377        80,182        71,156        98,921        102,502   

Investment income ratio*

    2.80     2.96     2.08     1.84     2.63

Total return, lowest to highest**

    24.99     15.05     (9.57 %)      9.58     18.64
    Sub-Account  
    International Equity Index Trust B Series 0  
    Year Ended
Dec. 31/13
    Year Ended
Dec. 31/12
    Year Ended
Dec. 31/11
    Year Ended
Dec. 31/10
    Year Ended
Dec. 31/09
 

Units, beginning of period

    101,611        112,325        38,114        23,162        5,553   

Units issued

    10,966        20,421        82,664        17,369        18,556   

Units redeemed

    (14,827     (31,135     (8,453     (2,417     (947
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Units, end of period

    97,750        101,611        112,325        38,114        23,162   
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Unit value, end of period $

    47.59        41.55        35.28        41.02        36.81   

Assets, end of period $

    4,652,174        4,222,165        3,963,357        1,563,604        852,707   

Investment income ratio*

    2.52     1.30     4.79     2.96     6.68

Total return, lowest to highest**

    14.54     15.48% to 17.76     (13.99 %)      11.43     27.56% to 43.56

 

102


Table of Contents

John Hancock Life Insurance Company of New York Separate Account B

Notes to Financial Statements (continued)

 

9. Financial Highlights

 

    Sub-Account  
    International Equity Index Trust B Series 1  
    Year Ended     Year Ended  
    Dec. 31/13     Dec. 31/12 (s)  

Units, beginning of period

    24,734        —     

Units issued

    1,353        24,949   

Units redeemed

    (3,140     (215
 

 

 

   

 

 

 

Units, end of period

    22,947        24,734   
 

 

 

   

 

 

 

Unit value, end of period $

    12.14        10.60   

Assets, end of period $

    278,688        262,226   

Investment income ratio*

    2.50     6.95

Total return, lowest to highest**

    14.56     6.02

 

(s) Reflects the period from commencement of operations on November 5, 2012 through December 31, 2012.

 

    Sub-Account  
    International Growth Stock Trust Series 0  
    Year Ended     Year Ended  
    Dec. 31/13     Dec. 31/12 (s)  

Units, beginning of period

    53,510        —     

Units issued

    4,449        53,738   

Units redeemed

    (6,430     (228
 

 

 

   

 

 

 

Units, end of period

    51,529        53,510   
 

 

 

   

 

 

 

Unit value, end of period $

    12.41        10.41   

Assets, end of period $

    639,451        557,127   

Investment income ratio*

    1.23     4.25

Total return, lowest to highest**

    19.18     4.12

 

(s) Reflects the period from commencement of operations on November 5, 2012 through December 31, 2012.

 

 

103


Table of Contents

John Hancock Life Insurance Company of New York Separate Account B

Notes to Financial Statements (continued)

 

9. Financial Highlights

 

    Sub-Account  
    International Growth Stock Trust Series 1  
    Year Ended     Year Ended  
    Dec. 31/13     Dec. 31/12 (s)  

Units, beginning of period

    16,283        —     

Units issued

    1,073        16,354   

Units redeemed

    (395     (71
 

 

 

   

 

 

 

Units, end of period

    16,961        16,283   
 

 

 

   

 

 

 

Unit value, end of period $

    12.40        10.41   

Assets, end of period $

    210,237        169,456   

Investment income ratio*

    1.25     4.01

Total return, lowest to highest**

    19.10     4.08

 

(s) Reflects the period from commencement of operations on November 5, 2012 through December 31, 2012.

 

    Sub-Account  
    International Small Company Trust Series 0  
    Year Ended     Year Ended     Year Ended     Year Ended     Year Ended  
    Dec. 31/13     Dec. 31/12     Dec. 31/11     Dec. 31/10     Dec. 31/09 (ax)  

Units, beginning of period

    26,976        86,864        28,843        24,956        —     

Units issued

    5,682        4,628        68,494        8,832        26,279   

Units redeemed

    (2,140     (64,516     (10,473     (4,945     (1,323
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Units, end of period

    30,518        26,976        86,864        28,843        24,956   
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Unit value, end of period $

    15.23        12.06        10.12        12.07        9.84   

Assets, end of period $

    464,898        325,389        878,654        348,068        245,594   

Investment income ratio*

    2.04     0.93     1.82     2.90     0.79

Total return, lowest to highest**

    26.30     12.82% to 19.23     (16.18 %)      22.62     (1.59 %) 

 

(ax) Reflects the period from commencement of operations on November 16, 2009 through December 31, 2009.

 

104


Table of Contents

John Hancock Life Insurance Company of New York Separate Account B

Notes to Financial Statements (continued)

 

9. Financial Highlights

 

    Sub-Account  
    International Small Company Trust Series 1  
    Year Ended
Dec. 31/13
    Year Ended
Dec. 31/12
    Year Ended
Dec. 31/11
    Year Ended
Dec. 31/10
    Year Ended
Dec. 31/09 (ax)
 

Units, beginning of period

    3,493        5,530        5,981        6,159        —     

Units issued

    240        267        246        392        6,197   

Units redeemed

    (453     (2,304     (697     (570     (38
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Units, end of period

    3,280        3,493        5,530        5,981        6,159   
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Unit value, end of period $

    15.22        12.04        10.10        12.06        9.83   

Assets, end of period $

    49,900        42,064        55,874        72,140        60,545   

Investment income ratio*

    1.89     1.26     1.60     2.80     0.79

Total return, lowest to highest**

    26.34     19.20     (16.23 %)      22.70     (1.70 %) 

(ax)  Reflects the period from commencement of operations on November 16, 2009 through December 31, 2009.

     

    Sub-Account  
    International Value Trust Series 0  
    Year Ended
Dec. 31/13
    Year Ended
Dec. 31/12
    Year Ended
Dec. 31/11
    Year Ended
Dec. 31/10
    Year Ended
Dec. 31/09
 

Units, beginning of period

    20,409        27,869        61,670        30,587        9,516   

Units issued

    7,890        3,983        7,031        66,946        22,519   

Units redeemed

    (3,996     (11,443     (40,832     (35,863     (1,448
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Units, end of period

    24,303        20,409        27,869        61,670        30,587   
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Unit value, end of period $

    17.64        13.98        11.71        13.43        12.43   

Assets, end of period $

    428,737        285,268        326,381        828,160        380,313   

Investment income ratio*

    1.95     2.82     1.69     2.42     3.06

Total return, lowest to highest**

    26.21     19.36% to 19.59     (12.80 %)      8.00     26.96% to 39.98

 

105


Table of Contents

John Hancock Life Insurance Company of New York Separate Account B

Notes to Financial Statements (continued)

 

9. Financial Highlights

 

    Sub-Account  
    International Value Trust Series 1  
    Year Ended
Dec. 31/13
    Year Ended
Dec. 31/12
    Year Ended
Dec. 31/11
    Year Ended
Dec. 31/10
    Year Ended
Dec. 31/09
 

Units, beginning of period

    47,850        47,442        42,358        34,764        14,922   

Units issued

    2,006        3,037        7,317        9,213        26,779   

Units redeemed

    (37,755     (2,629     (2,233     (1,619     (6,937
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Units, end of period

    12,101        47,850        47,442        42,358        34,764   
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Unit value, end of period $

    27.37        21.70        18.18        20.86        19.32   

Assets, end of period $

    331,196        1,038,305        862,318        883,441        671,440   

Investment income ratio*

    0.79     2.76     2.49     2.07     5.37

Total return, lowest to highest**

    26.15     19.38     (12.85 %)      7.98     35.77
    Sub-Account  
    Investment Quality Bond Trust Series 0  
    Year Ended
Dec. 31/13
    Year Ended
Dec. 31/12
    Year Ended
Dec. 31/11
    Year Ended
Dec. 31/10
    Year Ended
Dec. 31/09
 

Units, beginning of period

    158,062        9,019        24,390        18,767        16,199   

Units issued

    2,682        188,465        4,092        8,263        3,085   

Units redeemed

    (150,372     (39,422     (19,463     (2,640     (517
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Units, end of period

    10,372        158,062        9,019        24,390        18,767   
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Unit value, end of period $

    15.14        15.43        14.33        13.26        12.33   

Assets, end of period $

    157,106        2,439,155        129,256        323,517        231,488   

Investment income ratio*

    0.41     3.52     2.78     5.97     5.26

Total return, lowest to highest**

    (1.88 %)      4.09% to 7.66     8.06     7.54     9.70% to 12.43

 

106


Table of Contents

John Hancock Life Insurance Company of New York Separate Account B

Notes to Financial Statements (continued)

 

9. Financial Highlights

 

    Sub-Account  
    Investment Quality Bond Trust Series 1  
    Year Ended
Dec. 31/13
    Year Ended
Dec. 31/12
    Year Ended
Dec. 31/11
    Year Ended
Dec. 31/10
    Year Ended
Dec. 31/09
 

Units, beginning of period

    9,770        11,641        13,459        15,281        20,496   

Units issued

    643        3,983        541        379        594   

Units redeemed

    (256     (5,854     (2,359     (2,201     (5,809
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Units, end of period

    10,157        9,770        11,641        13,459        15,281   
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Unit value, end of period $

    21.87        22.29        20.72        19.18        17.85   

Assets, end of period $

    222,114        217,852        241,263        258,119        272,726   

Investment income ratio*

    3.90     1.92     4.12     4.99     4.69

Total return, lowest to highest**

    (1.92 %)      7.59     8.07     7.46     12.45
    Sub-Account  
    Large Cap Growth  
    Year Ended
Dec. 31/13
    Year Ended
Dec. 31/12
    Year Ended
Dec. 31/11
    Year Ended
Dec. 31/10
    Year Ended
Dec. 31/09 (ba)
 

Units, beginning of period

    1,668        1,178        576        237        101   

Units issued

    1,699        767        1,688        417        189   

Units redeemed

    (376     (277     (1,086     (78     (53
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Units, end of period

    2,991        1,668        1,178        576        237   
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Unit value, end of period $

    45.56        33.46        28.04        28.27        22.97   

Assets, end of period $

    136,344        55,847        33,056        16,291        5,454   

Investment income ratio*

    0.61     0.05     0.00     0.31     0.82

Total return, lowest to highest**

    36.15     7.49% to 19.31     (0.80 %)      23.06     24.69% to 41.05

 

(ba) Renamed on November 16, 2009. Previously known as Turner Core Growth Trust.

 

107


Table of Contents

John Hancock Life Insurance Company of New York Separate Account B

Notes to Financial Statements (continued)

 

9. Financial Highlights

 

     Sub-Account  
     Large Cap Value  
     Year Ended
Dec. 31/13 (ag)
    Year Ended
Dec. 31/12
    Year Ended
Dec. 31/11
    Year Ended
Dec. 31/10
    Year Ended
Dec. 31/09
 

Units, beginning of period

     1,325        1,074        620        422        178   

Units issued

     2,926        353        956        276        310   

Units redeemed

     (358     (102     (502     (78     (66
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Units, end of period

     3,893        1,325        1,074        620        422   
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Unit value, end of period $

     21.75        16.20        13.81        14.41        13.18   

Assets, end of period $

     84,641        21,462        14,830        8,930        5,565   

Investment income ratio*

     3.52     0.88     0.39     0.82     1.03

Total return, lowest to highest**

     34.22     10.97% to 17.29     (4.11 %)      9.27     19.01% to 27.24

(ag)  Renamed on April 29, 2013. Previously known as Business Opportunity Value.

     

     Sub-Account  
     Lifestyle Aggressive Trust Series 0  
     Year Ended
Dec. 31/13
    Year Ended
Dec. 31/12
    Year Ended
Dec. 31/11
    Year Ended
Dec. 31/10
    Year Ended
Dec. 31/09
 

Units, beginning of period

     568,585        394,551        504,312        802,573        573,191   

Units issued

     102,618        220,007        171,543        82,576        288,873   

Units redeemed

     (139,386     (45,973     (281,304     (380,837     (59,491
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Units, end of period

     531,817        568,585        394,551        504,312        802,573   
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Unit value, end of period $

     18.39        14.51        12.43        13.29        11.41   

Assets, end of period $

     9,780,876        8,248,307        4,905,842        6,703,568        9,157,825   

Investment income ratio*

     2.74     1.68     1.85     1.57     1.28

Total return, lowest to highest**

     26.77     9.51% to 16.67     (6.46 %)      16.50     26.59% to 40.08

 

108


Table of Contents

John Hancock Life Insurance Company of New York Separate Account B

Notes to Financial Statements (continued)

 

9. Financial Highlights

 

    Sub-Account  
    Lifestyle Aggressive Trust Series 1  
    Year Ended
Dec. 31/13
    Year Ended
Dec. 31/12
    Year Ended
Dec. 31/11
    Year Ended
Dec. 31/10
    Year Ended
Dec. 31/09
 

Units, beginning of period

    28,457        25,099        23,381        22,149        23,308   

Units issued

    2,836        4,311        2,499        4,231        8,806   

Units redeemed

    (1,160     (953     (781     (2,999     (9,965
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Units, end of period

    30,133        28,457        25,099        23,381        22,149   
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Unit value, end of period $

    20.14        15.90        13.63        14.58        12.52   

Assets, end of period $

    606,938        452,335        342,128        340,892        277,321   

Investment income ratio*

    2.58     1.50     1.80     1.99     0.94

Total return, lowest to highest**

    26.72     16.61     (6.50 %)      16.45     35.62
    Sub-Account  
    Lifestyle Balanced Trust Series 0  
    Year Ended
Dec. 31/13
    Year Ended
Dec. 31/12
    Year Ended
Dec. 31/11
    Year Ended
Dec. 31/10
    Year Ended
Dec. 31/09
 

Units, beginning of period

    1,423,172        1,038,503        1,301,355        837,827        570,851   

Units issued

    346,414        515,242        345,463        550,331        384,712   

Units redeemed

    (216,603     (130,573     (608,315     (86,803     (117,736
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Units, end of period

    1,552,983        1,423,172        1,038,503        1,301,355        837,827   
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Unit value, end of period $

    16.85        14.93        13.34        13.25        11.85   

Assets, end of period $

    26,169,856        21,243,036        13,853,108        17,243,464        9,931,974   

Investment income ratio*

    3.07     2.62     3.79     3.50     5.27

Total return, lowest to highest**

    12.89     6.76% to 11.90     0.67     11.78     21.41% to 31.35

 

109


Table of Contents

John Hancock Life Insurance Company of New York Separate Account B

Notes to Financial Statements (continued)

 

9. Financial Highlights

 

    Sub-Account  
    Lifestyle Balanced Trust Series 1  
    Year Ended
Dec. 31/13
    Year Ended
Dec. 31/12
    Year Ended
Dec. 31/11
    Year Ended
Dec. 31/10
    Year Ended
Dec. 31/09
 

Units, beginning of period

    230,822        239,441        249,006        256,294        253,510   

Units issued

    1,801        1,522        1,924        2,992        23,124   

Units redeemed

    (7,624     (10,141     (11,489     (10,280     (20,340
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Units, end of period

    224,999        230,822        239,441        249,006        256,294   
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Unit value, end of period $

    22.44        19.90        17.79        17.68        15.82   

Assets, end of period $

    5,048,408        4,592,077        4,258,264        4,400,961        4,053,664   

Investment income ratio*

    2.86     2.28     3.33     2.78     4.49

Total return, lowest to highest**

    12.79     11.87     0.63     11.75     30.76
    Sub-Account  
    Lifestyle Conservative Trust Series 0  
    Year Ended
Dec. 31/13
    Year Ended
Dec. 31/12
    Year Ended
Dec. 31/11
    Year Ended
Dec. 31/10
    Year Ended
Dec. 31/09
 

Units, beginning of period

    231,764        160,667        111,014        54,770        11,323   

Units issued

    61,958        94,054        87,150        63,991        63,564   

Units redeemed

    (79,548     (22,957     (37,497     (7,747     (20,117
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Units, end of period

    214,174        231,764        160,667        111,014        54,770   
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Unit value, end of period $

    15.62        15.02        13.84        13.27        12.15   

Assets, end of period $

    3,346,371        3,481,888        2,223,564        1,473,461        665,378   

Investment income ratio*

    3.65     3.29     5.16     3.98     9.89

Total return, lowest to highest**

    3.99     4.72% to 8.55     4.27     9.25     15.08% to 21.63

 

110


Table of Contents

John Hancock Life Insurance Company of New York Separate Account B

Notes to Financial Statements (continued)

 

9. Financial Highlights

 

     Sub-Account  
     Lifestyle Conservative Trust Series 1  
     Year Ended
Dec. 31/13
    Year Ended
Dec. 31/12
    Year Ended
Dec. 31/11
    Year Ended
Dec. 31/10
    Year Ended
Dec. 31/09
 

Units, beginning of period

     6,953        7,161        5,741        5,335        24,145   

Units issued

     69        53        1,761        763        894   

Units redeemed

     (218     (261     (341     (357     (19,704
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Units, end of period

     6,804        6,953        7,161        5,741        5,335   
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Unit value, end of period $

     21.98        21.16        19.50        18.71        17.14   

Assets, end of period $

     149,499        147,084        139,604        107,368        91,438   

Investment income ratio*

     3.50     2.87     4.70     2.91     2.55

Total return, lowest to highest**

     3.88     8.52     4.23     9.13     21.71
     Sub-Account  
     Lifestyle Growth Trust Series 0  
     Year Ended
Dec. 31/13
    Year Ended
Dec. 31/12
    Year Ended
Dec. 31/11
    Year Ended
Dec. 31/10
    Year Ended
Dec. 31/09
 

Units, beginning of period

     1,480,274        1,453,499        1,374,170        1,270,440        897,691   

Units issued

     340,603        334,817        968,939        566,038        479,069   

Units redeemed

     (195,059     (308,042     (889,610     (462,308     (106,320
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Units, end of period

     1,625,818        1,480,274        1,453,499        1,374,170        1,270,440   
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Unit value, end of period $

     17.62        14.76        12.96        13.16        11.64   

Assets, end of period $

     28,643,878        21,845,708        18,831,147        18,083,931        14,788,574   

Investment income ratio*

     2.71     2.00     2.82     2.84     4.01

Total return, lowest to highest**

     19.38     7.98% to 13.91     (1.55 %)      13.04     23.39% to 35.36

 

111


Table of Contents

John Hancock Life Insurance Company of New York Separate Account B

Notes to Financial Statements (continued)

 

9. Financial Highlights

 

     Sub-Account  
     Lifestyle Growth Trust Series 1  
     Year Ended
Dec. 31/13
    Year Ended
Dec. 31/12
    Year Ended
Dec. 31/11
    Year Ended
Dec. 31/10
    Year Ended
Dec. 31/09
 

Units, beginning of period

     105,854        105,925        101,677        100,138        100,452   

Units issued

     4,817        3,612        7,046        6,832        8,782   

Units redeemed

     (4,464     (3,683     (2,798     (5,293     (9,096
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Units, end of period

     106,207        105,854        105,925        101,677        100,138   
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Unit value, end of period $

     21.40        17.93        15.74        16.00        14.16   

Assets, end of period $

     2,272,044        1,897,471        1,667,484        1,626,663        1,417,539   

Investment income ratio*

     2.54     1.87     2.81     2.47     3.40

Total return, lowest to highest**

     19.34     13.87     (1.60 %)      13.02     33.31
     Sub-Account  
     Lifestyle Moderate Trust Series 0  
     Year Ended
Dec. 31/13
    Year Ended
Dec. 31/12
    Year Ended
Dec. 31/11
    Year Ended
Dec. 31/10
    Year Ended
Dec. 31/09
 

Units, beginning of period

     270,413        1,139,379        153,964        79,197        64,876   

Units issued

     114,596        92,490        1,027,707        88,997        47,142   

Units redeemed

     (39,635     (961,456     (42,292     (14,230     (32,821
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Units, end of period

     345,374        270,413        1,139,379        153,964        79,197   
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Unit value, end of period $

     16.45        14.92        13.48        13.17        11.90   

Assets, end of period $

     5,683,325        4,035,304        15,358,416        2,027,303        942,124   

Investment income ratio*

     3.70     1.66     5.20     3.87     6.04

Total return, lowest to highest**

     10.26     5.97% to 10.70     2.38     10.69     19.31% to 27.32

 

112


Table of Contents

John Hancock Life Insurance Company of New York Separate Account B

Notes to Financial Statements (continued)

 

9. Financial Highlights

 

     Sub-Account  
     Lifestyle Moderate Trust Series 1  
     Year Ended
Dec. 31/13
    Year Ended
Dec. 31/12
    Year Ended
Dec. 31/11
    Year Ended
Dec. 31/10
    Year Ended
Dec. 31/09
 

Units, beginning of period

     45,128        52,235        51,917        51,867        42,377   

Units issued

     314        858        1,259        1,001        10,587   

Units redeemed

     (2,190     (7,965     (941     (951     (1,097
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Units, end of period

     43,252        45,128        52,235        51,917        51,867   
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Unit value, end of period $

     22.22        20.16        18.22        17.80        16.10   

Assets, end of period $

     960,936        909,650        951,447        924,144        835,131   

Investment income ratio*

     2.93     2.38     3.67     2.72     5.08

Total return, lowest to highest**

     10.22     10.67     2.33     10.55     27.26
     Sub-Account  
     Mid Cap Index Trust Series 0  
     Year Ended
Dec. 31/13
    Year Ended
Dec. 31/12
    Year Ended
Dec. 31/11
    Year Ended
Dec. 31/10
    Year Ended
Dec. 31/09
 

Units, beginning of period

     138,736        70,214        115,650        11,782        41,283   

Units issued

     22,799        95,530        63,595        107,379        78,745   

Units redeemed

     (16,744     (27,008     (109,031     (3,511     (108,246
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Units, end of period

     144,791        138,736        70,214        115,650        11,782   
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Unit value, end of period $

     25.23        18.95        16.13        16.48        13.07   

Assets, end of period $

     3,652,538        2,629,705        1,132,251        1,905,779        154,005   

Investment income ratio*

     1.18     1.69     0.62     2.22     0.64

Total return, lowest to highest**

     33.09     8.00% to 17.54     (2.14 %)      26.06     29.11% to 42.62

 

113


Table of Contents

John Hancock Life Insurance Company of New York Separate Account B

Notes to Financial Statements (continued)

 

9. Financial Highlights

 

     Sub-Account  
     Mid Cap Index Trust Series 1  
     Year Ended
Dec. 31/13
    Year Ended
Dec. 31/12
    Year Ended
Dec. 31/11
    Year Ended
Dec. 31/10
    Year Ended
Dec. 31/09
 

Units, beginning of period

     8,389        8,644        9,539        10,178        12,269   

Units issued

     763        245        440        562        994   

Units redeemed

     (468     (500     (1,335     (1,201     (3,085
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Units, end of period

     8,684        8,389        8,644        9,539        10,178   
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Unit value, end of period $

     38.49        28.93        24.63        25.19        20.00   

Assets, end of period $

     334,200        242,693        212,875        240,331        203,541   

Investment income ratio*

     1.08     1.47     0.67     1.05     1.04

Total return, lowest to highest**

     33.03     17.48     (2.25 %)      25.98     36.76
     Sub-Account  
     Mid Cap Stock Trust Series 0  
     Year Ended
Dec. 31/13
    Year Ended
Dec. 31/12
    Year Ended
Dec. 31/11
    Year Ended
Dec. 31/10
    Year Ended
Dec. 31/09
 

Units, beginning of period

     17,793        15,484        12,671        12,510        9,511   

Units issued

     3,444        5,483        5,515        4,725        7,805   

Units redeemed

     (7,868     (3,174     (2,702     (4,564     (4,806
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Units, end of period

     13,369        17,793        15,484        12,671        12,510   
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Unit value, end of period $

     68.19        49.83        40.73        44.84        36.43   

Assets, end of period $

     911,647        886,676        630,691        568,179        455,808   

Investment income ratio*

     0.07     0.00     0.00     0.00     0.00

Total return, lowest to highest**

     36.84     8.31% to 22.34     (9.16 %)      23.07     29.99% to 34.85

 

114


Table of Contents

John Hancock Life Insurance Company of New York Separate Account B

Notes to Financial Statements (continued)

 

9. Financial Highlights

 

     Sub-Account  
     Mid Cap Stock Trust Series 1  
     Year Ended
Dec. 31/13
    Year Ended
Dec. 31/12
    Year Ended
Dec. 31/11
    Year Ended
Dec. 31/10
    Year Ended
Dec. 31/09
 

Units, beginning of period

     12,913        13,667        13,851        15,055        18,269   

Units issued

     557        632        822        1,118        1,670   

Units redeemed

     (968     (1,386     (1,006     (2,322     (4,884
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Units, end of period

     12,502        12,913        13,667        13,851        15,055   
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Unit value, end of period $

     31.35        22.92        18.75        20.65        16.78   

Assets, end of period $

     391,932        295,880        256,242        286,016        252,575   

Investment income ratio*

     0.04     0.00     0.00     0.00     0.00

Total return, lowest to highest**

     36.82     22.21     (9.20 %)      23.08     31.35
     Sub-Account  
     Mid Value Trust Series 0  
     Year Ended
Dec. 31/13
    Year Ended
Dec. 31/12
    Year Ended
Dec. 31/11
    Year Ended
Dec. 31/10
    Year Ended
Dec. 31/09
 

Units, beginning of period

     43,627        35,419        68,428        22,660        11,409   

Units issued

     3,136        18,031        19,833        55,069        24,863   

Units redeemed

     (20,437     (9,823     (52,842     (9,301     (13,612
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Units, end of period

     26,326        43,627        35,419        68,428        22,660   
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Unit value, end of period $

     36.05        27.42        22.94        24.10        20.74   

Assets, end of period $

     949,157        1,196,393        812,525        1,648,879        470,071   

Investment income ratio*

     1.10     1.00     0.57     3.34     0.73

Total return, lowest to highest**

     31.47     12.75% to 19.54     (4.80 %)      16.16     32.28% to 49.15

 

115


Table of Contents

John Hancock Life Insurance Company of New York Separate Account B

Notes to Financial Statements (continued)

 

9. Financial Highlights

 

    Sub-Account  
    Mid Value Trust Series 1  
    Year Ended
Dec. 31/13
    Year Ended
Dec. 31/12
    Year Ended
Dec. 31/11
    Year Ended
Dec. 31/10
    Year Ended
Dec. 31/09 (n)
 

Units, beginning of period

    11,435        15,275        14,468        15,456        —     

Units issued

    652        829        2,541        1,467        16,343   

Units redeemed

    (2,433     (4,669     (1,734     (2,455     (887
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Units, end of period

    9,654        11,435        15,275        14,468        15,456   
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Unit value, end of period $

    23.49        17.88        14.96        15.73        13.54   

Assets, end of period $

    226,791        204,439        228,460        227,611        209,332   

Investment income ratio*

    1.06     0.82     0.77     2.07     0.49

Total return, lowest to highest**

    31.39     19.53     (4.93 %)      16.15     35.44

(n)    Fund available in prior year but no activity.

       

    Sub-Account  
    Money Market Trust B Series 0  
    Year Ended
Dec. 31/13
    Year Ended
Dec. 31/12
    Year Ended
Dec. 31/11
    Year Ended
Dec. 31/10
    Year Ended
Dec. 31/09
 

Units, beginning of period

    438,090        491,597        470,488        359,102        362,321   

Units issued

    759,455        846,867        698,976        550,328        719,950   

Units redeemed

    (821,330     (900,374     (677,867     (438,942     (723,169
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Units, end of period

    376,215        438,090        491,597        470,488        359,102   
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Unit value, end of period $

    17.37        17.37        17.36        17.35        17.34   

Assets, end of period $

    6,536,519        7,610,293        8,535,672        8,162,330        6,227,080   

Investment income ratio*

    0.01     0.04     0.00     0.04     0.48

Total return, lowest to highest**

    0.01     0.03     0.08     0.03     0.20% to 0.47

 

116


Table of Contents

John Hancock Life Insurance Company of New York Separate Account B

Notes to Financial Statements (continued)

 

9. Financial Highlights

 

     Sub-Account  
     Money Market Trust Series 1  
     Year Ended
Dec. 31/13
    Year Ended
Dec. 31/12
    Year Ended
Dec. 31/11
    Year Ended
Dec. 31/10
    Year Ended
Dec. 31/09
 

Units, beginning of period

     74,418        107,837        106,998        129,525        128,986   

Units issued

     139,128        16,789        11,456        11,284        51,332   

Units redeemed

     (10,648     (50,208     (10,617     (33,811     (50,793
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Units, end of period

     202,898        74,418        107,837        106,998        129,525   
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Unit value, end of period $

     13.46        13.46        13.46        13.45        13.45   

Assets, end of period $

     2,730,900        1,001,628        1,451,269        1,438,933        1,741,838   

Investment income ratio*

     0.00     0.00     0.00     0.00     0.20

Total return, lowest to highest**

     0.01     0.01     0.07     0.00     0.19
     Sub-Account  
     Natural Resources Trust Series 0  
     Year Ended
Dec. 31/13
    Year Ended
Dec. 31/12
    Year Ended
Dec. 31/11
    Year Ended
Dec. 31/10
    Year Ended
Dec. 31/09
 

Units, beginning of period

     65,421        94,037        116,645        81,225        24,905   

Units issued

     9,457        85,851        27,482        47,755        62,686   

Units redeemed

     (10,387     (114,467     (50,090     (12,335     (6,366
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Units, end of period

     64,491        65,421        94,037        116,645        81,225   
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Unit value, end of period $

     17.49        16.97        16.87        21.16        18.36   

Assets, end of period $

     1,127,832        1,110,017        1,586,281        2,468,009        1,491,187   

Investment income ratio*

     0.62     0.97     0.60     0.89     1.30

Total return, lowest to highest**

     3.07     0.58% to 7.03     (20.27 %)      15.25     28.14% to 59.35

 

117


Table of Contents

John Hancock Life Insurance Company of New York Separate Account B

Notes to Financial Statements (continued)

 

9. Financial Highlights

 

     Sub-Account  
     Natural Resources Trust Series 1  
     Year Ended
Dec. 31/13
    Year Ended
Dec. 31/12
    Year Ended
Dec. 31/11
    Year Ended
Dec. 31/10
    Year Ended
Dec. 31/09
 

Units, beginning of period

     4,002        4,502        4,312        4,332        3,577   

Units issued

     806        140        773        220        1,346   

Units redeemed

     (869     (640     (583     (240     (591
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Units, end of period

     3,939        4,002        4,502        4,312        4,332   
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Unit value, end of period $

     41.37        40.18        39.97        50.15        43.52   

Assets, end of period $

     162,934        160,776        179,957        216,262        188,565   

Investment income ratio*

     0.61     0.78     0.51     0.66     1.14

Total return, lowest to highest**

     2.97     0.52     (20.29 %)      15.21     59.19
     Sub-Account  
     Real Estate Securities Trust Series 0  
     Year Ended
Dec. 31/13
    Year Ended
Dec. 31/12
    Year Ended
Dec. 31/11
    Year Ended
Dec. 31/10
    Year Ended
Dec. 31/09
 

Units, beginning of period

     30,697        22,685        16,370        8,690        5,802   

Units issued

     1,874        11,223        8,506        9,377        11,654   

Units redeemed

     (4,503     (3,211     (2,191     (1,697     (8,766
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Units, end of period

     28,068        30,697        22,685        16,370        8,690   
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Unit value, end of period $

     105.43        105.48        89.90        82.05        63.50   

Assets, end of period $

     2,959,281        3,238,133        2,039,556        1,343,174        551,907   

Investment income ratio*

     1.97     1.96     1.78     2.45     4.29

Total return, lowest to highest**

     (0.05 %)      4.78% to 17.33     9.58     29.20     30.26% to 54.31

 

118


Table of Contents

John Hancock Life Insurance Company of New York Separate Account B

Notes to Financial Statements (continued)

 

9. Financial Highlights

 

     Sub-Account  
     Real Estate Securities Trust Series 1  
     Year Ended
Dec. 31/13
    Year Ended
Dec. 31/12
    Year Ended
Dec. 31/11
    Year Ended
Dec. 31/10
    Year Ended
Dec. 31/09
 

Units, beginning of period

     12,592        12,475        13,098        12,592        12,704   

Units issued

     1,360        1,087        444        1,169        1,781   

Units redeemed

     (677     (970     (1,067     (663     (1,893
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Units, end of period

     13,275        12,592        12,475        13,098        12,592   
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Unit value, end of period $

     38.08        38.12        32.51        29.70        22.99   

Assets, end of period $

     505,546        480,041        405,554        388,985        289,444   

Investment income ratio*

     1.98     1.77     1.51     1.96     3.53

Total return, lowest to highest**

     (0.10 %)      17.26     9.47     29.19     30.17
     Sub-Account  
     Real Return Bond Trust Series 0  
     Year Ended
Dec. 31/13
    Year Ended
Dec. 31/12
    Year Ended
Dec. 31/11
    Year Ended
Dec. 31/10
    Year Ended
Dec. 31/09
 

Units, beginning of period

     79,808        65,041        42,266        32,641        24,234   

Units issued

     13,520        50,315        30,677        16,387        19,828   

Units redeemed

     (29,421     (35,548     (7,902     (6,762     (11,421
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Units, end of period

     63,907        79,808        65,041        42,266        32,641   
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Unit value, end of period $

     14.24        15.69        14.41        12.85        11.81   

Assets, end of period $

     910,159        1,252,408        937,609        543,299        385,612   

Investment income ratio*

     2.70     1.81     4.86     12.47     9.40

Total return, lowest to highest**

     (9.25 %)      4.13% to 8.86     12.14     8.82     10.55% to 19.54

 

119


Table of Contents

John Hancock Life Insurance Company of New York Separate Account B

Notes to Financial Statements (continued)

 

9. Financial Highlights

 

     Sub-Account  
     Real Return Bond Trust Series 1  
     Year Ended
Dec. 31/13
    Year Ended
Dec. 31/12
    Year Ended
Dec. 31/11
    Year Ended
Dec. 31/10
    Year Ended
Dec. 31/09
 

Units, beginning of period

     1,816        1,886        1,825        1,761        1,497   

Units issued

     95        59        832        171        398   

Units redeemed

     (197     (129     (771     (107     (134
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Units, end of period

     1,714        1,816        1,886        1,825        1,761   
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Unit value, end of period $

     20.69        22.80        20.95        18.70        17.18   

Assets, end of period $

     35,456        41,406        39,505        34,110        30,248   

Investment income ratio*

     2.56     1.76     3.72     11.63     9.20

Total return, lowest to highest**

     (9.28 %)      8.86     12.02     8.83     19.47
     Sub-Account  
     Science & Technology Trust Series 0  
     Year Ended
Dec. 31/13
    Year Ended
Dec. 31/12
    Year Ended
Dec. 31/11
    Year Ended
Dec. 31/10
    Year Ended
Dec. 31/09
 

Units, beginning of period

     28,839        16,648        13,853        19,639        18,978   

Units issued

     6,106        13,942        4,059        7,393        42,811   

Units redeemed

     (6,006     (1,751     (1,264     (13,179     (42,150
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Units, end of period

     28,939        28,839        16,648        13,853        19,639   
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Unit value, end of period $

     23.78        16.57        14.99        16.24        13.02   

Assets, end of period $

     688,221        477,746        249,482        224,965        255,779   

Investment income ratio*

     0.00     0.00     0.00     0.00     0.00

Total return, lowest to highest**

     43.55     1.76% to 10.54     (7.72 %)      24.69     35.42% to 64.57

 

120


Table of Contents

John Hancock Life Insurance Company of New York Separate Account B

Notes to Financial Statements (continued)

 

9. Financial Highlights

 

    Sub-Account  
    Science & Technology Trust Series 1  
    Year Ended     Year Ended     Year Ended     Year Ended     Year Ended  
    Dec. 31/13     Dec. 31/12     Dec. 31/11     Dec. 31/10     Dec. 31/09  

Units, beginning of period

    17,629        21,828        27,956        27,933        31,760   

Units issued

    1,490        1,582        1,824        3,473        6,540   

Units redeemed

    (3,139     (5,781     (7,952     (3,450     (10,367
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Units, end of period

    15,980        17,629        21,828        27,956        27,933   
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Unit value, end of period $

    14.26        9.94        9.00        9.75        7.82   

Assets, end of period $

    227,926        175,190        196,394        272,650        218,621   

Investment income ratio*

    0.00     0.00     0.00     0.00     0.00

Total return, lowest to highest**

    43.52     10.45     (7.74 %)      24.62     64.48
    Sub-Account  
    Short Term Government Income Trust Series 0  
    Year Ended     Year Ended     Year Ended     Year Ended  
    Dec. 31/13     Dec. 31/12     Dec. 31/11     Dec. 31/10 (bf)  

Units, beginning of period

    47,036        44,778        74,042        —     

Units issued

    8,005        10,165        9,317        83,678   

Units redeemed

    (14,117     (7,907     (38,581     (9,636
 

 

 

   

 

 

   

 

 

   

 

 

 

Units, end of period

    40,924        47,036        44,778        74,042   
 

 

 

   

 

 

   

 

 

   

 

 

 

Unit value, end of period $

    10.52        10.60        10.48        10.19   

Assets, end of period $

    430,654        498,654        469,168        754,552   

Investment income ratio*

    1.97     1.71     1.75     1.52

Total return, lowest to highest**

    (0.74 %)      0.55% to 1.18     2.83     1.91

 

(bf) Reflects the period from commencement of operations on May 3, 2010 through December 31, 2010.

 

 

121


Table of Contents

John Hancock Life Insurance Company of New York Separate Account B

Notes to Financial Statements (continued)

 

9. Financial Highlights

 

    Sub-Account  
    Short Term Government Income Trust Series 1  
    Year Ended     Year Ended     Year Ended     Year Ended  
    Dec. 31/13     Dec. 31/12     Dec. 31/11     Dec. 31/10 (bf)  

Units, beginning of period

    36,394        38,074        40,356        —     

Units issued

    3,266        2,314        7,099        43,587   

Units redeemed

    (1,632     (3,994     (9,381     (3,231
 

 

 

   

 

 

   

 

 

   

 

 

 

Units, end of period

    38,028        36,394        38,074        40,356   
 

 

 

   

 

 

   

 

 

   

 

 

 

Unit value, end of period $

    10.50        10.59        10.47        10.19   

Assets, end of period $

    399,419        385,582        398,566        411,062   

Investment income ratio*

    2.07     1.65     2.26     1.47

Total return, lowest to highest**

    (0.86 %)      1.21     2.77     1.86

 

(bf) Reflects the period from commencement of operations on May 3, 2010 through December 31, 2010.

 

    Sub-Account  
    Small Cap Growth Trust Series 0  
    Year Ended     Year Ended     Year Ended     Year Ended     Year Ended  
    Dec. 31/13     Dec. 31/12     Dec. 31/11     Dec. 31/10     Dec. 31/09  

Units, beginning of period

    12,358        8,595        6,726        6,800        13,321   

Units issued

    4,985        5,077        3,690        1,706        18,171   

Units redeemed

    (1,542     (1,314     (1,821     (1,780     (24,692
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Units, end of period

    15,801        12,358        8,595        6,726        6,800   
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Unit value, end of period $

    30.46        21.12        18.13        19.45        15.92   

Assets, end of period $

    481,384        261,066        155,822        130,819        108,283   

Investment income ratio*

    0.00     0.00     0.00     0.00     0.00

Total return, lowest to highest**

    44.22     4.70% to 16.53     (6.80 %)      22.14     33.17% to 40.36

 

122


Table of Contents

John Hancock Life Insurance Company of New York Separate Account B

Notes to Financial Statements (continued)

 

9. Financial Highlights

 

    Sub-Account  
    Small Cap Growth Trust Series 1  
    Year Ended     Year Ended     Year Ended     Year Ended     Year Ended  
    Dec. 31/13     Dec. 31/12     Dec. 31/11     Dec. 31/10     Dec. 31/09  

Units, beginning of period

    853        897        1,368        1,285        2,148   

Units issued

    417        71        158        161        202   

Units redeemed

    (152     (115     (629     (78     (1,065
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Units, end of period

    1,118        853        897        1,368        1,285   
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Unit value, end of period $

    25.69        17.83        15.31        16.43        13.46   

Assets, end of period $

    28,691        15,182        13,721        22,471        17,291   

Investment income ratio*

    0.00     0.00     0.00     0.00     0.00

Total return, lowest to highest**

    44.08     16.47     (6.81 %)      22.08     34.57
    Sub-Account  
    Small Cap Index Trust Series 0  
    Year Ended     Year Ended     Year Ended     Year Ended     Year Ended  
    Dec. 31/13     Dec. 31/12     Dec. 31/11     Dec. 31/10     Dec. 31/09  

Units, beginning of period

    133,813        40,642        122,660        20,653        21,026   

Units issued

    12,750        99,749        41,298        110,194        42,423   

Units redeemed

    (29,130     (6,578     (123,316     (8,187     (42,796
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Units, end of period

    117,433        133,813        40,642        122,660        20,653   
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Unit value, end of period $

    24.79        17.87        15.40        16.10        12.74   

Assets, end of period $

    2,911,545        2,391,062        625,675        1,974,975        263,036   

Investment income ratio*

    1.55     2.96     0.66     0.97     0.90

Total return, lowest to highest**

    38.75     10.12% to 16.06     (4.37 %)      26.43     26.70% to 35.11

 

123


Table of Contents

John Hancock Life Insurance Company of New York Separate Account B

Notes to Financial Statements (continued)

 

9. Financial Highlights

 

    Sub-Account  
    Small Cap Index Trust Series 1  
    Year Ended     Year Ended     Year Ended     Year Ended     Year Ended  
    Dec. 31/13     Dec. 31/12     Dec. 31/11     Dec. 31/10     Dec. 31/09  

Units, beginning of period

    5,108        5,537        5,645        6,740        8,191   

Units issued

    103        130        243        391        846   

Units redeemed

    (270     (559     (351     (1,486     (2,297
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Units, end of period

    4,941        5,108        5,537        5,645        6,740   
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Unit value, end of period $

    31.10        22.43        19.32        20.24        16.01   

Assets, end of period $

    153,601        114,552        106,959        114,197        107,917   

Investment income ratio*

    1.47     2.02     1.15     0.47     0.84

Total return, lowest to highest**

    38.61     16.09     (4.50 %)      26.36     26.64
    Sub-Account  
    Small Cap Opportunities Trust Series 0  
    Year Ended     Year Ended     Year Ended     Year Ended     Year Ended  
    Dec. 31/13     Dec. 31/12     Dec. 31/11     Dec. 31/10     Dec. 31/09  

Units, beginning of period

    6,622        5,968        3,707        2,631        15,740   

Units issued

    47,355        1,423        98,758        1,481        29,648   

Units redeemed

    (715     (769     (96,497     (405     (42,757
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Units, end of period

    53,262        6,622        5,968        3,707        2,631   
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Unit value, end of period $

    18.97        13.52        11.57        11.94        9.21   

Assets, end of period $

    1,010,418        89,550        69,052        44,272        24,224   

Investment income ratio*

    0.51     0.00     0.02     0.00     0.00

Total return, lowest to highest**

    40.28     10.99% to 16.88     (3.13 %)      29.71     27.43% to 41.34

 

124


Table of Contents

John Hancock Life Insurance Company of New York Separate Account B

Notes to Financial Statements (continued)

 

9. Financial Highlights

 

    Sub-Account  
    Small Cap Opportunities Trust Series 1  
    Year Ended     Year Ended     Year Ended     Year Ended     Year Ended  
    Dec. 31/13     Dec. 31/12     Dec. 31/11     Dec. 31/10     Dec. 31/09  

Units, beginning of period

    3,888        4,345        4,172        4,113        4,444   

Units issued

    989        266        421        551        649   

Units redeemed

    (1,588     (723     (248     (492     (980
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Units, end of period

    3,289        3,888        4,345        4,172        4,113   
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Unit value, end of period $

    38.54        27.50        23.54        24.31        18.74   

Assets, end of period $

    126,761        106,925        102,284        101,420        77,097   

Investment income ratio*

    0.63     0.00     0.10     0.00     0.00

Total return, lowest to highest**

    40.16     16.84     (3.16 %)      29.67     33.87
    Sub-Account  
    Small Cap Value Trust Series 0  
    Year Ended     Year Ended     Year Ended     Year Ended     Year Ended  
    Dec. 31/13     Dec. 31/12     Dec. 31/11     Dec. 31/10     Dec. 31/09  

Units, beginning of period

    8,581        7,038        5,682        5,129        4,288   

Units issued

    3,879        2,469        2,078        1,484        1,280   

Units redeemed

    (977     (926     (722     (931     (439
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Units, end of period

    11,483        8,581        7,038        5,682        5,129   
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Unit value, end of period $

    64.51        48.39        41.79        41.32        32.75   

Assets, end of period $

    740,817        415,214        294,133        234,770        167,996   

Investment income ratio*

    0.66     1.00     0.91     0.43     0.76

Total return, lowest to highest**

    33.33     10.07% to 15.78     1.15     26.15     28.08% to 36.59

 

125


Table of Contents

John Hancock Life Insurance Company of New York Separate Account B

Notes to Financial Statements (continued)

 

9. Financial Highlights

 

    Sub-Account  
    Small Cap Value Trust Series 1  
    Year Ended     Year Ended     Year Ended     Year Ended     Year Ended  
    Dec. 31/13     Dec. 31/12     Dec. 31/11     Dec. 31/10     Dec. 31/09  

Units, beginning of period

    2,339        2,310        2,163        2,049        4,102   

Units issued

    2,392        1,733        198        252        1,591   

Units redeemed

    (2,004     (1,704     (51     (138     (3,644
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Units, end of period

    2,727        2,339        2,310        2,163        2,049   
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Unit value, end of period $

    22.95        17.21        14.88        14.72        11.68   

Assets, end of period $

    62,567        40,239        34,358        31,836        23,913   

Investment income ratio*

    0.62     0.81     0.84     0.37     0.53

Total return, lowest to highest**

    33.31     15.70     1.04     26.10     28.65
    Sub-Account  
    Small Company Value Trust Series 0  
    Year Ended     Year Ended     Year Ended     Year Ended     Year Ended  
    Dec. 31/13     Dec. 31/12     Dec. 31/11     Dec. 31/10     Dec. 31/09  

Units, beginning of period

    35,450        24,458        22,129        14,175        10,204   

Units issued

    3,492        127,871        4,454        19,254        5,322   

Units redeemed

    (2,199     (116,879     (2,125     (11,300     (1,351
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Units, end of period

    36,743        35,450        24,458        22,129        14,175   
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Unit value, end of period $

    22.78        17.30        14.86        15.00        12.36   

Assets, end of period $

    837,044        613,287        363,493        331,996        175,185   

Investment income ratio*

    1.78     0.18     0.65     1.51     0.44%   

Total return, lowest to highest**

    31.68     11.42% to 16.41     (0.94 %)      21.39     27.82% to 35.35

 

126


Table of Contents

John Hancock Life Insurance Company of New York Separate Account B

Notes to Financial Statements (continued)

 

9. Financial Highlights

 

    Sub-Account  
    Small Company Value Trust Series 1  
    Year Ended     Year Ended     Year Ended     Year Ended     Year Ended  
    Dec. 31/13     Dec. 31/12     Dec. 31/11     Dec. 31/10     Dec. 31/09  

Units, beginning of period

    9,649        11,407        11,649        11,776        14,462   

Units issued

    686        786        1,546        1,851        2,711   

Units redeemed

    (1,623     (2,544     (1,788     (1,978     (5,397
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Units, end of period

    8,712        9,649        11,407        11,649        11,776   
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Unit value, end of period $

    39.90        30.32        26.07        26.31        21.68   

Assets, end of period $

    347,540        292,480        297,308        306,459        255,268   

Investment income ratio*

    1.71     0.26     0.58     1.46     0.39

Total return, lowest to highest**

    31.61     16.30     (0.93 %)      21.35     27.69
    Sub-Account  
    Smaller Company Growth Trust Series 0  
    Year Ended     Year Ended     Year Ended     Year Ended     Year Ended  
    Dec. 31/13 (af)     Dec. 31/12     Dec. 31/11     Dec. 31/10     Dec. 31/09 (ax)  

Units, beginning of period

    45,010        45,865        44,688        45,193        —     

Units issued

    732        1,069        42,853        2,133        45,380   

Units redeemed

    (45,742     (1,924     (41,676     (2,638     (187
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Units, end of period

    —          45,010        45,865        44,688        45,193   
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Unit value, end of period $

    19.23        14.23        12.24        13.16        10.52   

Assets, end of period $

    —          640,412        561,278        588,313        475,523   

Investment income ratio*

    0.00     0.00     0.00     0.00     0.00

Total return, lowest to highest**

    35.12     7.90% to 16.27     (7.04 %)      25.12     5.22

 

(af) Terminated as an investment option and funds transferred to Small Cap Opportunities Trust on December 9, 2013.
(ax) Reflects the period from commencement of operations on November 16, 2009 through December 31, 2009.

 

 

127


Table of Contents

John Hancock Life Insurance Company of New York Separate Account B

Notes to Financial Statements (continued)

 

9. Financial Highlights

 

    Sub-Account  
    Smaller Company Growth Trust Series 1  
    Year Ended     Year Ended     Year Ended     Year Ended     Year Ended  
    Dec. 31/13 (af)     Dec. 31/12     Dec. 31/11     Dec. 31/10     Dec. 31/09 (ax)  

Units, beginning of period

    3,180        1,679        3,322        4,016        —     

Units issued

    45        1,622        138        310        4,320   

Units redeemed

    (3,225     (121     (1,781     (1,004     (304
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Units, end of period

    —          3,180        1,679        3,322        4,016   
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Unit value, end of period $

    19.19        14.21        12.22        13.16        10.52   

Assets, end of period $

    —          45,183        20,526        43,717        42,261   

Investment income ratio*

    0.00     0.00     0.00     0.00     0.00

Total return, lowest to highest**

    35.06     16.22     (7.10 %)      25.04     5.22

(af)   Terminated as an investment option and funds transferred to Small Cap Opportunities Trust on December 9, 2013.

(ax)  Reflects the period from commencement of operations on November 16, 2009 through December 31, 2009.

 

      

     

    Sub-Account  
    Strategic Income Opportunities Trust Series 0  
    Year Ended     Year Ended     Year Ended     Year Ended     Year Ended  
    Dec. 31/13     Dec. 31/12     Dec. 31/11     Dec. 31/10 (be)     Dec. 31/09  

Units, beginning of period

    177,119        34,725        22,410        7,408        2,701   

Units issued

    337,638        417,618        15,955        17,686        5,624   

Units redeemed

    (278,056     (275,224     (3,640     (2,684     (917
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Units, end of period

    236,701        177,119        34,725        22,410        7,408   
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Unit value, end of period $

    18.22        17.55        15.54        15.22        13.13   

Assets, end of period $

    4,311,480        3,108,036        539,478        341,040        97,268   

Investment income ratio*

    5.95     9.07     12.57     14.80     7.36

Total return, lowest to highest**

    3.81     7.30% to 12.94     2.08     15.91     18.51% to 26.78

 

(be) Renamed on May 3, 2010. Previously known as Strategic Income Trust.

 

 

128


Table of Contents

John Hancock Life Insurance Company of New York Separate Account B

Notes to Financial Statements (continued)

 

9. Financial Highlights

 

    Sub-Account  
    Strategic Income Opportunities Trust Series 1  
    Year Ended     Year Ended     Year Ended     Year Ended     Year Ended  
    Dec. 31/13     Dec. 31/12     Dec. 31/11     Dec. 31/10 (be)     Dec. 31/09  

Units, beginning of period

    13,170        13,384        11,607        2,439        7,495   

Units issued

    617        403        5,160        10,986        52   

Units redeemed

    (2,267     (617     (3,383     (1,818     (5,108
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Units, end of period

    11,520        13,170        13,384        11,607        2,439   
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Unit value, end of period $

    24.58        23.68        20.98        20.56        17.74   

Assets, end of period $

    283,198        311,836        280,795        238,694        43,292   

Investment income ratio*

    5.48     6.85     11.52     26.88     4.47

Total return, lowest to highest**

    3.82     12.86     2.03     15.89     26.64

(be)  Renamed on May 3, 2010. Previously known as Strategic Income Trust.

     

    Sub-Account  
    Total Bond Market Trust B Series 0  
    Year Ended     Year Ended     Year Ended     Year Ended     Year Ended  
    Dec. 31/13     Dec. 31/12     Dec. 31/11     Dec. 31/10     Dec. 31/09  

Units, beginning of period

    50,602        10,018        7,181        5,247        3,382   

Units issued

    172,979        127,517        5,492        2,881        2,969   

Units redeemed

    (207,661     (86,933     (2,655     (947     (1,104
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Units, end of period

    15,920        50,602        10,018        7,181        5,247   
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Unit value, end of period $

    22.27        22.83        21.94        20.39        19.14   

Assets, end of period $

    354,564        1,155,231        219,717        146,368        100,415   

Investment income ratio*

    3.15     1.09     5.18     5.21     5.27

Total return, lowest to highest**

    (2.44 %)      2.03% to 4.08     7.60     6.49     4.86% to 6.29

 

129


Table of Contents

John Hancock Life Insurance Company of New York Separate Account B

Notes to Financial Statements (continued)

 

9. Financial Highlights

 

    Sub-Account  
    Total Return Trust Series 0  
    Year Ended     Year Ended     Year Ended     Year Ended     Year Ended  
    Dec. 31/13     Dec. 31/12     Dec. 31/11     Dec. 31/10     Dec. 31/09  

Units, beginning of period

    125,330        117,320        106,097        187,153        24,859   

Units issued

    43,266        59,676        56,501        210,002        216,140   

Units redeemed

    (51,871     (51,666     (45,278     (291,058     (53,846
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Units, end of period

    116,725        125,330        117,320        106,097        187,153   
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Unit value, end of period $

    17.22        17.57        16.18        15.57        14.46   

Assets, end of period $

    2,010,204        2,201,829        1,898,381        1,651,112        2,705,660   

Investment income ratio*

    3.59     2.12     4.82     2.18     5.59

Total return, lowest to highest**

    (1.98 %)      4.25% to 8.57     3.97     7.66     8.24% to 13.71
    Sub-Account  
    Total Return Trust Series 1  
    Year Ended     Year Ended     Year Ended     Year Ended     Year Ended  
    Dec. 31/13     Dec. 31/12     Dec. 31/11     Dec. 31/10     Dec. 31/09  

Units, beginning of period

    25,157        26,111        31,488        28,377        25,743   

Units issued

    1,306        1,107        1,923        6,420        8,930   

Units redeemed

    (3,693     (2,061     (7,300     (3,309     (6,296
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Units, end of period

    22,770        25,157        26,111        31,488        28,377   
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Unit value, end of period $

    28.66        29.26        26.97        25.95        24.11   

Assets, end of period $

    652,605        735,987        704,145        817,175        684,132   

Investment income ratio*

    3.08     1.97     4.12     2.45     4.20

Total return, lowest to highest**

    (2.03 %)      8.49     3.91     7.64     13.60

 

130


Table of Contents

John Hancock Life Insurance Company of New York Separate Account B

Notes to Financial Statements (continued)

 

9. Financial Highlights

 

     Sub-Account  
     Total Stock Market Index Trust Series 0  
     Year Ended
Dec. 31/13
    Year Ended
Dec. 31/12
    Year Ended
Dec. 31/11
    Year Ended
Dec. 31/10
    Year Ended
Dec. 31/09
 

Units, beginning of period

     10,411        7,841        6,243        4,647        1,449   

Units issued

     6,921        3,303        2,309        2,347        4,630   

Units redeemed

     (2,309     (733     (711     (751     (1,432
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Units, end of period

     15,023        10,411        7,841        6,243        4,647   
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Unit value, end of period $

     71.52        53.59        46.38        46.23        39.42   

Assets, end of period $

     1,074,462        557,974        363,633        288,609        183,219   

Investment income ratio*

     1.80     1.77     1.46     1.60     2.45

Total return, lowest to highest**

     33.45     7.92% to 15.56     0.33     17.26     25.14% to 33.63
     Sub-Account  
     Total Stock Market Index Trust Series 1  
     Year Ended
Dec. 31/13
    Year Ended
Dec. 31/12
    Year Ended
Dec. 31/11
    Year Ended
Dec. 31/10
    Year Ended
Dec. 31/09
 

Units, beginning of period

     8,543        8,946        9,279        8,838        8,030   

Units issued

     67        3,226        164        903        1,389   

Units redeemed

     (443     (3,629     (497     (462     (581
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Units, end of period

     8,167        8,543        8,946        9,279        8,838   
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Unit value, end of period $

     21.48        16.10        13.94        13.90        11.86   

Assets, end of period $

     175,418        137,559        124,712        129,005        104,843   

Investment income ratio*

     1.43     1.46     1.25     1.41     1.69

Total return, lowest to highest**

     33.39     15.50     0.28     17.19     28.86

 

131


Table of Contents

John Hancock Life Insurance Company of New York Separate Account B

Notes to Financial Statements (continued)

 

9. Financial Highlights

 

    Sub-Account  
    Ultra Short Term Bond Trust Series 0  
    Year Ended
Dec. 31/13
    Year Ended
Dec. 31/12
    Year Ended
Dec. 31/11 (n)
 

Units, beginning of period

    6,408        159        —     

Units issued

    13,226        8,455        208   

Units redeemed

    (5,510     (2,206     (49
 

 

 

   

 

 

   

 

 

 

Units, end of period

    14,124        6,408        159   
 

 

 

   

 

 

   

 

 

 

Unit value, end of period $

    10.07        10.07        10.00   

Assets, end of period $

    142,183        64,514        1,584   

Investment income ratio*

    1.67     1.88     2.22

Total return, lowest to highest**

    (0.02 %)      0.17% to 0.66     0.09

 

(n) Fund available in prior year but no activity.

 

    Sub-Account  
    U.S. Equity Trust Series 0  
    Year Ended
Dec. 31/13
    Year Ended
Dec. 31/12 (g)
 

Units, beginning of period

    62,708        —     

Units issued

    4,238        65,879   

Units redeemed

    (3,984     (3,171
 

 

 

   

 

 

 

Units, end of period

    62,962        62,708   
 

 

 

   

 

 

 

Unit value, end of period $

    13.20        10.28   

Assets, end of period $

    830,873        644,709   

Investment income ratio*

    1.74     2.42

Total return, lowest to highest**

    28.36     2.81% to 6.03

 

(g) Reflects the period from commencement of operations on April 30, 2012 through December 31, 2012.

 

 

132


Table of Contents

John Hancock Life Insurance Company of New York Separate Account B

Notes to Financial Statements (continued)

 

9. Financial Highlights

 

     Sub-Account  
     U.S. Equity Trust Series 1  
     Year Ended
Dec. 31/13
    Year Ended
Dec. 31/12 (g)
 

Units, beginning of period

     7,490        —     

Units issued

     222        7,893   

Units redeemed

     (2,488     (403
  

 

 

   

 

 

 

Units, end of period

     5,224        7,490   
  

 

 

   

 

 

 

Unit value, end of period $

     13.18        10.28   

Assets, end of period $

     68,841        76,975   

Investment income ratio*

     1.68     2.13

Total return, lowest to highest**

     28.22     2.77

 

(g) Reflects the period from commencement of operations on April 30, 2012 through December 31, 2012.

 

    Sub-Account  
    Utilities Trust Series 0  
    Year Ended
Dec. 31/13
    Year Ended
Dec. 31/12
    Year Ended
Dec. 31/11
    Year Ended
Dec. 31/10
    Year Ended
Dec. 31/09
 

Units, beginning of period

    28,581        75,101        25,062        22,486        19,584   

Units issued

    6,493        10,023        53,483        7,647        7,501   

Units redeemed

    (3,801     (56,543     (3,444     (5,071     (4,599
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Units, end of period

    31,273        28,581        75,101        25,062        22,486   
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Unit value, end of period $

    26.50        21.97        19.33        18.10        15.88   

Assets, end of period $

    828,969        627,938        1,451,912        453,682        357,057   

Investment income ratio*

    2.23     2.76     5.14     2.60     4.96

Total return, lowest to highest**

    20.65     10.75% to 13.63     6.80     14.00     28.79% to 33.58

 

133


Table of Contents

John Hancock Life Insurance Company of New York Separate Account B

Notes to Financial Statements (continued)

 

9. Financial Highlights

 

     Sub-Account  
     Utilities Trust Series 1  
     Year Ended
Dec. 31/13
    Year Ended
Dec. 31/12
    Year Ended
Dec. 31/11
    Year Ended
Dec. 31/10
    Year Ended
Dec. 31/09
 

Units, beginning of period

     3,458        3,526        3,575        3,624        4,524   

Units issued

     71        47        58        70        374   

Units redeemed

     (1,392     (115     (107     (119     (1,274
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Units, end of period

     2,137        3,458        3,526        3,575        3,624   
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Unit value, end of period $

     33.15        27.50        24.19        22.68        19.91   

Assets, end of period $

     70,782        95,035        85,259        81,064        72,139   

Investment income ratio*

     1.95     3.70     3.79     2.45     4.69

Total return, lowest to highest**

     20.57     13.66     6.65     13.92     33.77
     Sub-Account  
     Value Trust Series 0  
     Year Ended
Dec. 31/13
    Year Ended
Dec. 31/12
    Year Ended
Dec. 31/11
    Year Ended
Dec. 31/10
    Year Ended
Dec. 31/09
 

Units, beginning of period

     19,350        10,669        7,383        5,549        4,556   

Units issued

     8,029        9,613        4,940        3,195        3,288   

Units redeemed

     (2,761     (932     (1,654     (1,361     (2,295
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Units, end of period

     24,618        19,350        10,669        7,383        5,549   
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Unit value, end of period $

     24.72        18.25        15.53        15.37        12.57   

Assets, end of period $

     608,489        353,136        165,719        113,505        69,753   

Investment income ratio*

     0.98     1.07     1.24     1.19     1.40

Total return, lowest to highest**

     35.44     6.68% to 17.50     1.03     22.30     33.21% to 45.49

 

134


Table of Contents

John Hancock Life Insurance Company of New York Separate Account B

Notes to Financial Statements (continued)

 

9. Financial Highlights

 

    Sub-Account  
    Value Trust Series 1  
    Year Ended
Dec. 31/13
    Year Ended
Dec. 31/12
    Year Ended
Dec. 31/11
    Year Ended
Dec. 31/10
    Year Ended
Dec. 31/09
 

Units, beginning of period

    10,300        9,858        12,416        13,661        20,879   

Units issued

    919        951        180        310        1,720   

Units redeemed

    (2,285     (509     (2,738     (1,555     (8,938
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Units, end of period

    8,934        10,300        9,858        12,416        13,661   
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Unit value, end of period $

    36.16        26.70        22.74        22.52        18.43   

Assets, end of period $

    323,011        275,039        224,188        279,615        251,718   

Investment income ratio*

    0.84     0.85     0.99     1.02     1.25

Total return, lowest to highest**

    35.39     17.42     0.98     22.22     41.18

 

135


Table of Contents

John Hancock Life Insurance Company of New York Separate Account B

Notes to Financial Statements (continued)

 

(*) 

These ratios, which are not annualized, represent the dividends, excluding distributions of capital gains, received by the sub-account from the underlying Trust portfolio, net of management fees assessed by the Trust portfolio adviser, divided by the average net assets of the sub-account. The recognition of investment income by the sub-account is affected by the timing of the declarations of dividends by the underlying Trust portfolio in which the sub-accounts invest. It is the practice of the Trust, for income tax reasons, to declare dividends in April for investment income received in the previous calendar year for all sub-accounts of the Trust except for the Money Market Trust which declares and reinvests dividends on a daily basis. Any dividend distribution received from a sub-account of the Trust is reinvested immediately, at the net asset value, in shares of that sub-account and retained as assets of the corresponding sub-account so that the unit value of the sub-account is not affected by the declaration and reinvestment of dividends.

(**) 

These ratios, which are not annualized, represent the total return for the period indicated, including changes in the value of the underlying Trust portfolio. There are no expenses of the Account that result in a direct reduction in unit values. The total return does not include any expenses assessed through the redemption of units; inclusion of these expenses in the calculation would result in a reduction in the total return presented. When no range is given, the lowest and highest values are the same.

 

136


Table of Contents
PART C
OTHER INFORMATION

Item 26. Exhibits

The following exhibits are filed as part of this Registration Statement:

(a) Resolution of Board of Directors establishing Separate Account B is incorporated by reference to post-effective amendment number 1, file number 333-157213, filed with the Commission in April 2010.

(b) Not applicable.

(c) (1) Underwriting and Distribution Agreement between John Hancock Life Insurance Company of New York and John Hancock Distributors LLC dated December 1, 2009, incorporated by reference to pre-effective amendment number 1 file number 333-157213, filed with the Commission in April 2010.

(2)(a) Specimen General Agent and Broker-Dealer Selling Agreement by and among John Hancock Life Insurance Company (U.S.A.), John Hancock Life Insurance Company of New York and John Hancock Distributors LLC effective August 2009, incorporated by reference to pre-effective amendment number 2, file number 333-157212, filed with the Commission in April 2011.

(b) List of third party broker-dealer firms included as Attachment A, incorporated by reference to post-effective amendment number 6, file number 333-179571, filed with the Commission on April 29, 2014.

(d)(1) Specimen Flexible Premium Variable Universal Life Insurance policy, filed herewith.

(2) Specimen Overloan Protection Rider, filed herewith.

(3) Specimen Accelerated Benefit Rider, filed herewith.

(e) Specimen policy application, filed herewith.

(f) (1) Declaration of Intention and Charter of First North American Life Assurance Company dated January 30, 1992, incorporated by reference to post-effective amendment number 7, file number 33-46217, filed with the Commission on February 25, 1998.

(a) Certificate of Amendment of the Declaration of Intention and Charter of First North American Life Assurance Company dated March 6, 1992, incorporated by reference to post-effective amendment number 7, file number 33-46217, filed with the Commission on February 25, 1998.

(b) Certificate of Amendment of the Declaration of Intention and Charter of the The Manufacturers Life Insurance Company of New York dated October 1, 1997, incorporated by reference to post-effective amendment number 7, file number 33-46217, filed with the Commission on February 25, 1998.

(c) Certificate of Amendment of the Declaration of Intention and Charter of The Manufacturers Life Insurance Company of New York dated January 1, 2005, incorporated by reference to pre-effective amendment number 1, file number 333-127543, filed with the Commission on November 16, 2005.

(d) Certificate of Amendment of the Declaration of Intention and Charter of John Hancock Life Insurance Company of New York dated July 26, 2006, incorporated by reference to post-effective amendment number 1, file number 333-131134, filed with the Commission in Apirl, 2007.

(e) Certificate of Amendment of the Declaration of Intention and Charter approved on August 20, 1997, incorpoated by reference to pre-effective amendment no. 1, file number 333-179571, filed with the Commission in May, 2012.


(f) Certificate of Amendment of the Declaration of Intention and Charter approved on August 28, 2002, incorpoated by reference to pre-effective amendment no. 1, file number 333-179571, filed with the Commission in May, 2012.

(g) Certificate of Amendment of the Declaration of Intention and Charter approved on November 20, 2009, incorpoated by reference to pre-effective amendment no. 1, file number 333-179571, filed with the Commission in May, 2012.

(2) By-laws of the John Hancock Life Insurance Company of New York (formerly, The Manufacturers Life Insurance Company of New York), incorporated by reference to Exhibit (6)(B) to post-effective amendment No. 7 file number 33-46217 filed with the Commission on February 25, 1998 on behalf of The Manufacturers Life Insurance Company of New York Separate Account A.

(a) Amendment to the By-Laws and Charter of John Hancock Life Insurance Company of New York dated November 17, 2005, incorporated by reference to post-effective amendment number 1 file number 333-131134 filed with the Commission in Apirl, 2007.

(b) Amended and Restated By-Laws of John Hancock Life Insurance Company of New York dated December 14, 2010, incorpoated by reference to pre-effective amendment no. 1, file number 333-179571, filed with the Commission in May, 2012.

(g) Specimen reinsurance agreement, is filed herewith.

(h) (1) Participation Agreement among The Manufacturers Life Insurance Company (U.S.A.), The Manufacturers Insurance Company of New York, PIMCO Variable Insurance Trust and PIMCO Advisors Distributors LLC dated April 30, 2004, incorporated by reference to pre-effective amendment number 1, file number 333-126668, filed with the Commission on October 12, 2005.

(2) Participation Agreement among John Hancock Life Insurance Company (U.S.A.), John Hancock Life Insurance Company of New York, and John Hancock Trust dated April 20, 2005, incorporated by reference to pre-effective amendment number 1, file number 333-126668, filed with the Commission on October 12, 2005.

(3) Participation Agreement among John Hancock Life Insurance Company (U.S.A.), John Hancock Life Insurance Company of New York, and M Financial Investment Advisers, Inc. dated November 13, 2009, incorporated by reference to file number 333-164150, filed with the Commission on January 4, 2010.

(4) Shareholder Information Agreement between John Hancock Life Insurance Company (U.S.A.), John Hancock Life Insurance Company of New York, John Hancock Life Insurance Company, John Hancock Variable Life Insurance, and John Hancock Trust portfolios (except American Funds Insurance Series) dated April 16, 2007, incorporated by reference to post-effective amendment number 9, file number 333-85284, filed with the Commission in April, 2007.

(5) Shareholder Information Agreement between John Hancock Life Insurance Company (U.S.A.), John Hancock Life Insurance Company of New York, John Hancock Life Insurance Company, John Hancock Variable Life Insurance, and John Hancock Trust on behalf of series of the Trust that are feeder funds of the American Funds Insurance Series dated April 16, 2007, incorporated by reference to post-effective amendment number 9, file number 333-85284, filed with the Commission in April, 2007.

(i) (1) Administrative Services Agreement between John Hancock Life Insurance Company (U.S.A.) (formerly, The Manufacturers Life Insurance Company (U.S.A.)) and John Hancock Life Insurance Company of New York (formerly, The Manufacturers Life Insurance Company of New York) dated January 1, 2001, incorporated by reference to post-effective amendment number 1, file number 333-131134, filed with the Commission in Apirl, 2007.

(a) Amendment No. 1 to Administrative Services Agreement between John Hancock Life Insurance Company (U.S.A.) and John Hancock Life Insurance Company of New York effective May 1, 2005, incorporated by reference to post-effective amendment number 1, file number 333-131134, filed with the Commission in Apirl, 2007.

(2) Investment Services Agreement between John Hancock Life Insurance Company of New York (formerly, The Manufacturers Life Insurance Company of New York) and The Manufacturers Life Insurance Company dated October 1, 1997, incorporated by reference to post-effective amendment number 1, file number 333-131134, filed with the Commission in Apirl, 2007.

(a) Amendment No. 1 to Investment Services Agreement between John Hancock Life Insurance Company of New York (formerly, The Manufacturers Life Insurance Company of New York) and The Manufacturers Life Insurance Company dated August 31, 2000, incorporated by reference to post-effective amendment number 1, file number 333-131134, filed with the Commission in Apirl, 2007.

(j) Not Applicable.

(k) Opinion and consent of counsel regarding the legality of the securities being registered, filed herewith.

(l) Not Applicable.


(m) Not Applicable.

(n) Consents of Independent Registered Public Accounting Firm, filed herewith.

(n)(1) Not Applicable.

(o) Not Applicable.

(p) Not Applicable.

(q) Memorandum Regarding Issuance, Face Amount Increase, Redemption and Transfer Procedures for the Policies, incorporated by reference to pre-effective amendment number 1, file number, 333-33504 filed with the Commission on May 3, 2001.

(i) Powers of Attorney for Craig Bromley, Thomas Borshoff, Paul M. Connolly, Michael Doughty, Ruth Ann Fleming, James D. Gallagher, Scott S. Hartz, Rex Schlaybaugh, Jr., and John Vrysen, filed herewith.

Item 27. Directors and Officers of the Depositor

OFFICERS AND DIRECTORS OF JOHN HANCOCK LIFE INSURANCE COMPANY of NEW YORK

Name and Principal Business Address Position with Depositor
Craig Bromley
601 Congress Street
Boston, MA 02210
Director, Chairman and President
Thomas Borshoff
536 Stone Road
Pittsford, NY 14534
Director
Paul M. Connolly
75 Indian Spring Road
Milton, MA 02186
Director
Michael Doughty
197 Clarendon Street
Boston, MA 02116
Director
Ruth Ann Fleming
205 Highland Avenue
Short Hills, NJ 07078
Director
James D. Gallagher
601 Congress Street
Boston, MA 02210
Director, Executive Vice President, General Counsel and Chief Administrative Officer
Scott S. Hartz
197 Clarendon Street
Boston, MA 02116
Director, Executive Vice President and Chief Investment Officer
Rex Schlaybaugh, Jr.
400 Renaissance Center
Detroit, MI 48243
Director

Name and Principal Business Address Position with Depositor
John G. Vrysen
601 Congress Street
Boston, MA 02210
Director and Senior Vice President
Executive Vice Presidents
James D. Gallagher* and General Counsel
Michael Doughty**
Steven Finch* and Chief Financial Officer
Scott S. Hartz** and Chief Investment Officer – US Investments
Senior Vice Presidents
Andrew G. Arnott*
Kevin J. Cloherty*
Barry Evans****
Peter Gordon*
Brian Heapps**
Gregory Mack*
Janis K. McDonough*****
H. Steven Moore**** and Treasurer
James O’Brien †††
Sebastian Pariath* and Head of Operations and Chief Information Officer
Timothy W. Ramza*
Alan R. Seghezzi**
Anthony Teta**
Brooks Tingle**
Vice Presidents
Emanuel Alves* Counsel and Corporate Secretary
John C.S. Anderson**
Roy V. Anderson*
Abigail M. Armstrong**
Kevin Askew*****
Ann E. Birle*****
Stephen J. Blewitt**
Robert Boyda**
David Campbell***
Bob Carroll**
Rick A. Carlson*
Brian Collins*
John J. Danello*
Brent Dennis**
Robert Donahue****
Paul Gallagher*
Ann Gencarella**
Richard Harris*** and Appointed Actuary
John Hatch*
Eugene Xavier Hodge, Jr.*
James C. Hoodlet**
Roy Kapoor****
Mitchell Karman* and Chief Compliance Officer & Counsel
Frank Knox* and Chief Compliance Officer – Retail Funds/Separate Accounts*
Hung Ko*** Vice President, Treasury
Robert Leach*
Scott Lively*
Nathaniel I. Margolis**
Cheryl Mallett****
John B. Maynard*
Karen McCafferty*

Name and Principal Business Address Position with Depositor
Scott A. McFetridge**
William McPadden**
Maureen Milet** and Chief Compliance Officer – Investments
Scott Morin*
Jeffrey H. Nataupsky*
Scott Navin**
Betty Ng***
Nina Nicolosi*
Jacques Ouimet**
Jeffrey Packard**
Gary M. Pelletier**
Tracey Polsgrove*
Krishna Ramdial**** Vice President, Treasury
S. Mark Ray**
Jill Rebman***
George Revoir*
Mark Rizza*
Andrew Ross****
Lisa Anne Ryan †††
Thomas Samoluk*
Martin Sheerin*
Gordon Shone*
Rob Stanley*
Tony Todisco*****
Simonetta Vendittelli***** and Controller
Peter de Vries***
Linda A. Watters*
Jeffery Whitehead*
Henry Wong**
Leo Zerilli*
Assistant Vice Presidents
Cathy Addison
Joanne Adkins
Stacey Agretelis
Patricia L. Allison
Eynshteyn Averbukh
Jack Barry
Naomi S. Bazak
P. J. Beltramini
William D. Bertrand
Daniel C. Budde
Jennifer Toone Campanella
Suzanne Cartledge
Tabitha Chinniah
Anjali Chitre
Catherine Collins
Thomas D. Crohan
Diane Cronin
Jaime Hertel Dasque
Lorn C. Davis
Todd D. Emmel
Allan M. Fen
Paul A. Fishbin
Michael A. Foreman
Arthur Francis
Philip W. Freiberger
Scott B. Garfield
John M. Garrison

Name and Principal Business Address Position with Depositor
Keith Gendron
William A. Gottlieb
Gerald C. Hanrahan, Jr.
Teresa S. Hayes
Charles Whitney Hill
Recep C. Kendircioglu
Bruce Kinna
Sally Kwan
Brigitte Labreche
Thomas Loftus
Timothy J. Malik
Robert Maulden
Kathleen E. McDonough
Reid W. McLay
Pamela Memishian
John P. Monahan
Geoffrey Norris
John O’Connor
E. David Pemsteim
Charlie Philbrook and Chief Risk Officer
David Pickett
Michael A. Pirrello
Malcolm Pittman
Jason M. Pratt
David P. Previte
Malcolm Quinn
Hilary Quosai
Kathryn Riley
Josephine M. Rolka
Timothy A. Roseen
Louise Santosuosso
Eileen Schindler and Chief Accountant
Mark Shannon
Susan Simi
Debbie Stickland
Michael Traynor
Joan Marie Uzdavinis
John Wallace
Sean A. Williams
Jennifer L Wilson
Sameh Youssef
Aleksandar Zivanovic

*Principal Business Office is 601 Congress Street, Boston, MA 02210

**Principal Business Office is 197 Clarendon Street, Boston, MA 02116

***Principal Business Office is 200 Bloor Street, Toronto, Canada M4W1E5

****Principal Business Office is 250 Bloor Street, Toronto, Canada M4W1E5

*****Principal Business Office is 380 Stuart Street, Boston, MA 02116

†Principal Business is 6400 Sheridan Drive, Williamsville, NY 14221

††Principal Business is 2001 Butterfield Road, Downers Grove, Illinois 60515

†††Principal Business is 200 Berkeley Street, Boston, MA 02116

††††Principal Business is 101 Huntington Avenue, Boston, MA 02116

Item 28. Persons Controlled by or Under Common Control with the Depositor or the Registrant

The Registrant is a separate account of the Depositor operating as a unit investment trust. The Registrant supports benefits payable under the Depositor’s variable life insurance policies by investing assets allocated to various investment options in shares of John Hancock Variable Insurance Trust (formerly, John Hancock Trust) and other mutual funds registered under the Investment Company Act of 1940 as open-end management investment companies of the “series” type.

On the effective date of the registration statement, the Company and its affilates are controlled by Manulife Financial Corporation.



Table of Contents

LOGO


Table of Contents

Item 29. Indemnification

The Form of Selling Agreement or Service Agreement between John Hancock Distributors LLC and various broker-dealers may provide that the selling broker-dealer indemnify and hold harmless John Hancock Distributors LLC and the Company, including their affiliates, officers, directors, employees and agents against losses, claims, liabilities or expenses (including reasonable attorney’s fees), arising out of or based upon a breach of the Selling or Service Agreement, or any applicable law or regulation or any applicable rule of any self-regulatory organization or similar provision consistent with industry practice.

Insofar as indemnification for liability arising under the Securities Act of 1933 may be permitted to directors, officers and controlling persons of the registrant pursuant to the foregoing provisions, or otherwise, the registrant has been advised that in the opinion of the Securities and Exchange Commission such indemnification is against public policy as expressed in the Act and is, therefore, unenforceable. In the event that a claim for indemnification against such liabilities (other than the payment by the registrant of expenses incurred or paid by a director, officer or controlling person of the registrant in the successful defense of any action, suit or proceeding) is asserted by such director, officer or controlling person in connection with the securities being registered, the registrant will, unless in the opinion of its counsel the matter has been settled by controlling precedent, submit to a court of appropriate jurisdiction the question whether such indemnification by it is against public policy as expressed in the Act and will be governed by the final adjudication of such issue.

Item 30. Principal Underwriter

(a) Set forth below is information concerning other investment companies for which John Hancock Distributors LLC, the principal underwriter of the contracts, acts as investment adviser or principal underwriter.

Name of Investment Company Capacity in Which Acting
John Hancock Variable Life Separate Account S Principal Underwriter
John Hancock Variable Life Separate Account U Principal Underwriter
John Hancock Variable Life Separate Account V Principal Underwriter
John Hancock Variable Life Separate Account UV Principal Underwriter
John Hancock Life Insurance Company (U.S.A.)
  Separate Account R
Principal Underwriter
John Hancock Life Insurance Company (U.S.A.)
  Separate Account T
Principal Underwriter
John Hancock Life Insurance Company (U.S.A.)
  Separate Account W
Principal Underwriter
John Hancock Life Insurance Company (U.S.A.)
  Separate Account X
Principal Underwriter
John Hancock Life Insurance Company (U.S.A.)
  Separate Account Q
Principal Underwriter
John Hancock Life Insurance Company (U.S.A.)
  Separate Account A
Principal Underwriter
John Hancock Life Insurance Company (U.S.A.)
  Separate Account N
Principal Underwriter
John Hancock Life Insurance Company (U.S.A.)
  Separate Account H
Principal Underwriter
John Hancock Life Insurance Company (U.S.A.)
  Separate Account I
Principal Underwriter
John Hancock Life Insurance Company (U.S.A.)
  Separate Account J
Principal Underwriter
John Hancock Life Insurance Company (U.S.A.)
  Separate Account K
Principal Underwriter
John Hancock Life Insurance Company (U.S.A.)
  Separate Account M
Principal Underwriter
John Hancock Life Insurance Company of New York
  Separate Account B
Principal Underwriter
John Hancock Life Insurance Company of New York
  Separate Account A
Principal Underwriter

(b) John Hancock Life Insurance Company (U.S.A.) is the sole member of John Hancock Distibutors LLC and the following comprise the Board of Managers and Officers of John Hancock Distributors LLC.


Name Title
Michael Doughty** Chairman, Director
Steven Finch* Director
James C. Hoodlet** Director
George Revoir* Director, President and Chief Executive Officer
Al Seghezzi** Director
Christopher Walker*** Director, Vice President, Investments
Emanuel Alves* Secretary
H. Steven Moore**** Senior Vice President, Treasurer
Brian Collins* Vice President, US Taxation
Kris Ramdial**** Vice President, Treasury
Jeffrey H. Long* Assistant Vice President, Chief Financial Officer and Financial Operations Principal
Michael Mahoney* Assistant Vice President and Chief Compliance Officer
David Pickett* Assistant Vice President and General Counsel

*Principal Business Office is 601 Congress Street, Boston, MA 02210

**Principal Business Office is 197 Clarendon Street, Boston, MA 02116

***Principal Business Office is 200 Bloor Street, Toronto, Canada M4W1E5

****Principal Business Office is 250 Bloor Street, Toronto, Canada M4W1E5

(c) John Hancock Distributors LLC

The information contained in the section titled “Principal Underwriter and Distributor” in the Statement of Additional Information, contained in this Registration Statement, is hereby incorporated by reference in response to Item 31.(c)(2-5).

Item 31. Location of Accounts and Records

The following entities prepare, maintain, and preserve the records required by Section 31(a) of the Act for the Registrant through written agreements between the parties to the effect that such services will be provided to the Registrant for such periods prescribed by the Rules and Regulations of the Commission under the Act and such records will be surrendered promptly on request: John Hancock Distributors LLC, John Hancock Place, Boston, Massachusetts 02117, serves as Registrant’s distributor and principal underwriter, and, in such capacities, keeps records regarding shareholders account records, canceled stock certificates. John Hancock (at the same address), in its capacity as Registrant’s depositor, and John Hancock Life Insurance Company of New York (at the same address), in its capacities as Registrant’s investment adviser, transfer agent, keep all other records required by Section 31 (a) of the Act.

Item 32. Management Services

All management services contracts are discussed in Part A or Part B.

Item 33. Fee Representation

Representation of Insurer Pursuant to Section 26 of the Investment Company Act of 1940.

John Hancock Life Insurance Company of New York hereby represents that the fees and charges deducted under the contracts issued pursuant to this registration statement, in the aggregate, are reasonable in relation to the services rendered, the expenses expected to be incurred, and the risks assumed by the Company.



Table of Contents

Signatures

Pursuant to the requirements of the Securities Act of 1933 and the Investment Company Act of 1940, the Registrant has caused this Registration Statement to be signed on its behalf in the City of Boston, Commonwealth of Massachusetts, as of the 15th day of July, 2014.

JOHN HANCOCK LIFE INSURANCE COMPANY of NEW YORK

John Hancock Life Insurance Company of New York Separate Account B

(Registrant)

JOHN HANCOCK LIFE INSURANCE COMPANY of NEW YORK

By: /s/ Craig Bromley


Craig Bromley
Principal Executive Officer

JOHN HANCOCK LIFE INSURANCE COMPANY of NEW YORK

(Depositor)

By: /s/ Craig Bromley


Craig Bromley

Principal Executive Officer


Signatures

Pursuant to the requirements of the Securities Act of 1933, this Registration Statement has been signed by the following persons in the capacities indicated as of the 15th day of July, 2014.

Signatures Title
/s/ Simonetta Vendittelli

Simonetta Vendittelli
Vice President and Controller
/s/ Steven Finch

Steven Finch
Executive Vice President and Chief Financial Officer
*

Craig Bromley
Director
*

Thomas Borshoff
Director
*

Paul M. Connolly
Director
*

Ruth Ann Fleming
Director
*

Michael Doughty
Director
*

James D. Gallagher
Director
*

Scott S. Hartz
Director
*

Rex E. Schlaybaugh, Jr.
Director
*

John G. Vrysen
Director


/s/James C. Hoodlet

James C. Hoodlet
*Pursuant to Power of Attorney


Dates Referenced Herein   and   Documents Incorporated by Reference

This ‘N-6/A’ Filing    Date    Other Filings
4/30/17
5/1/15497
4/30/15
7/25/14EFFECT
Filed as of:7/16/14
Filed on:7/15/14
4/29/14485BPOS
3/28/14
3/27/14
1/1/14
12/31/1324F-2NT,  NSAR-U
12/15/13
12/9/13485BPOS,  497
7/17/13
4/29/13485BPOS
1/1/13
12/31/1224F-2NT,  NSAR-U
11/5/12
7/1/12
4/30/12485BPOS
1/1/12
12/31/1124F-2NT,  NSAR-U
10/31/11497
6/27/11
1/1/11
12/31/1024F-2NT,  NSAR-U
12/14/10
5/3/10485BPOS
1/4/10
1/1/10
12/31/0924F-2NT,  NSAR-U
12/1/09
11/20/09
11/16/09497
11/13/09
5/4/09497,  EFFECT
9/30/08
1/1/08
4/16/07
7/26/06
11/17/05
11/16/05N-6/A
10/12/05
5/1/05485BPOS
4/20/05
1/1/05
4/30/04485BPOS
8/28/02
5/3/01S-6/A
1/1/01
8/31/00
2/25/98
10/1/97
8/20/97
7/22/92
3/6/92
2/10/92
1/30/92
 List all Filings 


3 Subsequent Filings that Reference this Filing

  As Of               Filer                 Filing    For·On·As Docs:Size             Issuer                      Filing Agent

 4/21/23  John Hancock Life Ins Co of NY… B 485BPOS     5/01/23    5:1.5M                                   Donnelley … Solutions/FA
 4/22/22  John Hancock Life Ins Co of NY… B 485BPOS     4/25/22    5:4.6M                                   Donnelley … Solutions/FA
 4/23/21  John Hancock Life Ins Co of NY… B 485BPOS     4/26/21    6:6M                                     Donnelley … Solutions/FA
Top
Filing Submission 0001193125-14-269400   –   Alternative Formats (Word / Rich Text, HTML, Plain Text, et al.)

Copyright © 2024 Fran Finnegan & Company LLC – All Rights Reserved.
AboutPrivacyRedactionsHelp — Fri., Apr. 19, 7:39:12.3am ET